Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Metabolic pathways (mmu01100)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1110020P
15Rik
KLA  ATP  ATP+KLA
 NM_197979 RIKEN cDNA 1110020P15 gene (1110020P15Rik), mRNA [NM_197979] KLA .86 .91 .84 .87 .81 .87 1.00
ATP .95 .99 1.12 1.12 1.07 .94 .94
KLA/ATP .88 .87 1.02 1.02 1.06 1.02 1.01
1190003J
15Rik
KLA  ATP  ATP+KLA
 AK004470 18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1190003J15 product:hypothetical Transthyretin/Transthyretin-related containing protein, full insert sequence. [AK004470] KLA 3.70 2.84 3.15 4.56 4.81 4.07 1.29
ATP .99 .87 1.37 1.71 5.17 19.64 3.47
KLA/ATP 3.00 3.08 3.34 3.61 9.32 19.35 12.86
1190003J
15Rik
KLA  ATP  ATP+KLA
 NM_029821 RIKEN cDNA 1190003J15 gene (1190003J15Rik), mRNA [NM_029821] KLA 4.65 3.78 3.57 5.26 6.06 5.74 1.52
ATP 1.00 .90 1.22 1.65 5.73 15.98 4.64
KLA/ATP 3.93 3.75 3.62 4.09 10.51 18.55 15.36
1500032D
16Rik
KLA  ATP  ATP+KLA
 NM_030087 RIKEN cDNA 1500032D16 gene (1500032D16Rik), transcript variant 1, mRNA [NM_030087] KLA .91 1.00 .92 .91 .84 .80 .69
ATP .97 1.03 1.16 1.31 1.13 .94 .69
KLA/ATP .98 1.03 1.11 1.34 1.12 .83 .50
1500032O
14Rik
KLA  ATP  ATP+KLA
 AK005350 adult male cerebellum cDNA, RIKEN full-length enriched library, clone:1500032O14 product:succinate dehydrogenase complex, subunit A, flavoprotein (Fp), full insert sequence. [AK005350] KLA 1.01 .97 .97 .98 1.01 1.05 1.04
ATP .61 .42 .41 .55 1.05 1.12 .96
KLA/ATP .62 .53 .54 .68 1.10 1.02 .88
1700012G
19Rik
KLA  ATP  ATP+KLA
 AK012010 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610311O05 product:hypothetical HAD-like structure containing protein, full insert sequence [AK012010] KLA .45 .39 .37 .43 .48 .64 .62
ATP .93 1.05 .88 .90 .63 .67 .56
KLA/ATP .43 .42 .42 .46 .49 .50 .37
1700012G
19Rik
KLA  ATP  ATP+KLA
 NM_025954 RIKEN cDNA 1700012G19 gene (1700012G19Rik), mRNA [NM_025954] KLA .34 .35 .28 .34 .42 .59 .70
ATP .92 .91 .88 .79 .70 1.27 .92
KLA/ATP .35 .33 .34 .32 .47 .80 .66
1700055N
04Rik
KLA  ATP  ATP+KLA
 AK081788 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130077J09 product:weakly similar to ALDEHYDE DEHYDROGENASE 7 (EC 1.2.1.5) [Homo sapiens], full insert sequence [AK081788] KLA .96 .98 .95 .97 .97 .96 1.06
ATP 1.01 1.00 .97 1.10 .95 .99 1.02
KLA/ATP .99 1.00 .97 1.00 1.00 .96 .97
1-Sep
KLA  ATP  ATP+KLA
 NM_017461 septin 1 (Sept1), mRNA [NM_017461] KLA .98 1.02 .97 .97 .98 1.13 1.08
ATP .94 1.02 1.05 1.09 .97 .95 1.08
KLA/ATP 1.02 .90 .97 1.04 .95 .98 1.01
2010204N
08Rik
KLA  ATP  ATP+KLA
 NM_001081137 RIKEN cDNA 2010204N08 gene (2010204N08Rik), mRNA [NM_001081137] KLA .99 .98 1.00 .96 .98 .98 .99
ATP .96 .98 1.06 1.14 .98 .97 .99
KLA/ATP .98 1.05 1.06 1.04 .99 .98 1.94
2010209O
12Rik
KLA  ATP  ATP+KLA
 NM_133913 RIKEN cDNA 2010209O12 gene (2010209O12Rik), mRNA [NM_133913] KLA .68 .70 .69 .66 .96 1.31 1.28
ATP 1.04 1.16 .86 .85 .97 2.50 2.50
KLA/ATP .76 .73 .51 .58 .55 1.46 2.34
2310005E
10Rik
KLA  ATP  ATP+KLA
 BC026843 RIKEN cDNA 2310005E10 gene, mRNA (cDNA clone IMAGE:4487182), complete cds. [BC026843] KLA .70 .65 .65 .65 .83 .90 .89
ATP 1.00 .95 .75 .31 .29 .58 .80
KLA/ATP .69 .54 .49 .28 .36 .56 .53
2310005E
10Rik
KLA  ATP  ATP+KLA
 NM_172398 RIKEN cDNA 2310005E10 gene (2310005E10Rik), mRNA [NM_172398] KLA .78 .71 .71 .71 .69 .90 .82
ATP 1.01 .95 1.18 .89 .68 .44 .62
KLA/ATP .71 .70 .88 .67 .60 .59 .63
2310079N
02Rik
KLA  ATP  ATP+KLA
 AK086714 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930047C07 product:RIKEN cDNA 2310079N02 gene, full insert sequence [AK086714] KLA .68 .70 .62 .74 .82 1.21 1.66
ATP .90 .87 .95 .89 .69 .60 1.58
KLA/ATP .63 .63 .70 .68 .56 .66 1.25
2310079N
02Rik
KLA  ATP  ATP+KLA
 NM_025636 RIKEN cDNA 2310079N02 gene (2310079N02Rik), mRNA [NM_025636] KLA .62 .65 .64 .62 .70 .99 1.32
ATP 1.04 .99 .98 1.14 .85 .36 .77
KLA/ATP .70 .70 .56 .74 .56 .47 .90
2410015N
17Rik
KLA  ATP  ATP+KLA
 NM_023203 RIKEN cDNA 2410015N17 gene (2410015N17Rik), mRNA [NM_023203] KLA .70 .71 .68 .57 .49 .39 .52
ATP .98 1.00 1.30 1.28 1.02 .65 .49
KLA/ATP .69 .71 .86 .84 .70 .52 .39
2410018C
20Rik
KLA  ATP  ATP+KLA
 NM_026423 RIKEN cDNA 2410018C20 gene (2410018C20Rik), mRNA [NM_026423] KLA .59 .58 .51 .47 .41 .42 .60
ATP 1.01 1.04 .99 1.04 .68 .47 .83
KLA/ATP .60 .61 .53 .56 .44 .42 .38
2610209A
20Rik
KLA  ATP  ATP+KLA
 NM_026010 RIKEN cDNA 2610209A20 gene (2610209A20Rik), mRNA [NM_026010] KLA .25 .25 .25 .28 .29 .40 .84
ATP .93 .93 .89 .56 .32 .33 .63
KLA/ATP .24 .25 .30 .26 .30 .29 .26
2810405K
02Rik
KLA  ATP  ATP+KLA
 NM_025582 RIKEN cDNA 2810405K02 gene (2810405K02Rik), mRNA [NM_025582] KLA .77 .68 .61 .70 .71 1.04 1.22
ATP .88 .87 1.16 1.24 1.07 .64 .92
KLA/ATP .65 .74 .89 .88 .88 .58 .54
2810423A
18Rik
KLA  ATP  ATP+KLA
 AK013141 10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810423A18 product:unclassifiable, full insert sequence [AK013141] KLA 1.03 .97 1.07 .95 1.09 1.26 1.38
ATP .96 .98 1.09 1.02 2.18 2.30 1.52
KLA/ATP .99 .97 .94 .75 1.93 3.39 2.34
4930431L
04Rik
KLA  ATP  ATP+KLA
 NM_175032 RIKEN cDNA 4930431L04 gene (4930431L04Rik), mRNA [NM_175032] KLA .96 1.04 1.08 1.08 1.11 .98 .98
ATP .96 1.02 1.02 1.00 1.07 .98 .99
KLA/ATP .99 1.01 1.05 .93 1.02 1.11 .97
4930438A
08Rik
KLA  ATP  ATP+KLA
 XM_001477470 gb|PREDICTED: Mus musculus RIKEN cDNA 4930438A08 gene (4930438A08Rik), mRNA [XM_001477470] KLA 1.78 1.45 1.69 1.62 1.69 1.48 1.31
ATP 1.07 1.04 1.24 1.13 1.13 1.61 1.67
KLA/ATP 1.83 1.46 1.58 1.30 1.43 1.36 1.95
4933405O
20Rik
KLA  ATP  ATP+KLA
 NM_172901 RIKEN cDNA 4933405O20 gene (4933405O20Rik), mRNA [NM_172901] KLA .98 .99 1.01 1.07 1.03 1.01 1.03
ATP .95 .97 .99 .96 .99 1.01 1.02
KLA/ATP .93 1.01 .99 .98 .98 .92 .96
4933434I
20Rik
KLA  ATP  ATP+KLA
 NM_026233 RIKEN cDNA 4933434I20 gene (4933434I20Rik), mRNA [NM_026233] KLA 1.00 1.02 1.00 .99 1.00 1.02 1.02
ATP .99 .99 1.02 .99 1.05 1.01 .99
KLA/ATP 1.03 .95 .95 1.02 .99 .97 1.00
6720408I
04Rik
KLA  ATP  ATP+KLA
 AK020107 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720408I04 product:hypothetical protein, full insert sequence. [AK020107] KLA .92 1.01 1.02 .96 .93 1.00 .99
ATP 1.00 .94 .90 .94 1.01 1.01 .98
KLA/ATP 1.00 .95 .92 .94 1.01 .97 .95
9130409I
23Rik
KLA  ATP  ATP+KLA
 NM_001033819 RIKEN cDNA 9130409I23 gene (9130409I23Rik), mRNA [NM_001033819] KLA 1.04 .98 1.00 1.04 1.05 1.07 1.00
ATP .98 1.01 1.05 1.06 .99 .98 1.01
KLA/ATP .98 1.03 .93 1.07 1.00 1.11 .96
A530057A
03Rik
KLA  ATP  ATP+KLA
 NM_001081089 RIKEN cDNA A530057A03 gene (A530057A03Rik), mRNA [NM_001081089] KLA 1.06 1.10 1.05 1.03 1.12 1.14 1.27
ATP 1.04 1.11 1.07 1.01 .97 .99 1.06
KLA/ATP 1.10 1.19 1.14 .96 1.11 .91 1.09
Aadat
KLA  ATP  ATP+KLA
 NM_011834 aminoadipate aminotransferase (Aadat), mRNA [NM_011834] KLA 1.05 1.06 1.04 .98 1.00 1.04 .98
ATP .98 .99 1.10 1.03 1.00 1.04 1.03
KLA/ATP 1.05 1.09 1.07 1.04 .97 1.06 1.05
Aanat
KLA  ATP  ATP+KLA
 NM_009591 arylalkylamine N-acetyltransferase (Aanat), mRNA [NM_009591] KLA 1.04 1.01 1.17 1.06 .96 1.09 .99
ATP .99 1.02 1.01 .99 1.01 .92 .99
KLA/ATP 1.01 1.06 1.01 1.04 .99 .99 1.02
Aass
KLA  ATP  ATP+KLA
 NM_013930 aminoadipate-semialdehyde synthase (Aass), nuclear gene encoding mitochondrial protein, mRNA [NM_013930] KLA 1.03 1.08 1.01 1.13 1.04 1.04 .99
ATP 1.00 .91 1.06 .99 .97 .95 1.01
KLA/ATP .98 1.00 1.01 .91 .96 .94 .91
Abat
KLA  ATP  ATP+KLA
 AK083062 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530041H11 product:hypothetical protein, full insert sequence. [AK083062] KLA 1.01 1.09 .97 .99 1.03 1.02 1.06
ATP .96 .99 1.00 1.11 1.04 .98 1.06
KLA/ATP 1.06 1.03 .96 1.06 1.10 1.06 .96
Abat
KLA  ATP  ATP+KLA
 NM_172961 4-aminobutyrate aminotransferase (Abat), nuclear gene encoding mitochondrial protein, mRNA [NM_172961] KLA 1.03 .96 .97 1.00 .92 .97 .96
ATP .97 .93 1.07 1.04 .97 .99 .98
KLA/ATP 1.03 1.01 1.00 .98 .94 .89 .97
Abo
KLA  ATP  ATP+KLA
 NM_030718 ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase, transferase B, alpha 1-3-galactosyltransferase) (Abo), mRNA [NM_030718] KLA 1.07 .93 .95 1.01 1.00 .97 .92
ATP .96 .95 .98 1.03 1.02 1.00 1.06
KLA/ATP 1.00 .96 1.05 1.07 1.04 .94 .99
Acaa1a
KLA  ATP  ATP+KLA
 NM_130864 acetyl-Coenzyme A acyltransferase 1A (Acaa1a), mRNA [NM_130864] KLA 1.53 1.60 1.88 2.07 2.41 2.64 1.82
ATP 1.07 .99 .98 1.10 .94 .83 1.58
KLA/ATP 1.64 1.64 1.73 1.75 1.61 1.39 1.85
Acaa1b
KLA  ATP  ATP+KLA
 NM_146230 acetyl-Coenzyme A acyltransferase 1B (Acaa1b), mRNA [NM_146230] KLA 1.52 1.66 1.93 2.04 2.32 2.51 1.83
ATP 1.04 .95 1.06 1.12 1.03 .93 1.59
KLA/ATP 1.76 1.72 1.76 1.95 1.76 1.51 1.86
Acaa2
KLA  ATP  ATP+KLA
 NM_177470 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) (Acaa2), nuclear gene encoding mitochondrial protein, mRNA [NM_177470] KLA .98 .94 1.00 1.00 .90 .81 .60
ATP 1.03 1.00 1.12 1.10 .84 .48 .50
KLA/ATP .98 .98 1.03 1.05 .99 .85 .40
Acaca
KLA  ATP  ATP+KLA
 NM_133360 acetyl-Coenzyme A carboxylase alpha (Acaca), mRNA [NM_133360] KLA .99 .94 .95 .93 .95 1.00 1.00
ATP .98 .97 .96 .93 .92 .96 .99
KLA/ATP 1.01 .96 .99 .92 .93 .94 .91
Acacb
KLA  ATP  ATP+KLA
 NM_133904 acetyl-Coenzyme A carboxylase beta (Acacb), mRNA [NM_133904] KLA 1.01 .93 1.00 .99 .95 1.03 .92
ATP .96 1.04 1.05 .98 1.04 1.11 1.05
KLA/ATP .90 1.01 1.05 1.03 .97 .96 1.08
Acad8
KLA  ATP  ATP+KLA
 NM_025862 acyl-Coenzyme A dehydrogenase family, member 8 (Acad8), mRNA [NM_025862] KLA .89 .84 .95 .94 .84 .78 .82
ATP 1.07 .98 .99 .74 .53 .57 .69
KLA/ATP .89 .88 .85 .65 .52 .60 .60
Acadl
KLA  ATP  ATP+KLA
 NM_007381 acyl-Coenzyme A dehydrogenase, long-chain (Acadl), nuclear gene encoding mitochondrial protein, mRNA [NM_007381] KLA 1.67 1.61 2.27 1.98 1.98 1.62 .89
ATP 1.24 1.19 1.25 1.30 1.36 1.15 .69
KLA/ATP 1.83 1.95 2.01 2.22 1.71 1.18 .84
Acadm
KLA  ATP  ATP+KLA
 NM_007382 acyl-Coenzyme A dehydrogenase, medium chain (Acadm), nuclear gene encoding mitochondrial protein, mRNA [NM_007382] KLA .57 .50 .50 .37 .34 .34 .54
ATP 1.09 1.08 1.16 .92 .67 .43 .51
KLA/ATP .55 .56 .57 .46 .41 .36 .29
Acads
KLA  ATP  ATP+KLA
 NM_007383 acyl-Coenzyme A dehydrogenase, short chain (Acads), nuclear gene encoding mitochondrial protein, mRNA [NM_007383] KLA .76 .78 .76 .69 .71 .71 .70
ATP 1.02 1.11 1.01 1.28 .75 .58 .79
KLA/ATP .80 .76 .66 .82 .56 .56 .53
Acadsb
KLA  ATP  ATP+KLA
 NM_025826 acyl-Coenzyme A dehydrogenase, short/branched chain (Acadsb), nuclear gene encoding mitochondrial protein, mRNA [NM_025826] KLA 1.30 1.38 1.39 1.23 1.50 1.35 1.26
ATP 1.18 1.36 1.31 1.24 .91 .73 1.18
KLA/ATP 1.44 1.26 1.22 1.41 .78 .68 1.19
Acadvl
KLA  ATP  ATP+KLA
 NM_017366 acyl-Coenzyme A dehydrogenase, very long chain (Acadvl), nuclear gene encoding mitochondrial protein, mRNA [NM_017366] KLA .88 .79 .75 .87 .66 .63 .90
ATP 1.07 .89 1.24 1.04 .91 .76 .88
KLA/ATP .78 .84 1.16 .90 .81 .64 .62
Acat1
KLA  ATP  ATP+KLA
 NM_144784 acetyl-Coenzyme A acetyltransferase 1 (Acat1), nuclear gene encoding mitochondrial protein, mRNA [NM_144784] KLA 1.04 .99 .95 .99 .81 .83 .51
ATP .89 .88 1.21 .99 .67 .36 .47
KLA/ATP .86 .97 1.18 .90 .64 .42 .35
Acat2
KLA  ATP  ATP+KLA
 NM_009338 acetyl-Coenzyme A acetyltransferase 2 (Acat2), mRNA [NM_009338] KLA 1.14 1.13 1.22 1.29 1.10 .93 .81
ATP 1.04 1.05 1.16 1.35 1.20 1.53 1.16
KLA/ATP 1.19 1.19 1.41 1.29 1.13 .92 .71
Acly
KLA  ATP  ATP+KLA
 AK043466 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730098H14 product:unclassifiable, full insert sequence. [AK043466] KLA .99 .97 .93 .93 .97 .98 .94
ATP 1.01 1.00 .93 .98 1.00 .95 1.00
KLA/ATP .99 1.01 .91 .94 .97 .95 1.02
Acly
KLA  ATP  ATP+KLA
 NM_134037 ATP citrate lyase (Acly), mRNA [NM_134037] KLA 1.03 1.18 1.07 .98 .99 .92 .97
ATP 1.04 1.26 1.05 1.29 .98 .91 1.07
KLA/ATP 1.19 1.12 .98 1.46 .88 .94 .81
Acmsd
KLA  ATP  ATP+KLA
 NM_001033041 amino carboxymuconate semialdehyde decarboxylase (Acmsd), mRNA [NM_001033041] KLA 1.03 1.05 .97 1.03 1.06 .95 .88
ATP .93 .99 1.03 1.00 .95 1.04 1.00
KLA/ATP .97 .89 1.07 1.03 .95 .91 .95
Aco1
KLA  ATP  ATP+KLA
 NM_007386 aconitase 1 (Aco1), mRNA [NM_007386] KLA .82 .85 .80 .78 .73 .74 .84
ATP 1.02 1.07 1.04 .96 .95 .88 .83
KLA/ATP .83 .86 .81 .80 .76 .73 .62
Aco2
KLA  ATP  ATP+KLA
 AK029122 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732494K09 product:hypothetical protein, full insert sequence [AK029122] KLA 1.02 1.02 .99 .98 .97 1.04 .83
ATP .98 1.04 1.05 .95 .95 1.02 1.00
KLA/ATP .96 .95 1.00 1.04 1.06 1.03 .99
Aco2
KLA  ATP  ATP+KLA
 NM_080633 aconitase 2, mitochondrial (Aco2), nuclear gene encoding mitochondrial protein, mRNA [NM_080633] KLA .93 .96 .97 .91 .97 .99 1.07
ATP 1.05 1.04 .98 .92 .90 .83 .99
KLA/ATP 1.01 1.06 .86 .89 .83 .93 .93
Acot1
KLA  ATP  ATP+KLA
 NM_012006 acyl-CoA thioesterase 1 (Acot1), mRNA [NM_012006] KLA .40 .34 .32 .29 .23 .17 .16
ATP 1.01 .95 1.14 1.10 .64 .26 .53
KLA/ATP .37 .37 .42 .42 .32 .20 .22
Acot2
KLA  ATP  ATP+KLA
 NM_134188 acyl-CoA thioesterase 2 (Acot2), nuclear gene encoding mitochondrial protein, mRNA [NM_134188] KLA .46 .49 .37 .43 .34 .37 .53
ATP 1.02 1.15 .87 .99 .54 .37 .96
KLA/ATP .51 .46 .44 .49 .36 .34 .49
Acot3
KLA  ATP  ATP+KLA
 NM_134246 acyl-CoA thioesterase 3 (Acot3), mRNA [NM_134246] KLA .95 .95 1.04 .99 1.01 .97 .98
ATP 1.03 .97 1.01 .92 1.02 .99 .99
KLA/ATP .98 1.00 1.07 .96 1.01 1.00 1.01
Acot4
KLA  ATP  ATP+KLA
 NM_134247 acyl-CoA thioesterase 4 (Acot4), mRNA [NM_134247] KLA .77 .77 .72 .74 .68 .81 .85
ATP .95 .96 .97 .83 .79 .84 .99
KLA/ATP .79 .78 .76 .75 .76 .76 .84
Acot5
KLA  ATP  ATP+KLA
 NM_145444 acyl-CoA thioesterase 5 (Acot5), mRNA [NM_145444] KLA 1.03 1.07 1.00 1.02 1.05 1.06 1.07
ATP .99 .97 1.06 1.05 1.00 1.01 1.06
KLA/ATP .98 .96 1.07 1.09 1.08 1.00 1.01
Acot7
KLA  ATP  ATP+KLA
 NM_133348 acyl-CoA thioesterase 7 (Acot7), mRNA [NM_133348] KLA 1.60 1.80 1.91 1.81 1.85 1.55 1.30
ATP .99 1.08 1.07 1.46 1.32 1.25 .99
KLA/ATP 1.81 1.84 1.79 2.42 2.08 1.68 .82
Acot8
KLA  ATP  ATP+KLA
 NM_133240 acyl-CoA thioesterase 8 (Acot8), mRNA [NM_133240] KLA 1.03 1.01 .85 1.11 1.32 1.56 1.41
ATP .98 1.02 1.00 1.07 .85 .95 1.38
KLA/ATP 1.04 .89 1.01 1.18 1.03 .96 1.70
Acox1
KLA  ATP  ATP+KLA
 NM_015729 acyl-Coenzyme A oxidase 1, palmitoyl (Acox1), mRNA [NM_015729] KLA .79 .81 .78 .68 .66 .69 .82
ATP .97 1.09 .93 .90 .81 .78 1.22
KLA/ATP .81 .82 .69 .68 .59 .70 .88
Acox2
KLA  ATP  ATP+KLA
 NM_053115 acyl-Coenzyme A oxidase 2, branched chain (Acox2), mRNA [NM_053115] KLA .99 1.04 1.04 1.06 1.01 1.01 .99
ATP 1.06 1.08 .97 1.04 1.02 1.00 1.02
KLA/ATP 1.07 1.05 1.03 1.01 1.01 1.04 1.02
Acox3
KLA  ATP  ATP+KLA
 NM_030721 acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), mRNA [NM_030721] KLA .56 .56 .63 .55 .50 .48 .68
ATP 1.10 1.00 .85 .76 .87 .44 .73
KLA/ATP .61 .66 .57 .49 .57 .48 .47
Acsbg1
KLA  ATP  ATP+KLA
 NM_053178 acyl-CoA synthetase bubblegum family member 1 (Acsbg1), mRNA [NM_053178] KLA .54 .60 .46 .48 .43 .54 .84
ATP .93 .86 .66 .53 .41 .96 1.25
KLA/ATP .60 .52 .44 .39 .38 .67 1.36
Acsbg2
KLA  ATP  ATP+KLA
 NM_001039114 acyl-CoA synthetase bubblegum family member 2 (Acsbg2), mRNA [NM_001039114] KLA .96 .99 1.05 1.00 .98 1.02 1.03
ATP 1.03 1.02 1.04 .97 1.00 1.03 .96
KLA/ATP 1.02 .98 .99 1.00 .92 1.00 .98
Acsl1
KLA  ATP  ATP+KLA
 NM_007981 acyl-CoA synthetase long-chain family member 1 (Acsl1), mRNA [NM_007981] KLA 6.45 6.43 6.31 6.46 7.76 10.38 13.72
ATP 1.02 1.14 1.04 1.69 2.56 4.02 2.69
KLA/ATP 6.36 6.25 5.41 6.54 4.81 4.79 9.93
Acsl3
KLA  ATP  ATP+KLA
 NM_001033606 acyl-CoA synthetase long-chain family member 3 (Acsl3), transcript variant 2, mRNA [NM_001033606] KLA .29 .27 .29 .29 .30 .32 .39
ATP 1.06 .98 1.19 1.92 2.34 .67 .75
KLA/ATP .27 .26 .39 .88 1.31 .50 .24
Acsl4
KLA  ATP  ATP+KLA
 NM_207625 acyl-CoA synthetase long-chain family member 4 (Acsl4), transcript variant 1, mRNA [NM_207625] KLA 1.16 1.03 1.01 1.21 1.21 1.51 1.70
ATP .89 .88 1.64 1.60 2.24 5.91 2.42
KLA/ATP .92 1.00 1.90 1.71 1.83 3.23 3.56
Acsl5
KLA  ATP  ATP+KLA
 NM_027976 acyl-CoA synthetase long-chain family member 5 (Acsl5), mRNA [NM_027976] KLA 1.32 1.46 1.54 1.51 2.04 2.20 2.31
ATP 1.02 1.10 .89 1.03 .92 .84 .99
KLA/ATP 1.42 1.54 1.17 1.29 .97 1.11 1.35
Acsl6
KLA  ATP  ATP+KLA
 AK147421 adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1038B08 product:acyl-CoA synthetase long-chain family member 6, full insert sequence [AK147421] KLA 1.00 .97 1.02 .99 .97 1.02 1.03
ATP .97 .96 .95 .97 1.00 1.03 1.04
KLA/ATP .99 .96 1.08 .96 1.01 .96 1.00
Acsl6
KLA  ATP  ATP+KLA
 NM_001033599 acyl-CoA synthetase long-chain family member 6 (Acsl6), transcript variant 4, mRNA [NM_001033599] KLA .97 .99 1.02 1.02 1.00 1.01 .99
ATP 1.01 1.01 1.02 1.00 1.00 1.01 1.04
KLA/ATP .97 1.06 1.00 1.02 .94 1.00 1.02
Acsm1
KLA  ATP  ATP+KLA
 NM_054094 acyl-CoA synthetase medium-chain family member 1 (Acsm1), mRNA [NM_054094] KLA .98 1.04 .95 1.00 1.04 .99 .97
ATP 1.04 1.04 1.03 .94 1.00 1.00 .97
KLA/ATP .98 .99 1.04 .98 .95 .95 .98
Acsm2
KLA  ATP  ATP+KLA
 AK165449 adult male kidney cDNA, RIKEN full-length enriched library, clone:F530004J10 product:unclassifiable, full insert sequence [AK165449] KLA 1.00 .98 .96 1.04 1.06 .98 .97
ATP 1.02 .98 1.01 1.07 .94 .99 1.02
KLA/ATP 1.07 1.06 1.05 1.03 1.01 .97 1.00
Acsm2
KLA  ATP  ATP+KLA
 NM_146197 acyl-CoA synthetase medium-chain family member 2 (Acsm2), mRNA [NM_146197] KLA .99 .98 .95 .99 .99 1.02 1.02
ATP .99 .95 1.03 .99 .99 1.02 1.03
KLA/ATP 1.01 1.03 .98 .99 .97 .95 1.00
Acsm3
KLA  ATP  ATP+KLA
 NM_212441 acyl-CoA synthetase medium-chain family member 3 (Acsm3), transcript variant 2, mRNA [NM_212441] KLA 1.02 .99 .98 .96 1.00 1.00 .96
ATP .96 1.01 .98 .87 .95 .98 .93
KLA/ATP 1.00 1.01 .92 .98 .89 .95 1.06
Acsm4
KLA  ATP  ATP+KLA
 NM_178414 acyl-CoA synthetase medium-chain family member 4 (Acsm4), mRNA [NM_178414] KLA 1.09 1.03 .95 1.05 1.01 1.00 .96
ATP .91 1.05 .92 .96 .93 1.05 1.04
KLA/ATP .95 .95 1.00 .97 .98 .99 .99
Acsm5
KLA  ATP  ATP+KLA
 NM_178758 acyl-CoA synthetase medium-chain family member 5 (Acsm5), mRNA [NM_178758] KLA .96 .98 1.04 1.00 1.04 1.05 1.01
ATP 1.01 1.00 1.01 1.02 .94 1.05 1.00
KLA/ATP .97 1.05 1.04 1.01 1.07 1.00 .96
Acss1
KLA  ATP  ATP+KLA
 NM_080575 acyl-CoA synthetase short-chain family member 1 (Acss1), nuclear gene encoding mitochondrial protein, mRNA [NM_080575] KLA .45 .41 .45 .62 .70 1.05 .43
ATP .95 .89 1.35 .86 .81 .57 .55
KLA/ATP .38 .37 .61 .51 1.13 1.17 .38
Acss2
KLA  ATP  ATP+KLA
 AK003738 18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1110017C11 product:acetyl-Coenzyme A synthetase 1 (AMP forming), full insert sequence. [AK003738] KLA 1.03 .94 1.02 .97 .93 1.01 1.16
ATP 1.05 .97 .98 1.03 .95 1.31 1.40
KLA/ATP .88 1.02 1.01 .93 .93 1.02 1.12
Acss2
KLA  ATP  ATP+KLA
 NM_019811 acyl-CoA synthetase short-chain family member 2 (Acss2), mRNA [NM_019811] KLA 1.19 1.23 1.40 1.49 1.68 1.67 1.82
ATP 1.10 1.19 1.13 1.16 1.06 3.14 2.63
KLA/ATP 1.27 1.35 1.37 1.42 1.47 3.47 2.86
Acss3
KLA  ATP  ATP+KLA
 NM_198636 acyl-CoA synthetase short-chain family member 3 (Acss3), mRNA [NM_198636] KLA .99 .98 .92 1.01 .99 1.03 .98
ATP .98 1.06 1.01 .97 .98 1.04 1.00
KLA/ATP .96 .97 1.05 1.01 .91 .98 1.04
Acy1
KLA  ATP  ATP+KLA
 NM_025371 aminoacylase 1 (Acy1), mRNA [NM_025371] KLA 1.09 1.23 1.15 1.16 1.14 1.11 .71
ATP 1.00 1.03 .98 1.13 1.30 1.30 1.13
KLA/ATP 1.22 1.18 .95 1.22 1.08 1.03 .71
Ada
KLA  ATP  ATP+KLA
 NM_007398 adenosine deaminase (Ada), mRNA [NM_007398] KLA .92 .93 .83 .92 .71 .59 .70
ATP .90 .91 1.24 1.79 1.48 .91 .43
KLA/ATP .82 .96 1.18 1.41 1.49 .78 .32
Adc
KLA  ATP  ATP+KLA
 NM_172875 arginine decarboxylase (Adc), mRNA [NM_172875] KLA .94 1.00 .90 .94 1.05 1.06 1.06
ATP .95 .94 .88 .90 .88 .75 .95
KLA/ATP .98 1.01 .86 .92 .90 .98 1.24
Adh1
KLA  ATP  ATP+KLA
 AK082149 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230014D21 product:unclassifiable, full insert sequence [AK082149] KLA .94 .96 .97 .95 1.01 .95 .96
ATP .99 1.05 .93 .91 1.02 1.04 1.00
KLA/ATP .87 .88 .94 .92 .86 1.04 .93
Adh1
KLA  ATP  ATP+KLA
 NM_007409 alcohol dehydrogenase 1 (class I) (Adh1), mRNA [NM_007409] KLA 1.02 .98 .96 1.04 1.01 1.04 1.08
ATP .96 1.03 1.00 1.03 1.05 1.01 1.04
KLA/ATP 1.02 1.03 1.04 1.01 1.04 1.09 1.04
Adh4
KLA  ATP  ATP+KLA
 NM_011996 alcohol dehydrogenase 4 (class II), pi polypeptide (Adh4), mRNA [NM_011996] KLA .95 .94 .93 1.07 1.04 .96 .99
ATP .95 .95 .95 .99 1.02 .93 .97
KLA/ATP 1.03 1.02 .92 .97 1.02 1.01 .99
Adh5
KLA  ATP  ATP+KLA
 NM_007410 alcohol dehydrogenase 5 (class III), chi polypeptide (Adh5), mRNA [NM_007410] KLA .93 .76 .71 .83 .61 .63 .76
ATP 1.02 .98 1.19 1.06 1.08 .85 .86
KLA/ATP .77 .76 1.06 .86 .87 .84 .62
Adh7
KLA  ATP  ATP+KLA
 NM_009626 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (Adh7), mRNA [NM_009626] KLA 1.07 1.01 1.02 .98 1.03 .99 1.01
ATP 1.03 1.09 1.02 1.08 1.03 1.09 1.01
KLA/ATP 1.10 1.03 1.06 1.02 1.05 1.06 1.13
Adi1
KLA  ATP  ATP+KLA
 NM_134052 acireductone dioxygenase 1 (Adi1), mRNA [NM_134052] KLA .53 .57 .42 .51 .42 .47 .78
ATP 1.21 1.20 1.11 1.26 1.07 .72 1.07
KLA/ATP .59 .52 .53 .58 .56 .71 .68
Adk
KLA  ATP  ATP+KLA
 NM_134079 adenosine kinase (Adk), mRNA [NM_134079] KLA .96 .94 .92 .79 .64 .45 .97
ATP 1.06 1.01 1.34 1.13 1.15 .97 .51
KLA/ATP .86 .94 1.22 .96 .85 .76 .32
Ado
KLA  ATP  ATP+KLA
 NM_001005419 2-aminoethanethiol (cysteamine) dioxygenase (Ado), mRNA [NM_001005419] KLA .33 .27 .24 .26 .35 .55 .84
ATP 1.07 1.26 1.21 1.07 .80 .54 .95
KLA/ATP .29 .30 .29 .31 .30 .27 .37
Adpgk
KLA  ATP  ATP+KLA
 NM_028121 ADP-dependent glucokinase (Adpgk), mRNA [NM_028121] KLA .77 .82 .76 .66 .66 .64 1.08
ATP 1.09 1.15 1.11 1.14 .89 .61 .87
KLA/ATP .90 .83 .71 .84 .56 .57 .47
Adsl
KLA  ATP  ATP+KLA
 NM_009634 adenylosuccinate lyase (Adsl), mRNA [NM_009634] KLA .87 .93 .90 .97 .82 .64 1.06
ATP 1.08 1.12 1.06 1.04 .80 .60 .86
KLA/ATP 1.02 .95 1.00 .86 .66 .49 .49
Adss
KLA  ATP  ATP+KLA
 NM_007422 adenylosuccinate synthetase, non muscle (Adss), mRNA [NM_007422] KLA 1.21 1.15 .96 .70 .35 .24 .51
ATP .93 1.08 .97 1.14 .93 .75 .47
KLA/ATP 1.24 1.19 .87 .99 .56 .40 .33
Adssl1
KLA  ATP  ATP+KLA
 NM_007421 adenylosuccinate synthetase like 1 (Adssl1), mRNA [NM_007421] KLA .67 .67 .53 .51 .32 .17 .20
ATP .87 .76 .96 .74 .73 .38 .60
KLA/ATP .58 .59 .64 .48 .62 .49 .37
Afmid
KLA  ATP  ATP+KLA
 NM_027827 arylformamidase (Afmid), mRNA [NM_027827] KLA .85 .95 .89 .82 1.00 1.22 1.18
ATP 1.06 1.11 1.05 1.16 1.11 .95 .69
KLA/ATP .96 1.09 .95 1.06 1.00 .99 .91
Agk
KLA  ATP  ATP+KLA
 NM_023538 acylglycerol kinase (Agk), mRNA [NM_023538] KLA 1.16 1.30 1.23 1.15 .96 .85 .86
ATP .97 .99 .99 1.04 .92 .88 .81
KLA/ATP 1.15 1.25 1.25 1.39 1.09 .93 .56
Agl
KLA  ATP  ATP+KLA
 AK036225 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630046L06 product:similar to GLYCOGEN DEBRANCHING ENZYME (GLYCOGEN DEBRANCHER) [INCLUDES: 4-ALPHA-GLUCANOTRANSFERASE (EC 2.4.1.25) (OLIGO-1,4-1,4-GLUCANTRANSFERAS KLA .94 .95 .94 .94 .97 .97 1.01
ATP 1.00 1.08 1.01 .86 1.03 1.02 1.01
KLA/ATP 1.05 1.02 .93 .85 .93 1.01 .94
Agl
KLA  ATP  ATP+KLA
 NM_001081326 amylo-1,6-glucosidase, 4-alpha-glucanotransferase (Agl), mRNA [NM_001081326] KLA .58 .51 .44 .39 .43 .64 .92
ATP .99 .98 1.01 .68 .90 1.23 .65
KLA/ATP .51 .50 .45 .33 .54 .85 .49
Agmat
KLA  ATP  ATP+KLA
 NM_001081408 agmatine ureohydrolase (agmatinase) (Agmat), mRNA [NM_001081408] KLA 1.13 1.09 1.11 1.30 1.10 1.15 1.17
ATP .85 .86 1.30 1.22 1.15 1.16 .95
KLA/ATP .95 1.04 1.53 1.30 1.37 1.10 1.03
Agpat1
KLA  ATP  ATP+KLA
 NM_018862 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (Agpat1), mRNA [NM_018862] KLA 1.24 1.27 1.16 1.37 1.37 1.51 1.65
ATP .99 1.09 1.19 1.29 1.20 1.03 1.27
KLA/ATP 1.27 1.33 1.37 1.49 1.28 1.17 1.55
Agpat2
KLA  ATP  ATP+KLA
 NM_026212 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (Agpat2), mRNA [NM_026212] KLA .88 .86 1.05 1.00 1.28 1.13 1.05
ATP 1.06 1.15 .95 1.09 .97 1.22 1.04
KLA/ATP .96 .94 .73 .87 .78 .97 .63
Agpat3
KLA  ATP  ATP+KLA
 NM_053014 1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3), mRNA [NM_053014] KLA 1.13 1.10 1.05 1.19 1.28 1.33 1.53
ATP .95 .95 .89 .84 .79 .82 1.41
KLA/ATP .95 1.03 1.08 .94 .77 .75 1.42
Agpat4
KLA  ATP  ATP+KLA
 NM_026644 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (Agpat4), mRNA [NM_026644] KLA 1.37 1.26 1.06 1.10 .98 1.29 1.77
ATP 1.05 .95 1.02 1.26 1.86 3.88 2.42
KLA/ATP 1.38 1.32 1.44 1.22 1.29 2.06 5.07
Agpat6
KLA  ATP  ATP+KLA
 NM_018743 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) (Agpat6), mRNA [NM_018743] KLA 1.14 1.08 1.21 1.15 1.17 1.25 1.50
ATP 1.05 1.02 .91 .91 1.11 1.42 1.26
KLA/ATP 1.16 1.17 .96 .87 1.00 1.40 1.35
Agpat9
KLA  ATP  ATP+KLA
 NM_172715 1-acylglycerol-3-phosphate O-acyltransferase 9 (Agpat9), transcript variant 1, mRNA [NM_172715] KLA .69 .70 .67 .64 .61 .61 .79
ATP .89 .77 .69 .57 2.26 2.30 1.90
KLA/ATP .67 .66 .68 .56 1.39 1.82 1.98
Agps
KLA  ATP  ATP+KLA
 NM_172666 alkylglycerone phosphate synthase (Agps), mRNA [NM_172666] KLA .97 1.04 1.08 .98 .98 1.11 1.31
ATP 1.03 1.09 1.21 1.08 .76 .98 1.18
KLA/ATP 1.02 1.09 1.05 .90 .71 .78 1.56
Agxt
KLA  ATP  ATP+KLA
 NM_016702 alanine-glyoxylate aminotransferase (Agxt), mRNA [NM_016702] KLA 1.01 .95 .96 1.05 1.01 .98 .94
ATP .95 1.03 1.03 .99 .97 .96 1.05
KLA/ATP .94 .99 1.01 1.01 .96 .92 .96
Agxt2
KLA  ATP  ATP+KLA
 NM_001031851 alanine-glyoxylate aminotransferase 2 (Agxt2), nuclear gene encoding mitochondrial protein, mRNA [NM_001031851] KLA .98 .99 1.04 1.05 .93 1.01 1.05
ATP 1.02 1.03 1.03 1.06 1.01 .96 .97
KLA/ATP 1.05 .98 .99 1.04 .99 1.02 1.01
Ahcy
KLA  ATP  ATP+KLA
 AK154302 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630016H08 product:S-adenosylhomocysteine hydrolase, full insert sequence. [AK154302] KLA .95 1.05 1.04 1.01 .92 .72 .57
ATP 1.05 1.14 1.15 1.38 1.30 .94 .51
KLA/ATP 1.04 1.15 1.21 1.25 .99 .70 .31
Ahcy
KLA  ATP  ATP+KLA
 L32836 (clone C7/B9) S-adenosyl homocysteine hydrolase (ahcy) mRNA, complete cds. [L32836] KLA 1.04 1.01 1.02 1.06 .90 .78 .61
ATP .97 1.01 1.21 1.44 1.23 .98 .52
KLA/ATP .97 1.06 1.18 1.30 1.05 .79 .32
Ahcy
KLA  ATP  ATP+KLA
 NM_016661 S-adenosylhomocysteine hydrolase (Ahcy), mRNA [NM_016661] KLA 1.07 1.02 1.18 1.07 1.07 .92 .72
ATP 1.04 1.11 1.13 1.51 1.21 .90 .59
KLA/ATP 1.13 1.28 1.17 1.33 .96 .84 .51
Ahcyl1
KLA  ATP  ATP+KLA
 NM_145542 S-adenosylhomocysteine hydrolase-like 1 (Ahcyl1), mRNA [NM_145542] KLA 1.19 1.36 1.32 1.12 1.03 .94 1.15
ATP 1.02 1.08 .88 .99 .97 .84 1.43
KLA/ATP 1.32 1.28 .99 1.29 .99 1.13 1.89
Ahcyl2
KLA  ATP  ATP+KLA
 AB041551 brain cDNA, clone MNCb-5555. [AB041551] KLA .99 1.03 .90 .81 .88 .81 .90
ATP 1.38 1.48 1.04 1.22 1.10 .81 .98
KLA/ATP 1.06 .86 .82 .86 1.00 1.02 1.03
Ahcyl2
KLA  ATP  ATP+KLA
 NM_021414 S-adenosylhomocysteine hydrolase-like 2 (Ahcyl2), mRNA [NM_021414] KLA 1.43 1.40 1.57 1.56 1.44 1.03 1.27
ATP 1.12 1.17 1.23 1.45 1.50 1.61 2.13
KLA/ATP 1.60 1.72 1.66 1.45 1.42 2.00 2.84
AK016943
KLA  ATP  ATP+KLA
 AK016943 adult male testis cDNA, RIKEN full-length enriched library, clone:4933427C01 product:hypothetical Arginine-rich region containing protein, full insert sequence. [AK016943] KLA .94 1.00 .99 .94 .99 1.07 1.06
ATP 1.08 1.03 1.07 1.05 1.00 .98 .99
KLA/ATP 1.02 .95 1.03 1.02 1.08 1.00 1.04
AK031343
KLA  ATP  ATP+KLA
 AK031343 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030410A06 product:unclassifiable, full insert sequence [AK031343] KLA 1.03 .97 .92 1.01 .97 .90 .94
ATP 1.00 1.00 .92 .95 .97 .99 .98
KLA/ATP .98 1.01 .86 .99 .91 .93 1.00
AK046580
KLA  ATP  ATP+KLA
 AK046580 4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430108N21 product:similar to CYTOCHROME C OXIDASE POLYPEPTIDE VA, MITOCHONDRIAL PRECURSOR (EC 1.9.3.1) [Rattus norvegicus], full insert sequence. [AK046580] KLA .94 .93 .98 1.02 1.13 1.13 1.01
ATP .84 .93 .87 .91 1.14 1.02 .98
KLA/ATP .88 .89 .99 .92 1.05 1.05 .95
AK047274
KLA  ATP  ATP+KLA
 AK047274 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930044L01 product:unclassifiable, full insert sequence. [AK047274] KLA .92 .85 .90 .92 .98 .93 .92
ATP 1.03 1.11 1.07 .90 .89 .93 .94
KLA/ATP .89 .96 .94 .84 .93 .92 .92
AK077927
KLA  ATP  ATP+KLA
 AK077927 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030447B09 product:unclassifiable, full insert sequence. [AK077927] KLA 3.15 2.64 2.14 1.56 1.86 1.87 1.23
ATP .91 .63 .45 .45 1.18 1.41 .90
KLA/ATP 2.53 2.04 1.88 .94 1.59 1.96 1.21
AK085608
KLA  ATP  ATP+KLA
 AK085608 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630046G10 product:unclassifiable, full insert sequence. [AK085608] KLA .89 .96 1.01 1.03 .96 .98 1.07
ATP 1.03 1.00 .96 1.01 1.05 1.04 1.00
KLA/ATP 1.00 1.00 .99 1.04 1.01 .99 1.00
AK085642
KLA  ATP  ATP+KLA
 AK085642 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630050A03 product:unclassifiable, full insert sequence [AK085642] KLA 1.09 1.00 .97 1.00 1.05 1.05 1.04
ATP 1.01 .95 .99 1.01 1.03 1.03 .98
KLA/ATP .98 1.03 .99 1.02 1.08 1.03 1.02
AK086155
KLA  ATP  ATP+KLA
 AK086155 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930008J19 product:unclassifiable, full insert sequence. [AK086155] KLA 1.02 1.05 1.02 1.02 .99 1.08 .93
ATP .98 1.06 1.35 1.04 .94 1.11 1.08
KLA/ATP .98 .94 1.11 1.03 1.04 1.04 1.13
AK087183
KLA  ATP  ATP+KLA
 AK087183 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030032L18 product:unclassifiable, full insert sequence. [AK087183] KLA .96 .95 .94 .93 .94 .89 .96
ATP 1.05 .94 .92 .90 .93 .84 .93
KLA/ATP 1.01 .97 .89 .91 .96 .87 .84
AK087232
KLA  ATP  ATP+KLA
 AK087232 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030037J19 product:unclassifiable, full insert sequence. [AK087232] KLA .99 1.12 1.03 1.03 1.01 .89 1.05
ATP 1.01 1.00 1.04 1.06 1.01 1.01 .92
KLA/ATP 1.02 1.05 .97 1.00 1.05 .84 .98
Ak1
KLA  ATP  ATP+KLA
 NM_021515 adenylate kinase 1 (Ak1), mRNA [NM_021515] KLA .81 .81 .75 .72 .58 .46 .29
ATP .96 1.11 1.07 1.35 1.10 .69 .68
KLA/ATP .81 .89 .83 1.08 .89 .59 .46
AK165218
KLA  ATP  ATP+KLA
 AK165218 6 days neonate spleen cDNA, RIKEN full-length enriched library, clone:F420008K05 product:lipin 2, full insert sequence. [AK165218] KLA .96 .94 .83 1.03 1.08 .97 1.07
ATP 1.20 1.84 1.52 2.12 1.12 1.23 1.14
KLA/ATP .97 1.03 1.17 1.13 .98 1.07 1.21
AK169742
KLA  ATP  ATP+KLA
 AK169742 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430016M08 product:glyceraldehyde-3-phosphate dehydrogenase, full insert sequence. [AK169742] KLA .82 .94 .91 .90 1.13 .93 1.79
ATP .59 .66 .72 .89 1.88 1.96 1.26
KLA/ATP .75 .69 .70 .84 1.00 1.13 1.46
Ak2
KLA  ATP  ATP+KLA
 NM_016895 adenylate kinase 2 (Ak2), transcript variant 2, mRNA [NM_016895] KLA 1.50 1.55 1.69 1.55 1.64 1.56 1.85
ATP 1.13 1.11 1.16 1.44 1.46 1.66 1.40
KLA/ATP 1.70 1.81 2.01 1.94 1.81 1.51 1.96
AK209324
KLA  ATP  ATP+KLA
 AK209324 cDNA, clone:Y2G0114L23, strand:plus, reference:ENSEMBL:Mouse-Transcript-ENST:ENSMUST00000060207, based on BLAT search. [AK209324] KLA .48 .51 .55 .57 .80 .90 1.17
ATP 1.01 .96 .73 .60 .76 .78 1.24
KLA/ATP .54 .46 .42 .54 .76 .76 .73
Ak3l1
KLA  ATP  ATP+KLA
 NM_009647 adenylate kinase 3 alpha-like 1 (Ak3l1), nuclear gene encoding mitochondrial protein, mRNA [NM_009647] KLA 2.47 2.87 2.76 2.37 2.11 1.57 2.16
ATP .97 1.03 1.13 1.13 1.98 3.05 1.11
KLA/ATP 2.67 2.98 2.40 2.27 2.78 2.30 1.22
Ak5
KLA  ATP  ATP+KLA
 NM_001081277 adenylate kinase 5 (Ak5), mRNA [NM_001081277] KLA 1.03 1.01 .98 1.03 .99 1.05 .97
ATP .97 1.01 1.03 .98 .99 .97 1.01
KLA/ATP .97 .96 1.08 .99 .98 .95 1.01
Ak7
KLA  ATP  ATP+KLA
 AK029555 adult male testis cDNA, RIKEN full-length enriched library, clone:4921526N12 product:hypothetical Adenylate kinase containing protein, full insert sequence [AK029555] KLA .97 .98 .99 1.03 .98 .98 1.04
ATP 1.04 .99 1.05 1.01 1.05 1.07 1.01
KLA/ATP 1.05 1.00 1.00 1.02 1.14 1.49 1.13
Akp3
KLA  ATP  ATP+KLA
 NM_007432 alkaline phosphatase 3, intestine, not Mn requiring (Akp3), mRNA [NM_007432] KLA .99 1.04 1.02 1.06 1.02 1.04 1.09
ATP 1.04 1.03 1.06 1.05 .98 1.01 1.05
KLA/ATP 1.04 1.01 1.00 1.02 1.06 1.07 1.01
Akp5
KLA  ATP  ATP+KLA
 NM_007433 alkaline phosphatase 5 (Akp5), mRNA [NM_007433] KLA .99 .97 .95 .95 .98 1.01 .96
ATP 1.01 .94 1.03 .96 .94 1.04 1.05
KLA/ATP .92 .94 .97 .96 .94 .94 .90
Akr1a4
KLA  ATP  ATP+KLA
 NM_021473 aldo-keto reductase family 1, member A4 (aldehyde reductase) (Akr1a4), mRNA [NM_021473] KLA .96 1.00 1.13 .96 1.13 1.16 1.43
ATP 1.06 1.07 .77 .94 .86 1.17 2.12
KLA/ATP 1.06 1.03 .65 .93 .85 1.38 2.61
Akr1b3
KLA  ATP  ATP+KLA
 AK054167 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230024H01 product:unclassifiable, full insert sequence [AK054167] KLA 1.06 .92 .98 1.01 1.02 1.04 .96
ATP 1.08 1.02 .99 .97 1.09 1.02 .99
KLA/ATP .99 1.01 .97 .99 1.02 .99 1.08
Akr1b3
KLA  ATP  ATP+KLA
 NM_009658 aldo-keto reductase family 1, member B3 (aldose reductase) (Akr1b3), mRNA [NM_009658] KLA .97 .99 .96 .91 .92 .93 .77
ATP 1.08 1.13 1.09 1.15 1.00 1.03 1.18
KLA/ATP 1.06 .98 .95 1.15 .89 .88 .82
Akr1b7
KLA  ATP  ATP+KLA
 NM_009731 aldo-keto reductase family 1, member B7 (Akr1b7), mRNA [NM_009731] KLA .92 .93 .93 .93 .97 .96 .84
ATP .97 1.01 .93 .88 .85 .95 .88
KLA/ATP .86 .92 .92 .82 .85 .94 1.02
Akr1b8
KLA  ATP  ATP+KLA
 NM_008012 aldo-keto reductase family 1, member B8 (Akr1b8), mRNA [NM_008012] KLA .64 .56 .49 .46 .31 .25 .25
ATP .95 .97 1.17 .90 .85 2.25 2.02
KLA/ATP .55 .53 .63 .47 .50 1.00 2.18
Akr1d1
KLA  ATP  ATP+KLA
 NM_145364 aldo-keto reductase family 1, member D1 (Akr1d1), mRNA [NM_145364] KLA 1.00 1.04 1.01 1.02 .98 1.01 .97
ATP 1.01 .99 .99 1.04 1.01 .99 1.00
KLA/ATP .98 1.03 .93 .96 .99 1.08 1.02
Alad
KLA  ATP  ATP+KLA
 AK044938 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130014K12 product:unclassifiable, full insert sequence [AK044938] KLA .98 .94 .97 .84 .90 .92 1.00
ATP 1.04 .93 .94 .91 .95 .93 .99
KLA/ATP .95 .95 .98 .94 .97 .87 .96
Alad
KLA  ATP  ATP+KLA
 NM_008525 aminolevulinate, delta-, dehydratase (Alad), mRNA [NM_008525] KLA .64 .69 .59 .51 .45 .49 .77
ATP 1.05 1.11 1.09 1.25 .89 .70 .94
KLA/ATP .74 .66 .63 .72 .53 .48 .64
Alas1
KLA  ATP  ATP+KLA
 NM_020559 aminolevulinic acid synthase 1 (Alas1), mRNA [NM_020559] KLA 1.90 2.05 1.99 2.15 2.41 2.00 1.62
ATP .96 1.03 .87 .98 2.70 9.15 6.49
KLA/ATP 1.88 2.04 1.63 1.99 3.06 7.03 8.41
Alas2
KLA  ATP  ATP+KLA
 NM_009653 aminolevulinic acid synthase 2, erythroid (Alas2), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_009653] KLA .94 1.05 1.03 .98 .93 .99 1.00
ATP 1.00 1.03 1.02 1.05 .95 .96 1.04
KLA/ATP 1.07 1.08 1.03 .94 .97 .98 .98
Aldh18a1
KLA  ATP  ATP+KLA
 NM_019698 aldehyde dehydrogenase 18 family, member A1 (Aldh18a1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_019698] KLA .71 .71 .63 .58 .72 1.04 1.22
ATP 1.25 1.41 .88 1.39 1.25 .73 1.37
KLA/ATP .86 .91 .43 .66 .47 .59 .59
Aldh1a1
KLA  ATP  ATP+KLA
 NM_013467 aldehyde dehydrogenase family 1, subfamily A1 (Aldh1a1), mRNA [NM_013467] KLA 1.06 .95 1.04 1.03 .98 1.08 1.07
ATP .94 1.03 1.01 1.00 1.00 1.07 .99
KLA/ATP 1.03 .98 1.02 1.01 1.05 1.05 1.02
Aldh1a2
KLA  ATP  ATP+KLA
 NM_009022 aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2), mRNA [NM_009022] KLA 1.10 1.09 1.04 1.05 1.16 1.14 1.06
ATP 1.03 1.02 1.03 .99 1.04 1.07 1.02
KLA/ATP 1.04 1.10 1.02 1.15 1.33 1.26 1.01
Aldh1a3
KLA  ATP  ATP+KLA
 AK086764 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930050B08 product:aldehyde dehydrogenase family 1, subfamily A3, full insert sequence. [AK086764] KLA .97 1.05 1.05 1.01 1.00 .98 .97
ATP 1.00 1.03 .99 .92 1.01 1.09 1.02
KLA/ATP 1.01 .99 1.06 1.00 .97 .98 1.00
Aldh1a3
KLA  ATP  ATP+KLA
 NM_053080 aldehyde dehydrogenase family 1, subfamily A3 (Aldh1a3), mRNA [NM_053080] KLA 1.03 .96 1.03 1.03 .96 .98 1.01
ATP .98 1.04 1.01 1.06 .98 1.01 1.08
KLA/ATP 1.02 1.00 1.02 .94 1.03 .99 .99
Aldh1a7
KLA  ATP  ATP+KLA
 NM_011921 aldehyde dehydrogenase family 1, subfamily A7 (Aldh1a7), mRNA [NM_011921] KLA 1.06 1.00 .97 1.04 1.05 1.03 .96
ATP 1.00 .94 1.04 1.06 1.01 1.00 1.05
KLA/ATP 1.06 .94 1.07 1.10 1.23 1.08 1.09
Aldh1b1
KLA  ATP  ATP+KLA
 NM_028270 aldehyde dehydrogenase 1 family, member B1 (Aldh1b1), nuclear gene encoding mitochondrial protein, mRNA [NM_028270] KLA 7.51 7.83 9.27 11.57 11.10 10.78 4.79
ATP .93 .91 .90 .89 .73 2.27 2.30
KLA/ATP 6.45 7.40 9.33 9.54 8.82 12.15 10.67
Aldh2
KLA  ATP  ATP+KLA
 AK163452 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105J09 product:aldehyde dehydrogenase 2, mitochondrial, full insert sequence [AK163452] KLA .62 .65 .59 .60 .63 .64 .49
ATP 1.01 .91 1.06 .93 1.18 .93 .41
KLA/ATP .70 .68 .70 .84 1.16 .96 .45
Aldh2
KLA  ATP  ATP+KLA
 NM_009656 aldehyde dehydrogenase 2, mitochondrial (Aldh2), nuclear gene encoding mitochondrial protein, mRNA [NM_009656] KLA .74 .81 .77 .65 .60 .53 .50
ATP .98 1.10 .90 1.17 1.04 .82 .60
KLA/ATP .84 .86 .77 .82 .72 .66 .51
Aldh3a1
KLA  ATP  ATP+KLA
 NM_007436 aldehyde dehydrogenase family 3, subfamily A1 (Aldh3a1), transcript variant 1, mRNA [NM_007436] KLA .98 .98 1.03 1.01 1.03 1.04 .97
ATP .98 1.01 1.06 .95 1.00 .96 1.02
KLA/ATP 1.07 1.08 .99 .98 1.03 .93 .98
Aldh3a2
KLA  ATP  ATP+KLA
 NM_007437 aldehyde dehydrogenase family 3, subfamily A2 (Aldh3a2), mRNA [NM_007437] KLA .86 .83 .79 .79 .80 .97 1.00
ATP .93 .98 .94 .89 .77 .87 1.02
KLA/ATP .78 .81 .67 .72 .65 .81 .97
Aldh3b1
KLA  ATP  ATP+KLA
 NM_026316 aldehyde dehydrogenase 3 family, member B1 (Aldh3b1), mRNA [NM_026316] KLA .82 .77 .69 .77 .72 .97 1.31
ATP .88 .85 1.13 .89 .71 .56 1.25
KLA/ATP .66 .72 .84 .66 .66 .52 1.17
Aldh3b2
KLA  ATP  ATP+KLA
 XM_129134 gb|PREDICTED: Mus musculus aldehyde dehydrogenase 3 family, member B2 (Aldh3b2), mRNA [XM_129134] KLA .91 .93 .85 .88 1.01 .99 1.37
ATP 1.12 1.11 .99 1.19 .87 .61 1.31
KLA/ATP .86 1.02 .90 1.01 .72 .54 1.21
Aldh4a1
KLA  ATP  ATP+KLA
 NM_175438 aldehyde dehydrogenase 4 family, member A1 (Aldh4a1), nuclear gene encoding mitochondrial protein, mRNA [NM_175438] KLA .90 .85 .85 .82 .87 .94 .87
ATP 1.05 1.16 1.03 1.02 .81 .83 1.00
KLA/ATP .92 .88 .84 .92 .82 .88 .91
Aldh5a1
KLA  ATP  ATP+KLA
 AK051603 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130059J11 product:succinate-semialdehyde dehydrogenase (EC 1.2.1.24) (fragment) homolog [Rattus norvegicus], full insert sequence. [AK051603] KLA 1.04 .99 1.06 1.03 1.01 1.09 1.08
ATP .94 .93 1.01 1.04 1.06 1.10 1.02
KLA/ATP 1.00 1.03 .83 1.02 1.06 1.03 1.04
Aldh5a1
KLA  ATP  ATP+KLA
 NM_172532 aldhehyde dehydrogenase family 5, subfamily A1 (Aldh5a1), mRNA [NM_172532] KLA .99 .98 .84 .95 .81 .63 .52
ATP .92 .83 1.21 1.06 .90 .70 .57
KLA/ATP .92 .96 1.24 .95 .89 .62 .59
Aldh6a1
KLA  ATP  ATP+KLA
 NM_134042 aldehyde dehydrogenase family 6, subfamily A1 (Aldh6a1), nuclear gene encoding mitochondrial protein, mRNA [NM_134042] KLA 1.02 .97 .98 1.15 1.31 1.39 .67
ATP .96 .92 1.21 .87 .64 .54 .55
KLA/ATP .82 .97 1.04 .87 .80 .59 .36
Aldh7a1
KLA  ATP  ATP+KLA
 NM_138600 aldehyde dehydrogenase family 7, member A1 (Aldh7a1), mRNA [NM_138600] KLA .98 1.03 1.08 1.12 1.08 .94 .99
ATP 1.01 1.03 1.00 1.03 .98 .82 .91
KLA/ATP 1.15 1.12 1.01 1.02 .90 .89 .83
Aldh9a1
KLA  ATP  ATP+KLA
 NM_019993 aldehyde dehydrogenase 9, subfamily A1 (Aldh9a1), mRNA [NM_019993] KLA .64 .64 .67 .48 .42 .24 .33
ATP 1.07 1.02 .75 .94 .68 .46 .42
KLA/ATP .72 .65 .43 .55 .37 .31 .24
Aldoa
KLA  ATP  ATP+KLA
 NM_007438 aldolase 1, A isoform (Aldoa), mRNA [NM_007438] KLA .81 .83 .75 .81 .83 .80 1.22
ATP .97 .93 .78 .78 1.01 1.14 1.35
KLA/ATP .80 .86 .84 .70 .80 .81 1.12
Aldoart1
KLA  ATP  ATP+KLA
 AK016845 adult male testis cDNA, RIKEN full-length enriched library, clone:4933417I20 product:ALDOLASE 1, A ISOFORM homolog [Mus musculus], full insert sequence [AK016845] KLA 1.01 1.01 1.03 .98 .95 .96 1.03
ATP 1.00 1.01 .98 .90 .99 1.03 .91
KLA/ATP .97 1.01 1.04 .99 1.07 1.00 .98
Aldob
KLA  ATP  ATP+KLA
 NM_144903 aldolase 2, B isoform (Aldob), mRNA [NM_144903] KLA .99 1.01 1.02 1.02 1.02 1.03 1.04
ATP 1.02 1.02 1.00 1.05 1.02 1.02 1.01
KLA/ATP 1.01 1.04 1.00 1.03 1.03 1.02 .97
Aldoc
KLA  ATP  ATP+KLA
 AK039267 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330009L16 product:aldolase 3, C isoform, full insert sequence [AK039267] KLA .84 .77 .75 .78 .51 .34 .14
ATP .86 .84 1.15 1.01 .85 .60 .33
KLA/ATP .71 .78 .94 .76 .60 .34 .14
Aldoc
KLA  ATP  ATP+KLA
 NM_009657 aldolase 3, C isoform (Aldoc), mRNA [NM_009657] KLA .88 .94 .93 .76 .72 .46 .16
ATP 1.02 1.17 1.00 1.29 1.00 .62 .76
KLA/ATP .99 1.00 .82 1.04 .71 .46 .18
Alg1
KLA  ATP  ATP+KLA
 NM_145362 asparagine-linked glycosylation 1 homolog (yeast, beta-1,4-mannosyltransferase) (Alg1), mRNA [NM_145362] KLA .79 .78 .77 .77 .77 1.01 1.26
ATP .95 .98 1.09 1.04 .89 .57 1.18
KLA/ATP .77 .83 .89 .78 .71 .62 .82
Alg11
KLA  ATP  ATP+KLA
 BC061469 asparagine-linked glycosylation 11 homolog (yeast, alpha-1,2-mannosyltransferase), mRNA (cDNA clone MGC:67180 IMAGE:6821552), complete cds [BC061469] KLA 1.14 1.03 1.11 1.24 1.36 1.33 1.92
ATP 1.13 1.01 .77 .62 .86 .98 1.04
KLA/ATP 1.32 1.05 .82 .69 .71 .81 .82
Alg11
KLA  ATP  ATP+KLA
 NM_183142 asparagine-linked glycosylation 11 homolog (yeast, alpha-1,2-mannosyltransferase) (Alg11), mRNA [NM_183142] KLA 1.30 1.30 1.18 1.35 1.28 1.33 1.56
ATP .94 .97 .96 .84 .75 1.22 1.37
KLA/ATP 1.21 1.36 1.24 1.07 .87 .91 .96
Alg12
KLA  ATP  ATP+KLA
 NM_145477 asparagine-linked glycosylation 12 homolog (yeast, alpha-1,6-mannosyltransferase) (Alg12), mRNA [NM_145477] KLA .90 .89 .96 1.01 1.25 1.45 1.51
ATP .89 .79 .64 .58 .61 1.15 1.59
KLA/ATP .89 .78 .67 .64 .72 .89 1.69
Alg13
KLA  ATP  ATP+KLA
 NM_026247 asparagine-linked glycosylation 13 homolog (S. cerevisiae) (Alg13), mRNA [NM_026247] KLA 1.17 1.10 1.22 1.18 1.05 1.11 1.12
ATP 1.07 1.02 1.39 1.23 1.09 1.06 .83
KLA/ATP 1.09 1.15 1.43 1.21 1.04 .97 1.00
Alg14
KLA  ATP  ATP+KLA
 AK017354 6 days neonate head cDNA, RIKEN full-length enriched library, clone:5430428G01 product:weakly similar to probable glycosyl transferase [Schizosaccharomyces pombe], full insert sequence [AK017354] KLA .93 .96 .92 .92 .81 .88 .66
ATP .93 .89 1.20 .94 .80 .58 .33
KLA/ATP .91 .90 1.14 .93 .78 .54 .26
Alg14
KLA  ATP  ATP+KLA
 NM_024178 asparagine-linked glycosylation 14 homolog (yeast) (Alg14), mRNA [NM_024178] KLA 1.04 1.15 1.03 1.07 1.03 1.22 1.08
ATP .93 1.06 1.19 1.21 1.01 .80 .63
KLA/ATP 1.05 1.16 1.24 1.37 1.15 1.09 .65
Alg2
KLA  ATP  ATP+KLA
 NM_019998 asparagine-linked glycosylation 2 homolog (yeast, alpha-1,3-mannosyltransferase) (Alg2), mRNA [NM_019998] KLA .61 .55 .56 .45 .59 .67 1.43
ATP 1.31 1.64 1.04 1.28 .69 .37 1.64
KLA/ATP .69 .82 .45 .66 .37 .37 .94
Alg3
KLA  ATP  ATP+KLA
 NM_145939 asparagine-linked glycosylation 3 homolog (yeast, alpha-1,3-mannosyltransferase) (Alg3), mRNA [NM_145939] KLA 1.20 1.27 1.20 1.19 1.20 1.21 1.40
ATP 1.05 1.11 1.02 1.35 1.17 1.01 1.20
KLA/ATP 1.36 1.34 1.13 1.51 1.20 1.17 1.02
Alg5
KLA  ATP  ATP+KLA
 NM_025442 asparagine-linked glycosylation 5 homolog (yeast, dolichyl-phosphate beta-glucosyltransferase) (Alg5), mRNA [NM_025442] KLA .87 .92 .84 .82 .70 .73 .98
ATP .95 .89 1.20 1.03 .87 .76 .96
KLA/ATP .82 .89 1.12 .92 .77 .58 .61
Alg6
KLA  ATP  ATP+KLA
 NM_001081264 asparagine-linked glycosylation 6 homolog (yeast, alpha-1,3,-glucosyltransferase) (Alg6), mRNA [NM_001081264] KLA .84 .83 .80 .69 .62 .58 .72
ATP 1.09 1.01 1.00 .90 .72 .46 .60
KLA/ATP .83 .87 .77 .75 .60 .46 .44
Alg8
KLA  ATP  ATP+KLA
 NM_199035 asparagine-linked glycosylation 8 homolog (yeast, alpha-1,3-glucosyltransferase) (Alg8), mRNA [NM_199035] KLA .94 .98 .94 .84 .84 .81 .96
ATP 1.02 1.15 .98 1.15 .90 .67 .66
KLA/ATP .98 1.02 .86 1.01 .75 .64 .54
Alg9
KLA  ATP  ATP+KLA
 AK021024 4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430313H07 product:unclassifiable, full insert sequence. [AK021024] KLA .98 .98 .96 1.01 1.00 .99 .97
ATP .96 .93 .96 .98 .98 .98 1.03
KLA/ATP .94 .91 1.02 1.04 1.00 1.01 1.01
Alg9
KLA  ATP  ATP+KLA
 NM_133981 asparagine-linked glycosylation 9 homolog (yeast, alpha 1,2 mannosyltransferase) (Alg9), mRNA [NM_133981] KLA 1.38 1.47 1.46 1.36 1.36 1.17 1.31
ATP 1.00 1.09 1.18 1.35 1.25 1.21 1.23
KLA/ATP 1.44 1.57 1.47 1.68 1.29 1.12 1.47
Allc
KLA  ATP  ATP+KLA
 AF278712 allantoicase mRNA, complete cds [AF278712] KLA 1.00 1.01 .95 1.01 1.10 1.05 1.01
ATP 1.00 1.05 1.05 1.04 1.04 1.10 .99
KLA/ATP .99 .94 1.14 1.04 1.10 1.00 1.05
Alox12
KLA  ATP  ATP+KLA
 NM_007440 arachidonate 12-lipoxygenase (Alox12), mRNA [NM_007440] KLA 1.35 1.36 1.42 1.25 1.25 1.13 1.15
ATP 1.05 1.01 1.03 1.04 1.04 1.42 1.20
KLA/ATP 1.36 1.29 1.23 1.26 1.24 1.31 1.80
Alox12b
KLA  ATP  ATP+KLA
 NM_009659 arachidonate 12-lipoxygenase, 12R type (Alox12b), mRNA [NM_009659] KLA 1.09 1.09 1.18 1.15 1.14 1.28 1.26
ATP .99 .92 1.09 1.07 1.03 1.10 1.29
KLA/ATP 1.16 1.20 1.27 1.30 1.21 1.19 1.30
Alox12e
KLA  ATP  ATP+KLA
 NM_145684 arachidonate lipoxygenase, epidermal (Alox12e), mRNA [NM_145684] KLA .97 .99 1.05 .94 .99 1.01 .96
ATP 1.00 .97 1.01 .98 1.01 1.01 .94
KLA/ATP .99 .92 .91 .98 .95 .95 .95
Alox15
KLA  ATP  ATP+KLA
 NM_009660 arachidonate 15-lipoxygenase (Alox15), mRNA [NM_009660] KLA 1.02 .93 .98 .96 .98 .95 .87
ATP .92 .95 1.09 1.01 .98 1.00 .97
KLA/ATP .97 .95 .98 .94 .98 .97 .92
Alox5
KLA  ATP  ATP+KLA
 NM_009662 arachidonate 5-lipoxygenase (Alox5), mRNA [NM_009662] KLA .83 .87 .88 .87 .71 .58 .21
ATP 1.03 1.03 1.14 1.21 .93 .55 .41
KLA/ATP .86 .85 .90 .97 .84 .61 .24
Alox8
KLA  ATP  ATP+KLA
 NM_009661 arachidonate 8-lipoxygenase (Alox8), mRNA [NM_009661] KLA 1.02 .99 1.01 1.00 .99 1.06 .95
ATP 1.04 .99 .86 .96 .92 1.02 .95
KLA/ATP .98 .99 1.03 1.00 .98 .91 .90
Alpi
KLA  ATP  ATP+KLA
 NM_001081082 alkaline phosphatase, intestinal (Alpi), mRNA [NM_001081082] KLA 1.03 1.06 .97 .99 1.06 1.04 1.02
ATP 1.02 1.04 1.00 1.09 1.06 .96 1.01
KLA/ATP .99 1.01 1.07 1.02 1.02 .93 .99
Alpl
KLA  ATP  ATP+KLA
 NM_007431 alkaline phosphatase, liver/bone/kidney (Alpl), mRNA [NM_007431] KLA .98 .95 1.02 1.00 .97 .99 1.08
ATP .99 1.06 .96 .99 .96 1.02 1.04
KLA/ATP .96 1.05 1.02 .94 1.03 1.03 1.01
Amacr
KLA  ATP  ATP+KLA
 NM_008537 alpha-methylacyl-CoA racemase (Amacr), mRNA [NM_008537] KLA .64 .63 .59 .57 .51 .48 .77
ATP .99 .93 1.20 1.14 .69 .61 1.01
KLA/ATP .62 .65 .73 .82 .67 .67 .51
Amd1
KLA  ATP  ATP+KLA
 NM_009665 S-adenosylmethionine decarboxylase 1 (Amd1), mRNA [NM_009665] KLA .71 .69 .69 .65 .62 .90 1.66
ATP 1.13 1.16 .83 .88 .87 1.04 1.21
KLA/ATP .80 .85 .61 .63 .63 .68 .77
Amd1
KLA  ATP  ATP+KLA
 Z14986 gb|M.musculus mRNA encoding adenosylmethionine decarboxylase. [Z14986] KLA .55 .52 .41 .38 .38 .81 1.42
ATP .87 .85 .86 .52 .84 1.43 1.06
KLA/ATP .50 .46 .41 .33 .49 .60 .59
Amdhd1
KLA  ATP  ATP+KLA
 XM_125854 gb|PREDICTED: Mus musculus amidohydrolase domain containing 1 (Amdhd1), mRNA [XM_125854] KLA 1.09 .88 1.02 1.27 1.11 1.07 .97
ATP .99 1.00 .98 .98 .94 .99 1.04
KLA/ATP 1.03 1.05 1.07 1.01 .98 .96 1.02
Ampd1
KLA  ATP  ATP+KLA
 NM_001033303 adenosine monophosphate deaminase 1 (isoform M) (Ampd1), mRNA [NM_001033303] KLA 1.16 1.10 1.14 1.19 1.09 1.15 1.15
ATP .98 .96 1.45 4.08 3.21 2.03 1.20
KLA/ATP 1.21 1.17 1.71 3.85 3.43 2.96 1.55
Ampd2
KLA  ATP  ATP+KLA
 NM_028779 adenosine monophosphate deaminase 2 (isoform L) (Ampd2), mRNA [NM_028779] KLA .81 .66 .53 .41 .43 .60 .87
ATP .91 .83 .96 .74 .82 1.00 1.04
KLA/ATP .72 .66 .66 .48 .67 .57 .48
Ampd3
KLA  ATP  ATP+KLA
 NM_009667 AMP deaminase 3 (Ampd3), mRNA [NM_009667] KLA 1.30 1.21 1.06 .72 .73 .81 1.16
ATP 1.07 1.16 1.00 1.22 2.65 2.99 1.80
KLA/ATP 1.38 1.30 .96 .91 .90 2.18 2.05
Amy1
KLA  ATP  ATP+KLA
 NM_007446 amylase 1, salivary (Amy1), transcript variant 1, mRNA [NM_007446] KLA 1.03 1.01 1.14 1.07 1.06 1.13 1.16
ATP .99 .98 1.08 1.06 1.09 1.18 1.11
KLA/ATP 1.06 1.10 1.19 1.13 1.16 1.43 1.21
Anpep
KLA  ATP  ATP+KLA
 NM_008486 alanyl (membrane) aminopeptidase (Anpep), mRNA [NM_008486] KLA .93 .81 .87 .91 1.05 1.06 .71
ATP .99 .98 1.00 1.08 1.04 .93 1.45
KLA/ATP .85 .89 .82 .97 .97 .93 .90
Aoc2
KLA  ATP  ATP+KLA
 NM_178932 amine oxidase, copper containing 2 (retina-specific) (Aoc2), mRNA [NM_178932] KLA 1.21 1.19 1.15 1.00 1.15 1.21 1.18
ATP 1.13 1.13 1.14 1.36 1.85 1.32 .76
KLA/ATP 1.27 1.34 1.12 1.32 1.67 1.37 1.05
Aoc3
KLA  ATP  ATP+KLA
 NM_009675 amine oxidase, copper containing 3 (Aoc3), mRNA [NM_009675] KLA .95 1.06 1.00 1.05 1.00 1.02 1.01
ATP 1.01 .90 1.04 1.07 1.06 1.06 .97
KLA/ATP 1.06 .98 .92 1.10 1.11 1.09 1.01
Aox1
KLA  ATP  ATP+KLA
 NM_009676 aldehyde oxidase 1 (Aox1), mRNA [NM_009676] KLA .87 .83 .82 .82 .71 .98 1.65
ATP 1.01 1.02 1.05 .84 .72 .86 .80
KLA/ATP .82 .84 .90 .73 .72 .82 1.06
Aox3
KLA  ATP  ATP+KLA
 NM_023617 aldehyde oxidase 3 (Aox3), mRNA [NM_023617] KLA .95 1.02 1.01 1.00 .99 1.01 1.04
ATP 1.04 1.03 1.01 .94 1.03 .92 .96
KLA/ATP 1.09 1.11 1.00 .97 .95 1.01 .94
Aox4
KLA  ATP  ATP+KLA
 NM_023631 aldehyde oxidase 4 (Aox4), mRNA [NM_023631] KLA .95 .97 .98 1.00 .98 .91 1.06
ATP .93 .99 .95 .99 .94 .95 1.00
KLA/ATP 1.05 1.00 .94 .98 .89 1.00 .93
Apip
KLA  ATP  ATP+KLA
 NM_019735 APAF1 interacting protein (Apip), mRNA [NM_019735] KLA .99 .99 .87 .95 .83 .92 1.04
ATP .86 .83 1.13 1.07 .91 .77 .91
KLA/ATP .84 .92 1.17 1.00 1.02 .86 1.02
Aprt
KLA  ATP  ATP+KLA
 M11310 gb|Mouse adenine phosphoribosyltransferase (APRT), complete cds [M11310] KLA .70 .70 .57 .69 .71 .78 1.14
ATP .88 .63 .44 .81 .63 .73 1.24
KLA/ATP .76 .59 .49 .67 .67 .68 .93
Aprt
KLA  ATP  ATP+KLA
 NM_009698 adenine phosphoribosyl transferase (Aprt), mRNA [NM_009698] KLA .74 .70 .73 .69 .64 .65 1.02
ATP 1.17 1.10 .90 1.10 .98 .66 1.42
KLA/ATP .84 .81 .70 .75 .73 .60 .95
Arg1
KLA  ATP  ATP+KLA
 NM_007482 arginase 1, liver (Arg1), mRNA [NM_007482] KLA .98 1.01 .97 .97 1.12 1.83 1.27
ATP .98 1.00 1.11 .94 .98 5.11 20.89
KLA/ATP .92 1.03 1.02 1.02 .99 3.54 18.22
Arg2
KLA  ATP  ATP+KLA
 NM_009705 arginase type II (Arg2), mRNA [NM_009705] KLA 1.93 1.99 2.17 2.47 2.41 2.13 4.33
ATP 1.01 1.08 1.69 5.21 16.98 33.44 6.60
KLA/ATP 2.20 2.09 3.52 10.32 17.71 32.56 24.21
Arsb
KLA  ATP  ATP+KLA
 AK083309 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920003D12 product:arylsulfatase B structural, full insert sequence. [AK083309] KLA .99 .88 .99 .93 .92 .98 1.00
ATP 1.07 1.12 1.10 .95 1.01 .97 .90
KLA/ATP .96 1.03 .95 .94 .94 .94 .99
Arsb
KLA  ATP  ATP+KLA
 NM_009712 arylsulfatase B (Arsb), mRNA [NM_009712] KLA 1.11 1.13 1.16 1.02 .93 .79 .60
ATP 1.04 1.21 1.12 1.46 1.00 .74 .56
KLA/ATP 1.20 1.32 1.05 1.33 .84 .72 .54
Asah1
KLA  ATP  ATP+KLA
 NM_019734 N-acylsphingosine amidohydrolase 1 (Asah1), mRNA [NM_019734] KLA .80 .84 .84 .69 .72 .78 1.09
ATP 1.04 1.26 1.00 1.15 .82 .53 .72
KLA/ATP .87 .89 .63 .82 .51 .47 .49
Asah2
KLA  ATP  ATP+KLA
 NM_018830 N-acylsphingosine amidohydrolase 2 (Asah2), mRNA [NM_018830] KLA 1.87 2.01 2.15 1.97 1.73 1.55 1.28
ATP .94 .87 .90 .86 .68 .59 .69
KLA/ATP 1.87 1.92 1.74 1.48 1.02 .84 .87
Asah3
KLA  ATP  ATP+KLA
 NM_175731 N-acylsphingosine amidohydrolase (alkaline ceramidase) 3 (Asah3), mRNA [NM_175731] KLA 1.01 .98 .99 1.01 1.09 1.01 1.05
ATP .97 1.02 1.00 1.01 1.01 1.07 1.08
KLA/ATP .96 .97 1.05 1.04 1.05 1.01 1.07
Asah3l
KLA  ATP  ATP+KLA
 AK046888 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930001C21 product:hypothetical protein, full insert sequence. [AK046888] KLA 1.18 1.09 1.15 1.30 1.15 1.19 1.02
ATP 1.05 1.06 1.33 1.50 1.65 1.53 .99
KLA/ATP 1.29 1.32 1.73 1.71 1.67 1.54 1.41
Asah3l
KLA  ATP  ATP+KLA
 NM_139306 N-acylsphingosine amidohydrolase 3-like (Asah3l), mRNA [NM_139306] KLA 1.16 1.09 1.05 .94 .82 .89 .89
ATP 1.10 .98 1.17 3.98 4.06 2.11 1.04
KLA/ATP 1.00 1.07 1.04 2.15 2.34 2.03 1.00
Asl
KLA  ATP  ATP+KLA
 NM_133768 argininosuccinate lyase (Asl), mRNA [NM_133768] KLA .88 .92 .83 .75 .78 .83 1.05
ATP 1.00 1.09 .93 1.21 1.02 .85 1.41
KLA/ATP .89 .96 .74 1.01 .81 .85 1.55
Asns
KLA  ATP  ATP+KLA
 NM_012055 asparagine synthetase (Asns), mRNA [NM_012055] KLA .89 .91 .75 .69 .53 .85 2.04
ATP .87 .80 1.06 .79 2.07 2.78 1.76
KLA/ATP .85 .80 .84 .58 1.02 1.08 .97
Ass1
KLA  ATP  ATP+KLA
 M31690 gb|Mouse argininosuccinate synthetase (Ass) mRNA, complete cds. [M31690] KLA 4.67 5.37 6.47 6.68 8.75 9.43 8.52
ATP 1.17 1.32 1.27 1.78 2.00 6.66 7.95
KLA/ATP 5.78 6.01 5.41 6.67 6.73 8.48 13.11
Ass1
KLA  ATP  ATP+KLA
 NM_007494 argininosuccinate synthetase 1 (Ass1), mRNA [NM_007494] KLA 4.88 5.58 7.14 7.84 10.68 11.29 9.93
ATP 1.12 1.29 1.28 1.75 2.04 7.76 9.44
KLA/ATP 5.70 6.62 5.49 8.11 6.90 9.65 16.23
Atic
KLA  ATP  ATP+KLA
 NM_026195 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (Atic), mRNA [NM_026195] KLA .86 .91 .91 .70 .63 .49 .77
ATP 1.16 1.33 1.00 1.41 .87 .41 .59
KLA/ATP 1.07 1.15 .70 1.01 .57 .31 .26
Atp5a1
KLA  ATP  ATP+KLA
 NM_007505 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 (Atp5a1), nuclear gene encoding mitochondrial protein, mRNA [NM_007505] KLA 1.02 1.10 1.08 1.14 1.13 1.03 .85
ATP 1.07 1.00 .95 .88 .91 .80 .75
KLA/ATP 1.11 1.09 1.08 .98 .88 .83 .61
Atp5b
KLA  ATP  ATP+KLA
 NM_016774 ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit (Atp5b), nuclear gene encoding mitochondrial protein, mRNA [NM_016774] KLA 1.11 1.13 1.13 1.09 1.15 1.07 1.24
ATP 1.02 1.09 .93 1.03 1.00 .97 1.00
KLA/ATP 1.11 1.19 .98 1.15 .89 1.01 1.03
Atp5c1
KLA  ATP  ATP+KLA
 NM_020615 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (Atp5c1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_020615] KLA .88 .85 .87 .98 .79 .90 .98
ATP .92 .82 1.11 .82 .80 .68 .77
KLA/ATP .79 .76 .96 .73 .83 .80 .68
Atp5d
KLA  ATP  ATP+KLA
 NM_025313 ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit (Atp5d), nuclear gene encoding mitochondrial protein, mRNA [NM_025313] KLA .84 .97 .92 .82 .91 .85 1.08
ATP 1.07 1.23 .92 1.35 1.15 .96 .97
KLA/ATP 1.05 1.00 .71 1.22 .91 1.09 1.16
Atp5e
KLA  ATP  ATP+KLA
 NM_025983 ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (Atp5e), nuclear gene encoding mitochondrial protein, mRNA [NM_025983] KLA .97 1.02 .91 .99 .90 .89 1.09
ATP 1.01 1.01 1.09 1.18 1.07 1.04 .87
KLA/ATP .99 .97 1.05 1.13 1.13 .90 .87
Atp5f1
KLA  ATP  ATP+KLA
 AK081249 adult male corpus striatum cDNA, RIKEN full-length enriched library, clone:C030026E11 product:ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1, full insert sequence. [AK081249] KLA 1.19 1.09 1.16 1.04 1.10 1.05 1.16
ATP .89 1.05 1.03 .97 .94 .98 1.20
KLA/ATP 1.09 .99 1.09 1.11 .98 .99 1.09
Atp5f1
KLA  ATP  ATP+KLA
 BC049640 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1, mRNA (cDNA clone IMAGE:6590806), complete cds. [BC049640] KLA 1.10 1.21 1.29 1.24 1.32 1.26 1.11
ATP .99 1.05 1.11 1.16 1.11 .86 .84
KLA/ATP 1.11 1.21 1.32 1.30 1.30 1.06 .77
Atp5f1
KLA  ATP  ATP+KLA
 NM_009725 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 (Atp5f1), nuclear gene encoding mitochondrial protein, mRNA [NM_009725] KLA 1.05 1.15 1.15 1.21 1.22 1.27 1.11
ATP 1.04 1.02 .99 .95 .97 .83 .88
KLA/ATP 1.18 1.08 1.14 1.02 1.06 .98 .69
Atp5g1
KLA  ATP  ATP+KLA
 NM_007506 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 1 (Atp5g1), nuclear gene encoding mitochondrial protein, mRNA [NM_007506] KLA .87 .97 .86 .93 .86 .82 .88
ATP 1.02 .97 1.09 1.28 1.26 1.00 .82
KLA/ATP .98 1.03 .99 1.16 1.15 1.02 .61
Atp5g2
KLA  ATP  ATP+KLA
 NM_026468 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 2 (Atp5g2), nuclear gene encoding mitochondrial protein, mRNA [NM_026468] KLA .86 .84 .84 .81 .78 .71 .70
ATP 1.05 1.08 1.06 1.30 1.15 .78 .62
KLA/ATP .92 .92 .92 1.09 .95 .74 .52
Atp5g3
KLA  ATP  ATP+KLA
 NM_175015 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 3 (Atp5g3), nuclear gene encoding mitochondrial protein, mRNA [NM_175015] KLA 1.29 1.12 1.05 1.36 1.13 1.16 .86
ATP 1.06 .96 1.44 .84 1.01 1.25 .81
KLA/ATP .89 .93 1.74 .96 1.00 1.07 .71
Atp5h
KLA  ATP  ATP+KLA
 NM_027862 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d (Atp5h), nuclear gene encoding mitochondrial protein, mRNA [NM_027862] KLA .86 .93 .85 .84 .84 .79 .84
ATP 1.01 1.04 .92 1.09 1.00 .89 .78
KLA/ATP .94 .92 .83 1.03 .92 .86 .78
Atp5j
KLA  ATP  ATP+KLA
 NM_016755 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F (Atp5j), nuclear gene encoding mitochondrial protein, mRNA [NM_016755] KLA .89 .90 .87 .96 .86 .90 .92
ATP .94 .96 1.06 .94 .89 1.04 .85
KLA/ATP .89 .88 1.04 .91 .94 .93 .87
Atp5j2
KLA  ATP  ATP+KLA
 AK153846 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920021K10 product:hypothetical protein, full insert sequence [AK153846] KLA .84 .87 .89 .90 1.00 .94 .99
ATP .50 .39 .43 .61 .93 .87 .82
KLA/ATP .64 .50 .54 .75 .88 .99 .97
Atp5j2
KLA  ATP  ATP+KLA
 NM_020582 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2 (Atp5j2), nuclear gene encoding mitochondrial protein, mRNA [NM_020582] KLA .91 .88 .87 .84 .81 .90 .91
ATP .93 1.00 1.16 1.20 1.10 .96 .82
KLA/ATP .86 .90 1.07 1.09 1.10 1.00 .86
Atp5k
KLA  ATP  ATP+KLA
 NM_007507 ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit e (Atp5k), nuclear gene encoding mitochondrial protein, mRNA [NM_007507] KLA 1.14 1.10 1.07 1.20 1.11 .80 .99
ATP 1.11 1.20 1.24 1.47 1.48 1.20 1.01
KLA/ATP 1.22 1.24 1.36 1.58 1.41 1.33 1.37
Atp5l
KLA  ATP  ATP+KLA
 NM_013795 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g (Atp5l), nuclear gene encoding mitochondrial protein, mRNA [NM_013795] KLA 1.04 .97 1.03 .98 .92 .93 .90
ATP 1.16 1.09 1.26 1.28 1.23 1.06 .71
KLA/ATP 1.05 1.03 1.30 1.27 1.28 1.07 .82
Atp5o
KLA  ATP  ATP+KLA
 NM_138597 ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (Atp5o), nuclear gene encoding mitochondrial protein, mRNA [NM_138597] KLA 1.01 .99 1.01 1.15 1.17 1.28 1.19
ATP 1.06 1.05 1.12 1.08 1.08 .95 .93
KLA/ATP 1.10 .98 1.13 1.28 1.04 1.05 1.05
Atp6ap1
KLA  ATP  ATP+KLA
 NM_018794 ATPase, H+ transporting, lysosomal accessory protein 1 (Atp6ap1), mRNA [NM_018794] KLA .73 .83 .89 .71 .74 .71 1.06
ATP 1.05 1.08 .94 1.12 .99 .79 1.07
KLA/ATP .90 .81 .72 .84 .62 .64 .97
Atp6v0a1
KLA  ATP  ATP+KLA
 AK045877 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230316H04 product:unclassifiable, full insert sequence [AK045877] KLA .65 .64 .58 .48 .57 .46 .29
ATP .64 .28 .48 .28 .45 .30 .91
KLA/ATP .51 .26 .37 .31 .54 .45 .63
Atp6v0a1
KLA  ATP  ATP+KLA
 NM_016920 ATPase, H+ transporting, lysosomal V0 subunit A1 (Atp6v0a1), mRNA [NM_016920] KLA .88 .91 .88 .80 .66 .52 .45
ATP 1.05 1.22 .91 1.05 .58 .40 1.46
KLA/ATP .97 1.04 .80 .89 .55 .43 .75
Atp6v0a2
KLA  ATP  ATP+KLA
 AK160318 16 days embryo lung cDNA, RIKEN full-length enriched library, clone:8430408C20 product:unclassifiable, full insert sequence [AK160318] KLA 1.21 1.13 1.18 1.30 1.39 1.58 1.38
ATP 1.10 .94 .55 .35 .72 .96 .84
KLA/ATP 1.12 1.08 .82 .54 .81 1.05 .59
Atp6v0a2
KLA  ATP  ATP+KLA
 BC112905 ATPase, H+ transporting, lysosomal V0 subunit A2, mRNA (cDNA clone MGC:118073 IMAGE:3670722), complete cds [BC112905] KLA 1.65 1.66 1.74 2.07 1.97 2.78 2.71
ATP .88 .61 .53 .30 .38 1.26 2.12
KLA/ATP 1.38 1.29 .91 .62 .59 1.36 2.13
Atp6v0a2
KLA  ATP  ATP+KLA
 NM_011596 ATPase, H+ transporting, lysosomal V0 subunit A2 (Atp6v0a2), mRNA [NM_011596] KLA 2.26 2.07 2.01 2.71 2.48 3.69 2.76
ATP .79 .64 .62 .42 .62 2.31 3.11
KLA/ATP 1.69 1.57 1.47 .90 1.06 2.56 4.84
Atp6v0a4
KLA  ATP  ATP+KLA
 NM_080467 ATPase, H+ transporting, lysosomal V0 subunit A4 (Atp6v0a4), mRNA [NM_080467] KLA 1.01 1.00 .99 1.03 1.01 1.02 .98
ATP 1.02 1.05 .93 1.03 1.05 1.01 .97
KLA/ATP 1.02 .94 1.00 .99 1.00 1.01 1.03
Atp6v0b
KLA  ATP  ATP+KLA
 NM_033617 ATPase, H+ transporting, lysosomal V0 subunit B (Atp6v0b), mRNA [NM_033617] KLA .91 1.00 1.07 .81 1.25 1.34 1.44
ATP 1.12 1.33 .80 1.41 1.47 1.67 1.77
KLA/ATP 1.20 1.16 .62 1.28 1.01 1.77 2.37
Atp6v0c
KLA  ATP  ATP+KLA
 NM_009729 ATPase, H+ transporting, lysosomal V0 subunit C (Atp6v0c), mRNA [NM_009729] KLA .89 .98 1.05 .90 1.18 1.38 1.52
ATP 1.07 1.28 .93 1.66 1.48 1.35 2.35
KLA/ATP 1.10 1.12 .67 1.50 1.18 1.66 2.51
Atp6v0d1
KLA  ATP  ATP+KLA
 NM_013477 ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477] KLA .84 .85 .94 .79 1.10 1.24 1.27
ATP 1.18 1.48 .94 1.40 1.12 .75 1.85
KLA/ATP 1.05 1.06 .59 1.06 .83 .85 1.96
Atp6v0d2
KLA  ATP  ATP+KLA
 NM_175406 ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406] KLA .77 .72 .64 .54 .43 .27 .18
ATP 1.19 1.35 1.06 1.47 1.46 .79 .96
KLA/ATP .78 .95 .63 1.12 1.21 1.01 .50
Atp6v0e
KLA  ATP  ATP+KLA
 AK134836 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330589P19 product:ATPase, H+ transporting, V0 subunit, full insert sequence. [AK134836] KLA 1.09 1.06 1.02 1.42 1.32 1.14 .92
ATP .93 1.18 1.02 1.34 1.72 1.34 1.44
KLA/ATP .97 .89 .94 1.32 2.01 1.43 1.72
Atp6v0e
KLA  ATP  ATP+KLA
 NM_025272 ATPase, H+ transporting, lysosomal V0 subunit E (Atp6v0e), mRNA [NM_025272] KLA 1.00 .95 .87 .99 .98 1.20 1.26
ATP .91 .98 1.11 1.17 1.29 1.54 1.59
KLA/ATP .86 .94 1.07 1.05 1.29 1.57 1.83
Atp6v0e2
KLA  ATP  ATP+KLA
 NM_133764 ATPase, H+ transporting, lysosomal V0 subunit E2 (Atp6v0e2), mRNA [NM_133764] KLA .98 .93 .90 .99 .88 .90 .92
ATP 1.08 1.02 1.03 1.07 .98 .88 .94
KLA/ATP .98 .99 .97 1.00 .89 .90 .88
Atp6v1a
KLA  ATP  ATP+KLA
 NM_007508 ATPase, H+ transporting, lysosomal V1 subunit A (Atp6v1a), mRNA [NM_007508] KLA .77 .77 .70 .59 .58 .61 .84
ATP 1.04 1.45 .99 1.82 1.34 1.00 1.21
KLA/ATP .82 .97 .55 1.13 .73 .99 1.09
Atp6v1b1
KLA  ATP  ATP+KLA
 NM_134157 ATPase, H+ transporting, lysosomal V1 subunit B1 (Atp6v1b1), mRNA [NM_134157] KLA 1.00 1.03 1.11 .95 1.01 1.00 1.03
ATP 1.02 1.05 1.01 .97 1.02 .97 1.02
KLA/ATP .98 .94 1.03 1.02 .99 1.00 .96
Atp6v1b2
KLA  ATP  ATP+KLA
 NM_007509 ATPase, H+ transporting, lysosomal V1 subunit B2 (Atp6v1b2), mRNA [NM_007509] KLA .89 .98 1.11 1.07 1.24 1.13 1.12
ATP 1.05 1.11 1.02 1.09 1.03 .79 1.39
KLA/ATP .97 1.05 .95 1.12 1.12 1.37 1.67
Atp6v1c1
KLA  ATP  ATP+KLA
 NM_025494 ATPase, H+ transporting, lysosomal V1 subunit C1 (Atp6v1c1), mRNA [NM_025494] KLA .61 .62 .59 .51 .56 .71 .92
ATP .98 .97 .93 1.07 1.42 1.00 1.28
KLA/ATP .61 .57 .48 .57 1.04 1.18 1.18
Atp6v1c2
KLA  ATP  ATP+KLA
 NM_133699 ATPase, H+ transporting, lysosomal V1 subunit C2 (Atp6v1c2), mRNA [NM_133699] KLA 1.00 .93 .98 .97 1.04 .99 .97
ATP 1.07 .97 .99 .97 .97 1.04 1.06
KLA/ATP 1.01 1.03 1.00 1.03 1.00 .91 .97
Atp6v1d
KLA  ATP  ATP+KLA
 NM_023721 ATPase, H+ transporting, lysosomal V1 subunit D (Atp6v1d), mRNA [NM_023721] KLA 1.45 1.39 1.73 1.95 1.83 2.08 1.29
ATP .91 .88 1.19 1.12 1.73 1.64 2.34
KLA/ATP 1.25 1.32 1.80 1.46 2.05 2.00 2.22
Atp6v1e1
KLA  ATP  ATP+KLA
 NM_007510 VATPase, H+ transporting, lysosomal V1 subunit E1 (Atp6v1e1), mRNA [NM_007510] KLA 1.48 1.55 1.79 1.73 1.79 1.59 1.37
ATP .88 .73 .59 .73 1.30 1.59 1.40
KLA/ATP 1.50 1.43 1.24 1.30 1.57 1.69 1.76
Atp6v1e2
KLA  ATP  ATP+KLA
 NM_029121 ATPase, H+ transporting, lysosomal V1 subunit E2 (Atp6v1e2), mRNA [NM_029121] KLA 1.01 1.04 1.11 1.14 1.19 1.15 1.11
ATP 1.00 .97 1.11 1.06 1.07 1.02 1.08
KLA/ATP 1.03 1.10 1.19 1.10 1.13 1.06 1.09
Atp6v1f
KLA  ATP  ATP+KLA
 NM_025381 ATPase, H+ transporting, lysosomal V1 subunit F (Atp6v1f), mRNA [NM_025381] KLA .92 .94 .93 .96 .96 1.02 1.05
ATP .97 .96 1.07 1.18 1.31 1.16 1.11
KLA/ATP .92 .96 1.06 1.12 1.28 1.24 1.14
Atp6v1g1
KLA  ATP  ATP+KLA
 NM_024173 ATPase, H+ transporting, lysosomal V1 subunit G1 (Atp6v1g1), mRNA [NM_024173] KLA .97 .94 .87 .99 .98 1.01 .96
ATP 1.02 1.02 1.09 1.10 1.29 1.23 1.41
KLA/ATP .83 .92 1.12 1.10 1.23 1.04 .97
Atp6v1g2
KLA  ATP  ATP+KLA
 NM_023179 ATPase, H+ transporting, lysosomal V1 subunit G2 (Atp6v1g2), mRNA [NM_023179] KLA 1.12 1.09 1.03 1.05 1.16 1.15 1.01
ATP .96 1.01 .93 1.06 .85 .83 1.05
KLA/ATP 1.04 1.07 .99 1.07 .90 .82 .98
Atp6v1g3
KLA  ATP  ATP+KLA
 NM_177397 ATPase, H+ transporting, lysosomal V1 subunit G3 (Atp6v1g3), mRNA [NM_177397] KLA 1.05 1.03 1.00 .99 .97 1.02 1.00
ATP 1.04 1.07 1.02 .98 1.05 1.00 1.00
KLA/ATP .99 .98 1.01 1.02 1.03 1.01 1.05
Atp6v1h
KLA  ATP  ATP+KLA
 AK081492 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130021C16 product:hypothetical V-ATPase subunit H containing protein, full insert sequence. [AK081492] KLA 1.09 .98 .77 .93 1.08 1.00 1.10
ATP 1.16 1.43 2.03 3.91 3.02 1.23 1.46
KLA/ATP 1.02 .98 1.06 2.30 2.07 1.28 1.06
Atp6v1h
KLA  ATP  ATP+KLA
 NM_133826 ATPase, H+ transporting, lysosomal V1 subunit H (Atp6v1h), mRNA [NM_133826] KLA 1.13 1.15 1.12 1.05 1.05 .96 1.20
ATP 1.04 1.04 .86 1.06 2.07 2.38 1.90
KLA/ATP 1.14 1.17 .98 1.09 1.55 2.06 1.29
AU021838
KLA  ATP  ATP+KLA
 AK032842 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720461H18 product:unclassifiable, full insert sequence [AK032842] KLA .87 .74 .81 .58 .51 .52 .55
ATP 1.00 1.03 1.09 .76 .43 .45 .42
KLA/ATP .81 .82 .68 .56 .38 .37 .31
Auh
KLA  ATP  ATP+KLA
 NM_016709 AU RNA binding protein/enoyl-coenzyme A hydratase (Auh), nuclear gene encoding mitochondrial protein, mRNA [NM_016709] KLA 1.02 .97 1.20 1.24 1.26 1.18 .91
ATP 1.11 .97 1.26 1.31 1.10 .88 .62
KLA/ATP 1.06 1.11 1.48 1.24 1.57 1.08 .90
B3galnt1
KLA  ATP  ATP+KLA
 NM_020026 UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 (B3galnt1), mRNA [NM_020026] KLA .64 .60 .62 .55 .47 .61 .93
ATP 1.00 .94 1.10 .85 .52 .44 .68
KLA/ATP .61 .62 .65 .53 .49 .49 .71
B3galt1
KLA  ATP  ATP+KLA
 NM_020283 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 (B3galt1), mRNA [NM_020283] KLA 1.02 1.01 .99 1.00 1.04 .97 1.04
ATP .95 1.03 1.00 .98 .98 1.02 1.00
KLA/ATP .95 .96 1.00 1.02 1.00 1.03 1.01
B3galt2
KLA  ATP  ATP+KLA
 NM_020025 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 (B3galt2), mRNA [NM_020025] KLA 1.03 1.03 1.00 1.02 1.01 1.02 1.06
ATP 1.06 1.04 .99 1.07 1.03 1.04 1.03
KLA/ATP 1.03 .99 1.07 1.04 1.00 1.11 1.03
B3galt4
KLA  ATP  ATP+KLA
 NM_019420 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (B3galt4), mRNA [NM_019420] KLA .77 .78 .99 1.07 1.51 1.56 1.56
ATP 1.08 1.12 .94 .81 .46 1.04 1.44
KLA/ATP .90 .88 .74 .85 .64 .97 1.21
B3galt5
KLA  ATP  ATP+KLA
 NM_033149 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3galt5), transcript variant 1, mRNA [NM_033149] KLA .78 .84 .81 .88 .86 .90 .80
ATP 1.03 .88 1.08 .91 .87 .73 .83
KLA/ATP .85 .80 .85 .85 .96 .89 .72
B3galt6
KLA  ATP  ATP+KLA
 NM_080445 UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 (B3galt6), mRNA [NM_080445] KLA .81 .80 .75 .72 .67 .82 1.26
ATP .94 .95 1.24 1.05 .63 .73 1.11
KLA/ATP .74 .76 .84 .75 .67 .61 .61
B3gat3
KLA  ATP  ATP+KLA
 AK079723 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430034G17 product:beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I), full insert sequence [AK079723] KLA 1.21 1.11 .94 .98 1.25 .98 .87
ATP .73 .53 .44 .56 1.39 1.36 .92
KLA/ATP .61 .59 .47 .75 1.73 1.08 .87
B3gat3
KLA  ATP  ATP+KLA
 NM_024256 beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (B3gat3), mRNA [NM_024256] KLA .95 1.03 1.06 .98 1.29 1.33 1.26
ATP 1.10 1.20 .96 1.25 .99 .86 1.13
KLA/ATP 1.13 1.12 .89 1.19 .99 .98 1.40
B3gnt1
KLA  ATP  ATP+KLA
 NM_175383 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3gnt1), mRNA [NM_175383] KLA .65 .62 .59 .58 .52 .53 .68
ATP .95 .97 1.14 1.07 .70 .60 1.38
KLA/ATP .66 .65 .72 .63 .51 .56 .86
B3gnt2
KLA  ATP  ATP+KLA
 NM_016888 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3gnt2), mRNA [NM_016888] KLA 6.47 6.07 7.88 5.30 4.92 2.72 2.46
ATP 1.22 1.39 1.13 1.57 3.07 2.25 2.06
KLA/ATP 7.06 7.52 5.27 7.28 4.11 2.44 1.98
B3gnt3
KLA  ATP  ATP+KLA
 NM_028189 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3gnt3), mRNA [NM_028189] KLA 1.13 1.04 1.04 1.01 .99 .79 .72
ATP 1.09 1.20 1.06 1.35 .93 .72 1.38
KLA/ATP 1.17 1.16 1.11 1.28 .82 .78 1.13
B3gnt4
KLA  ATP  ATP+KLA
 NM_198611 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 (B3gnt4), mRNA [NM_198611] KLA 1.17 1.22 1.16 1.14 1.07 1.04 .99
ATP 1.01 1.04 1.01 .98 .99 1.02 .92
KLA/ATP 1.14 1.20 1.15 1.10 1.12 1.08 1.15
B3gnt5
KLA  ATP  ATP+KLA
 NM_054052 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3gnt5), mRNA [NM_054052] KLA 1.10 1.13 1.09 1.05 .95 .97 .94
ATP 1.04 1.03 1.08 1.20 1.53 1.55 1.34
KLA/ATP 1.08 1.17 1.07 1.08 1.18 1.58 2.54
B4galnt1
KLA  ATP  ATP+KLA
 BC022180 beta-1,4-N-acetyl-galactosaminyl transferase 1, mRNA (cDNA clone IMAGE:4006866), complete cds. [BC022180] KLA .96 .90 .91 .98 .85 .63 .76
ATP 1.00 .91 1.19 1.19 1.01 .78 1.38
KLA/ATP .95 .90 1.11 1.03 .90 .76 .90
B4galnt1
KLA  ATP  ATP+KLA
 NM_008080 beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4galnt1), mRNA [NM_008080] KLA .72 .81 .80 .67 .64 .51 .63
ATP 1.01 1.16 .85 1.04 .67 .50 .82
KLA/ATP .87 .87 .52 .81 .49 .41 .57
B4galt1
KLA  ATP  ATP+KLA
 NM_022305 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (B4galt1), mRNA [NM_022305] KLA .58 .56 .55 .59 .75 1.18 1.17
ATP 1.10 1.15 1.07 1.14 1.05 .71 1.11
KLA/ATP .60 .62 .62 .66 .74 .71 1.10
B4galt2
KLA  ATP  ATP+KLA
 NM_017377 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (B4galt2), mRNA [NM_017377] KLA 1.02 .98 .98 1.02 1.04 1.04 1.00
ATP .98 1.01 1.09 1.64 1.22 .96 .94
KLA/ATP .98 1.03 1.04 1.25 1.10 1.00 1.01
B4galt3
KLA  ATP  ATP+KLA
 BC021830 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3, mRNA (cDNA clone IMAGE:3978260), **** WARNING: chimeric clone ****. [BC021830] KLA .94 .90 .98 1.03 .97 .92 1.01
ATP .89 .82 .99 .87 .86 .91 .94
KLA/ATP .94 .93 .95 .97 .91 .96 .97
B4galt3
KLA  ATP  ATP+KLA
 NM_020579 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 (B4galt3), mRNA [NM_020579] KLA 2.83 2.66 2.21 1.34 .99 1.02 1.09
ATP 1.08 1.11 .77 .64 1.24 1.15 1.12
KLA/ATP 3.28 2.99 2.00 1.55 2.04 2.13 1.47
B4galt4
KLA  ATP  ATP+KLA
 NM_019804 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 (B4galt4), mRNA [NM_019804] KLA .88 .92 .89 .94 .68 .49 .40
ATP .93 .93 1.09 .94 .56 .38 .47
KLA/ATP .91 .86 .98 .94 .78 .45 .30
B4galt6
KLA  ATP  ATP+KLA
 NM_019737 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 (B4galt6), mRNA [NM_019737] KLA .46 .48 .57 .53 .90 .96 .81
ATP 1.09 1.13 .72 .53 .18 .22 .51
KLA/ATP .56 .51 .26 .30 .15 .25 .60
B4galt7
KLA  ATP  ATP+KLA
 NM_146045 xylosylprotein beta1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) (B4galt7), mRNA [NM_146045] KLA .52 .55 .52 .57 .66 .82 1.05
ATP 1.00 1.02 .75 .66 .70 .83 1.48
KLA/ATP .53 .54 .49 .46 .49 .71 1.05
Baat
KLA  ATP  ATP+KLA
 NM_007519 bile acid-Coenzyme A: amino acid N-acyltransferase (Baat), mRNA [NM_007519] KLA .98 .99 1.01 .95 .97 .97 1.01
ATP .97 .97 1.01 .99 1.12 1.01 1.00
KLA/ATP 1.02 1.04 1.00 1.05 1.10 .99 1.01
BB135800
KLA  ATP  ATP+KLA
 BB135800 gb|BB135800 RIKEN full-length enriched, adult male bone Mus musculus cDNA clone 9830130K22 3. [BB135800] KLA 1.36 1.43 1.30 1.43 1.57 2.06 1.47
ATP 1.10 1.08 .99 1.05 1.12 1.64 1.99
KLA/ATP 1.45 1.58 1.65 1.46 1.76 2.32 6.28
Bcat1
KLA  ATP  ATP+KLA
 NM_001024468 branched chain aminotransferase 1, cytosolic (Bcat1), transcript variant 1, mRNA [NM_001024468] KLA 1.04 1.03 .98 1.04 .99 1.02 1.03
ATP 1.00 1.01 1.02 1.01 1.12 1.25 1.09
KLA/ATP .99 1.00 1.04 1.04 1.01 1.08 1.15
Bcat2
KLA  ATP  ATP+KLA
 NM_009737 branched chain aminotransferase 2, mitochondrial (Bcat2), nuclear gene encoding mitochondrial protein, mRNA [NM_009737] KLA 1.06 1.05 1.08 .97 1.08 .96 1.61
ATP 1.07 1.42 .96 1.55 .87 .66 .96
KLA/ATP 1.27 1.29 .84 1.36 .81 .76 .92
Bckdha
KLA  ATP  ATP+KLA
 NM_007533 branched chain ketoacid dehydrogenase E1, alpha polypeptide (Bckdha), mRNA [NM_007533] KLA .81 .83 .84 .77 .72 .67 .73
ATP 1.14 1.20 1.15 1.50 1.10 .74 .69
KLA/ATP .97 .94 .83 1.03 .86 .75 .71
Bckdhb
KLA  ATP  ATP+KLA
 NM_199195 branched chain ketoacid dehydrogenase E1, beta polypeptide (Bckdhb), nuclear gene encoding mitochondrial protein, mRNA [NM_199195] KLA 2.08 2.24 2.30 2.39 2.45 1.95 1.17
ATP .95 1.02 1.24 1.37 .98 .41 .44
KLA/ATP 2.12 2.34 2.71 3.07 2.12 1.25 .54
Bcmo1
KLA  ATP  ATP+KLA
 NM_021486 beta-carotene 15,15-monooxygenase (Bcmo1), mRNA [NM_021486] KLA 1.05 .97 1.02 1.07 1.00 1.04 1.15
ATP .96 .98 1.03 1.06 .98 1.05 1.02
KLA/ATP 1.01 1.03 1.08 1.09 1.03 1.09 1.03
Bdh1
KLA  ATP  ATP+KLA
 NM_001122683 3-hydroxybutyrate dehydrogenase, type 1 (Bdh1), transcript variant 2, mRNA [NM_001122683] KLA .89 .82 .80 .87 .90 .92 1.01
ATP .94 1.00 .89 .90 .82 .91 1.24
KLA/ATP .84 .82 .88 .76 .90 .88 .91
Bdh1
KLA  ATP  ATP+KLA
 NM_175177 3-hydroxybutyrate dehydrogenase, type 1 (Bdh1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_175177] KLA .61 .62 .57 .76 .75 .63 .64
ATP .95 .95 1.24 1.06 .81 1.28 1.87
KLA/ATP .57 .65 .78 .64 .63 .81 .70
Bdh2
KLA  ATP  ATP+KLA
 NM_027208 3-hydroxybutyrate dehydrogenase, type 2 (Bdh2), mRNA [NM_027208] KLA .85 .86 .78 .83 .75 .88 .83
ATP .95 .96 1.24 1.15 1.27 1.15 .95
KLA/ATP .82 .86 1.01 .97 1.04 1.05 1.09
Bhmt
KLA  ATP  ATP+KLA
 NM_016668 betaine-homocysteine methyltransferase (Bhmt), mRNA [NM_016668] KLA 1.02 1.04 1.02 .95 1.04 1.03 1.05
ATP .98 .96 1.08 1.02 .98 1.02 1.08
KLA/ATP .96 1.02 1.04 1.01 .98 .94 1.01
Bpgm
KLA  ATP  ATP+KLA
 NM_007563 2,3-bisphosphoglycerate mutase (Bpgm), mRNA [NM_007563] KLA .78 .85 .78 .85 .98 1.02 1.07
ATP .98 .81 .61 .49 .38 .73 1.33
KLA/ATP .74 .74 .64 .57 .51 .73 .97
Bpnt1
KLA  ATP  ATP+KLA
 NM_011794 bisphosphate 3-nucleotidase 1 (Bpnt1), mRNA [NM_011794] KLA 1.14 1.15 1.07 1.09 .98 .90 1.07
ATP .93 .96 1.17 1.28 1.02 1.02 1.16
KLA/ATP 1.06 1.15 1.27 1.28 1.01 .90 .85
Bst1
KLA  ATP  ATP+KLA
 NM_009763 bone marrow stromal cell antigen 1 (Bst1), mRNA [NM_009763] KLA 2.26 2.15 2.90 3.73 4.89 5.96 6.57
ATP 1.05 1.06 1.31 1.52 1.57 4.31 4.76
KLA/ATP 2.29 2.31 3.10 2.98 3.09 5.35 13.91
Btd
KLA  ATP  ATP+KLA
 NM_025295 biotinidase (Btd), mRNA [NM_025295] KLA .89 .88 .87 .74 .90 1.07 1.06
ATP .97 1.05 1.26 1.39 1.39 2.45 2.08
KLA/ATP .86 .89 1.01 1.14 1.11 1.74 2.61
C1galt1
KLA  ATP  ATP+KLA
 AK008884 adult male stomach cDNA, RIKEN full-length enriched library, clone:2210410E06 product:hypothetical protein, full insert sequence. [AK008884] KLA .54 .48 .42 .32 .28 .45 .72
ATP 1.17 1.18 1.11 .81 1.43 1.00 .59
KLA/ATP .51 .48 .48 .44 .68 .64 .27
C1galt1
KLA  ATP  ATP+KLA
 NM_052993 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (C1galt1), mRNA [NM_052993] KLA .93 .90 .80 .78 .68 .99 1.98
ATP 1.02 1.14 1.15 1.19 1.43 2.25 2.52
KLA/ATP .87 .85 .75 .89 .81 1.82 3.06
C1galt1c
1
KLA  ATP  ATP+KLA
 AK161729 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830428K17 product:hypothetical protein, full insert sequence. [AK161729] KLA .93 .94 .93 .99 .96 1.04 1.00
ATP .99 .95 .97 .97 1.00 .95 .95
KLA/ATP 1.02 .97 .99 .87 .91 .92 .90
C1galt1c
1
KLA  ATP  ATP+KLA
 NM_021550 C1GALT1-specific chaperone 1 (C1galt1c1), mRNA [NM_021550] KLA 1.20 1.10 1.28 1.27 1.23 1.09 1.29
ATP 1.13 1.00 1.24 1.01 .86 1.05 1.48
KLA/ATP 1.17 1.25 1.55 1.15 1.24 1.14 1.63
Cad
KLA  ATP  ATP+KLA
 NM_023525 carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (Cad), mRNA [NM_023525] KLA .88 .82 .73 .65 .53 .46 .59
ATP 1.00 1.00 .94 .86 .74 .60 .67
KLA/ATP .86 .81 .76 .65 .55 .46 .44
Cbr1
KLA  ATP  ATP+KLA
 U31966 carbonyl reductase (Cbr1) mRNA, complete cds. [U31966] KLA .79 .82 .80 .76 .69 .91 .89
ATP .95 .90 1.24 1.29 1.39 1.58 2.18
KLA/ATP .82 .79 1.22 1.01 1.41 1.76 1.89
Cbr2
KLA  ATP  ATP+KLA
 NM_007621 carbonyl reductase 2 (Cbr2), mRNA [NM_007621] KLA 1.04 1.02 .94 1.08 1.10 1.15 .31
ATP 1.04 .97 1.18 1.27 1.37 1.11 .44
KLA/ATP 1.06 1.09 1.32 1.27 1.33 1.00 .41
Cbr3
KLA  ATP  ATP+KLA
 NM_173047 carbonyl reductase 3 (Cbr3), mRNA [NM_173047] KLA .37 .38 .29 .33 .21 .23 .42
ATP .97 .84 1.07 .78 1.72 6.22 1.28
KLA/ATP .38 .35 .52 .33 1.22 2.51 1.25
Cbs
KLA  ATP  ATP+KLA
 NM_144855 cystathionine beta-synthase (Cbs), transcript variant 1, mRNA [NM_144855] KLA .95 1.02 .94 .94 .99 .99 1.00
ATP 1.00 1.14 1.04 .85 .99 .94 .91
KLA/ATP 1.01 1.08 .97 1.02 .97 .88 .98
Ccbl1
KLA  ATP  ATP+KLA
 NM_172404 cysteine conjugate-beta lyase 1 (Ccbl1), mRNA [NM_172404] KLA .68 .64 .61 .59 .58 .75 .89
ATP 1.02 .96 .89 .80 .63 .48 .97
KLA/ATP .71 .68 .61 .64 .53 .50 .60
Ccbl2
KLA  ATP  ATP+KLA
 NM_173763 cysteine conjugate-beta lyase 2 (Ccbl2), mRNA [NM_173763] KLA 2.01 2.14 2.03 1.98 1.40 .85 .65
ATP .96 .91 1.14 .95 .81 1.04 .68
KLA/ATP 2.05 2.10 2.27 1.79 1.55 1.00 .57
Cd38
KLA  ATP  ATP+KLA
 NM_007646 CD38 antigen (Cd38), mRNA [NM_007646] KLA 3.61 5.39 8.63 9.62 24.42 36.25 76.13
ATP 1.00 1.05 1.36 1.70 2.26 8.41 7.84
KLA/ATP 4.45 4.89 5.01 7.93 5.74 14.08 40.05
Cda
KLA  ATP  ATP+KLA
 NM_028176 cytidine deaminase (Cda), mRNA [NM_028176] KLA .92 .97 .89 .86 .87 .85 .88
ATP 1.08 1.11 1.00 1.40 1.40 1.04 1.09
KLA/ATP .98 .95 .90 .96 .88 .93 .97
Cdipt
KLA  ATP  ATP+KLA
 NM_026638 CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) (Cdipt), mRNA [NM_026638] KLA .75 .74 .71 .67 .79 .87 1.15
ATP 1.07 1.03 .76 .81 .75 .77 1.18
KLA/ATP .82 .72 .51 .53 .51 .72 1.22
Cdo1
KLA  ATP  ATP+KLA
 NM_033037 cysteine dioxygenase 1, cytosolic (Cdo1), mRNA [NM_033037] KLA 1.28 1.33 1.27 1.30 1.24 1.26 1.10
ATP 1.09 1.13 1.79 7.13 7.75 3.67 1.26
KLA/ATP 1.31 1.37 1.77 5.21 6.82 4.19 1.94
Cds1
KLA  ATP  ATP+KLA
 NM_173370 CDP-diacylglycerol synthase 1 (Cds1), mRNA [NM_173370] KLA 2.81 2.96 3.63 3.43 3.28 1.96 .97
ATP 1.08 1.05 .86 .90 .78 .83 1.17
KLA/ATP 2.84 2.92 2.34 2.04 1.61 1.01 .98
Cds2
KLA  ATP  ATP+KLA
 NM_138651 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 (Cds2), mRNA [NM_138651] KLA 1.05 1.06 1.06 1.17 1.32 1.73 2.21
ATP .97 .93 .91 .77 .97 1.88 3.79
KLA/ATP 1.09 1.12 1.07 .94 1.16 1.49 4.77
Cel
KLA  ATP  ATP+KLA
 NM_009885 carboxyl ester lipase (Cel), mRNA [NM_009885] KLA 1.06 1.02 1.06 1.07 1.07 1.08 1.11
ATP 1.01 1.04 1.18 1.09 1.09 1.21 1.09
KLA/ATP 1.06 .97 1.24 1.16 1.19 1.21 1.10
Cept1
KLA  ATP  ATP+KLA
 NM_133869 choline/ethanolaminephosphotransferase 1 (Cept1), mRNA [NM_133869] KLA 3.40 3.07 3.72 5.13 5.83 5.57 2.91
ATP 1.09 1.05 1.09 .81 1.14 2.16 1.37
KLA/ATP 3.35 3.19 4.07 2.89 3.10 3.27 4.09
Ces3
KLA  ATP  ATP+KLA
 NM_053200 carboxylesterase 3 (Ces3), mRNA [NM_053200] KLA 1.04 .95 .92 1.03 1.00 1.02 .88
ATP 1.02 .98 1.01 .95 .99 1.01 .98
KLA/ATP 1.02 .93 1.03 .97 1.05 1.00 1.01
Chdh
KLA  ATP  ATP+KLA
 AK052715 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630034H06 product:CHOLINE DEHYDROGENASE (FRAGMENT) homolog [Homo sapiens], full insert sequence [AK052715] KLA 1.05 1.02 1.04 1.10 1.06 1.17 .88
ATP .96 1.01 .99 1.00 1.01 .98 .97
KLA/ATP .99 1.01 1.00 1.04 .99 .99 1.06
Chdh
KLA  ATP  ATP+KLA
 NM_175343 choline dehydrogenase (Chdh), mRNA [NM_175343] KLA .97 .99 1.07 1.01 .81 .98 1.15
ATP .98 1.06 1.04 1.17 1.02 1.00 .99
KLA/ATP 1.06 1.01 1.01 .99 .98 .99 1.12
Chka
KLA  ATP  ATP+KLA
 AK014174 13 days embryo head cDNA, RIKEN full-length enriched library, clone:3110043M12 product:choline kinase, full insert sequence. [AK014174] KLA .42 .41 .44 .58 .89 .72 .81
ATP .83 .53 3.69 5.23 2.51 1.20 .99
KLA/ATP .37 .40 3.80 4.15 2.66 1.08 1.73
Chka
KLA  ATP  ATP+KLA
 NM_013490 choline kinase alpha (Chka), transcript variant 1, mRNA [NM_013490] KLA .62 .60 .67 .66 .85 .88 1.05
ATP 1.09 1.02 2.21 7.77 6.32 3.01 1.39
KLA/ATP .67 .65 1.77 6.85 7.26 3.77 2.70
Chkb
KLA  ATP  ATP+KLA
 NM_007692 choline kinase beta (Chkb), mRNA [NM_007692] KLA .71 .73 .70 .66 .86 .79 .78
ATP .97 .86 .73 .87 1.36 1.43 .96
KLA/ATP .68 .55 .52 .62 1.24 1.30 1.11
Chpf
KLA  ATP  ATP+KLA
 NM_001001566 chondroitin polymerizing factor (Chpf), transcript variant 1, mRNA [NM_001001566] KLA 1.22 1.19 1.09 1.18 1.71 2.50 3.34
ATP 1.06 1.08 1.08 .97 1.05 1.69 3.23
KLA/ATP 1.12 1.19 1.20 1.18 1.23 1.54 2.83
Chpt1
KLA  ATP  ATP+KLA
 NM_144807 choline phosphotransferase 1 (Chpt1), mRNA [NM_144807] KLA 1.16 1.18 1.24 1.15 1.16 1.10 1.23
ATP 1.01 1.05 1.16 1.09 .99 .97 .98
KLA/ATP 1.20 1.15 1.13 1.18 1.17 1.33 1.25
Chsy1
KLA  ATP  ATP+KLA
 NM_001081163 carbohydrate (chondroitin) synthase 1 (Chsy1), mRNA [NM_001081163] KLA .48 .42 .32 .36 .30 .44 .73
ATP .87 .88 1.09 .66 .54 1.20 .79
KLA/ATP .39 .39 .50 .37 .48 .47 .36
Chsy3
KLA  ATP  ATP+KLA
 AK043732 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830026G02 product:hypothetical protein, full insert sequence. [AK043732] KLA 1.07 1.05 1.07 .97 1.00 1.04 .98
ATP 1.00 .92 .99 1.01 1.04 1.02 1.03
KLA/ATP 1.02 1.04 .95 .97 1.01 1.06 .98
Chsy3
KLA  ATP  ATP+KLA
 NM_001081328 chondroitin sulfate synthase 3 (Chsy3), mRNA [NM_001081328] KLA 1.11 1.07 1.03 1.01 1.01 .99 1.04
ATP 1.01 1.00 1.05 1.00 1.01 .98 1.02
KLA/ATP 1.10 1.07 .97 .98 .99 1.03 .99
Ckb
KLA  ATP  ATP+KLA
 NM_021273 creatine kinase, brain (Ckb), mRNA [NM_021273] KLA .72 .75 .67 .61 .56 .45 .48
ATP 1.11 1.16 .92 1.17 1.13 .63 .75
KLA/ATP .82 .83 .67 .68 .56 .46 .28
Ckm
KLA  ATP  ATP+KLA
 NM_007710 creatine kinase, muscle (Ckm), mRNA [NM_007710] KLA .93 1.01 1.07 .99 .95 1.03 1.08
ATP .94 1.00 1.04 1.05 .96 1.02 .99
KLA/ATP .90 1.10 1.07 1.05 1.05 .99 .98
Ckmt1
KLA  ATP  ATP+KLA
 NM_009897 creatine kinase, mitochondrial 1, ubiquitous (Ckmt1), nuclear gene encoding mitochondrial protein, mRNA [NM_009897] KLA 1.05 .99 1.00 1.02 1.02 1.02 1.12
ATP 1.02 1.04 .99 .94 1.01 .95 1.10
KLA/ATP .98 1.03 1.06 1.00 .99 1.06 1.19
Ckmt2
KLA  ATP  ATP+KLA
 NM_198415 creatine kinase, mitochondrial 2 (Ckmt2), nuclear gene encoding mitochondrial protein, mRNA [NM_198415] KLA 1.10 .99 1.01 1.02 1.07 1.06 1.02
ATP .97 1.00 1.05 1.00 .96 1.03 1.02
KLA/ATP 1.02 .99 1.10 .96 .99 1.06 1.02
Cmas
KLA  ATP  ATP+KLA
 NM_009908 cytidine monophospho-N-acetylneuraminic acid synthetase (Cmas), mRNA [NM_009908] KLA .47 .49 .45 .51 .54 .58 .90
ATP 1.08 1.07 .97 1.19 1.07 .58 .84
KLA/ATP .53 .54 .48 .48 .46 .51 .61
Cmbl
KLA  ATP  ATP+KLA
 NM_181588 carboxymethylenebutenolidase-like (Pseudomonas) (Cmbl), mRNA [NM_181588] KLA .63 .61 .59 .44 .28 .18 .16
ATP .90 .88 1.29 1.08 .77 .19 .40
KLA/ATP .57 .60 .76 .60 .50 .20 .17
Cmpk1
KLA  ATP  ATP+KLA
 NM_025647 cytidine monophosphate (UMP-CMP) kinase 1 (Cmpk1), mRNA [NM_025647] KLA 1.32 1.31 1.32 1.37 1.15 1.07 1.22
ATP 1.12 1.11 1.24 1.48 1.19 1.05 1.40
KLA/ATP 1.32 1.50 1.51 1.61 1.38 1.22 1.69
Cmpk2
KLA  ATP  ATP+KLA
 NM_020557 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial (Cmpk2), nuclear gene encoding mitochondrial protein, mRNA [NM_020557] KLA 45.62 35.73 40.02 38.05 26.87 32.74 16.83
ATP 1.12 1.13 1.07 1.09 1.70 19.99 11.48
KLA/ATP 40.89 44.06 53.14 44.67 39.01 36.20 40.60
Cndp1
KLA  ATP  ATP+KLA
 NM_177450 carnosine dipeptidase 1 (metallopeptidase M20 family) (Cndp1), mRNA [NM_177450] KLA .98 1.00 1.00 1.00 .99 .93 1.04
ATP 1.02 .96 .98 .97 .97 .95 .96
KLA/ATP 1.04 1.04 .95 .94 .98 .96 .94
Cndp2
KLA  ATP  ATP+KLA
 NM_023149 CNDP dipeptidase 2 (metallopeptidase M20 family) (Cndp2), mRNA [NM_023149] KLA .88 .96 1.08 .98 1.35 1.73 1.59
ATP 1.09 1.27 .77 1.02 1.04 1.30 1.67
KLA/ATP 1.17 1.04 .63 1.09 .95 1.78 2.70
Coasy
KLA  ATP  ATP+KLA
 NM_027896 Coenzyme A synthase (Coasy), mRNA [NM_027896] KLA .50 .51 .45 .46 .58 .74 .99
ATP .98 .99 .91 .94 .55 .52 1.08
KLA/ATP .50 .48 .44 .45 .39 .39 .72
Comt
KLA  ATP  ATP+KLA
 NM_007744 catechol-O-methyltransferase (Comt), transcript variant 2, mRNA [NM_007744] KLA .46 .45 .42 .38 .37 .38 .50
ATP .91 .90 .89 .84 .73 .38 .72
KLA/ATP .44 .44 .43 .37 .39 .31 .32
Coq2
KLA  ATP  ATP+KLA
 NM_027978 coenzyme Q2 homolog, prenyltransferase (yeast) (Coq2), mRNA [NM_027978] KLA .94 .98 1.00 .84 .87 .84 .96
ATP 1.05 .97 1.18 .86 .67 .48 .60
KLA/ATP .96 1.03 1.20 .81 .67 .58 .64
Coq3
KLA  ATP  ATP+KLA
 NM_172687 coenzyme Q3 homolog, methyltransferase (yeast) (Coq3), mRNA [NM_172687] KLA .99 .93 .95 .84 .81 .85 1.04
ATP 1.02 1.06 .91 .90 .74 .77 .88
KLA/ATP 1.02 1.08 .83 .85 .73 .75 .87
Coq5
KLA  ATP  ATP+KLA
 NM_026504 coenzyme Q5 homolog, methyltransferase (yeast) (Coq5), mRNA [NM_026504] KLA .94 .96 1.00 1.10 1.24 1.27 1.36
ATP .94 .95 .91 .98 .75 .63 1.01
KLA/ATP .93 .97 1.02 1.00 .87 .74 .90
Coq6
KLA  ATP  ATP+KLA
 NM_172582 coenzyme Q6 homolog (yeast) (Coq6), mRNA [NM_172582] KLA 1.02 1.14 1.11 1.07 .94 .78 1.01
ATP 1.06 1.14 .99 1.34 1.08 .63 .79
KLA/ATP 1.09 1.29 1.02 1.21 .93 .73 .76
Coq7
KLA  ATP  ATP+KLA
 NM_009940 demethyl-Q 7 (Coq7), mRNA [NM_009940] KLA .99 1.01 .91 .99 .88 .91 1.25
ATP .98 .95 1.19 1.19 1.06 .99 .87
KLA/ATP .98 .99 1.24 1.14 1.08 .95 .71
Cox10
KLA  ATP  ATP+KLA
 NM_178379 COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast) (Cox10), nuclear gene encoding mitochondrial protein, mRNA [NM_178379] KLA 1.17 1.20 1.24 1.24 1.14 1.13 1.35
ATP 1.16 1.18 .99 1.15 .83 .98 1.06
KLA/ATP 1.24 1.39 1.07 1.11 .85 .95 .91
Cox11
KLA  ATP  ATP+KLA
 NM_199008 COX11 homolog, cytochrome c oxidase assembly protein (yeast) (Cox11), nuclear gene encoding mitochondrial protein, mRNA [NM_199008] KLA 1.83 1.61 1.94 2.09 1.50 1.70 1.52
ATP 1.03 .81 .97 .50 1.06 1.67 1.34
KLA/ATP 1.64 1.57 2.06 1.10 1.38 2.09 2.00
Cox15
KLA  ATP  ATP+KLA
 NM_144874 COX15 homolog, cytochrome c oxidase assembly protein (yeast) (Cox15), nuclear gene encoding mitochondrial protein, mRNA [NM_144874] KLA 1.93 1.96 2.10 2.26 1.93 1.90 1.24
ATP .98 .84 1.17 .86 .65 1.34 1.12
KLA/ATP 1.85 2.05 2.30 2.09 1.97 2.46 1.74
Cox17
KLA  ATP  ATP+KLA
 BU555670 gb|AGENCOURT_10230668 NIH_MGC_143 Mus musculus cDNA clone IMAGE:6583112 5, mRNA sequence [BU555670] KLA 1.13 .87 1.10 1.08 1.01 1.29 .91
ATP 1.04 1.13 1.24 1.15 1.22 1.79 1.07
KLA/ATP 1.19 1.12 1.39 1.48 1.39 2.27 1.69
Cox17
KLA  ATP  ATP+KLA
 NM_001017429 cytochrome c oxidase, subunit XVII assembly protein homolog (yeast) (Cox17), mRNA [NM_001017429] KLA 1.62 1.49 1.47 1.96 1.86 1.75 1.72
ATP 1.00 .96 1.10 1.07 1.36 1.54 1.37
KLA/ATP 1.61 1.70 2.34 1.84 2.25 2.44 2.17
Cox4i1
KLA  ATP  ATP+KLA
 NM_009941 cytochrome c oxidase subunit IV isoform 1 (Cox4i1), mRNA [NM_009941] KLA .94 .92 .88 1.05 1.00 .86 .85
ATP 1.02 1.01 1.03 1.06 1.15 1.18 .91
KLA/ATP 1.05 1.01 1.12 1.05 .99 1.07 1.02
Cox4i2
KLA  ATP  ATP+KLA
 NM_053091 cytochrome c oxidase subunit IV isoform 2 (Cox4i2), nuclear gene encoding mitochondrial protein, mRNA [NM_053091] KLA 1.10 .97 1.01 1.05 1.10 1.15 1.47
ATP .99 1.00 .98 .95 1.01 1.10 1.06
KLA/ATP 1.06 1.05 1.08 .94 1.03 1.01 1.20
Cox5a
KLA  ATP  ATP+KLA
 NM_007747 cytochrome c oxidase, subunit Va (Cox5a), nuclear gene encoding mitochondrial protein, mRNA [NM_007747] KLA 1.45 1.31 1.22 1.31 1.35 1.54 1.90
ATP .98 .98 1.08 .97 1.06 1.24 1.11
KLA/ATP 1.11 1.27 1.38 1.29 1.36 1.54 1.48
Cox5b
KLA  ATP  ATP+KLA
 NM_009942 cytochrome c oxidase, subunit Vb (Cox5b), mRNA [NM_009942] KLA 1.02 .96 .93 .98 .98 1.10 1.09
ATP .92 1.01 1.08 1.17 1.01 1.05 1.08
KLA/ATP .94 1.03 1.08 1.23 1.18 1.30 1.19
Cox6a1
KLA  ATP  ATP+KLA
 NM_007748 cytochrome c oxidase, subunit VI a, polypeptide 1 (Cox6a1), nuclear gene encoding mitochondrial protein, mRNA [NM_007748] KLA .93 .94 .90 .98 .95 1.01 1.03
ATP .93 .91 1.03 .89 .86 .88 .82
KLA/ATP .98 .83 1.08 1.06 .96 .81 .79
Cox6a2
KLA  ATP  ATP+KLA
 NM_009943 cytochrome c oxidase, subunit VI a, polypeptide 2 (Cox6a2), nuclear gene encoding mitochondrial protein, mRNA [NM_009943] KLA 1.12 1.15 1.13 1.37 2.13 3.23 3.70
ATP 1.02 .99 1.31 1.51 1.15 .69 1.13
KLA/ATP 1.01 1.21 1.40 1.46 1.17 1.00 1.89
Cox6b1
KLA  ATP  ATP+KLA
 NM_025628 cytochrome c oxidase, subunit VIb polypeptide 1 (Cox6b1), mRNA [NM_025628] KLA 1.28 1.19 1.23 1.20 1.23 1.33 1.13
ATP .89 1.05 1.22 1.48 1.35 1.33 .93
KLA/ATP 1.28 1.39 1.48 1.91 1.50 1.65 1.25
Cox6b2
KLA  ATP  ATP+KLA
 NM_183405 cytochrome c oxidase subunit VIb polypeptide 2 (Cox6b2), mRNA [NM_183405] KLA 1.74 1.90 2.21 2.20 2.20 2.21 1.17
ATP 1.01 1.01 1.20 1.47 1.39 1.37 1.06
KLA/ATP 1.86 1.94 2.28 2.62 2.56 2.12 1.80
Cox6c
KLA  ATP  ATP+KLA
 NM_053071 cytochrome c oxidase, subunit VIc (Cox6c), mRNA [NM_053071] KLA 1.13 1.05 1.01 1.38 1.02 .85 .90
ATP 1.01 .89 1.23 1.09 1.26 1.24 .80
KLA/ATP 1.01 1.08 1.66 1.12 1.34 1.19 .89
Cox7b
KLA  ATP  ATP+KLA
 NM_025379 cytochrome c oxidase subunit VIIb (Cox7b), nuclear gene encoding mitochondrial protein, mRNA [NM_025379] KLA 1.00 .91 .98 .97 .97 .91 .92
ATP 1.06 1.12 1.35 1.42 1.21 1.06 .78
KLA/ATP 1.13 1.07 1.26 1.41 1.18 1.06 .91
Cox7b2
KLA  ATP  ATP+KLA
 NM_030052 cytochrome c oxidase subunit VIIb2 (Cox7b2), mRNA [NM_030052] KLA 1.03 1.07 .98 1.02 1.03 1.04 .95
ATP .97 1.00 1.04 .97 1.04 .99 1.01
KLA/ATP .95 .96 1.02 .97 1.06 1.05 .99
Cox7c
KLA  ATP  ATP+KLA
 NM_007749 cytochrome c oxidase, subunit VIIc (Cox7c), nuclear gene encoding mitochondrial protein, mRNA [NM_007749] KLA 1.38 1.24 1.08 1.42 1.21 1.05 1.06
ATP 1.03 1.05 1.34 1.43 1.33 1.13 .77
KLA/ATP 1.16 1.32 1.73 1.81 1.60 1.55 1.03
Cox8a
KLA  ATP  ATP+KLA
 NM_007750 cytochrome c oxidase, subunit VIIIa (Cox8a), mRNA [NM_007750] KLA .91 .91 .96 1.02 1.01 .98 1.19
ATP 1.07 1.05 1.03 1.22 1.11 .97 .85
KLA/ATP .98 1.02 1.10 1.14 1.21 .97 .90
Cox8b
KLA  ATP  ATP+KLA
 NM_007751 cytochrome c oxidase, subunit VIIIb (Cox8b), nuclear gene encoding mitochondrial protein, mRNA [NM_007751] KLA .98 1.03 .99 .98 1.06 1.05 1.03
ATP 1.01 .99 .91 1.09 1.06 .98 .99
KLA/ATP 1.07 1.02 .86 1.03 1.06 1.04 1.00
Cox8c
KLA  ATP  ATP+KLA
 NM_001039049 cytochrome c oxidase, subunit VIIIc (Cox8c), nuclear gene encoding mitochondrial protein, mRNA [NM_001039049] KLA .97 1.03 1.05 1.05 1.00 1.03 1.03
ATP 1.06 1.04 1.04 1.02 .95 1.06 1.01
KLA/ATP 1.04 1.01 1.01 1.03 1.00 1.16 .98
Cpox
KLA  ATP  ATP+KLA
 NM_007757 coproporphyrinogen oxidase (Cpox), mRNA [NM_007757] KLA .92 .75 .68 .69 .53 .37 .61
ATP 1.07 1.05 .90 .59 .39 .65 .95
KLA/ATP .68 .71 .78 .57 .35 .38 .40
Cps1
KLA  ATP  ATP+KLA
 AK028683 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732433M03 product:weakly similar to carbamoyl-phosphate synthase (glutamine-hydrolyzing) (EC 6.3.5.5) large chain [Schizosaccharomyces pombe], full insert sequence. [A KLA .99 1.01 1.08 1.02 1.01 .96 1.05
ATP .96 1.00 .94 .97 .98 .98 1.05
KLA/ATP .97 1.09 1.04 .99 1.05 1.03 .96
Cps1
KLA  ATP  ATP+KLA
 AK028683 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732433M03 product:weakly similar to carbamoyl-phosphate synthase (glutamine-hydrolyzing) (EC 6.3.5.5) large chain [Schizosaccharomyces pombe], full insert sequence. [AK KLA 1.03 1.04 1.06 .96 1.08 1.08 1.03
ATP .99 .98 1.09 1.07 .97 1.02 1.09
KLA/ATP .98 1.00 .95 1.10 1.00 1.05 1.09
Crls1
KLA  ATP  ATP+KLA
 AK078599 11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030418E13 product:unclassifiable, full insert sequence [AK078599] KLA .82 .86 .79 .88 .81 .89 .89
ATP .92 .91 1.00 .98 .87 .90 .68
KLA/ATP .77 .84 .81 .83 .80 .84 .58
Crls1
KLA  ATP  ATP+KLA
 NM_001024385 cardiolipin synthase 1 (Crls1), transcript variant 1, mRNA [NM_001024385] KLA .95 .98 .88 .88 .83 .67 1.02
ATP 1.13 1.14 .96 1.08 1.26 1.02 .86
KLA/ATP .98 .98 .83 .81 .73 .74 .77
Cryl1
KLA  ATP  ATP+KLA
 AK020717 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230106J09 product:crystallin, lamda 1, full insert sequence. [AK020717] KLA .45 .49 .55 .54 .60 .51 .76
ATP .89 .88 .99 .73 .60 .51 .87
KLA/ATP .45 .48 .62 .57 .61 .45 .72
Cryl1
KLA  ATP  ATP+KLA
 NM_030004 crystallin, lambda 1 (Cryl1), mRNA [NM_030004] KLA .79 .72 .81 .65 .59 .40 .39
ATP 1.13 1.20 1.20 1.36 1.02 .41 .39
KLA/ATP .88 .87 .87 .99 .73 .46 .24
Cs
KLA  ATP  ATP+KLA
 NM_026444 citrate synthase (Cs), nuclear gene encoding mitochondrial protein, mRNA [NM_026444] KLA 1.09 1.07 1.04 1.05 1.08 1.15 1.14
ATP .91 .93 1.02 .90 .90 1.08 1.38
KLA/ATP .99 1.04 1.09 .98 .98 .90 1.13
Csad
KLA  ATP  ATP+KLA
 NM_144942 cysteine sulfinic acid decarboxylase (Csad), mRNA [NM_144942] KLA .93 .95 .94 .92 .97 .90 .78
ATP .92 .80 .70 .68 .73 .64 .62
KLA/ATP .87 .86 .82 .81 .97 .69 .57
Csgalnac
t1
KLA  ATP  ATP+KLA
 NM_172753 chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Csgalnact1), mRNA [NM_172753] KLA 1.01 .98 .84 .94 .95 .94 1.02
ATP .97 1.00 .98 .93 .92 1.00 1.03
KLA/ATP .99 .94 .94 .86 .94 .93 1.04
Csgalnac
t2
KLA  ATP  ATP+KLA
 NM_030165 chondroitin sulfate N-acetylgalactosaminyltransferase 2 (Csgalnact2), mRNA [NM_030165] KLA .41 .41 .39 .42 .41 .65 .65
ATP .94 .95 1.04 .77 1.00 1.01 .98
KLA/ATP .35 .37 .38 .32 .70 1.01 .79
Csl
KLA  ATP  ATP+KLA
 NM_027945 citrate synthase like (Csl), mRNA [NM_027945] KLA 1.41 1.32 1.35 1.51 1.61 1.39 1.58
ATP 1.17 1.15 .98 1.23 1.18 1.33 2.00
KLA/ATP 1.32 1.53 1.45 1.59 1.13 1.14 1.77
Cth
KLA  ATP  ATP+KLA
 NM_145953 cystathionase (cystathionine gamma-lyase) (Cth), mRNA [NM_145953] KLA 1.95 1.88 2.04 1.99 1.70 1.19 1.05
ATP 1.05 1.03 1.17 1.26 1.76 2.05 1.00
KLA/ATP 1.79 2.03 2.06 1.83 1.66 1.53 .99
Ctps
KLA  ATP  ATP+KLA
 NM_016748 cytidine 5-triphosphate synthase (Ctps), mRNA [NM_016748] KLA .47 .41 .26 .18 .14 .21 .37
ATP .87 .80 1.08 .67 .73 .63 .33
KLA/ATP .40 .39 .41 .28 .27 .38 .13
Ctps2
KLA  ATP  ATP+KLA
 NM_018737 cytidine 5-triphosphate synthase 2 (Ctps2), mRNA [NM_018737] KLA .76 .77 .71 .73 .67 .75 1.09
ATP .98 .93 .99 .86 .76 .64 .81
KLA/ATP .77 .74 .71 .63 .62 .60 .86
Cyc1
KLA  ATP  ATP+KLA
 NM_025567 cytochrome c-1 (Cyc1), mRNA [NM_025567] KLA 1.02 1.01 1.02 .89 1.07 1.03 1.22
ATP 1.11 1.23 1.08 1.20 1.16 .87 1.09
KLA/ATP 1.15 1.07 .97 1.22 .91 .94 1.12
Cyp11a1
KLA  ATP  ATP+KLA
 NM_019779 cytochrome P450, family 11, subfamily a, polypeptide 1 (Cyp11a1), nuclear gene encoding mitochondrial protein, mRNA [NM_019779] KLA 1.03 1.00 .96 1.04 1.05 1.03 .97
ATP 1.00 .99 .99 1.02 1.04 1.00 .99
KLA/ATP .99 1.03 1.05 .98 .95 .95 .96
Cyp11b2
KLA  ATP  ATP+KLA
 NM_009991 cytochrome P450, family 11, subfamily b, polypeptide 2 (Cyp11b2), nuclear gene encoding mitochondrial protein, mRNA [NM_009991] KLA .93 1.00 1.03 1.05 1.04 1.09 1.03
ATP 1.01 1.00 1.02 1.11 .99 1.02 1.01
KLA/ATP 1.03 .98 .84 1.10 1.05 1.38 .98
Cyp17a1
KLA  ATP  ATP+KLA
 NM_007809 cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), mRNA [NM_007809] KLA 1.55 1.60 1.71 1.73 1.51 1.58 1.18
ATP .94 1.01 1.27 1.44 1.39 1.36 1.11
KLA/ATP 1.48 1.79 1.95 2.05 1.92 1.75 1.56
Cyp19a1
KLA  ATP  ATP+KLA
 NM_007810 cytochrome P450, family 19, subfamily a, polypeptide 1 (Cyp19a1), mRNA [NM_007810] KLA 1.04 .97 1.05 1.03 .99 1.02 .98
ATP 1.00 1.02 1.00 .93 .97 .99 1.08
KLA/ATP .99 .99 1.07 1.02 .98 .97 .98
Cyp1a1
KLA  ATP  ATP+KLA
 NM_009992 cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1), mRNA [NM_009992] KLA 1.07 .99 1.02 1.01 1.00 1.00 1.11
ATP .99 1.02 1.01 .95 .96 .94 1.09
KLA/ATP 1.01 1.03 .98 .96 .96 .95 1.51
Cyp1a2
KLA  ATP  ATP+KLA
 NM_009993 cytochrome P450, family 1, subfamily a, polypeptide 2 (Cyp1a2), mRNA [NM_009993] KLA 1.01 .99 .98 1.02 .97 .97 1.00
ATP 1.01 .98 1.03 1.01 1.04 1.02 1.04
KLA/ATP .99 1.00 1.05 1.03 .98 .97 .99
Cyp21a1
KLA  ATP  ATP+KLA
 NM_009995 cytochrome P450, family 21, subfamily a, polypeptide 1 (Cyp21a1), mRNA [NM_009995] KLA .96 1.04 .98 1.05 1.00 .98 1.03
ATP 1.02 .93 1.02 1.11 1.03 1.04 1.10
KLA/ATP .91 1.00 1.02 1.01 1.04 .90 1.00
Cyp24a1
KLA  ATP  ATP+KLA
 NM_009996 cytochrome P450, family 24, subfamily a, polypeptide 1 (Cyp24a1), nuclear gene encoding mitochondrial protein, mRNA [NM_009996] KLA .98 .91 1.01 1.00 1.01 1.01 1.02
ATP .97 .93 1.01 1.01 1.01 .97 1.05
KLA/ATP 1.00 1.04 .98 .95 .97 1.03 .85
Cyp27a1
KLA  ATP  ATP+KLA
 NM_024264 cytochrome P450, family 27, subfamily a, polypeptide 1 (Cyp27a1), nuclear gene encoding mitochondrial protein, mRNA [NM_024264] KLA 1.03 .98 1.22 1.00 .87 .57 .40
ATP 1.07 1.06 .99 1.18 .71 .41 .38
KLA/ATP 1.02 1.10 1.24 1.03 .72 .50 .34
Cyp27b1
KLA  ATP  ATP+KLA
 AB006034 mRNA for 25-hydroxyvitamin D3 1alpha-hydroxylase, partial cds. [AB006034] KLA 1.04 .99 .98 .99 .97 .97 1.00
ATP 1.00 .99 .94 .99 1.05 .95 1.00
KLA/ATP 1.02 .97 .99 .99 .97 .92 1.00
Cyp27b1
KLA  ATP  ATP+KLA
 NM_010009 cytochrome P450, family 27, subfamily b, polypeptide 1 (Cyp27b1), nuclear gene encoding mitochondrial protein, mRNA [NM_010009] KLA 1.18 1.18 1.27 1.18 1.24 1.23 1.12
ATP 1.07 .95 1.21 1.13 1.17 1.17 1.03
KLA/ATP 1.13 1.10 1.36 1.27 1.34 1.13 1.06
Cyp2a12
KLA  ATP  ATP+KLA
 NM_133657 cytochrome P450, family 2, subfamily a, polypeptide 12 (Cyp2a12), mRNA [NM_133657] KLA 1.03 1.08 1.00 .98 1.00 1.03 1.03
ATP 1.01 .98 1.03 1.08 1.02 .99 1.01
KLA/ATP .97 1.01 .97 1.06 1.03 1.03 .99
Cyp2a4
KLA  ATP  ATP+KLA
 NM_009997 cytochrome P450, family 2, subfamily a, polypeptide 4 (Cyp2a4), mRNA [NM_009997] KLA 1.02 .99 1.00 1.00 .98 1.04 1.01
ATP 1.01 1.00 1.01 1.03 .99 1.01 .99
KLA/ATP 1.03 1.03 1.01 1.04 .98 1.03 1.01
Cyp2a5
KLA  ATP  ATP+KLA
 NM_007812 cytochrome P450, family 2, subfamily a, polypeptide 5 (Cyp2a5), mRNA [NM_007812] KLA 1.04 .95 .95 1.02 1.01 .94 1.06
ATP 1.03 .95 1.05 1.08 .99 .97 1.03
KLA/ATP 1.01 1.06 .92 1.08 1.05 1.01 1.01
Cyp2b10
KLA  ATP  ATP+KLA
 NM_009999 cytochrome P450, family 2, subfamily b, polypeptide 10 (Cyp2b10), transcript variant 2, mRNA [NM_009999] KLA .98 1.03 .97 1.02 1.02 .97 1.03
ATP 1.03 .99 1.02 1.02 .98 1.02 .99
KLA/ATP 1.04 1.00 1.02 .93 .97 .93 .91
Cyp2b13
KLA  ATP  ATP+KLA
 NM_007813 cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), mRNA [NM_007813] KLA .99 1.02 1.00 1.06 1.05 1.03 .99
ATP .96 .96 .96 .98 .99 .95 .98
KLA/ATP 1.00 1.03 1.04 1.02 1.01 1.06 .99
Cyp2b19
KLA  ATP  ATP+KLA
 AK029227 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831430P04 product:cytochrome P450, 2b19, full insert sequence. [AK029227] KLA .96 .98 1.02 1.09 1.06 1.00 1.08
ATP 1.02 1.06 .91 1.05 1.00 .97 .95
KLA/ATP .99 .93 .96 1.03 1.00 1.04 1.00
Cyp2b19
KLA  ATP  ATP+KLA
 NM_007814 cytochrome P450, family 2, subfamily b, polypeptide 19 (Cyp2b19), mRNA [NM_007814] KLA 1.14 1.20 1.18 1.17 1.17 1.21 1.14
ATP .96 1.01 1.11 1.08 .99 1.08 1.10
KLA/ATP 1.09 1.05 1.17 1.16 1.16 1.10 1.07
Cyp2b23
KLA  ATP  ATP+KLA
 NM_001081148 cytochrome P450, family 2, subfamily b, polypeptide 23 (Cyp2b23), mRNA [NM_001081148] KLA 1.09 .96 1.01 .95 .97 1.01 .92
ATP .97 1.00 .92 .92 .98 .97 .94
KLA/ATP 1.01 1.02 1.03 .94 .94 .93 .97
Cyp2b9
KLA  ATP  ATP+KLA
 NM_010000 cytochrome P450, family 2, subfamily b, polypeptide 9 (Cyp2b9), mRNA [NM_010000] KLA .99 1.00 1.02 1.01 1.03 .98 1.03
ATP 1.01 .98 .97 .98 1.01 .96 .98
KLA/ATP 1.00 1.04 .94 1.04 1.02 1.03 .99
Cyp2c29
KLA  ATP  ATP+KLA
 NM_007815 cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815] KLA 1.01 .95 1.06 1.12 1.01 1.02 1.12
ATP 1.03 1.02 1.01 1.06 .98 .98 .96
KLA/ATP 1.09 1.14 1.02 .98 .99 .98 .98
Cyp2c37
KLA  ATP  ATP+KLA
 NM_010001 cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001] KLA 1.27 1.43 1.64 1.52 1.65 1.43 1.45
ATP .99 .96 1.03 1.13 1.10 1.03 1.27
KLA/ATP 1.37 1.49 1.22 1.46 1.16 1.12 1.24
Cyp2c38
KLA  ATP  ATP+KLA
 NM_010002 cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002] KLA 1.01 1.06 .98 .96 1.07 .98 .97
ATP 1.01 1.09 1.04 .98 1.00 1.03 .98
KLA/ATP 1.03 .98 1.03 1.04 1.00 1.00 1.01
Cyp2c39
KLA  ATP  ATP+KLA
 NM_010003 cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003] KLA 1.04 1.01 .97 1.00 .99 1.01 .98
ATP 1.04 1.07 .95 1.00 .96 1.03 1.01
KLA/ATP 1.03 1.01 1.02 1.01 1.05 1.05 .99
Cyp2c40
KLA  ATP  ATP+KLA
 NM_010004 cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004] KLA .96 1.06 1.05 1.03 .99 1.01 1.02
ATP .96 1.01 1.02 .97 1.01 1.02 .99
KLA/ATP 1.06 1.03 1.04 .98 1.05 1.01 .97
Cyp2c44
KLA  ATP  ATP+KLA
 NM_001001446 cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446] KLA .98 1.04 .93 1.05 1.01 .93 .94
ATP 1.02 1.01 1.01 1.04 1.02 1.02 1.00
KLA/ATP .93 .95 1.00 1.05 1.07 1.01 1.01
Cyp2c54
KLA  ATP  ATP+KLA
 NM_206537 cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537] KLA .98 .99 1.04 .97 1.06 1.03 1.04
ATP .99 .98 1.10 1.03 1.03 .98 1.03
KLA/ATP 1.02 1.04 .89 .98 .99 .93 .99
Cyp2c55
KLA  ATP  ATP+KLA
 NM_028089 cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089] KLA .97 1.02 1.01 .99 .99 1.00 .94
ATP 1.04 .98 1.09 .97 1.05 .99 1.06
KLA/ATP 1.04 1.01 1.15 1.03 1.05 1.05 1.09
Cyp2c65
KLA  ATP  ATP+KLA
 AK008688 adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688] KLA .95 .97 1.02 1.00 .97 1.10 1.04
ATP .98 1.05 1.00 1.10 .98 .99 1.03
KLA/ATP .96 .97 .99 1.01 1.03 1.04 1.03
Cyp2c66
KLA  ATP  ATP+KLA
 NM_001011707 cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707] KLA 1.03 1.04 .99 1.00 1.06 1.11 1.01
ATP .97 1.01 1.03 1.00 .98 1.03 1.04
KLA/ATP 1.08 .97 1.15 1.02 1.04 1.06 1.08
Cyp2c70
KLA  ATP  ATP+KLA
 NM_145499 cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499] KLA 1.05 .94 .95 .86 1.06 .96 .99
ATP 1.01 .98 .69 .69 .97 .87 1.09
KLA/ATP 1.00 .97 .74 .74 .81 .86 1.17
Cyp2e1
KLA  ATP  ATP+KLA
 NM_021282 cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1), mRNA [NM_021282] KLA .99 1.03 1.05 1.01 .99 1.06 1.00
ATP .96 .93 .98 1.05 1.01 1.03 1.10
KLA/ATP 1.04 .99 1.02 1.00 1.05 1.04 .99
Cyp2j11
KLA  ATP  ATP+KLA
 NM_001004141 cytochrome P450, family 2, subfamily j, polypeptide 11 (Cyp2j11), mRNA [NM_001004141] KLA .95 1.02 1.07 .95 .95 .92 .83
ATP .95 1.02 1.05 .93 .92 .90 1.00
KLA/ATP 1.05 .96 1.00 .97 .90 .82 .86
Cyp2j13
KLA  ATP  ATP+KLA
 NM_145548 cytochrome P450, family 2, subfamily j, polypeptide 13 (Cyp2j13), mRNA [NM_145548] KLA 1.01 .99 .98 1.00 .98 .96 .92
ATP .99 1.03 1.01 .98 .95 1.01 1.02
KLA/ATP .96 1.03 1.02 1.03 .96 .95 .96
Cyp2j5
KLA  ATP  ATP+KLA
 NM_010007 cytochrome P450, family 2, subfamily j, polypeptide 5 (Cyp2j5), mRNA [NM_010007] KLA 1.00 .99 1.05 1.01 1.00 1.06 1.06
ATP .99 1.00 1.03 1.09 1.00 1.03 1.01
KLA/ATP 1.03 .98 1.09 1.11 1.06 1.09 1.01
Cyp2j9
KLA  ATP  ATP+KLA
 NM_028979 cytochrome P450, family 2, subfamily j, polypeptide 9 (Cyp2j9), mRNA [NM_028979] KLA .84 .88 .97 .91 .75 .66 .66
ATP 1.10 .98 .99 .92 .90 .73 .64
KLA/ATP .88 .95 .93 .86 .80 .78 .59
Cyp2r1
KLA  ATP  ATP+KLA
 NM_177382 cytochrome P450, family 2, subfamily r, polypeptide 1 (Cyp2r1), mRNA [NM_177382] KLA .98 1.09 1.11 1.07 1.12 1.16 1.47
ATP 1.05 1.11 1.12 1.00 .84 .69 1.11
KLA/ATP 1.05 1.01 1.17 .99 .85 .76 .79
Cyp2u1
KLA  ATP  ATP+KLA
 AK142740 16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830039I11 product:cytochrome P450, family 2, subfamily u, polypeptide 1, full insert sequence [AK142740] KLA .85 .89 .83 .86 .76 .80 .94
ATP .97 1.09 .99 .90 .84 .87 .96
KLA/ATP .82 .88 .85 .80 .79 .81 .89
Cyp3a11
KLA  ATP  ATP+KLA
 NM_007818 cytochrome P450, family 3, subfamily a, polypeptide 11 (Cyp3a11), mRNA [NM_007818] KLA .96 .94 1.06 1.04 .96 .94 .97
ATP 1.00 1.01 .94 .95 .94 .92 .98
KLA/ATP .98 1.06 1.06 .98 .88 .93 .91
Cyp3a13
KLA  ATP  ATP+KLA
 NM_007819 cytochrome P450, family 3, subfamily a, polypeptide 13 (Cyp3a13), mRNA [NM_007819] KLA .99 .98 .98 1.03 .97 1.01 1.07
ATP 1.00 1.01 1.01 1.04 1.01 .99 1.00
KLA/ATP 1.06 1.01 1.00 1.08 1.09 1.01 1.09
Cyp3a16
KLA  ATP  ATP+KLA
 NM_007820 cytochrome P450, family 3, subfamily a, polypeptide 16 (Cyp3a16), mRNA [NM_007820] KLA .95 .99 .96 .96 1.00 1.03 .99
ATP 1.04 1.03 .98 .97 .98 1.03 1.01
KLA/ATP .96 .91 .96 .97 1.03 1.00 1.04
Cyp3a25
KLA  ATP  ATP+KLA
 NM_019792 cytochrome P450, family 3, subfamily a, polypeptide 25 (Cyp3a25), mRNA [NM_019792] KLA 1.00 .96 1.01 1.04 .99 .99 1.01
ATP 1.01 1.02 .97 1.01 1.02 .93 .95
KLA/ATP .97 1.09 1.04 1.01 .99 .97 .97
Cyp3a41a
KLA  ATP  ATP+KLA
 NM_017396 cytochrome P450, family 3, subfamily a, polypeptide 41A (Cyp3a41a), mRNA [NM_017396] KLA 1.02 .99 .98 .95 .93 .93 1.06
ATP 1.00 .96 1.02 .97 .97 .95 1.02
KLA/ATP 1.03 1.02 1.07 .97 .93 .97 .97
Cyp3a44
KLA  ATP  ATP+KLA
 NM_177380 cytochrome P450, family 3, subfamily a, polypeptide 44 (Cyp3a44), mRNA [NM_177380] KLA 1.05 1.03 1.05 1.02 1.08 1.00 1.03
ATP .97 1.00 1.03 1.07 .99 .99 .99
KLA/ATP 1.04 .99 .99 1.06 1.04 1.06 1.00
Cyp4a10
KLA  ATP  ATP+KLA
 NM_010011 cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011] KLA 1.14 1.13 1.13 1.13 1.15 1.12 1.06
ATP 1.02 1.01 1.09 1.03 1.10 1.11 1.00
KLA/ATP 1.09 1.11 1.36 1.23 1.25 1.09 1.02
Cyp4a10
KLA  ATP  ATP+KLA
 X71478 gb|M.musculus Cyp4a-10 mRNA. [X71478] KLA .94 .97 .93 1.01 1.01 1.09 1.26
ATP .96 1.07 1.04 1.18 .88 .77 1.18
KLA/ATP 1.00 .99 .98 .98 .84 .80 1.24
Cyp4a12a
KLA  ATP  ATP+KLA
 NM_177406 cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406] KLA 1.08 1.04 1.02 1.06 .98 1.05 1.05
ATP .98 1.00 1.10 .99 .96 1.04 .98
KLA/ATP 1.07 1.05 1.11 .96 1.06 1.02 .97
Cyp4a12b
KLA  ATP  ATP+KLA
 NM_172306 cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306] KLA 1.03 1.05 .95 .99 .94 1.02 1.12
ATP .93 .99 .95 1.00 .93 .95 1.01
KLA/ATP .98 1.01 1.09 1.00 .90 .91 .93
Cyp4a14
KLA  ATP  ATP+KLA
 NM_007822 cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822] KLA .99 1.00 1.00 .97 .96 .97 1.01
ATP .95 .95 .93 .90 .93 .99 1.03
KLA/ATP .97 .99 1.04 .93 .95 .96 .97
Cyp4a29
KLA  ATP  ATP+KLA
 NM_001100183 cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183] KLA .94 .98 1.04 1.00 .98 1.06 1.03
ATP 1.01 1.02 1.03 1.02 1.01 1.02 .97
KLA/ATP 1.05 1.09 1.03 1.03 .97 1.02 .91
Cyp4a31
KLA  ATP  ATP+KLA
 NM_201640 cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640] KLA 1.14 .99 1.00 .98 1.06 1.03 .96
ATP 1.01 1.05 1.04 .91 .98 .99 .99
KLA/ATP .99 1.03 1.04 .99 .95 .97 1.06
Cyp4f13
KLA  ATP  ATP+KLA
 NM_130882 cytochrome P450, family 4, subfamily f, polypeptide 13 (Cyp4f13), mRNA [NM_130882] KLA .96 .94 1.02 .99 1.11 1.26 1.34
ATP 1.03 1.05 1.03 1.24 .88 .61 .88
KLA/ATP 1.05 1.02 1.01 1.13 .87 .75 1.20
Cyp4f14
KLA  ATP  ATP+KLA
 NM_022434 cytochrome P450, family 4, subfamily f, polypeptide 14 (Cyp4f14), mRNA [NM_022434] KLA 1.06 1.01 1.08 1.04 1.03 1.00 1.05
ATP 1.07 .94 .92 1.01 1.00 .97 1.06
KLA/ATP 1.04 .99 .82 .95 .93 1.05 1.11
Cyp4f15
KLA  ATP  ATP+KLA
 NM_134127 cytochrome P450, family 4, subfamily f, polypeptide 15 (Cyp4f15), mRNA [NM_134127] KLA .98 .95 1.05 1.02 .98 .96 1.05
ATP 1.01 .98 1.09 1.03 1.03 1.02 1.08
KLA/ATP 1.02 .97 .98 .98 .99 1.01 1.02
Cyp4f16
KLA  ATP  ATP+KLA
 NM_024442 cytochrome P450, family 4, subfamily f, polypeptide 16 (Cyp4f16), mRNA [NM_024442] KLA .87 .91 .89 .94 1.01 1.03 1.34
ATP 1.12 1.16 1.07 1.15 .88 .61 1.00
KLA/ATP .95 1.05 .92 .98 .72 .68 1.02
Cyp4f18
KLA  ATP  ATP+KLA
 NM_024444 cytochrome P450, family 4, subfamily f, polypeptide 18 (Cyp4f18), mRNA [NM_024444] KLA 1.03 1.06 1.06 1.15 1.13 1.14 1.29
ATP 1.00 1.06 1.16 1.36 1.36 1.11 1.06
KLA/ATP 1.03 1.11 1.14 1.22 1.20 1.93 2.92
Cyp4f39
KLA  ATP  ATP+KLA
 NM_177307 cytochrome P450, family 4, subfamily f, polypeptide 39 (Cyp4f39), mRNA [NM_177307] KLA .96 1.00 .97 1.06 1.03 1.09 1.07
ATP .99 .95 .93 1.05 .81 .86 1.24
KLA/ATP .97 .88 .84 .91 .89 .96 1.07
Cyp51
KLA  ATP  ATP+KLA
 NM_020010 cytochrome P450, family 51 (Cyp51), mRNA [NM_020010] KLA 1.05 1.08 1.11 .93 .82 .50 .52
ATP 1.01 1.07 1.27 1.22 .98 .75 1.09
KLA/ATP 1.06 1.10 1.09 1.03 .72 .44 .39
Cyp7a1
KLA  ATP  ATP+KLA
 NM_007824 cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1), mRNA [NM_007824] KLA 1.03 .99 .97 1.00 .97 1.03 .99
ATP .99 .99 1.02 1.04 .99 .99 1.03
KLA/ATP 1.03 1.00 .99 .99 .91 .97 .99
Cyp8b1
KLA  ATP  ATP+KLA
 NM_010012 cytochrome P450, family 8, subfamily b, polypeptide 1 (Cyp8b1), mRNA [NM_010012] KLA .98 1.06 1.04 1.00 1.03 1.03 1.06
ATP 1.00 .99 1.02 1.04 1.06 1.01 1.09
KLA/ATP 1.08 .99 1.05 1.19 1.11 1.11 1.01
D5Wsu178
e
KLA  ATP  ATP+KLA
 NM_027652 DNA segment, Chr 5, Wayne State University 178, expressed (D5Wsu178e), mRNA [NM_027652] KLA .78 .80 .72 .75 .69 .70 .96
ATP 1.03 1.09 1.13 1.04 1.22 1.10 .91
KLA/ATP .78 .82 .72 .80 .96 .87 .73
Dak
KLA  ATP  ATP+KLA
 NM_145496 dihydroxyacetone kinase 2 homolog (yeast) (Dak), mRNA [NM_145496] KLA 1.00 1.03 1.04 .98 1.06 .90 .85
ATP 1.13 1.16 .89 1.01 .74 .67 .85
KLA/ATP 1.07 1.07 .90 .98 .66 .56 .81
Dao1
KLA  ATP  ATP+KLA
 NM_010018 D-amino acid oxidase 1 (Dao1), mRNA [NM_010018] KLA 1.00 .95 1.02 1.00 .97 1.03 .99
ATP 1.00 .93 .99 .92 1.02 .98 1.03
KLA/ATP 1.00 1.01 1.05 .99 1.03 1.00 1.08
Dbh
KLA  ATP  ATP+KLA
 NM_138942 dopamine beta hydroxylase (Dbh), mRNA [NM_138942] KLA 1.01 1.08 1.18 1.11 1.17 1.25 1.19
ATP .95 1.03 1.04 1.10 1.11 1.06 1.06
KLA/ATP 1.12 1.04 1.05 1.17 1.16 1.11 1.11
Dbt
KLA  ATP  ATP+KLA
 NM_010022 dihydrolipoamide branched chain transacylase E2 (Dbt), nuclear gene encoding mitochondrial protein, mRNA [NM_010022] KLA .98 1.06 1.02 1.14 1.31 1.11 1.09
ATP 1.04 .96 .97 1.07 .71 .84 1.09
KLA/ATP .97 1.09 .96 .96 .79 .81 .68
Dck
KLA  ATP  ATP+KLA
 NM_007832 deoxycytidine kinase (Dck), mRNA [NM_007832] KLA 2.69 2.67 3.17 3.00 3.16 3.18 2.10
ATP 1.15 1.32 1.25 1.48 1.19 3.17 1.47
KLA/ATP 2.71 2.88 2.59 4.36 3.64 4.49 3.08
Dct
KLA  ATP  ATP+KLA
 NM_010024 dopachrome tautomerase (Dct), mRNA [NM_010024] KLA 1.01 .97 .97 1.01 1.00 .99 1.02
ATP .97 1.00 1.00 1.00 .98 .98 1.01
KLA/ATP .97 1.01 1.07 1.02 .97 .95 1.04
Dctd
KLA  ATP  ATP+KLA
 NM_178788 dCMP deaminase (Dctd), mRNA [NM_178788] KLA .70 .66 .64 .65 .59 .62 .71
ATP 1.02 1.10 .86 .84 .63 .60 .62
KLA/ATP .72 .68 .66 .62 .63 .59 .65
Dcxr
KLA  ATP  ATP+KLA
 AK161732 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830431D24 product:dicarbonyl L-xylulose reductase, full insert sequence [AK161732] KLA .98 .92 1.04 1.10 1.00 .86 .81
ATP .94 .87 1.16 .99 .91 .72 .93
KLA/ATP .92 .86 1.14 .92 .91 .73 .80
Dcxr
KLA  ATP  ATP+KLA
 NM_026428 dicarbonyl L-xylulose reductase (Dcxr), mRNA [NM_026428] KLA 1.10 1.11 1.23 1.31 1.68 1.35 .62
ATP 1.17 1.23 1.04 1.66 1.10 .59 .64
KLA/ATP 1.23 1.19 .99 1.74 1.06 .87 .82
Ddc
KLA  ATP  ATP+KLA
 NM_016672 dopa decarboxylase (Ddc), mRNA [NM_016672] KLA 1.27 1.28 1.34 1.33 1.34 1.21 1.05
ATP 1.02 .99 1.05 .98 1.02 1.02 1.14
KLA/ATP 1.24 1.22 1.28 1.25 1.12 1.20 1.35
Ddost
KLA  ATP  ATP+KLA
 NM_007838 dolichyl-di-phosphooligosaccharide-protein glycotransferase (Ddost), mRNA [NM_007838] KLA .88 .99 1.00 .83 .86 .92 .96
ATP 1.11 1.34 1.05 1.20 .91 .83 .87
KLA/ATP 1.07 1.01 .77 1.11 .66 .79 .82
Degs1
KLA  ATP  ATP+KLA
 NM_007853 degenerative spermatocyte homolog 1 (Drosophila) (Degs1), mRNA [NM_007853] KLA .83 .80 .78 .74 .58 .38 .67
ATP 1.14 1.08 1.10 1.18 1.53 1.19 .96
KLA/ATP .88 .88 .82 .78 .76 .57 .52
Degs2
KLA  ATP  ATP+KLA
 NM_027299 degenerative spermatocyte homolog 2 (Drosophila), lipid desaturase (Degs2), mRNA [NM_027299] KLA 1.03 .99 .93 .99 1.05 1.03 .94
ATP 1.00 1.02 1.05 .97 1.06 .92 .99
KLA/ATP 1.04 1.06 1.00 .93 1.00 .94 .94
Dgat1
KLA  ATP  ATP+KLA
 NM_010046 diacylglycerol O-acyltransferase 1 (Dgat1), mRNA [NM_010046] KLA 1.05 1.03 1.09 .93 1.04 1.06 1.42
ATP 1.06 1.12 1.23 1.57 1.34 2.37 1.50
KLA/ATP 1.11 1.10 .97 1.24 1.10 2.12 2.03
Dgat2
KLA  ATP  ATP+KLA
 NM_026384 diacylglycerol O-acyltransferase 2 (Dgat2), mRNA [NM_026384] KLA 2.44 2.65 2.86 3.52 3.45 2.83 1.41
ATP .97 .97 1.07 1.81 1.69 2.29 1.29
KLA/ATP 2.21 2.45 2.36 2.76 3.16 4.51 3.63
Dgka
KLA  ATP  ATP+KLA
 NM_016811 diacylglycerol kinase, alpha (Dgka), mRNA [NM_016811] KLA 3.34 3.15 3.23 3.20 2.95 1.29 .45
ATP 1.11 .97 1.01 .90 1.32 1.39 1.33
KLA/ATP 2.97 3.42 3.95 2.85 2.49 1.47 1.21
Dgkb
KLA  ATP  ATP+KLA
 AK032509 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574F24 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus nor KLA .92 .92 .98 .93 1.01 1.06 1.00
ATP 1.03 1.05 .97 1.00 .95 1.03 .99
KLA/ATP 1.00 1.07 1.02 .97 1.00 .96 .97
Dgkb
KLA  ATP  ATP+KLA
 AK083222 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630029D13 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus norvegi KLA 1.02 1.02 1.12 1.01 1.00 1.05 .99
ATP .97 1.01 1.06 .95 1.07 1.03 1.03
KLA/ATP .95 .99 1.05 1.02 1.04 .96 1.06
Dgkb
KLA  ATP  ATP+KLA
 AK122355 mRNA for mKIAA0718 protein [AK122355] KLA 1.03 .96 1.11 1.02 .95 .94 .97
ATP 1.00 .99 1.09 1.01 1.02 .96 .95
KLA/ATP .97 1.00 1.05 1.03 .95 1.02 .95
Dgkb
KLA  ATP  ATP+KLA
 NM_178681 diacylglycerol kinase, beta (Dgkb), mRNA [NM_178681] KLA 1.05 1.08 1.03 1.04 .94 1.01 1.04
ATP 1.04 1.02 1.04 .95 1.01 1.03 1.05
KLA/ATP 1.09 .95 1.00 1.03 1.06 1.05 1.05
Dgkd
KLA  ATP  ATP+KLA
 AK076439 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832425N18 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK-DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (FRAGMENT) homolog [Homo KLA .43 .42 .38 .38 .44 .36 .28
ATP 1.08 1.06 .96 1.28 1.01 .42 .25
KLA/ATP .42 .41 .38 .39 .46 .40 .23
Dgkd
KLA  ATP  ATP+KLA
 AK172901 mRNA for mKIAA0145 protein [AK172901] KLA .27 .25 .22 .22 .23 .23 .22
ATP .87 .79 .81 .66 .58 .34 .31
KLA/ATP .22 .22 .19 .15 .20 .22 .15
Dgke
KLA  ATP  ATP+KLA
 NM_019505 diacylglycerol kinase, epsilon (Dgke), mRNA [NM_019505] KLA 1.17 1.16 1.09 .92 .86 .99 1.25
ATP 1.02 1.01 .92 .79 .99 1.14 1.10
KLA/ATP 1.19 1.16 .98 .87 .97 1.05 .88
Dgkg
KLA  ATP  ATP+KLA
 AK089261 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107L03 product:SIMILAR TO DIACYLGLYCEROL KINASE 3 (GAMMA) homolog [Mus musculus], full insert sequence. [AK089261] KLA .95 .91 .97 .98 .97 .93 .96
ATP 1.04 1.02 .96 .93 .98 .89 .88
KLA/ATP 1.02 .99 .92 .86 .95 .92 .90
Dgkg
KLA  ATP  ATP+KLA
 NM_138650 diacylglycerol kinase, gamma (Dgkg), mRNA [NM_138650] KLA .65 .64 .62 .78 .86 .68 .53
ATP .92 .99 1.04 .83 .67 .71 .55
KLA/ATP .60 .66 .66 .65 .84 1.00 .59
Dgkh
KLA  ATP  ATP+KLA
 AK031069 13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930402B05 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (DIACYLGLYCEROL KI KLA 3.02 2.91 2.42 2.25 1.93 1.46 1.40
ATP 1.04 1.08 1.10 1.28 1.46 1.35 .98
KLA/ATP 3.66 4.04 3.53 1.88 1.69 1.34 1.47
Dgkh
KLA  ATP  ATP+KLA
 NM_001081336 diacylglycerol kinase, eta (Dgkh), mRNA [NM_001081336] KLA 6.71 7.34 7.44 7.69 6.90 4.13 3.15
ATP .98 .96 1.02 1.20 2.01 3.95 2.09
KLA/ATP 6.79 7.17 6.53 7.03 4.73 5.21 5.62
Dgki
KLA  ATP  ATP+KLA
 AK086550 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930036J18 product:DIACYLGLYCEROL KINASE, IOTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- IOTA) (DAG KINASE IOTA) homolog [Homo sapiens], full insert sequence. [AK086550] KLA 1.03 1.00 .96 1.07 1.00 1.08 .95
ATP 1.06 .99 1.02 .96 .98 1.02 1.03
KLA/ATP .99 .99 .99 .97 .99 .92 .99
Dgki
KLA  ATP  ATP+KLA
 NM_001081206 diacylglycerol kinase, iota (Dgki), mRNA [NM_001081206] KLA .99 .96 .89 .99 .92 .98 1.02
ATP 1.00 1.01 .95 1.00 .95 .90 1.02
KLA/ATP .91 .86 1.02 .99 1.02 .90 .98
Dgkq
KLA  ATP  ATP+KLA
 NM_199011 diacylglycerol kinase, theta (Dgkq), mRNA [NM_199011] KLA 1.09 .95 1.05 .98 .93 .96 1.11
ATP .99 .78 .66 .44 .99 1.04 1.23
KLA/ATP .98 .73 .66 .47 .67 .89 1.15
Dgkz
KLA  ATP  ATP+KLA
 NM_138306 diacylglycerol kinase zeta (Dgkz), mRNA [NM_138306] KLA .21 .22 .23 .29 .56 1.23 1.39
ATP 1.08 1.25 .90 1.22 .85 .57 1.44
KLA/ATP .23 .22 .18 .31 .60 .80 1.45
Dguok
KLA  ATP  ATP+KLA
 NM_013764 deoxyguanosine kinase (Dguok), nuclear gene encoding mitochondrial protein, mRNA [NM_013764] KLA .83 .71 .91 .93 1.12 1.27 .96
ATP 1.13 .93 1.13 1.04 .65 .51 .91
KLA/ATP .81 .79 1.05 .80 .90 .68 .86
Dhcr24
KLA  ATP  ATP+KLA
 NM_053272 24-dehydrocholesterol reductase (Dhcr24), mRNA [NM_053272] KLA .50 .50 .44 .42 .35 .28 .36
ATP 1.09 1.12 1.01 1.09 .72 .43 1.05
KLA/ATP .51 .54 .46 .54 .33 .22 .18
Dhcr7
KLA  ATP  ATP+KLA
 NM_007856 7-dehydrocholesterol reductase (Dhcr7), mRNA [NM_007856] KLA .58 .54 .52 .49 .39 .47 .71
ATP 1.01 1.09 1.17 1.19 .71 .39 .74
KLA/ATP .58 .56 .58 .64 .47 .45 .32
Dhfr
KLA  ATP  ATP+KLA
 L26316 dihydrofolate reductase (dhfr) mRNA, complete cds. [L26316] KLA .63 .69 .61 .62 .53 .57 .45
ATP .93 .93 1.10 1.12 .84 .49 .39
KLA/ATP .66 .59 .72 .74 .67 .65 .90
Dhfr
KLA  ATP  ATP+KLA
 NM_010049 dihydrofolate reductase (Dhfr), mRNA [NM_010049] KLA .52 .51 .48 .47 .39 .49 .33
ATP .90 .90 1.13 1.05 .76 .40 .28
KLA/ATP .46 .48 .58 .59 .59 .57 .68
Dhodh
KLA  ATP  ATP+KLA
 NM_020046 dihydroorotate dehydrogenase (Dhodh), nuclear gene encoding mitochondrial protein, mRNA [NM_020046] KLA .75 .68 .63 .77 .65 .59 .86
ATP 1.10 1.01 1.16 1.14 .95 .53 .71
KLA/ATP .70 .74 .85 .83 .64 .54 .42
Dhrs3
KLA  ATP  ATP+KLA
 NM_011303 dehydrogenase/reductase (SDR family) member 3 (Dhrs3), mRNA [NM_011303] KLA .40 .37 .41 .39 .50 .67 .72
ATP 1.15 1.16 .94 1.04 .84 .34 .92
KLA/ATP .47 .44 .35 .40 .48 .49 .89
Dhrs4
KLA  ATP  ATP+KLA
 NM_030686 dehydrogenase/reductase (SDR family) member 4 (Dhrs4), transcript variant 2, mRNA [NM_030686] KLA .94 1.05 1.17 .99 .96 .84 .74
ATP 1.03 1.09 1.11 1.45 1.11 .79 .88
KLA/ATP 1.10 1.17 1.19 1.38 1.09 .87 .69
Dhrs9
KLA  ATP  ATP+KLA
 AK089247 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630104J01 product:RETINOL DEHYDROGENASE HOMOLOG ISOFORM-2 homolog [Homo sapiens], full insert sequence [AK089247] KLA 1.17 1.17 1.22 1.43 1.27 1.05 .64
ATP 1.09 1.08 1.50 1.44 1.47 1.25 2.42
KLA/ATP 1.06 1.17 1.87 1.67 1.52 1.25 1.91
Dhrs9
KLA  ATP  ATP+KLA
 NM_175512 dehydrogenase/reductase (SDR family) member 9 (Dhrs9), mRNA [NM_175512] KLA 1.04 1.13 1.20 1.23 1.16 1.05 1.00
ATP 1.04 1.21 1.12 1.45 1.05 1.06 2.49
KLA/ATP 1.13 1.25 1.10 1.35 .98 1.26 1.97
Dlat
KLA  ATP  ATP+KLA
 NM_145614 dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) (Dlat), mRNA [NM_145614] KLA 1.00 1.05 1.03 .95 .87 .83 1.15
ATP .94 1.01 1.22 1.09 .80 .57 .91
KLA/ATP .96 1.01 1.05 .98 .70 .48 .54
Dld
KLA  ATP  ATP+KLA
 NM_007861 dihydrolipoamide dehydrogenase (Dld), mRNA [NM_007861] KLA 1.60 1.66 1.84 1.66 1.47 1.16 1.17
ATP 1.05 1.08 1.21 1.06 1.15 1.24 .93
KLA/ATP 1.52 1.63 1.65 1.42 1.17 1.05 .79
Dld
KLA  ATP  ATP+KLA
 U73445 dihydrolipoamide dehydrogenase (Dld) mRNA, complete cds. [U73445] KLA 1.48 1.43 1.43 1.47 1.25 1.05 1.16
ATP .94 .93 1.18 .86 1.02 1.46 .97
KLA/ATP 1.39 1.37 1.50 1.10 1.11 1.14 .85
Dlst
KLA  ATP  ATP+KLA
 AK171100 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630223O05 product:dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), full insert sequence [AK171100] KLA .90 .87 .88 .83 1.10 .86 1.09
ATP .97 .78 .47 .80 2.22 1.46 1.21
KLA/ATP 1.00 .91 .66 .76 1.24 1.06 1.04
Dlst
KLA  ATP  ATP+KLA
 NM_030225 dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), mRNA [NM_030225] KLA 1.15 1.22 1.20 1.11 1.02 .97 1.13
ATP 1.02 1.01 1.02 .95 1.01 1.36 1.19
KLA/ATP 1.23 1.29 1.23 1.19 .99 .98 .99
Dmgdh
KLA  ATP  ATP+KLA
 NM_028772 dimethylglycine dehydrogenase precursor (Dmgdh), nuclear gene encoding mitochondrial protein, mRNA [NM_028772] KLA .97 1.02 .98 .99 1.02 .92 .99
ATP 1.04 .94 .91 1.03 1.04 .94 1.01
KLA/ATP .95 .97 .99 .99 .98 1.06 1.02
Dnmt1
KLA  ATP  ATP+KLA
 NM_010066 DNA methyltransferase (cytosine-5) 1 (Dnmt1), mRNA [NM_010066] KLA .32 .30 .28 .26 .32 .58 .51
ATP .94 1.04 .99 .78 .75 .47 .68
KLA/ATP .33 .31 .30 .30 .56 .66 .52
Dnmt3a
KLA  ATP  ATP+KLA
 NM_007872 DNA methyltransferase 3A (Dnmt3a), transcript variant 1, mRNA [NM_007872] KLA .58 .57 .54 .54 .65 .85 .94
ATP 1.01 1.05 1.03 1.60 2.57 1.20 2.38
KLA/ATP .59 .60 .65 1.00 2.83 2.61 2.34
Dnmt3a
KLA  ATP  ATP+KLA
 NM_153743 DNA methyltransferase 3A (Dnmt3a), transcript variant 2, mRNA [NM_153743] KLA .46 .49 .44 .48 .60 .82 .90
ATP .90 .86 .91 1.13 2.27 .71 2.86
KLA/ATP .43 .49 .58 .72 2.57 1.56 2.61
Dnmt3b
KLA  ATP  ATP+KLA
 NM_001003961 DNA methyltransferase 3B (Dnmt3b), transcript variant 1, mRNA [NM_001003961] KLA .74 .72 .79 .63 .66 .62 .62
ATP 1.02 .92 .95 .66 .63 .90 .74
KLA/ATP .68 .74 .78 .61 .59 .69 .58
Dnmt3l
KLA  ATP  ATP+KLA
 NM_019448 DNA (cytosine-5-)-methyltransferase 3-like (Dnmt3l), transcript variant 1, mRNA [NM_019448] KLA 1.22 1.26 1.09 1.10 1.00 1.56 4.71
ATP .97 1.05 1.19 1.16 1.91 11.10 2.62
KLA/ATP 1.30 1.33 1.44 1.18 1.29 5.28 5.91
Dolk
KLA  ATP  ATP+KLA
 NM_177648 dolichol kinase (Dolk), mRNA [NM_177648] KLA .55 .54 .57 .56 .59 .71 .77
ATP .91 .89 .74 .44 .28 .25 .78
KLA/ATP .57 .53 .44 .34 .28 .20 .27
Dpagt1
KLA  ATP  ATP+KLA
 NM_007875 dolichyl-phosphate (UDP-N-acetylglucosamine) acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) (Dpagt1), mRNA [NM_007875] KLA .72 .75 .76 .66 .61 .52 .61
ATP 1.07 1.04 1.06 .99 .89 .67 .69
KLA/ATP .81 .75 .80 .69 .58 .41 .35
Dpm1
KLA  ATP  ATP+KLA
 NM_010072 dolichol-phosphate (beta-D) mannosyltransferase 1 (Dpm1), mRNA [NM_010072] KLA .89 .88 .83 .96 .90 .85 .84
ATP .93 .86 1.07 .88 .80 .81 .86
KLA/ATP .85 .79 .99 .84 .82 .76 .67
Dpm2
KLA  ATP  ATP+KLA
 NM_010073 dolichol-phosphate (beta-D) mannosyltransferase 2 (Dpm2), mRNA [NM_010073] KLA .83 .89 .88 .88 1.15 1.34 1.44
ATP .99 1.01 .87 .98 1.09 1.49 1.65
KLA/ATP .90 .82 .73 .93 1.04 1.74 2.55
Dpm3
KLA  ATP  ATP+KLA
 NM_026767 dolichyl-phosphate mannosyltransferase polypeptide 3 (Dpm3), mRNA [NM_026767] KLA 1.10 1.06 .99 1.08 .96 1.08 .91
ATP .93 .97 1.24 1.24 1.12 1.03 1.00
KLA/ATP 1.07 1.15 1.24 1.28 1.15 1.07 1.05
Dpyd
KLA  ATP  ATP+KLA
 NM_170778 dihydropyrimidine dehydrogenase (Dpyd), mRNA [NM_170778] KLA .94 .95 1.00 .98 .99 .98 .97
ATP 1.04 .95 1.02 1.01 1.02 1.02 .98
KLA/ATP 1.03 .98 .98 1.02 1.02 1.05 .93
Dse
KLA  ATP  ATP+KLA
 NM_172508 dermatan sulfate epimerase (Dse), mRNA [NM_172508] KLA 4.51 4.22 4.21 3.25 2.18 1.50 1.26
ATP 1.04 1.26 1.07 1.08 .92 .85 .88
KLA/ATP 3.97 4.74 3.69 4.03 1.65 .68 .90
Dtymk
KLA  ATP  ATP+KLA
 NM_001105667 deoxythymidylate kinase (Dtymk), transcript variant 1, mRNA [NM_001105667] KLA .62 .62 .59 .51 .46 .53 .50
ATP 1.02 .99 1.24 1.08 .67 .33 .36
KLA/ATP .60 .58 .73 .64 .47 .31 .26
Dtymk
KLA  ATP  ATP+KLA
 NM_023136 deoxythymidylate kinase (Dtymk), transcript variant 2, mRNA [NM_023136] KLA .69 .65 .55 .62 .39 .37 .38
ATP .90 .88 1.44 1.32 .99 .48 .33
KLA/ATP .57 .63 .88 .81 .67 .35 .14
Dut
KLA  ATP  ATP+KLA
 NM_023595 deoxyuridine triphosphatase (Dut), nuclear gene encoding mitochondrial protein, mRNA [NM_023595] KLA .50 .47 .37 .34 .18 .14 .16
ATP 1.01 .97 1.27 1.27 .94 .23 .17
KLA/ATP .47 .48 .62 .52 .41 .22 .12
Ears2
KLA  ATP  ATP+KLA
 AK129469 mRNA for mKIAA1970 protein [AK129469] KLA .84 .88 .83 .81 .86 .92 .97
ATP .98 .97 .85 .85 .90 .92 .86
KLA/ATP .85 .84 .85 .97 .90 .95 .90
Ears2
KLA  ATP  ATP+KLA
 NM_026140 glutamyl-tRNA synthetase 2 (mitochondrial)(putative) (Ears2), nuclear gene encoding mitochondrial protein, mRNA [NM_026140] KLA .75 .73 .71 .69 .75 .84 1.22
ATP 1.12 1.02 .87 .70 .41 .53 .83
KLA/ATP .79 .84 .72 .56 .42 .38 .44
Ebp
KLA  ATP  ATP+KLA
 NM_007898 phenylalkylamine Ca2+ antagonist (emopamil) binding protein (Ebp), mRNA [NM_007898] KLA .77 .75 .66 .77 .61 .71 .67
ATP .83 .83 1.15 .99 .88 .83 .95
KLA/ATP .67 .72 .95 .79 .86 .75 .74
Echs1
KLA  ATP  ATP+KLA
 NM_053119 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial (Echs1), nuclear gene encoding mitochondrial protein, mRNA [NM_053119] KLA .57 .55 .52 .54 .60 .82 .90
ATP .99 .97 1.07 1.15 .77 .37 .81
KLA/ATP .55 .56 .55 .66 .53 .39 .41
Ehhadh
KLA  ATP  ATP+KLA
 NM_023737 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase (Ehhadh), mRNA [NM_023737] KLA .74 .77 .80 .88 .71 .67 .74
ATP 1.02 1.06 1.04 .90 .70 .84 .83
KLA/ATP .79 .81 .80 .65 .59 .79 .55
Eno1
KLA  ATP  ATP+KLA
 NM_023119 enolase 1, alpha non-neuron (Eno1), mRNA [NM_023119] KLA .95 1.06 1.16 .78 1.04 .91 1.33
ATP 1.32 1.63 .81 1.78 1.08 1.07 1.65
KLA/ATP 1.50 1.43 .46 1.67 .61 1.02 1.97
Eno2
KLA  ATP  ATP+KLA
 NM_013509 enolase 2, gamma neuronal (Eno2), mRNA [NM_013509] KLA .84 .85 .72 .81 1.23 1.24 2.08
ATP 1.07 1.13 1.14 3.24 4.11 1.61 2.43
KLA/ATP .93 .89 .85 1.68 3.37 1.66 2.69
Eno3
KLA  ATP  ATP+KLA
 NM_007933 enolase 3, beta muscle (Eno3), mRNA [NM_007933] KLA .85 .86 .88 .84 .67 .70 1.00
ATP .92 .90 1.28 1.20 .96 .59 .68
KLA/ATP .82 .90 1.10 .99 .94 .52 .51
Enpp1
KLA  ATP  ATP+KLA
 ENSMUST00000105520 ens|Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E- NPP 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) (Lymphocyte antigen 41) (Ly-41) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1 KLA .71 .79 .64 .61 .55 .51 .32
ATP .85 .97 .85 .72 .62 .45 .28
KLA/ATP .72 .73 .61 .66 .60 .55 .27
Enpp1
KLA  ATP  ATP+KLA
 NM_008813 ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1), mRNA [NM_008813] KLA .82 .83 .77 .83 .65 .64 .51
ATP .89 .90 1.21 1.00 .98 .87 .64
KLA/ATP .72 .76 .96 .87 1.00 .94 .51
Enpp3
KLA  ATP  ATP+KLA
 BC005527 ectonucleotide pyrophosphatase [BC005527] KLA 1.06 .99 .98 1.01 .97 .99 .96
ATP .93 1.08 .99 1.05 .94 1.05 1.10
KLA/ATP .95 .96 1.10 .99 .95 .94 1.03
Enpp3
KLA  ATP  ATP+KLA
 BC006944 ectonucleotide pyrophosphatase/phosphodiesterase 3, mRNA (cDNA clone IMAGE:2655671), complete cds. [BC006944] KLA 1.02 1.01 1.03 1.08 1.04 1.01 1.01
ATP .97 1.01 .96 1.00 .98 1.07 .99
KLA/ATP 1.01 .99 1.07 1.02 .97 .98 .92
Enpp3
KLA  ATP  ATP+KLA
 NM_134005 ectonucleotide pyrophosphatase/phosphodiesterase 3 (Enpp3), mRNA [NM_134005] KLA 1.01 .95 .99 .98 1.05 1.04 .98
ATP .98 .98 1.03 .98 .96 1.00 .98
KLA/ATP .97 1.03 1.04 .93 1.02 .99 1.04
Enpp7
KLA  ATP  ATP+KLA
 NM_001030291 ectonucleotide pyrophosphatase/phosphodiesterase 7 (Enpp7), mRNA [NM_001030291] KLA 1.00 1.03 1.01 1.01 .95 1.07 1.05
ATP 1.01 1.01 .99 .99 1.04 .98 1.01
KLA/ATP .96 .96 .95 .96 1.02 1.01 .99
Ephx2
KLA  ATP  ATP+KLA
 NM_007940 epoxide hydrolase 2, cytoplasmic (Ephx2), mRNA [NM_007940] KLA 1.03 .96 .96 1.03 1.02 1.03 .87
ATP .97 .95 1.09 1.08 1.00 1.06 .96
KLA/ATP .97 1.03 1.07 1.09 1.13 .98 1.00
Eprs
KLA  ATP  ATP+KLA
 NM_029735 glutamyl-prolyl-tRNA synthetase (Eprs), mRNA [NM_029735] KLA .91 .97 .84 .80 .73 .74 1.32
ATP .97 1.13 1.17 1.10 1.19 .83 1.03
KLA/ATP .95 .98 .91 .76 .72 .61 .70
Es1
KLA  ATP  ATP+KLA
 NM_007954 esterase 1 (Es1), mRNA [NM_007954] KLA 1.02 1.01 .99 1.03 1.03 1.00 1.03
ATP .98 1.03 1.05 1.00 .97 1.03 1.05
KLA/ATP 1.02 1.01 .99 1.03 1.00 1.01 .99
Es22
KLA  ATP  ATP+KLA
 NM_133660 esterase 22 (Es22), mRNA [NM_133660] KLA 1.14 1.11 1.11 1.11 1.03 1.00 1.00
ATP 1.01 .94 1.00 .95 1.01 .97 .96
KLA/ATP 1.05 1.13 1.08 1.01 1.00 1.00 1.02
Etnk1
KLA  ATP  ATP+KLA
 XM_908334 gb|PREDICTED: Mus musculus ethanolamine kinase 1 (Etnk1), mRNA [XM_908334] KLA 5.38 5.56 5.81 5.53 4.73 4.65 2.51
ATP 1.01 1.05 1.13 1.21 1.24 2.34 2.30
KLA/ATP 5.41 5.64 5.14 6.04 5.38 4.90 5.42
Etnk2
KLA  ATP  ATP+KLA
 NM_175443 ethanolamine kinase 2 (Etnk2), mRNA [NM_175443] KLA 3.96 3.87 3.49 2.74 1.76 1.22 1.04
ATP 1.03 1.09 1.14 1.15 1.11 1.20 1.10
KLA/ATP 3.78 3.98 3.07 2.56 1.95 1.49 1.15
Ext1
KLA  ATP  ATP+KLA
 NM_010162 exostoses (multiple) 1 (Ext1), mRNA [NM_010162] KLA 8.02 9.48 10.78 9.03 6.83 4.24 1.43
ATP 1.00 .94 .88 1.62 4.37 4.32 1.35
KLA/ATP 9.43 9.15 8.69 10.86 8.81 4.92 3.46
Ext2
KLA  ATP  ATP+KLA
 NM_010163 exostoses (multiple) 2 (Ext2), mRNA [NM_010163] KLA .99 .95 .85 .85 .72 .67 .60
ATP 1.07 1.02 1.01 .90 .70 .49 .86
KLA/ATP .99 .91 .88 .85 .58 .50 .64
Extl1
KLA  ATP  ATP+KLA
 NM_019578 exostoses (multiple)-like 1 (Extl1), mRNA [NM_019578] KLA 1.03 1.03 1.03 .99 1.03 .95 .97
ATP 1.03 1.09 1.03 .94 .99 .98 1.02
KLA/ATP .99 1.01 1.01 1.07 .95 .92 .95
Extl2
KLA  ATP  ATP+KLA
 NM_021388 exostoses (multiple)-like 2 (Extl2), mRNA [NM_021388] KLA 1.36 1.48 1.15 1.02 .99 1.10 .79
ATP 1.09 1.00 .81 1.52 1.76 .97 1.13
KLA/ATP 1.63 1.39 1.03 1.04 .96 .73 .78
Extl3
KLA  ATP  ATP+KLA
 NM_018788 exostoses (multiple)-like 3 (Extl3), mRNA [NM_018788] KLA .83 .84 .88 .82 .79 .91 1.10
ATP .98 1.03 .90 .74 .63 .82 1.25
KLA/ATP .87 .87 .81 .70 .67 .73 1.10
Fah
KLA  ATP  ATP+KLA
 NM_010176 fumarylacetoacetate hydrolase (Fah), mRNA [NM_010176] KLA 1.01 1.09 1.04 1.13 1.02 .76 .69
ATP 1.09 1.09 1.02 1.22 1.08 .90 .58
KLA/ATP 1.14 1.09 1.13 1.19 .97 .91 .65
Fahd1
KLA  ATP  ATP+KLA
 NM_023480 fumarylacetoacetate hydrolase domain containing 1 (Fahd1), nuclear gene encoding mitochondrial protein, mRNA [NM_023480] KLA .36 .34 .34 .40 .42 .55 .63
ATP .88 .86 .83 .71 .35 .42 .73
KLA/ATP .34 .32 .39 .36 .37 .41 .52
Fasn
KLA  ATP  ATP+KLA
 NM_007988 fatty acid synthase (Fasn), mRNA [NM_007988] KLA .51 .49 .46 .44 .41 .35 .41
ATP .98 .93 .98 .96 .83 .67 .62
KLA/ATP .52 .47 .48 .58 .51 .44 .25
Fbp1
KLA  ATP  ATP+KLA
 NM_019395 fructose bisphosphatase 1 (Fbp1), mRNA [NM_019395] KLA .91 .95 1.03 1.01 1.00 1.02 .80
ATP .96 .96 .99 .95 .86 .84 .64
KLA/ATP .88 .96 .87 .92 .92 .84 .70
Fbp2
KLA  ATP  ATP+KLA
 NM_007994 fructose bisphosphatase 2 (Fbp2), mRNA [NM_007994] KLA 1.03 1.03 .95 1.02 1.02 1.03 1.06
ATP 1.03 1.03 1.05 1.01 .97 1.01 1.17
KLA/ATP .96 .92 1.06 .85 1.07 .97 1.12
Fdft1
KLA  ATP  ATP+KLA
 NM_010191 farnesyl diphosphate farnesyl transferase 1 (Fdft1), mRNA [NM_010191] KLA .96 .99 .98 .99 .88 .78 .77
ATP 1.00 1.01 1.08 1.10 .93 1.02 1.28
KLA/ATP .98 .97 .98 1.04 .97 .87 .73
Fdps
KLA  ATP  ATP+KLA
 AK077979 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030492I17 product:farnesyl diphosphate synthetase, full insert sequence. [AK077979] KLA .76 .79 .79 .69 .65 .37 .49
ATP .63 .70 .85 .30 .46 .89 .86
KLA/ATP .54 .52 .63 .39 .42 .40 .31
Fdps
KLA  ATP  ATP+KLA
 NM_134469 farnesyl diphosphate synthetase (Fdps), mRNA [NM_134469] KLA .87 .93 .89 .97 .76 .43 .48
ATP 1.12 1.10 1.05 1.23 1.05 .60 .88
KLA/ATP .93 .99 1.00 1.02 .70 .45 .33
Fech
KLA  ATP  ATP+KLA
 NM_007998 ferrochelatase (Fech), nuclear gene encoding mitochondrial protein, mRNA [NM_007998] KLA .93 .80 .68 .81 .65 .59 .57
ATP .97 .91 1.31 .95 .74 .97 .77
KLA/ATP .65 .77 .98 .70 .62 .64 .52
Fh1
KLA  ATP  ATP+KLA
 NM_010209 fumarate hydratase 1 (Fh1), mRNA [NM_010209] KLA 1.00 .88 .79 .83 .55 .36 .39
ATP 1.05 1.05 1.08 .98 .89 .49 .45
KLA/ATP .91 .95 1.06 .92 .72 .41 .18
Flad1
KLA  ATP  ATP+KLA
 NM_177041 RFad1, flavin adenine dinucleotide synthetase, homolog (yeast) (Flad1), mRNA [NM_177041] KLA .86 .91 .90 1.00 1.13 1.42 1.85
ATP .94 .96 .95 .99 .68 1.02 2.24
KLA/ATP .84 .82 .78 .87 .70 1.08 2.77
Fpgs
KLA  ATP  ATP+KLA
 NM_010236 folylpolyglutamyl synthetase (Fpgs), nuclear gene encoding mitochondrial protein, mRNA [NM_010236] KLA .45 .40 .39 .37 .40 .40 .69
ATP .98 .87 1.10 .89 .80 .93 .82
KLA/ATP .46 .39 .44 .39 .59 .56 .43
Fpgt
KLA  ATP  ATP+KLA
 AK030969 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830472G17 product:unclassifiable, full insert sequence. [AK030969] KLA .98 1.01 1.03 1.02 .99 .99 1.07
ATP 1.04 .96 .98 .98 .99 1.02 .99
KLA/ATP 1.03 .94 .87 1.01 1.02 1.01 1.03
Fpgt
KLA  ATP  ATP+KLA
 NM_029330 fucose-1-phosphate guanylyltransferase (Fpgt), mRNA [NM_029330] KLA 1.06 1.10 1.12 1.10 1.13 1.14 1.23
ATP .99 .98 .91 .84 1.02 1.31 1.51
KLA/ATP 1.05 1.02 .93 .87 .99 1.52 1.55
Ftcd
KLA  ATP  ATP+KLA
 NM_080845 formiminotransferase cyclodeaminase (Ftcd), mRNA [NM_080845] KLA 1.01 .93 .98 .93 .99 1.06 1.05
ATP 1.01 1.00 .96 .96 .95 .93 1.04
KLA/ATP 1.00 .99 .99 .97 .98 .92 .93
Fuk
KLA  ATP  ATP+KLA
 NM_172283 fucokinase (Fuk), transcript variant 1, mRNA [NM_172283] KLA .74 .78 .76 .78 .75 .87 .85
ATP .91 .92 1.22 .75 .54 1.26 1.16
KLA/ATP .73 .74 .95 .64 .72 1.37 1.01
Fut1
KLA  ATP  ATP+KLA
 NM_008051 fucosyltransferase 1 (Fut1), mRNA [NM_008051] KLA .94 1.00 .99 1.00 .97 .98 1.00
ATP 1.05 .97 1.00 .99 1.04 1.00 .98
KLA/ATP 1.01 1.02 .99 1.02 1.06 1.04 .99
Fut2
KLA  ATP  ATP+KLA
 NM_018876 fucosyltransferase 2 (Fut2), mRNA [NM_018876] KLA .97 .97 1.01 1.02 .98 1.04 1.01
ATP 1.05 1.00 .97 .99 1.05 1.02 1.07
KLA/ATP 1.00 .99 1.03 1.00 1.03 .99 1.07
Fut4
KLA  ATP  ATP+KLA
 NM_010242 fucosyltransferase 4 (Fut4), mRNA [NM_010242] KLA .90 .81 .83 .74 .60 .54 .76
ATP 1.13 .97 .68 .48 1.03 .99 .60
KLA/ATP .89 .89 .65 .50 .67 .78 .43
Fut7
KLA  ATP  ATP+KLA
 NM_013524 fucosyltransferase 7 (Fut7), mRNA [NM_013524] KLA .32 .32 .32 .49 .61 .56 .53
ATP .95 .77 .83 .56 .29 .40 .60
KLA/ATP .28 .28 .35 .29 .29 .26 .40
Fut8
KLA  ATP  ATP+KLA
 NM_016893 fucosyltransferase 8 (Fut8), mRNA [NM_016893] KLA 1.94 2.07 2.76 2.41 2.70 1.87 1.31
ATP 1.04 1.15 1.04 1.06 .69 .88 1.12
KLA/ATP 1.99 2.22 1.76 2.02 1.28 1.78 1.60
Fut9
KLA  ATP  ATP+KLA
 NM_010243 fucosyltransferase 9 (Fut9), mRNA [NM_010243] KLA .99 .99 1.02 1.02 1.02 1.02 .98
ATP .99 1.01 .99 .98 1.01 .99 1.04
KLA/ATP 1.00 .97 1.06 1.00 .96 1.01 .96
G6pc
KLA  ATP  ATP+KLA
 NM_008061 glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061] KLA .96 .94 1.04 1.07 1.09 1.06 1.02
ATP .98 1.05 1.09 1.04 1.05 1.00 1.01
KLA/ATP 1.03 1.05 1.06 .96 1.02 1.00 .99
G6pc2
KLA  ATP  ATP+KLA
 NM_021331 glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331] KLA .99 1.03 1.00 .98 .95 1.02 .98
ATP .95 1.06 .97 1.08 1.16 1.26 1.04
KLA/ATP .94 .99 1.05 6.99 3.55 1.48 1.11
G6pc3
KLA  ATP  ATP+KLA
 NM_175935 glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935] KLA .88 .89 .89 .80 .75 .68 .88
ATP .99 1.05 .95 1.14 .92 .64 .81
KLA/ATP .92 .90 .79 .94 .70 .62 .58
G6pd2
KLA  ATP  ATP+KLA
 NM_019468 glucose-6-phosphate dehydrogenase 2 (G6pd2), mRNA [NM_019468] KLA 1.07 1.13 1.31 .96 1.22 1.19 1.70
ATP 1.23 1.51 .85 1.48 .93 .89 1.34
KLA/ATP 1.56 1.52 .71 1.40 .72 1.04 2.61
G6pdx
KLA  ATP  ATP+KLA
 NM_008062 glucose-6-phosphate dehydrogenase X-linked (G6pdx), mRNA [NM_008062] KLA .77 .81 .85 .74 .84 .90 1.44
ATP 1.11 1.12 .85 .85 .76 .86 1.07
KLA/ATP .96 .88 .63 .72 .58 .77 1.91
Gaa
KLA  ATP  ATP+KLA
 NM_008064 glucosidase, alpha, acid (Gaa), mRNA [NM_008064] KLA .85 .84 .84 .78 .83 .87 1.18
ATP .97 .96 .75 .78 .74 .72 1.01
KLA/ATP .88 .91 .78 .78 .71 .71 .86
Gad1
KLA  ATP  ATP+KLA
 AK054554 10 days neonate olfactory brain cDNA, RIKEN full-length enriched library, clone:E530004P22 product:glutamic acid decarboxylase 1, full insert sequence. [AK054554] KLA 1.03 1.00 1.00 1.00 1.00 .98 1.10
ATP 1.03 .91 1.01 1.05 .99 .97 1.08
KLA/ATP .97 .99 .99 1.10 1.02 1.09 .96
Gad1
KLA  ATP  ATP+KLA
 NM_008077 glutamic acid decarboxylase 1 (Gad1), mRNA [NM_008077] KLA 1.03 .99 1.00 1.01 1.01 .97 .99
ATP 1.02 1.02 1.01 .99 1.02 1.03 .98
KLA/ATP .96 1.03 1.04 .99 .99 1.04 1.01
Gad2
KLA  ATP  ATP+KLA
 NM_008078 glutamic acid decarboxylase 2 (Gad2), mRNA [NM_008078] KLA 1.03 1.07 1.11 1.11 1.04 .99 1.07
ATP .97 .99 1.02 1.02 1.01 .95 .97
KLA/ATP 1.05 1.08 1.04 1.01 1.00 1.06 1.00
Gal3st1
KLA  ATP  ATP+KLA
 NM_016922 galactose-3-O-sulfotransferase 1 (Gal3st1), mRNA [NM_016922] KLA 1.02 .94 .99 .97 .97 .95 .97
ATP .97 1.03 .97 1.04 1.02 .98 .96
KLA/ATP .95 1.00 .93 1.04 .96 1.01 .99
Galc
KLA  ATP  ATP+KLA
 NM_008079 galactosylceramidase (Galc), mRNA [NM_008079] KLA .70 .68 .66 .54 .40 .42 .62
ATP 1.11 1.33 1.00 1.23 .90 .72 .61
KLA/ATP .80 .80 .56 .71 .46 .53 .48
Gale
KLA  ATP  ATP+KLA
 NM_178389 galactose-4-epimerase, UDP (Gale), mRNA [NM_178389] KLA .74 .68 .72 .72 .67 .68 .54
ATP 1.13 .96 1.10 .91 .82 1.20 1.42
KLA/ATP .74 .69 .84 .71 .93 1.03 1.13
Galk1
KLA  ATP  ATP+KLA
 NM_016905 galactokinase 1 (Galk1), mRNA [NM_016905] KLA .85 .85 .76 .72 .63 .46 .50
ATP 1.02 1.07 1.02 1.33 1.01 .53 .62
KLA/ATP .90 .94 .87 1.00 .79 .50 .35
Galk2
KLA  ATP  ATP+KLA
 NM_175154 galactokinase 2 (Galk2), mRNA [NM_175154] KLA .86 .78 .66 .78 .65 .65 .67
ATP .96 .83 .79 .61 .54 .66 .95
KLA/ATP .62 .68 .67 .50 .42 .70 .94
Galns
KLA  ATP  ATP+KLA
 NM_016722 galactosamine (N-acetyl)-6-sulfate sulfatase (Galns), mRNA [NM_016722] KLA .99 1.00 1.06 1.00 1.07 1.14 1.41
ATP 1.18 1.19 .97 1.33 1.03 .80 1.15
KLA/ATP 1.11 1.12 .96 1.38 .85 .83 1.55
Galnt1
KLA  ATP  ATP+KLA
 NM_013814 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (Galnt1), mRNA [NM_013814] KLA .93 1.00 .93 .94 .87 .95 .98
ATP 1.13 1.22 1.08 1.18 .89 .59 .75
KLA/ATP 1.11 1.10 .91 1.11 .60 .53 .49
Galnt10
KLA  ATP  ATP+KLA
 BC016585 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10, mRNA (cDNA clone MGC:27969 IMAGE:3595220), complete cds. [BC016585] KLA .83 .86 .89 .79 .73 .64 .74
ATP 1.11 .96 .89 1.06 .81 .71 1.01
KLA/ATP .92 .94 .85 .86 .70 .67 .94
Galnt10
KLA  ATP  ATP+KLA
 NM_134189 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (Galnt10), mRNA [NM_134189] KLA .74 .71 .67 .70 .55 .58 .62
ATP .82 .75 1.10 .88 .68 .74 .94
KLA/ATP .63 .69 .91 .72 .68 .64 .82
Galnt11
KLA  ATP  ATP+KLA
 AK079811 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430075I06 product:unclassifiable, full insert sequence. [AK079811] KLA 1.05 .98 .97 .97 .99 .96 1.01
ATP .99 1.04 .96 .95 .95 .93 1.01
KLA/ATP .98 1.04 1.04 .90 .93 1.01 1.01
Galnt11
KLA  ATP  ATP+KLA
 NM_144908 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (Galnt11), mRNA [NM_144908] KLA .57 .54 .46 .38 .41 .48 .71
ATP .93 1.00 .94 .92 .58 .32 .55
KLA/ATP .52 .57 .50 .47 .40 .33 .23
Galnt12
KLA  ATP  ATP+KLA
 NM_172693 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (Galnt12), mRNA [NM_172693] KLA .40 .35 .35 .28 .18 .19 .29
ATP 1.16 1.05 1.10 .93 .58 .27 .37
KLA/ATP .42 .38 .41 .26 .27 .18 .15
Galnt13
KLA  ATP  ATP+KLA
 AK035964 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630021K14 product:unclassifiable, full insert sequence [AK035964] KLA .99 1.03 1.05 .98 1.00 .99 .99
ATP .99 1.02 .98 .98 .97 1.04 .98
KLA/ATP .97 1.02 1.01 .94 1.01 .99 .95
Galnt13
KLA  ATP  ATP+KLA
 NM_173030 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (Galnt13), mRNA [NM_173030] KLA 1.01 1.03 1.04 1.06 1.02 1.02 .99
ATP .98 .95 1.02 .98 1.03 .99 1.04
KLA/ATP 1.01 .97 1.00 1.09 1.02 1.00 1.03
Galnt14
KLA  ATP  ATP+KLA
 AK002747 adult male kidney cDNA, RIKEN full-length enriched library, clone:0610033M06 product:RIKEN cDNA 0610033M06 gene, full insert sequence. [AK002747] KLA 1.07 1.00 1.08 1.05 .96 1.02 .97
ATP .96 1.05 1.04 1.00 1.04 .99 1.06
KLA/ATP 1.05 .97 1.00 .98 1.06 .99 1.02
Galnt14
KLA  ATP  ATP+KLA
 NM_027864 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (Galnt14), mRNA [NM_027864] KLA 1.05 1.07 1.08 1.06 1.03 1.06 1.08
ATP 1.06 1.04 1.05 1.00 1.00 .97 1.04
KLA/ATP 1.04 1.08 1.03 1.02 1.02 1.00 1.06
Galnt2
KLA  ATP  ATP+KLA
 NM_139272 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (Galnt2), mRNA [NM_139272] KLA .75 .72 .72 .68 .70 .97 1.07
ATP 1.14 1.14 .98 1.07 .88 .76 1.42
KLA/ATP .85 .80 .61 .70 .53 .78 1.52
Galnt3
KLA  ATP  ATP+KLA
 AK087219 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030036B02 product:UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3, full insert sequence. [AK087219] KLA 1.04 1.00 .95 .98 .95 1.00 .98
ATP 1.02 1.01 1.02 .95 1.15 .96 .96
KLA/ATP .96 .94 .92 .94 1.02 .96 .97
Galnt3
KLA  ATP  ATP+KLA
 NM_015736 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (Galnt3), mRNA [NM_015736] KLA 1.28 1.22 1.16 1.13 .85 .79 .57
ATP .90 .93 1.04 .95 1.43 2.94 .63
KLA/ATP 1.12 1.21 1.17 1.08 1.08 1.17 .79
Galnt3
KLA  ATP  ATP+KLA
 U70538 UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-T3 mRNA, complete cds. [U70538] KLA 1.21 1.09 1.14 1.04 .82 .70 .57
ATP .91 .91 1.08 .91 1.33 2.59 .52
KLA/ATP 1.03 1.11 1.11 .90 .89 1.08 .57
Galnt4
KLA  ATP  ATP+KLA
 NM_015737 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (Galnt4), mRNA [NM_015737] KLA .79 .79 .66 .65 .52 .57 .71
ATP .90 .78 .52 .44 .34 .70 .82
KLA/ATP .74 .67 .50 .54 .41 .42 .47
Galnt6
KLA  ATP  ATP+KLA
 NM_172451 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (Galnt6), mRNA [NM_172451] KLA .58 .53 .62 .59 .79 1.35 1.55
ATP 1.06 1.06 .76 1.03 2.22 2.64 3.21
KLA/ATP .63 .59 .51 .55 1.24 2.04 2.79
Galnt7
KLA  ATP  ATP+KLA
 NM_144731 UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (Galnt7), mRNA [NM_144731] KLA 1.89 2.01 1.94 1.67 1.45 .84 .63
ATP 1.03 1.12 1.07 1.12 .68 .44 .76
KLA/ATP 2.08 2.11 1.58 1.78 .87 .62 .53
Galntl1
KLA  ATP  ATP+KLA
 NM_001081421 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 1 (Galntl1), mRNA [NM_001081421] KLA 1.03 1.01 1.01 .96 .91 .99 .97
ATP 1.03 1.01 1.02 .95 .94 .92 .99
KLA/ATP 1.02 1.03 .97 .92 .97 .89 .96
Galntl2
KLA  ATP  ATP+KLA
 AK019470 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4631401E18 product:similar to UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7 [Homo sapiens], full insert sequence [AK019470] KLA .90 .94 .88 .98 .81 1.02 1.21
ATP .99 .92 1.16 1.48 2.08 1.48 1.01
KLA/ATP .98 .99 .93 1.14 2.12 1.85 1.11
Galntl4
KLA  ATP  ATP+KLA
 AK084671 13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330027L06 product:hypothetical protein, full insert sequence. [AK084671] KLA .99 1.05 .99 1.02 .86 1.02 1.03
ATP .98 .97 1.07 1.03 .95 .93 .98
KLA/ATP 1.05 .99 .95 .99 .99 .95 1.04
Galntl4
KLA  ATP  ATP+KLA
 NM_173739 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (Galntl4), mRNA [NM_173739] KLA 1.07 1.00 1.04 .94 1.04 1.03 1.03
ATP 1.05 1.02 .99 1.00 .95 .99 .96
KLA/ATP 1.01 1.01 .98 .96 1.00 .98 1.00
Galntl5
KLA  ATP  ATP+KLA
 NM_026449 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 (Galntl5), mRNA [NM_026449] KLA .98 1.09 1.04 1.00 .97 .90 .96
ATP 1.06 1.03 1.01 1.00 1.11 .92 .99
KLA/ATP 1.08 .99 1.04 .93 .98 .97 .96
Galt
KLA  ATP  ATP+KLA
 NM_016658 galactose-1-phosphate uridyl transferase (Galt), mRNA [NM_016658] KLA .63 .59 .54 .59 .57 .79 1.08
ATP .88 .77 .92 .79 .74 .88 .95
KLA/ATP .53 .53 .60 .49 .59 .80 1.10
Gamt
KLA  ATP  ATP+KLA
 NM_010255 guanidinoacetate methyltransferase (Gamt), mRNA [NM_010255] KLA .83 .81 .79 .71 .64 .49 .39
ATP 1.01 1.05 1.07 1.29 1.03 .50 .40
KLA/ATP .84 .88 .86 1.02 .84 .52 .21
Ganab
KLA  ATP  ATP+KLA
 NM_008060 alpha glucosidase 2 alpha neutral subunit (Ganab), mRNA [NM_008060] KLA .91 .99 .97 .88 .86 .84 .88
ATP 1.01 1.20 .99 1.02 .77 .70 .76
KLA/ATP 1.02 1.10 .90 .85 .66 .66 .77
Ganc
KLA  ATP  ATP+KLA
 NM_172672 glucosidase, alpha; neutral C (Ganc), mRNA [NM_172672] KLA 1.02 .97 1.02 1.00 1.00 .98 .98
ATP 1.06 1.04 1.03 1.00 .71 .71 1.05
KLA/ATP 1.02 1.09 1.18 .97 .83 .79 1.07
Gapdh
KLA  ATP  ATP+KLA
 NM_008084 glyceraldehyde-3-phosphate dehydrogenase (Gapdh), mRNA [NM_008084] KLA .83 .87 .98 .70 .98 .82 1.34
ATP 1.24 1.33 .70 1.26 .95 .96 1.64
KLA/ATP 1.08 1.18 .50 .98 .61 .79 1.40
Gapdhs
KLA  ATP  ATP+KLA
 NM_008085 glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (Gapdhs), mRNA [NM_008085] KLA .99 .98 .97 .99 1.00 1.01 1.02
ATP 1.02 1.01 .98 1.05 .98 .97 1.02
KLA/ATP 1.00 1.02 .95 1.02 .95 .94 .94
Gart
KLA  ATP  ATP+KLA
 AK168445 13 days embryo liver cDNA, RIKEN full-length enriched library, clone:I920021A03 product:phosphoribosylglycinamide formyltransferase, full insert sequence. [AK168445] KLA .88 .80 .73 .71 .52 .48 .75
ATP 1.03 .98 1.11 1.02 .61 .37 .52
KLA/ATP .81 .86 .87 .75 .49 .30 .26
Gart
KLA  ATP  ATP+KLA
 NM_010256 phosphoribosylglycinamide formyltransferase (Gart), mRNA [NM_010256] KLA .68 .73 .60 .50 .46 .57 .70
ATP .97 1.03 .93 .91 .59 .39 .58
KLA/ATP .69 .70 .58 .59 .39 .32 .33
Gatm
KLA  ATP  ATP+KLA
 NM_025961 glycine amidinotransferase (L-arginine:glycine amidinotransferase) (Gatm), nuclear gene encoding mitochondrial protein, mRNA [NM_025961] KLA 1.12 1.10 1.08 1.22 1.29 1.64 .65
ATP 1.02 1.14 1.14 1.48 .82 .21 .15
KLA/ATP 1.15 1.11 1.08 1.36 .67 .26 .17
Gba
KLA  ATP  ATP+KLA
 NM_001077411 glucosidase, beta, acid (Gba), mRNA [NM_001077411] KLA .86 .89 .92 .84 .95 1.11 1.65
ATP .97 .99 .60 .74 .63 .76 2.19
KLA/ATP .95 .85 .52 .74 .50 .81 2.57
Gbe1
KLA  ATP  ATP+KLA
 NM_028803 glucan (1,4-alpha-), branching enzyme 1 (Gbe1), mRNA [NM_028803] KLA 1.04 1.04 .96 .99 .65 .63 .96
ATP .90 .75 1.15 .71 .93 3.49 .88
KLA/ATP .92 1.00 1.08 .79 .86 1.22 .74
Gbgt1
KLA  ATP  ATP+KLA
 NM_139197 globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Gbgt1), mRNA [NM_139197] KLA 1.13 1.21 1.26 1.34 1.62 1.88 2.04
ATP 1.00 1.02 1.02 1.04 .93 .92 1.07
KLA/ATP 1.14 1.22 1.11 1.13 .98 1.08 1.62
Gcdh
KLA  ATP  ATP+KLA
 U18992 glutaryl-CoA dehydrogenase mRNA, complete cds. [U18992] KLA .93 .79 .71 .83 .76 .74 .79
ATP 1.03 1.08 1.25 1.15 .86 .56 .75
KLA/ATP .72 .82 1.12 .93 .68 .50 .48
Gch1
KLA  ATP  ATP+KLA
 NM_008102 GTP cyclohydrolase 1 (Gch1), mRNA [NM_008102] KLA 7.78 7.74 8.92 8.50 8.61 6.39 4.13
ATP 1.00 1.05 1.80 4.55 8.06 5.95 2.30
KLA/ATP 7.70 8.52 9.93 14.71 14.00 8.42 4.27
Gck
KLA  ATP  ATP+KLA
 NM_010292 glucokinase (Gck), mRNA [NM_010292] KLA 1.03 .99 1.04 1.02 .97 .98 1.00
ATP 1.01 .97 1.08 .99 1.06 .98 .96
KLA/ATP 1.06 1.01 .96 .98 .98 1.01 1.01
Gclc
KLA  ATP  ATP+KLA
 NM_010295 glutamate-cysteine ligase, catalytic subunit (Gclc), mRNA [NM_010295] KLA .42 .38 .24 .19 .22 .26 .59
ATP 1.07 1.03 1.24 2.13 4.71 25.45 1.33
KLA/ATP .35 .36 .44 1.21 2.16 4.41 1.54
Gclm
KLA  ATP  ATP+KLA
 NM_008129 glutamate-cysteine ligase , modifier subunit (Gclm), mRNA [NM_008129] KLA .87 .91 .79 .58 .46 .46 1.30
ATP 1.26 1.41 .93 1.28 2.39 5.57 2.40
KLA/ATP .98 1.10 .59 .93 .97 2.74 2.75
Gcnt1
KLA  ATP  ATP+KLA
 NM_010265 glucosaminyl (N-acetyl) transferase 1, core 2 (Gcnt1), mRNA [NM_010265] KLA .33 .30 .26 .23 .20 .22 .28
ATP 1.02 .99 1.11 .96 1.12 .71 1.76
KLA/ATP .31 .27 .29 .31 .34 .38 .42
Gcnt1
KLA  ATP  ATP+KLA
 NM_173442 glucosaminyl (N-acetyl) transferase 1, core 2 (Gcnt1), mRNA [NM_173442] KLA .13 .10 .07 .06 .05 .08 .12
ATP .91 .82 1.08 .69 1.32 .45 .88
KLA/ATP .11 .10 .08 .06 .23 .25 .12
Gcnt2
KLA  ATP  ATP+KLA
 NM_133219 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (Gcnt2), transcript variant 3, mRNA [NM_133219] KLA 2.85 3.32 3.45 3.25 3.04 2.61 1.40
ATP 1.04 1.11 1.09 1.14 1.36 2.40 1.76
KLA/ATP 3.01 3.24 2.59 2.73 2.30 2.47 2.34
Gcnt3
KLA  ATP  ATP+KLA
 NM_028087 glucosaminyl (N-acetyl) transferase 3, mucin type (Gcnt3), mRNA [NM_028087] KLA 1.01 1.07 .98 .93 1.07 1.03 1.01
ATP 1.06 1.00 1.02 1.00 1.01 1.07 1.03
KLA/ATP 1.10 1.01 .95 .97 .97 1.04 .98
Gcs1
KLA  ATP  ATP+KLA
 NM_020619 glucosidase 1 (Gcs1), mRNA [NM_020619] KLA .62 .60 .59 .54 .50 .56 .95
ATP .95 .96 1.04 .81 .62 .68 1.23
KLA/ATP .63 .61 .68 .53 .46 .42 .60
Gda
KLA  ATP  ATP+KLA
 NM_010266 guanine deaminase (Gda), mRNA [NM_010266] KLA 3.01 3.35 3.91 4.08 3.78 1.70 1.21
ATP 1.05 1.05 1.15 1.13 1.25 1.99 1.32
KLA/ATP 3.04 3.63 3.25 3.16 2.29 1.87 1.59
Gfpt1
KLA  ATP  ATP+KLA
 NM_013528 glutamine fructose-6-phosphate transaminase 1 (Gfpt1), mRNA [NM_013528] KLA 1.65 1.73 1.88 1.89 1.81 1.81 2.11
ATP 1.13 1.24 1.25 1.43 2.76 2.99 3.85
KLA/ATP 1.78 2.02 1.88 1.75 1.97 3.84 6.84
Gfpt2
KLA  ATP  ATP+KLA
 NM_013529 glutamine fructose-6-phosphate transaminase 2 (Gfpt2), mRNA [NM_013529] KLA 1.28 1.31 1.50 1.32 1.18 1.25 1.11
ATP .98 1.00 1.05 1.72 2.72 2.21 1.07
KLA/ATP 1.34 1.42 1.38 2.19 2.19 1.93 1.54
Ggps1
KLA  ATP  ATP+KLA
 AK138564 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330064P13 product:geranylgeranyl diphosphate synthase 1, full insert sequence [AK138564] KLA 1.17 1.19 1.22 1.09 1.12 1.25 1.22
ATP 1.02 1.06 .90 .91 1.06 1.11 .92
KLA/ATP 1.23 1.10 1.10 1.19 1.22 1.09 .89
Ggps1
KLA  ATP  ATP+KLA
 NM_010282 geranylgeranyl diphosphate synthase 1 (Ggps1), mRNA [NM_010282] KLA 1.17 1.17 1.29 1.28 1.22 1.57 1.73
ATP .88 .84 .99 .85 .97 2.03 2.04
KLA/ATP 1.08 1.10 1.34 1.11 1.23 1.95 2.71
Ggt1
KLA  ATP  ATP+KLA
 NM_008116 gamma-glutamyltransferase 1 (Ggt1), mRNA [NM_008116] KLA 1.03 1.00 1.00 1.05 1.00 1.02 1.02
ATP 1.00 1.00 .96 1.00 1.03 1.02 .99
KLA/ATP .98 .99 1.04 1.00 .99 .98 .98
Ggt5
KLA  ATP  ATP+KLA
 NM_011820 gamma-glutamyltransferase 5 (Ggt5), mRNA [NM_011820] KLA .89 .91 .92 .89 .86 .79 .58
ATP 1.00 1.03 .93 .97 .84 .80 .59
KLA/ATP 1.00 .92 .93 .98 .83 .79 .68
Ggt6
KLA  ATP  ATP+KLA
 NM_027819 gamma-glutamyltransferase 6 (Ggt6), mRNA [NM_027819] KLA 1.03 .90 .98 1.07 1.00 1.02 .98
ATP 1.02 1.07 .90 1.02 1.03 1.03 .94
KLA/ATP .99 1.04 .98 .97 1.02 1.01 .96
Ggt7
KLA  ATP  ATP+KLA
 NM_144786 gamma-glutamyltransferase 7 (Ggt7), mRNA [NM_144786] KLA .96 1.03 .97 1.01 1.00 .98 .89
ATP 1.03 1.02 1.01 .92 .94 .97 1.00
KLA/ATP .98 .95 1.05 .89 .92 .94 .94
Gk2
KLA  ATP  ATP+KLA
 NM_010294 glycerol kinase 2 (Gk2), mRNA [NM_010294] KLA 1.26 1.28 1.65 1.55 1.96 1.59 1.41
ATP .99 1.02 1.00 1.17 1.20 1.63 1.06
KLA/ATP 1.39 1.49 1.34 1.36 1.21 1.45 1.30
Glb1
KLA  ATP  ATP+KLA
 NM_009752 galactosidase, beta 1 (Glb1), mRNA [NM_009752] KLA .93 .96 1.02 .85 .86 .81 .80
ATP 1.03 1.10 1.01 1.13 .97 .82 .75
KLA/ATP 1.08 1.04 .86 1.06 .81 .81 .66
Glce
KLA  ATP  ATP+KLA
 NM_033320 glucuronyl C5-epimerase (Glce), mRNA [NM_033320] KLA 1.00 .97 .88 .78 .59 .68 1.00
ATP 1.10 1.02 1.03 .95 2.32 2.94 2.07
KLA/ATP .95 .95 .94 .78 1.49 1.99 1.84
Gldc
KLA  ATP  ATP+KLA
 NM_138595 glycine decarboxylase (Gldc), mRNA [NM_138595] KLA .77 .75 .63 .67 .70 .76 .89
ATP .98 1.02 .97 1.03 1.33 2.46 2.61
KLA/ATP .84 .69 .75 .73 .87 2.08 2.77
Gls2
KLA  ATP  ATP+KLA
 NM_001033264 glutaminase 2 (liver, mitochondrial) (Gls2), nuclear gene encoding mitochondrial protein, mRNA [NM_001033264] KLA 1.03 .98 1.02 .97 .98 .88 .80
ATP .94 1.01 1.04 1.08 1.26 1.20 .87
KLA/ATP .95 .98 1.15 1.02 1.29 .99 .87
Glt28d2
KLA  ATP  ATP+KLA
 NM_177130 glycosyltransferase 28 domain containing 2 (Glt28d2), mRNA [NM_177130] KLA .98 1.02 1.04 .99 .93 .98 1.05
ATP .98 1.01 1.04 1.07 .97 1.00 .94
KLA/ATP 1.01 1.05 .98 .99 .94 .99 1.02
Glud1
KLA  ATP  ATP+KLA
 NM_008133 glutamate dehydrogenase 1 (Glud1), mRNA [NM_008133] KLA .70 .70 .63 .54 .52 .54 .59
ATP .96 .91 1.01 1.05 .96 .66 .47
KLA/ATP .67 .66 .61 .69 .70 .51 .27
Glul
KLA  ATP  ATP+KLA
 NM_008131 glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131] KLA .58 .54 .47 .41 .30 .31 .40
ATP .96 .99 1.46 2.55 2.16 2.88 1.34
KLA/ATP .57 .56 .83 1.52 1.27 1.20 .97
Glul
KLA  ATP  ATP+KLA
 X16314 gb|M.musculus mRNA for glutamine synthetase. [X16314] KLA .86 .95 .79 .87 .78 .99 .83
ATP .95 1.03 1.09 1.27 1.14 1.37 1.00
KLA/ATP .88 .97 .89 1.12 1.01 1.19 .91
Glyctk
KLA  ATP  ATP+KLA
 NM_174846 glycerate kinase (Glyctk), transcript variant 1, mRNA [NM_174846] KLA .98 1.05 1.12 1.07 1.13 1.16 1.11
ATP 1.04 1.07 .93 .93 .72 .97 1.22
KLA/ATP 1.02 1.02 .94 .89 .82 1.00 1.26
Gmds
KLA  ATP  ATP+KLA
 NM_146041 GDP-mannose 4, 6-dehydratase (Gmds), mRNA [NM_146041] KLA 1.08 1.19 1.08 1.00 .87 .56 .41
ATP .97 1.07 1.05 1.30 1.03 .55 .37
KLA/ATP 1.18 1.12 .98 1.11 .75 .53 .27
Gmppa
KLA  ATP  ATP+KLA
 NM_133708 GDP-mannose pyrophosphorylase A (Gmppa), mRNA [NM_133708] KLA 1.03 1.04 1.03 .92 1.02 1.04 1.35
ATP 1.05 1.17 .81 1.16 .73 .59 1.61
KLA/ATP 1.19 1.16 .74 1.16 .72 .72 1.46
Gmppb
KLA  ATP  ATP+KLA
 NM_177910 GDP-mannose pyrophosphorylase B (Gmppb), mRNA [NM_177910] KLA 2.41 2.66 2.76 3.33 3.47 3.38 1.74
ATP .91 .92 .78 .74 .43 1.76 2.06
KLA/ATP 2.31 2.72 2.59 2.32 1.87 2.93 2.37
Gmps
KLA  ATP  ATP+KLA
 NM_001033300 guanine monphosphate synthetase (Gmps), mRNA [NM_001033300] KLA 1.04 1.13 1.05 .91 .79 .75 .96
ATP 1.12 1.17 1.01 1.24 .99 1.02 .82
KLA/ATP 1.18 1.08 .92 1.11 .86 .94 .62
Gne
KLA  ATP  ATP+KLA
 AK033507 adult male colon cDNA, RIKEN full-length enriched library, clone:9030414E18 product:UDP-N-acetylglucosamine-2-epimerase [AK033507] KLA .70 .66 .67 .69 .61 .68 .75
ATP .86 .72 .65 .66 .94 .74 .60
KLA/ATP .66 .56 .66 .60 .67 .64 .51
Gne
KLA  ATP  ATP+KLA
 NM_015828 glucosamine (Gne), mRNA [NM_015828] KLA .60 .61 .65 .67 .62 .56 .62
ATP .92 .78 .51 .54 .98 .55 .73
KLA/ATP .57 .47 .37 .36 .54 .39 .27
Gnpda1
KLA  ATP  ATP+KLA
 NM_011937 glucosamine-6-phosphate deaminase 1 (Gnpda1), mRNA [NM_011937] KLA .33 .30 .29 .21 .22 .42 .62
ATP .98 1.09 .86 .92 .71 .43 1.17
KLA/ATP .36 .34 .29 .31 .35 .54 .75
Gnpda2
KLA  ATP  ATP+KLA
 NM_001038015 glucosamine-6-phosphate deaminase 2 (Gnpda2), mRNA [NM_001038015] KLA .86 .82 .76 .87 .74 .89 1.14
ATP .92 .83 1.04 .83 .77 .88 .72
KLA/ATP .75 .81 .97 .79 .85 1.04 .88
Gns
KLA  ATP  ATP+KLA
 AK040524 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430105C13 product:glucosamine (N-acetyl)-6-sulfatase, full insert sequence. [AK040524] KLA 2.06 2.05 1.93 2.03 2.37 1.56 1.22
ATP 1.18 1.15 .98 2.24 1.28 1.03 1.52
KLA/ATP 2.15 2.20 1.53 2.63 1.61 1.42 1.54
Gns
KLA  ATP  ATP+KLA
 NM_029364 glucosamine (N-acetyl)-6-sulfatase (Gns), mRNA [NM_029364] KLA 1.48 1.47 1.80 1.48 1.81 2.03 1.87
ATP 1.09 1.27 .92 1.16 .95 .85 1.54
KLA/ATP 1.57 1.62 1.22 1.69 .98 1.34 1.93
Got1
KLA  ATP  ATP+KLA
 NM_010324 glutamate oxaloacetate transaminase 1, soluble (Got1), mRNA [NM_010324] KLA .68 .70 .66 .56 .50 .57 .99
ATP 1.01 1.24 1.55 1.59 1.47 1.03 1.68
KLA/ATP .68 .71 .66 .77 1.13 2.33 1.89
Got2
KLA  ATP  ATP+KLA
 NM_010325 glutamate oxaloacetate transaminase 2, mitochondrial (Got2), nuclear gene encoding mitochondrial protein, mRNA [NM_010325] KLA .84 .86 .88 .75 .75 .63 .61
ATP 1.02 1.12 .98 1.15 .98 .67 .86
KLA/ATP .92 .89 .75 .89 .68 .70 .77
Gpaa1
KLA  ATP  ATP+KLA
 NM_010331 GPI anchor attachment protein 1 (Gpaa1), mRNA [NM_010331] KLA .93 .99 .97 .99 .87 .85 .87
ATP 1.05 1.16 1.03 1.14 1.03 .85 .79
KLA/ATP 1.05 1.08 .96 1.01 .81 .89 .81
Gpam
KLA  ATP  ATP+KLA
 NM_008149 glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), nuclear gene encoding mitochondrial protein, mRNA [NM_008149] KLA 1.04 .97 1.00 1.04 .90 .96 1.00
ATP .98 1.18 1.10 .95 .70 .98 1.37
KLA/ATP 1.03 1.06 1.05 1.01 .79 .89 1.00
Gpi1
KLA  ATP  ATP+KLA
 L09104 glucose phosphate isomerase mRNA, 3 end. [L09104] KLA .92 1.02 .99 1.01 .92 1.04 1.07
ATP 1.05 1.06 1.11 1.14 1.01 1.00 1.04
KLA/ATP 1.06 1.09 1.01 .96 .93 .93 1.04
Gpi1
KLA  ATP  ATP+KLA
 NM_008155 glucose phosphate isomerase 1 (Gpi1), mRNA [NM_008155] KLA .77 .76 .69 .66 .61 .59 .85
ATP .96 .97 .97 .93 .90 .73 .77
KLA/ATP .75 .76 .73 .69 .66 .54 .59
Gpt
KLA  ATP  ATP+KLA
 NM_182805 glutamic pyruvic transaminase, soluble (Gpt), mRNA [NM_182805] KLA .82 .81 .80 .82 .78 .83 1.05
ATP 1.01 1.00 1.07 1.23 1.20 .77 1.01
KLA/ATP .85 .86 .93 1.01 1.32 .83 .97
Gpt2
KLA  ATP  ATP+KLA
 NM_173866 glutamic pyruvate transaminase (alanine aminotransferase) 2 (Gpt2), mRNA [NM_173866] KLA .82 .87 .84 .69 .64 .80 .91
ATP .97 1.08 1.06 .95 1.33 2.66 1.89
KLA/ATP .81 .83 .67 .70 1.07 2.66 1.63
Grhpr
KLA  ATP  ATP+KLA
 NM_080289 glyoxylate reductase/hydroxypyruvate reductase (Grhpr), mRNA [NM_080289] KLA .82 .79 .68 .60 .42 .28 .56
ATP .93 .99 1.24 1.33 .91 .54 .71
KLA/ATP .74 .78 .84 .86 .61 .31 .39
Gss
KLA  ATP  ATP+KLA
 NM_008180 glutathione synthetase (Gss), mRNA [NM_008180] KLA 1.21 1.26 1.25 1.17 1.00 .75 1.11
ATP 1.06 1.12 1.04 1.21 3.15 7.87 2.60
KLA/ATP 1.24 1.35 1.22 1.38 2.28 4.32 2.63
Gstz1
KLA  ATP  ATP+KLA
 NM_010363 glutathione transferase zeta 1 (maleylacetoacetate isomerase) (Gstz1), mRNA [NM_010363] KLA .94 .85 .93 .85 .83 .71 .87
ATP 1.12 1.08 1.17 1.16 .78 .44 .71
KLA/ATP .96 .98 .97 1.03 .74 .47 .56
Guk1
KLA  ATP  ATP+KLA
 NM_008193 guanylate kinase 1 (Guk1), mRNA [NM_008193] KLA 1.32 1.31 1.23 1.15 1.08 .77 .77
ATP 1.09 1.09 1.12 1.12 .96 .68 1.24
KLA/ATP 1.22 1.31 1.39 1.38 1.05 .85 .87
Gulo
KLA  ATP  ATP+KLA
 NM_178747 gulonolactone (L-) oxidase (Gulo), mRNA [NM_178747] KLA 1.01 .97 1.03 1.04 1.01 .98 .99
ATP 1.00 .99 .99 .98 1.04 1.02 .98
KLA/ATP .97 .98 1.03 1.00 .98 .94 .97
Gusb
KLA  ATP  ATP+KLA
 NM_010368 glucuronidase, beta (Gusb), mRNA [NM_010368] KLA .65 .67 .62 .52 .52 .47 .52
ATP 1.07 1.11 .95 1.00 .80 .57 .58
KLA/ATP .72 .71 .56 .62 .52 .48 .38
Gyk
KLA  ATP  ATP+KLA
 AK037633 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130030N17 product:unclassifiable, full insert sequence [AK037633] KLA 5.44 4.98 5.36 4.61 4.88 2.89 1.97
ATP 1.17 1.65 4.22 2.33 6.88 2.27 1.07
KLA/ATP 5.99 9.29 15.97 4.69 3.09 3.74 2.06
Gyk
KLA  ATP  ATP+KLA
 AK086200 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930012N15 product:glycerol kinase, full insert sequence. [AK086200] KLA 1.16 1.08 1.12 1.03 1.02 1.07 .98
ATP .93 1.01 1.12 .95 1.14 .96 .98
KLA/ATP 1.23 1.24 1.22 .95 1.10 .96 1.06
Gyk
KLA  ATP  ATP+KLA
 NM_008194 glycerol kinase (Gyk), transcript variant 1, mRNA [NM_008194] KLA 2.56 2.95 3.62 4.16 5.93 5.02 2.77
ATP 1.04 1.19 1.02 1.51 2.16 4.68 1.09
KLA/ATP 2.65 2.96 2.71 4.15 2.62 4.18 3.09
Gyk
KLA  ATP  ATP+KLA
 NM_212444 glycerol kinase (Gyk), transcript variant 2, mRNA [NM_212444] KLA 3.95 4.35 5.39 5.59 8.90 6.88 3.32
ATP 1.12 1.38 1.20 1.70 2.32 4.01 .95
KLA/ATP 3.99 4.03 4.00 5.56 2.86 3.73 3.14
H2-Ke6
KLA  ATP  ATP+KLA
 NM_013543 H2-K region expressed gene 6 (H2-Ke6), mRNA [NM_013543] KLA 1.00 1.03 .95 .96 .88 .79 .63
ATP .96 1.01 .98 1.44 1.13 .66 .59
KLA/ATP .99 1.08 1.19 1.48 1.19 .73 .49
H6pd
KLA  ATP  ATP+KLA
 NM_173371 hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (H6pd), mRNA [NM_173371] KLA .89 .91 .89 .78 .64 .85 1.14
ATP .98 1.06 .86 .67 .38 .49 1.45
KLA/ATP .96 .96 .81 .70 .44 .43 1.19
Hadh
KLA  ATP  ATP+KLA
 NM_008212 hydroxyacyl-Coenzyme A dehydrogenase (Hadh), nuclear gene encoding mitochondrial protein, mRNA [NM_008212] KLA .75 .75 .72 .64 .54 .37 .49
ATP 1.12 1.19 1.08 1.28 .96 .43 .41
KLA/ATP .76 .81 .68 .85 .56 .42 .21
Hadha
KLA  ATP  ATP+KLA
 AK050856 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030026J11 product:hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit, full insert KLA .96 .92 .91 .80 .97 .92 .90
ATP .72 .64 .63 .71 .91 .93 .93
KLA/ATP .79 .72 .68 .73 .87 .90 .88
Hadha
KLA  ATP  ATP+KLA
 NM_178878 hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit (Hadha), nuclear gene encoding mitochondrial protein, mRNA [NM_178878] KLA 1.10 1.17 1.36 1.16 1.23 1.10 1.00
ATP 1.16 1.22 1.03 1.40 1.09 .79 1.11
KLA/ATP 1.33 1.35 1.16 1.41 1.00 .92 1.31
Hadhb
KLA  ATP  ATP+KLA
 NM_145558 hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit (Hadhb), nuclear gene encoding mitochondrial protein, mRNA [NM_145558] KLA .85 .88 .76 .77 .70 .54 .58
ATP 1.08 1.13 1.05 1.01 .84 .53 .58
KLA/ATP .79 .91 .83 .80 .61 .46 .44
Hal
KLA  ATP  ATP+KLA
 NM_010401 histidine ammonia lyase (Hal), mRNA [NM_010401] KLA .97 1.01 1.01 .99 .83 .90 .97
ATP 1.03 1.12 1.05 1.07 1.20 1.74 1.70
KLA/ATP .96 1.00 .97 .99 1.07 1.72 1.29
Hao1
KLA  ATP  ATP+KLA
 AF104312 glycolate oxidase mRNA, complete cds. [AF104312] KLA .85 .89 .77 .82 .79 .79 1.13
ATP .88 .99 .95 1.90 1.11 .82 1.22
KLA/ATP .86 .81 .72 1.28 1.14 .91 1.07
Hao3
KLA  ATP  ATP+KLA
 NM_019545 hydroxyacid oxidase (glycolate oxidase) 3 (Hao3), mRNA [NM_019545] KLA 1.03 1.03 1.00 1.08 .97 .99 .94
ATP 1.04 1.01 1.03 .97 1.07 1.01 1.01
KLA/ATP 1.00 .97 1.03 .98 1.01 1.02 1.04
Hdc
KLA  ATP  ATP+KLA
 NM_008230 histidine decarboxylase (Hdc), mRNA [NM_008230] KLA 27.59 25.41 24.74 28.27 21.96 24.39 9.08
ATP 1.04 1.03 1.59 2.85 3.81 12.00 3.74
KLA/ATP 25.83 28.35 36.64 27.70 32.70 29.32 26.26
Hexa
KLA  ATP  ATP+KLA
 NM_010421 hexosaminidase A (Hexa), mRNA [NM_010421] KLA .74 .76 .70 .63 .57 .52 .51
ATP .98 1.04 .82 .81 .68 .52 .64
KLA/ATP .76 .78 .63 .60 .48 .37 .31
Hexb
KLA  ATP  ATP+KLA
 NM_010422 hexosaminidase B (Hexb), mRNA [NM_010422] KLA .82 .90 .81 .70 .64 .64 .71
ATP .95 1.03 1.11 .83 .72 .58 .63
KLA/ATP .80 .83 .77 .68 .53 .45 .50
Hgd
KLA  ATP  ATP+KLA
 NM_013547 homogentisate 1, 2-dioxygenase (Hgd), mRNA [NM_013547] KLA .97 1.03 .95 1.05 1.02 1.00 .99
ATP 1.02 1.00 .99 .99 .97 .96 1.06
KLA/ATP 1.00 .96 1.00 .97 1.08 1.12 1.08
Hgsnat
KLA  ATP  ATP+KLA
 NM_029884 heparan-alpha-glucosaminide N-acetyltransferase (Hgsnat), mRNA [NM_029884] KLA .73 .74 .73 .76 .70 1.27 1.85
ATP .91 .98 1.13 1.21 1.13 1.59 2.63
KLA/ATP .69 .68 .78 .98 1.06 2.45 4.56
Hibadh
KLA  ATP  ATP+KLA
 NM_145567 3-hydroxyisobutyrate dehydrogenase (Hibadh), mRNA [NM_145567] KLA 1.18 1.20 1.52 1.58 1.53 1.48 .93
ATP 1.13 1.04 1.21 1.15 1.07 .87 .79
KLA/ATP 1.27 1.34 1.79 1.40 1.49 1.17 .93
Hibch
KLA  ATP  ATP+KLA
 NM_146108 3-hydroxyisobutyryl-Coenzyme A hydrolase (Hibch), mRNA [NM_146108] KLA .47 .44 .40 .33 .30 .39 .82
ATP .92 .92 1.45 1.12 .69 .61 .91
KLA/ATP .42 .41 .56 .40 .34 .45 .55
Hk1
KLA  ATP  ATP+KLA
 J05277 gb|Mouse hexokinase mRNA, complete cds [J05277] KLA 1.49 1.45 1.66 1.78 1.51 1.29 .99
ATP 1.11 1.05 1.15 1.20 2.31 2.17 1.09
KLA/ATP 1.63 1.51 1.70 1.47 1.94 1.92 1.40
Hk1
KLA  ATP  ATP+KLA
 NM_010438 hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438] KLA 1.58 1.75 2.05 1.84 1.96 1.67 1.31
ATP 1.06 1.25 1.01 1.49 2.23 1.79 1.20
KLA/ATP 1.87 1.96 1.51 1.93 1.71 1.94 1.72
Hk2
KLA  ATP  ATP+KLA
 NM_013820 hexokinase 2 (Hk2), mRNA [NM_013820] KLA 4.09 4.09 3.17 2.37 1.53 1.62 2.02
ATP .98 .92 1.08 2.24 3.82 3.86 .97
KLA/ATP 4.07 3.94 4.17 3.53 5.42 4.65 1.54
Hk3
KLA  ATP  ATP+KLA
 NM_001033245 hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245] KLA 1.52 1.68 1.94 1.85 2.21 2.89 1.98
ATP 1.01 1.07 .87 .99 1.01 1.26 2.62
KLA/ATP 1.63 1.74 1.67 1.69 1.44 2.01 3.53
Hkdc1
KLA  ATP  ATP+KLA
 NM_145419 hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419] KLA 1.10 1.08 1.12 1.12 1.02 1.07 1.04
ATP .96 1.04 1.06 4.28 10.50 3.91 1.34
KLA/ATP .98 1.04 1.14 5.33 12.44 8.68 1.77
Hlcs
KLA  ATP  ATP+KLA
 NM_139145 holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) (Hlcs), mRNA [NM_139145] KLA .60 .62 .54 .59 .71 1.01 1.28
ATP 1.07 1.06 .91 .85 .54 .41 .51
KLA/ATP .65 .64 .48 .58 .48 .56 .86
Hmbs
KLA  ATP  ATP+KLA
 AK158160 adult inner ear cDNA, RIKEN full-length enriched library, clone:F930036J03 product:unclassifiable, full insert sequence. [AK158160] KLA .95 1.03 .98 .98 .94 1.01 1.06
ATP .98 1.02 1.04 .98 .87 .97 .95
KLA/ATP .99 .98 .97 .97 .94 .98 1.02
Hmbs
KLA  ATP  ATP+KLA
 NM_013551 hydroxymethylbilane synthase (Hmbs), transcript variant 1, mRNA [NM_013551] KLA .51 .49 .44 .43 .43 .57 .76
ATP .94 .95 .98 .88 .61 .35 .72
KLA/ATP .50 .46 .41 .37 .32 .31 .37
Hmgcl
KLA  ATP  ATP+KLA
 NM_008254 3-hydroxy-3-methylglutaryl-Coenzyme A lyase (Hmgcl), mRNA [NM_008254] KLA .37 .34 .39 .48 .63 .86 .71
ATP .87 .84 .93 .82 .69 .91 1.21
KLA/ATP .32 .33 .38 .38 .71 1.31 1.25
Hmgcr
KLA  ATP  ATP+KLA
 NM_008255 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (Hmgcr), mRNA [NM_008255] KLA 2.15 2.09 2.02 1.44 1.13 .88 1.02
ATP 1.05 1.16 1.43 1.53 1.83 2.60 1.87
KLA/ATP 2.16 2.23 1.99 1.81 1.34 1.81 1.79
Hmgcs1
KLA  ATP  ATP+KLA
 AK078743 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030402P03 product:similar to hydroxymethylglutaryl-CoA synthase (EC 4.1.3.5) (fragment) [Gallus gallus], full insert sequence. [AK078743] KLA 1.06 1.08 .98 .81 .88 .71 .86
ATP 1.39 1.87 10.43 2.82 1.19 1.14 1.09
KLA/ATP 1.36 1.59 5.22 1.83 1.21 .75 .66
Hmgcs1
KLA  ATP  ATP+KLA
 NM_145942 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1), mRNA [NM_145942] KLA 1.16 1.10 1.26 1.16 .88 .63 .69
ATP 1.01 1.10 1.87 2.36 1.98 .89 .97
KLA/ATP 1.12 1.20 1.33 1.69 1.39 .67 .51
Hmgcs2
KLA  ATP  ATP+KLA
 NM_008256 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (Hmgcs2), nuclear gene encoding mitochondrial protein, mRNA [NM_008256] KLA .92 1.10 1.00 .99 1.08 1.06 1.14
ATP .99 1.02 1.00 1.00 .98 1.08 .92
KLA/ATP .99 1.00 1.00 1.03 1.28 1.06 1.00
Hpd
KLA  ATP  ATP+KLA
 NM_008277 4-hydroxyphenylpyruvic acid dioxygenase (Hpd), mRNA [NM_008277] KLA .94 1.10 1.04 1.02 .97 .97 1.06
ATP 1.05 1.07 .96 1.01 1.09 .97 1.01
KLA/ATP 1.02 1.03 1.12 1.00 .98 1.06 1.02
Hprt1
KLA  ATP  ATP+KLA
 NM_013556 hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1), mRNA [NM_013556] KLA .82 .77 .81 .79 .53 .43 .39
ATP .97 .89 1.40 .89 .82 .68 .25
KLA/ATP .73 .69 1.09 .68 .66 .42 .13
Hpse
KLA  ATP  ATP+KLA
 NM_152803 heparanase (Hpse), mRNA [NM_152803] KLA 1.99 1.93 2.60 2.97 2.72 1.99 1.34
ATP 1.17 1.20 1.06 1.43 1.25 .98 1.30
KLA/ATP 2.23 2.49 2.45 2.70 1.84 2.05 2.71
Hrasls3
KLA  ATP  ATP+KLA
 AK052657 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657] KLA 4.07 4.01 2.57 2.26 1.94 1.66 1.10
ATP .93 .92 1.00 .96 .95 .99 1.08
KLA/ATP 3.36 2.63 1.76 1.26 1.41 1.22 1.27
Hrasls3
KLA  ATP  ATP+KLA
 NM_139269 HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269] KLA 11.37 10.85 12.50 16.13 13.98 17.12 6.64
ATP .86 .78 .96 .89 .84 .99 1.03
KLA/ATP 8.90 10.50 15.81 13.10 11.95 11.16 10.19
Hsd11b1
KLA  ATP  ATP+KLA
 NM_008288 hydroxysteroid 11-beta dehydrogenase 1 (Hsd11b1), transcript variant 1, mRNA [NM_008288] KLA 1.02 1.05 1.08 1.06 1.17 1.25 2.06
ATP 1.06 1.08 1.05 1.15 1.10 1.21 1.70
KLA/ATP 1.09 1.13 1.12 1.11 1.15 1.21 1.71
Hsd17b1
KLA  ATP  ATP+KLA
 NM_010475 hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), mRNA [NM_010475] KLA .85 .93 .83 .86 .82 .84 .92
ATP 1.11 1.11 1.02 1.96 1.92 1.07 .99
KLA/ATP .88 .92 .89 1.56 2.01 1.13 1.34
Hsd17b10
KLA  ATP  ATP+KLA
 NM_016763 hydroxysteroid (17-beta) dehydrogenase 10 (Hsd17b10), nuclear gene encoding mitochondrial protein, mRNA [NM_016763] KLA .90 .86 .78 .80 .83 .71 1.06
ATP 1.11 1.05 1.19 1.30 1.25 .80 .80
KLA/ATP .83 .95 1.30 1.16 1.00 .86 .88
Hsd17b12
KLA  ATP  ATP+KLA
 AK076088 10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810004A21 product:hydroxysteroid (17-beta) dehydrogenase 12, full insert sequence. [AK076088] KLA 1.03 .87 .97 1.11 1.17 1.00 1.15
ATP 1.03 1.11 1.81 1.27 1.57 1.18 1.14
KLA/ATP 1.00 .90 1.26 .97 1.03 .97 .98
Hsd17b12
KLA  ATP  ATP+KLA
 NM_019657 hydroxysteroid (17-beta) dehydrogenase 12 (Hsd17b12), mRNA [NM_019657] KLA 1.12 1.30 1.47 1.16 1.07 1.34 1.20
ATP 1.01 1.28 1.28 1.14 1.06 1.05 .93
KLA/ATP 1.21 1.44 1.63 1.51 .91 .81 .87
Hsd17b2
KLA  ATP  ATP+KLA
 NM_008290 hydroxysteroid (17-beta) dehydrogenase 2 (Hsd17b2), mRNA [NM_008290] KLA .99 1.05 .95 1.05 1.04 1.04 .97
ATP 1.03 .98 .98 1.03 .97 .99 1.06
KLA/ATP 1.10 1.01 1.01 1.03 1.02 .97 1.03
Hsd17b3
KLA  ATP  ATP+KLA
 NM_008291 hydroxysteroid (17-beta) dehydrogenase 3 (Hsd17b3), mRNA [NM_008291] KLA .99 .93 .99 1.04 .96 1.00 .96
ATP 1.01 .98 .98 .95 .98 1.01 .98
KLA/ATP .96 1.07 .99 .96 .91 .95 .94
Hsd17b4
KLA  ATP  ATP+KLA
 NM_008292 hydroxysteroid (17-beta) dehydrogenase 4 (Hsd17b4), mRNA [NM_008292] KLA .86 .77 .82 .76 .61 .63 .59
ATP .98 .98 1.31 1.09 1.02 .80 .64
KLA/ATP .80 .86 1.04 .87 .85 .68 .54
Hsd17b6
KLA  ATP  ATP+KLA
 NM_013786 hydroxysteroid (17-beta) dehydrogenase 6 (Hsd17b6), mRNA [NM_013786] KLA .97 1.03 .99 1.00 1.02 .96 1.02
ATP .96 1.04 .94 .97 .97 1.04 1.01
KLA/ATP .89 .99 1.03 .94 .98 .98 .95
Hsd17b7
KLA  ATP  ATP+KLA
 NM_010476 hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7), mRNA [NM_010476] KLA .87 .86 .78 .85 .86 .76 .77
ATP 1.05 .94 1.22 .87 .69 .67 1.48
KLA/ATP .88 .76 .91 .70 .53 .34 .36
Hsd3b1
KLA  ATP  ATP+KLA
 NM_008293 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (Hsd3b1), mRNA [NM_008293] KLA .98 .97 .93 .92 1.00 .98 .95
ATP .93 1.01 1.00 1.04 .94 1.01 .88
KLA/ATP 1.01 .92 1.06 .98 1.03 .95 .97
Hsd3b2
KLA  ATP  ATP+KLA
 ENSMUST00000107022 ens|3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3- beta-HSD II) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (E KLA 1.06 .89 .93 .99 1.00 1.03 .96
ATP .94 1.03 .96 .91 .94 1.01 .93
KLA/ATP .93 1.01 .99 1.02 1.00 1.05 1.01
Hsd3b2
KLA  ATP  ATP+KLA
 NM_153193 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (Hsd3b2), mRNA [NM_153193] KLA 1.00 .99 1.00 1.05 .97 1.00 1.07
ATP .99 .99 .97 1.07 1.02 .99 1.01
KLA/ATP 1.02 1.07 .96 .98 1.02 1.08 .98
Hsd3b4
KLA  ATP  ATP+KLA
 NM_001111336 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 1, mRNA [NM_001111336] KLA 1.01 1.03 .98 1.02 1.03 1.00 .92
ATP 1.06 1.06 1.03 .94 1.06 .96 .97
KLA/ATP 1.04 1.04 1.10 .94 .94 .98 .97
Hsd3b4
KLA  ATP  ATP+KLA
 NM_008294 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 2, mRNA [NM_008294] KLA 1.06 1.09 1.11 1.13 1.04 1.13 1.12
ATP 1.00 .96 1.24 1.06 1.11 1.04 1.12
KLA/ATP 1.06 1.05 1.15 1.15 1.16 1.14 1.12
Hsd3b5
KLA  ATP  ATP+KLA
 NM_008295 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 (Hsd3b5), mRNA [NM_008295] KLA 1.00 .97 1.10 .92 .98 1.05 1.09
ATP 1.02 .95 .99 .95 .97 .93 .99
KLA/ATP .96 1.06 1.01 1.03 1.02 1.00 1.00
Hsd3b6
KLA  ATP  ATP+KLA
 NM_013821 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 6 (Hsd3b6), mRNA [NM_013821] KLA 1.06 1.09 1.05 1.02 .98 1.09 1.04
ATP 1.03 .96 1.05 1.01 1.02 1.00 1.04
KLA/ATP 1.02 1.02 1.06 1.03 1.04 1.14 1.06
Hsd3b7
KLA  ATP  ATP+KLA
 NM_133943 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (Hsd3b7), transcript variant 1, mRNA [NM_133943] KLA .44 .39 .41 .32 .35 .47 .79
ATP 1.17 1.01 .82 .89 1.02 .96 1.61
KLA/ATP .47 .42 .35 .34 .49 .56 .89
Hyal1
KLA  ATP  ATP+KLA
 NM_008317 hyaluronoglucosaminidase 1 (Hyal1), mRNA [NM_008317] KLA .31 .28 .26 .26 .29 .53 .76
ATP 1.03 1.03 .71 1.21 1.31 .46 3.39
KLA/ATP .31 .32 .33 .53 .84 .58 2.71
Hyal2
KLA  ATP  ATP+KLA
 NM_010489 hyaluronoglucosaminidase 2 (Hyal2), mRNA [NM_010489] KLA .34 .25 .21 .25 .32 .56 .91
ATP 1.07 .83 .83 .66 1.51 1.39 2.21
KLA/ATP .31 .25 .23 .20 .94 1.21 2.14
Hyal3
KLA  ATP  ATP+KLA
 NM_178020 hyaluronoglucosaminidase 3 (Hyal3), mRNA [NM_178020] KLA 1.07 1.00 .94 1.01 .99 1.03 1.03
ATP 1.03 1.06 2.20 4.46 3.50 1.36 1.02
KLA/ATP .98 .97 1.03 1.73 2.32 1.45 1.09
Hyal4
KLA  ATP  ATP+KLA
 AK014599 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632428M18 product:similar to HYALURONIDASE 4 [Homo sapiens], full insert sequence [AK014599] KLA .95 .97 .88 .89 .91 .93 .90
ATP .96 .97 .97 .97 .91 1.02 .91
KLA/ATP .89 .88 .93 .93 .95 .97 .89
Hyal5
KLA  ATP  ATP+KLA
 NM_028957 hyaluronoglucosaminidase 5 (Hyal5), mRNA [NM_028957] KLA 1.02 1.02 1.01 .94 .96 1.06 1.05
ATP 1.01 1.00 .98 1.06 1.03 1.00 1.08
KLA/ATP 1.04 .97 1.00 1.01 1.11 1.02 1.05
Hyal6
KLA  ATP  ATP+KLA
 NM_028920 hyaluronoglucosaminidase 6 (Hyal6), mRNA [NM_028920] KLA .92 .96 .90 1.00 .99 .98 1.01
ATP 1.02 1.01 1.06 .98 1.07 .99 1.02
KLA/ATP .96 1.02 .97 1.01 1.03 1.06 .95
Hyi
KLA  ATP  ATP+KLA
 NM_026601 hydroxypyruvate isomerase homolog (E. coli) (Hyi), mRNA [NM_026601] KLA .37 .43 .38 .50 .53 .54 .87
ATP .92 .68 .59 .59 .52 .42 .44
KLA/ATP .41 .36 .42 .33 .36 .32 .34
Idh1
KLA  ATP  ATP+KLA
 NM_010497 isocitrate dehydrogenase 1 (NADP+), soluble (Idh1), transcript variant 2, mRNA [NM_010497] KLA .71 .74 .69 .70 .54 .45 .63
ATP 1.22 1.28 1.00 1.28 1.06 .62 .81
KLA/ATP .76 .81 .68 .88 .55 .47 .40
Idh2
KLA  ATP  ATP+KLA
 NM_173011 isocitrate dehydrogenase 2 (NADP+), mitochondrial (Idh2), nuclear gene encoding mitochondrial protein, mRNA [NM_173011] KLA .83 .83 .88 .94 .66 .31 .38
ATP 1.04 1.09 1.14 1.48 1.26 .39 .49
KLA/ATP .90 .92 1.04 1.10 .82 .41 .20
Idh3a
KLA  ATP  ATP+KLA
 NM_029573 isocitrate dehydrogenase 3 (NAD+) alpha (Idh3a), nuclear gene encoding mitochondrial protein, mRNA [NM_029573] KLA .99 1.06 .85 .83 .67 .51 .73
ATP .95 1.07 1.12 1.22 .93 .46 .52
KLA/ATP .92 1.00 .91 1.12 .75 .42 .21
Idh3b
KLA  ATP  ATP+KLA
 NM_130884 isocitrate dehydrogenase 3 (NAD+) beta (Idh3b), nuclear gene encoding mitochondrial protein, mRNA [NM_130884] KLA .89 .94 .94 .89 .97 1.00 1.12
ATP 1.01 1.07 .94 1.16 .94 .52 .68
KLA/ATP .92 .94 .78 1.05 .78 .73 .58
Idh3g
KLA  ATP  ATP+KLA
 NM_008323 isocitrate dehydrogenase 3 (NAD+), gamma (Idh3g), nuclear gene encoding mitochondrial protein, mRNA [NM_008323] KLA .74 .69 .66 .68 .61 .55 .63
ATP .94 .91 1.06 1.09 .93 .66 .62
KLA/ATP .72 .74 .80 .80 .73 .56 .48
Idi1
KLA  ATP  ATP+KLA
 NM_177960 isopentenyl-diphosphate delta isomerase (Idi1), transcript variant 2, mRNA [NM_177960] KLA 1.43 1.49 1.51 1.22 .89 .45 .52
ATP 1.02 1.06 1.43 1.32 .86 .62 1.15
KLA/ATP 1.37 1.36 1.52 1.45 .84 .35 .32
Idi2
KLA  ATP  ATP+KLA
 AK029364 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833405L16 product:weakly similar to ISOPENTENYL PYROPHOSPHATE ISOMERASE TYPE 2 (CDNA FLJ32388 FIS, CLONE SKMUS1000129, MODERATELY SIMILAR TO ISOPENTENYL-DIPHOSPHATE DELTA KLA 1.08 1.09 1.06 1.07 1.08 1.05 1.05
ATP 1.02 1.05 1.01 1.04 1.00 1.13 1.07
KLA/ATP 1.09 1.01 1.00 1.07 1.07 1.04 1.06
Ids
KLA  ATP  ATP+KLA
 NM_010498 iduronate 2-sulfatase (Ids), transcript variant 1, mRNA [NM_010498] KLA 1.25 1.29 1.33 1.30 1.22 1.23 1.13
ATP 1.02 1.11 1.09 1.09 .81 .64 .83
KLA/ATP 1.24 1.22 1.13 1.13 .78 .77 .86
Idua
KLA  ATP  ATP+KLA
 NM_008325 iduronidase, alpha-L- (Idua), mRNA [NM_008325] KLA .88 .91 1.00 .87 .91 1.00 1.22
ATP .97 1.03 .99 1.04 .89 .64 .85
KLA/ATP .93 .97 1.01 .97 .72 .63 .86
Il4i1
KLA  ATP  ATP+KLA
 NM_010215 interleukin 4 induced 1 (Il4i1), mRNA [NM_010215] KLA 13.98 13.74 14.90 14.92 13.89 12.12 3.25
ATP 1.02 .98 1.14 1.59 4.45 6.63 2.41
KLA/ATP 16.09 15.56 19.65 19.66 18.47 14.84 12.99
Impa1
KLA  ATP  ATP+KLA
 NM_018864 inositol (myo)-1(or 4)-monophosphatase 1 (Impa1), mRNA [NM_018864] KLA .96 .92 .90 .96 .97 1.04 1.10
ATP 1.13 1.12 1.17 1.23 1.80 1.87 1.41
KLA/ATP .92 .99 1.01 1.06 1.50 1.62 1.29
Impa2
KLA  ATP  ATP+KLA
 NM_053261 inositol (myo)-1(or 4)-monophosphatase 2 (Impa2), mRNA [NM_053261] KLA .74 .70 .67 .66 .47 .34 .21
ATP .95 .84 1.13 1.12 .78 .26 .24
KLA/ATP .64 .65 .85 .82 .67 .31 .17
Impad1
KLA  ATP  ATP+KLA
 AK147096 17 days embryo kidney cDNA, RIKEN full-length enriched library, clone:I920165A15 product:hypothetical protein, full insert sequence [AK147096] KLA 1.24 1.16 1.08 .87 .84 .79 .67
ATP 1.01 .98 .87 .50 1.58 1.49 .50
KLA/ATP 1.17 1.08 .95 .59 1.31 .99 .41
Impad1
KLA  ATP  ATP+KLA
 NM_177730 inositol monophosphatase domain containing 1 (Impad1), mRNA [NM_177730] KLA 1.83 1.73 1.69 1.97 1.48 1.27 1.26
ATP 1.04 .91 .89 .57 1.14 3.17 2.06
KLA/ATP 1.67 1.65 1.64 .98 1.14 2.21 3.24
Impdh1
KLA  ATP  ATP+KLA
 NM_011829 inosine 5-phosphate dehydrogenase 1 (Impdh1), mRNA [NM_011829] KLA 1.03 .99 .86 .89 .71 .52 .55
ATP .89 .81 .82 .81 .90 1.01 .85
KLA/ATP .91 .79 .76 .83 .90 .99 .64
Impdh2
KLA  ATP  ATP+KLA
 NM_011830 inosine 5-phosphate dehydrogenase 2 (Impdh2), mRNA [NM_011830] KLA .88 .92 .76 .67 .48 .46 .62
ATP 1.07 1.12 .90 1.26 1.15 .82 .48
KLA/ATP .97 .98 .81 .98 .79 .61 .33
Indo
KLA  ATP  ATP+KLA
 NM_008324 indoleamine-pyrrole 2,3 dioxygenase (Indo), mRNA [NM_008324] KLA 1.56 1.62 1.87 1.73 1.52 1.38 1.28
ATP 1.09 1.01 1.08 1.02 1.00 1.06 1.07
KLA/ATP 1.53 1.60 1.78 1.50 1.49 1.40 3.38
Indol1
KLA  ATP  ATP+KLA
 NM_145949 indoleamine-pyrrole 2,3 dioxygenase-like 1 (Indol1), mRNA [NM_145949] KLA 2.01 2.13 2.31 2.13 2.14 2.14 2.52
ATP .96 .98 1.06 1.12 .99 1.18 1.25
KLA/ATP 2.03 2.15 1.83 1.54 1.38 1.32 2.07
Inpp1
KLA  ATP  ATP+KLA
 AK009002 adult male tongue cDNA, RIKEN full-length enriched library, clone:2300002C06 product:unclassifiable, full insert sequence. [AK009002] KLA 1.33 1.23 1.55 1.72 1.37 1.24 .76
ATP .95 .81 1.03 .79 .56 .87 .70
KLA/ATP 1.08 1.04 1.17 1.04 .89 .95 .92
Inpp1
KLA  ATP  ATP+KLA
 NM_008384 inositol polyphosphate-1-phosphatase (Inpp1), mRNA [NM_008384] KLA 1.43 1.67 2.01 2.24 1.74 1.68 1.01
ATP 1.10 1.00 .97 1.01 .73 1.01 .95
KLA/ATP 1.52 1.63 1.66 1.42 1.07 1.57 1.55
Inpp4a
KLA  ATP  ATP+KLA
 NM_030266 inositol polyphosphate-4-phosphatase, type I (Inpp4a), transcript variant 1, mRNA [NM_030266] KLA 1.25 1.48 1.49 1.81 2.10 1.96 1.57
ATP .91 .89 .94 1.01 1.15 1.91 2.75
KLA/ATP 1.31 1.15 1.12 1.22 1.36 2.03 4.30
Inpp4a
KLA  ATP  ATP+KLA
 NM_172971 inositol polyphosphate-4-phosphatase, type I (Inpp4a), transcript variant 2, mRNA [NM_172971] KLA 1.05 1.09 1.20 1.18 1.27 1.06 1.05
ATP 1.07 1.00 .98 .98 1.06 1.00 1.34
KLA/ATP 1.12 1.10 .97 1.08 1.16 .96 1.00
Inpp4b
KLA  ATP  ATP+KLA
 AK053554 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130107I17 product:INOSITOL POLYPHOSPHATE 4-PHOSPHATASE TYPE II-ALPHA homolog [Rattus norvegicus], full insert sequence [AK053554] KLA .64 .55 .53 .51 .41 .54 .72
ATP .99 .98 1.17 .82 .65 .47 .50
KLA/ATP .57 .58 .71 .49 .52 .40 .26
Inpp4b
KLA  ATP  ATP+KLA
 NM_001024617 inositol polyphosphate-4-phosphatase, type II (Inpp4b), mRNA [NM_001024617] KLA .72 .73 .54 .69 .58 .65 .90
ATP 1.10 1.11 .99 .95 .76 .52 .65
KLA/ATP .72 .65 .70 .76 .65 .60 .41
Inpp5a
KLA  ATP  ATP+KLA
 NM_183144 inositol polyphosphate-5-phosphatase A (Inpp5a), mRNA [NM_183144] KLA .69 .67 .56 .50 .52 .83 1.14
ATP .97 1.04 .97 1.34 1.22 2.44 1.59
KLA/ATP .66 .65 .53 .58 .76 2.72 1.65
Inpp5b
KLA  ATP  ATP+KLA
 AF040095 inositol polyphosphate 5-phosphatase II splice variant (INPP5P) mRNA, partial cds. [AF040095] KLA .99 .98 1.05 1.03 1.06 1.15 1.09
ATP 1.05 1.00 .97 1.10 1.04 .99 1.00
KLA/ATP 1.03 .98 2.59 .99 1.05 1.05 1.20
Inpp5b
KLA  ATP  ATP+KLA
 NM_008385 inositol polyphosphate-5-phosphatase B (Inpp5b), nuclear gene encoding mitochondrial protein, mRNA [NM_008385] KLA 3.86 4.11 5.04 4.87 5.30 4.56 2.35
ATP .95 .97 .87 .85 1.15 1.62 1.53
KLA/ATP 4.32 4.36 4.10 4.65 3.31 3.30 2.63
Inpp5e
KLA  ATP  ATP+KLA
 NM_033134 inositol polyphosphate-5-phosphatase E (Inpp5e), mRNA [NM_033134] KLA .78 .76 .84 .81 .91 .96 1.16
ATP 1.17 1.19 .92 .82 .64 .87 1.30
KLA/ATP .88 .85 .74 .69 .60 .78 1.26
Ippk
KLA  ATP  ATP+KLA
 NM_199056 inositol 1,3,4,5,6-pentakisphosphate 2-kinase (Ippk), mRNA [NM_199056] KLA .92 .89 .86 .89 .91 .98 1.06
ATP 1.02 1.05 .88 .73 1.71 1.23 1.10
KLA/ATP .88 .85 .83 .71 .77 1.07 .84
Isyna1
KLA  ATP  ATP+KLA
 NM_023627 myo-inositol 1-phosphate synthase A1 (Isyna1), mRNA [NM_023627] KLA .81 .77 .83 .75 .74 .61 .82
ATP 1.21 1.16 1.10 1.74 1.62 1.17 .87
KLA/ATP .97 .93 .80 1.24 1.27 .88 .52
Itpa
KLA  ATP  ATP+KLA
 NM_025922 inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (Itpa), mRNA [NM_025922] KLA 1.02 .96 1.01 1.18 1.37 1.83 1.44
ATP .96 .93 1.08 .95 .92 1.66 1.38
KLA/ATP .86 .94 1.20 1.08 1.28 2.15 2.45
Itpk1
KLA  ATP  ATP+KLA
 NM_172584 inositol 1,3,4-triphosphate 5/6 kinase (Itpk1), mRNA [NM_172584] KLA 1.80 1.90 1.99 2.00 1.71 1.70 1.57
ATP 1.02 1.04 .98 1.13 1.20 1.21 .99
KLA/ATP 2.15 1.89 1.63 1.91 1.33 1.69 1.53
Itpka
KLA  ATP  ATP+KLA
 NM_146125 inositol 1,4,5-trisphosphate 3-kinase A (Itpka), mRNA [NM_146125] KLA 6.50 5.98 5.46 4.17 2.98 2.72 1.97
ATP 1.13 .98 1.19 1.19 2.36 2.47 1.17
KLA/ATP 7.72 7.92 10.01 7.02 8.80 6.84 1.93
Itpkc
KLA  ATP  ATP+KLA
 AK051297 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130031K05 product:weakly similar to INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C [Homo sapiens], full insert sequence. [AK051297] KLA 1.15 1.02 1.00 1.09 1.07 1.03 1.00
ATP .91 1.03 1.02 .99 .98 1.03 1.02
KLA/ATP .94 .95 1.06 .99 .95 .98 1.02
Itpkc
KLA  ATP  ATP+KLA
 NM_181593 inositol 1,4,5-trisphosphate 3-kinase C (Itpkc), mRNA [NM_181593] KLA .76 .68 .76 1.00 1.61 1.01 1.14
ATP 1.18 1.09 1.14 4.49 3.58 1.64 1.04
KLA/ATP .85 .78 1.05 2.67 3.12 1.34 1.41
Ivd
KLA  ATP  ATP+KLA
 NM_019826 isovaleryl coenzyme A dehydrogenase (Ivd), nuclear gene encoding mitochondrial protein, mRNA [NM_019826] KLA .93 .88 .91 .89 .82 .81 .61
ATP 1.02 1.01 1.17 1.19 .90 1.34 1.05
KLA/ATP .92 .96 1.01 .98 .79 .91 1.24
Kdsr
KLA  ATP  ATP+KLA
 NM_027534 3-ketodihydrosphingosine reductase (Kdsr), mRNA [NM_027534] KLA .54 .46 .41 .39 .38 .40 .46
ATP .98 .97 1.23 1.13 1.01 .68 .52
KLA/ATP .48 .49 .59 .69 .92 .55 .31
Khk
KLA  ATP  ATP+KLA
 NM_008439 ketohexokinase (Khk), mRNA [NM_008439] KLA .83 .86 .78 .75 .63 .49 .44
ATP .95 .97 1.06 1.25 1.05 .65 .50
KLA/ATP .84 .89 .92 1.03 .85 .57 .40
Kl
KLA  ATP  ATP+KLA
 AB010088 mRNA for secreted isoform of Klotho protein, complete cds [AB010088] KLA 1.02 1.00 1.01 .97 1.02 1.04 1.01
ATP 1.03 1.03 .99 1.00 .99 .97 1.01
KLA/ATP 1.03 .93 .98 .87 .96 .92 .93
Kl
KLA  ATP  ATP+KLA
 NM_013823 klotho (Kl), mRNA [NM_013823] KLA .97 .96 1.08 .95 1.01 .95 1.05
ATP .96 1.07 1.02 1.06 1.05 1.00 1.02
KLA/ATP .95 1.02 1.04 1.04 1.11 1.01 .96
Kmo
KLA  ATP  ATP+KLA
 NM_133809 kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (Kmo), mRNA [NM_133809] KLA 2.27 2.39 2.79 2.51 2.33 1.55 .70
ATP .95 1.15 1.11 1.08 .94 .98 .63
KLA/ATP 2.15 2.35 2.11 1.65 1.33 1.30 .72
Kynu
KLA  ATP  ATP+KLA
 BC026950 kynureninase (L-kynurenine hydrolase), mRNA (cDNA clone MGC:30315 IMAGE:5136970), complete cds. [BC026950] KLA .99 1.04 1.04 1.02 1.11 1.05 .98
ATP 1.06 1.00 1.01 1.04 1.08 .99 .97
KLA/ATP 1.08 1.07 .95 .99 1.06 1.11 1.02
Kynu
KLA  ATP  ATP+KLA
 NM_027552 kynureninase (L-kynurenine hydrolase) (Kynu), mRNA [NM_027552] KLA 1.86 1.93 2.04 1.85 1.45 1.18 1.10
ATP .99 1.01 1.05 1.12 1.00 1.03 1.09
KLA/ATP 1.84 1.75 2.04 1.63 1.46 1.26 1.27
Lalba
KLA  ATP  ATP+KLA
 NM_010679 lactalbumin, alpha (Lalba), mRNA [NM_010679] KLA 1.22 1.08 1.11 1.30 1.21 1.45 1.04
ATP .90 .93 1.44 1.16 1.30 1.43 1.24
KLA/ATP 1.10 1.20 1.71 1.50 1.52 1.69 1.47
Lao1
KLA  ATP  ATP+KLA
 NM_133892 L-amino acid oxidase 1 (Lao1), mRNA [NM_133892] KLA 1.03 1.03 1.04 1.00 .98 1.01 .98
ATP 1.01 1.03 1.02 .92 1.05 .98 .99
KLA/ATP 1.02 .96 1.04 .94 .96 .97 .97
Lap3
KLA  ATP  ATP+KLA
 NM_024434 leucine aminopeptidase 3 (Lap3), mRNA [NM_024434] KLA 2.95 3.13 3.13 3.67 3.18 2.01 1.07
ATP 1.02 1.02 1.23 1.18 1.30 1.63 .91
KLA/ATP 2.72 3.04 4.11 3.89 3.99 3.42 .86
Lass2
KLA  ATP  ATP+KLA
 NM_029789 LAG1 homolog, ceramide synthase 2 (Lass2), mRNA [NM_029789] KLA .79 .81 .81 .68 .72 .72 1.08
ATP 1.02 1.11 .95 1.07 .94 .70 1.25
KLA/ATP .86 .86 .62 .78 .64 .63 .97
Lass4
KLA  ATP  ATP+KLA
 AK036108 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630036I10 product:longevity assurance homolog 4 (S. cerevisiae), full insert sequence. [AK036108] KLA .86 .82 .81 .76 .78 .71 .76
ATP 1.05 .97 .93 .71 .86 .79 .75
KLA/ATP .90 .81 .80 .72 .80 .74 .72
Lass4
KLA  ATP  ATP+KLA
 NM_026058 LAG1 homolog, ceramide synthase 4 (Lass4), mRNA [NM_026058] KLA .64 .61 .59 .67 .59 .56 .55
ATP .91 .92 1.09 .90 .62 .55 .61
KLA/ATP .63 .65 .73 .66 .60 .55 .55
Lass5
KLA  ATP  ATP+KLA
 NM_028015 LAG1 homolog, ceramide synthase 5 (Lass5), mRNA [NM_028015] KLA .62 .60 .53 .42 .37 .34 .66
ATP 1.05 1.15 1.02 1.21 .85 .53 .90
KLA/ATP .68 .64 .53 .54 .39 .37 .42
Lass6
KLA  ATP  ATP+KLA
 AK136463 adult male colon cDNA, RIKEN full-length enriched library, clone:9030601N10 product:unclassifiable, full insert sequence [AK136463] KLA 6.80 6.12 6.10 6.59 4.37 2.19 3.16
ATP 1.11 1.03 1.26 1.13 2.24 2.53 .84
KLA/ATP 6.23 6.58 7.50 5.95 5.29 2.64 1.33
Lass6
KLA  ATP  ATP+KLA
 NM_172856 LAG1 homolog, ceramide synthase 6 (Lass6), mRNA [NM_172856] KLA 8.82 11.21 11.49 12.30 10.83 7.97 7.15
ATP 1.11 1.13 1.22 1.58 2.13 4.41 4.45
KLA/ATP 10.82 12.09 9.72 11.37 7.17 5.10 9.51
Lct
KLA  ATP  ATP+KLA
 NM_001081078 lactase (Lct), mRNA [NM_001081078] KLA .93 .83 .71 .83 .89 .99 .84
ATP 1.03 .98 .86 .92 .82 .85 .85
KLA/ATP .80 .88 .75 .78 .89 .87 .86
Ldha
KLA  ATP  ATP+KLA
 NM_010699 lactate dehydrogenase A (Ldha), mRNA [NM_010699] KLA .89 .80 .84 .93 .96 1.04 1.23
ATP 1.05 1.04 .96 .87 1.21 1.43 1.11
KLA/ATP .93 .87 .87 .93 1.24 1.53 .96
Ldhal6b
KLA  ATP  ATP+KLA
 NM_175349 lactate dehydrogenase A-like 6B (Ldhal6b), mRNA [NM_175349] KLA .89 .90 .94 .92 1.04 1.11 1.20
ATP .99 .91 .90 .88 .90 .88 1.17
KLA/ATP .93 .97 .87 .89 .91 1.00 1.20
Ldhb
KLA  ATP  ATP+KLA
 NM_008492 lactate dehydrogenase B (Ldhb), mRNA [NM_008492] KLA 1.00 .97 .96 1.00 .78 .63 .39
ATP .84 .89 1.11 1.24 1.01 .67 .47
KLA/ATP .94 1.03 1.35 1.92 1.40 .85 .47
Ldhc
KLA  ATP  ATP+KLA
 NM_013580 lactate dehydrogenase C (Ldhc), mRNA [NM_013580] KLA .98 1.02 1.04 1.02 .97 .95 .99
ATP 1.02 1.00 .97 .96 1.00 1.00 .95
KLA/ATP .96 1.10 1.07 .95 1.03 1.06 1.03
Lias
KLA  ATP  ATP+KLA
 NM_024471 lipoic acid synthetase (Lias), nuclear gene encoding mitochondrial protein, mRNA [NM_024471] KLA 1.05 1.12 1.11 1.12 1.22 1.24 1.31
ATP .93 .95 .98 1.00 .81 .95 1.24
KLA/ATP 1.05 1.07 1.01 1.03 .90 1.18 1.14
Lipc
KLA  ATP  ATP+KLA
 NM_008280 lipase, hepatic (Lipc), mRNA [NM_008280] KLA 1.00 1.01 .96 .99 1.01 1.06 1.05
ATP 1.02 1.03 1.15 .98 .93 1.03 .89
KLA/ATP 1.04 .92 1.07 .98 .99 .93 1.00
Lipf
KLA  ATP  ATP+KLA
 NM_026334 lipase, gastric (Lipf), mRNA [NM_026334] KLA .98 1.00 1.09 1.07 1.04 1.12 1.11
ATP .96 .98 1.02 1.03 1.00 .99 1.05
KLA/ATP 1.03 1.05 .99 1.03 1.04 1.08 1.05
Lipg
KLA  ATP  ATP+KLA
 NM_010720 lipase, endothelial (Lipg), mRNA [NM_010720] KLA 10.93 11.98 13.48 13.21 13.64 13.36 3.84
ATP 1.02 .97 1.44 1.72 1.38 1.91 1.52
KLA/ATP 11.30 13.74 13.52 14.68 10.21 9.64 10.43
Lipt1
KLA  ATP  ATP+KLA
 AK048005 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130029F12 product:similar to LIPOYLTRANSFERASE [Homo sapiens], full insert sequence [AK048005] KLA 1.00 1.02 1.00 .99 1.07 .93 .98
ATP 1.01 1.08 1.07 .94 .99 .98 .97
KLA/ATP .92 1.03 1.01 .96 .93 .92 .91
Lipt1
KLA  ATP  ATP+KLA
 NM_001037918 lipoyltransferase 1 (Lipt1), nuclear gene encoding mitochondrial protein, mRNA [NM_001037918] KLA .65 .69 .66 .67 .66 .69 1.01
ATP .99 .92 .79 .67 .58 .81 .81
KLA/ATP .74 .70 .66 .61 .57 .67 .72
LOC10003
9707
KLA  ATP  ATP+KLA
 XM_001473273 gb|PREDICTED: Mus musculus similar to 5, 10-methenyltetrahydrofolate synthetase (LOC100039707), mRNA [XM_001473273] KLA 1.15 1.22 1.34 1.10 1.24 .99 .95
ATP 1.05 1.05 1.00 1.00 .97 .91 .81
KLA/ATP 1.23 1.38 1.14 1.17 .91 .93 .86
LOC10004
4148
KLA  ATP  ATP+KLA
 XM_001471861 ref|PREDICTED: Mus musculus hypothetical protein LOC100044148 (LOC100044148), mRNA [XM_001471861] KLA 1.51 1.56 1.48 1.55 1.62 1.57 1.54
ATP 1.06 .97 1.08 .99 .93 1.35 1.36
KLA/ATP 1.54 1.49 1.70 1.46 1.47 1.47 1.60
Lpcat1
KLA  ATP  ATP+KLA
 AK155286 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630214O14 product:Hypothetical phospholipid and glycerol acyltransferase, full insert sequence [AK155286] KLA .94 .83 1.02 .83 1.42 .92 .90
ATP 1.33 1.28 1.03 .82 1.24 .58 .81
KLA/ATP 1.16 1.13 .83 .60 .71 .53 .50
Lpcat2
KLA  ATP  ATP+KLA
 NM_173014 lysophosphatidylcholine acyltransferase 2 (Lpcat2), mRNA [NM_173014] KLA 1.61 1.75 1.91 2.26 3.20 3.80 3.31
ATP 1.06 1.08 1.21 1.23 1.11 1.94 1.31
KLA/ATP 1.61 1.55 1.72 1.65 1.14 1.27 2.62
Lpin1
KLA  ATP  ATP+KLA
 AF180471 Lpin1 (Kiaa0188) mRNA, complete cds [AF180471] KLA .26 .24 .29 .31 .26 .25 .24
ATP 1.23 .96 1.11 .97 .82 .43 .62
KLA/ATP .27 .25 .42 .37 .49 .34 .22
Lpin1
KLA  ATP  ATP+KLA
 NM_015763 lipin 1 (Lpin1), transcript variant 2, mRNA [NM_015763] KLA .19 .19 .18 .20 .18 .16 .19
ATP 1.02 .99 1.06 .93 .70 .35 .70
KLA/ATP .18 .17 .27 .25 .30 .25 .16
Lpin3
KLA  ATP  ATP+KLA
 NM_022883 lipin 3 (Lpin3), mRNA [NM_022883] KLA .99 .98 1.06 1.04 1.01 .99 .99
ATP 1.03 1.01 1.02 .92 1.00 1.03 .91
KLA/ATP 1.03 .97 .99 .99 .92 .91 1.02
Lss
KLA  ATP  ATP+KLA
 AK147680 adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1106O04 product:lanosterol synthase, full insert sequence [AK147680] KLA .52 .46 .46 .47 .49 .43 .44
ATP .93 .92 1.44 .97 .55 .39 .46
KLA/ATP .46 .45 .56 .47 .44 .32 .15
Lss
KLA  ATP  ATP+KLA
 NM_146006 lanosterol synthase (Lss), mRNA [NM_146006] KLA .77 .80 .87 .80 .90 .70 .80
ATP 1.04 1.09 1.03 1.18 .73 .67 1.63
KLA/ATP .79 .89 .87 .88 .57 .46 .43
Lta4h
KLA  ATP  ATP+KLA
 NM_008517 leukotriene A4 hydrolase (Lta4h), mRNA [NM_008517] KLA .84 .85 .77 .59 .48 .46 .63
ATP .99 1.20 1.11 1.29 1.02 .98 .83
KLA/ATP .86 .85 .72 .95 .72 .92 .59
Ltc4s
KLA  ATP  ATP+KLA
 NM_008521 leukotriene C4 synthase (Ltc4s), mRNA [NM_008521] KLA .96 .97 .92 .83 .62 .43 .13
ATP .94 .98 .97 1.09 .77 .51 .27
KLA/ATP .92 .89 .88 .81 .68 .49 .26
Lycat
KLA  ATP  ATP+KLA
 NM_001081071 lysocardiolipin acyltransferase (Lycat), mRNA [NM_001081071] KLA 1.03 .96 1.02 .97 1.02 .94 .99
ATP 1.09 1.08 .99 .94 .75 .90 1.06
KLA/ATP 1.02 1.10 .98 .91 .73 .97 1.03
Man1a
KLA  ATP  ATP+KLA
 NM_008548 mannosidase 1, alpha (Man1a), mRNA [NM_008548] KLA 1.15 1.18 1.19 .93 .66 .37 .35
ATP 1.09 1.21 1.08 1.89 1.20 1.15 .63
KLA/ATP 1.15 1.25 1.02 1.36 .83 .61 .35
Man1a2
KLA  ATP  ATP+KLA
 AK078291 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430575L20 product:unclassifiable, full insert sequence [AK078291] KLA 1.27 1.23 1.12 .98 .77 .89 .85
ATP .97 1.03 1.00 .87 .74 1.09 1.05
KLA/ATP 1.19 1.20 1.11 1.02 .89 .94 .93
Man1a2
KLA  ATP  ATP+KLA
 NM_010763 mannosidase, alpha, class 1A, member 2 (Man1a2), mRNA [NM_010763] KLA 1.36 1.42 1.22 1.13 .86 1.12 1.12
ATP .93 .98 .95 .76 .75 1.51 1.47
KLA/ATP 1.34 1.39 1.25 1.15 1.09 1.21 1.55
Man1b1
KLA  ATP  ATP+KLA
 NM_001029983 mannosidase, alpha, class 1B, member 1 (Man1b1), mRNA [NM_001029983] KLA .72 .76 .73 .68 .84 .77 .93
ATP .99 .79 .31 .46 .75 .75 1.03
KLA/ATP .81 .58 .25 .36 .57 .55 .92
Man1c1
KLA  ATP  ATP+KLA
 NM_207237 mannosidase, alpha, class 1C, member 1 (Man1c1), mRNA [NM_207237] KLA .46 .43 .41 .30 .26 .43 .44
ATP 1.03 1.12 .85 .98 .61 .35 .76
KLA/ATP .48 .44 .32 .34 .33 .43 .34
Man2a1
KLA  ATP  ATP+KLA
 NM_008549 mannosidase 2, alpha 1 (Man2a1), mRNA [NM_008549] KLA 1.59 1.57 1.60 1.75 1.24 1.22 .67
ATP .99 .83 .66 .40 .52 1.00 .61
KLA/ATP 1.42 1.35 1.26 .78 1.32 1.61 .88
Man2a2
KLA  ATP  ATP+KLA
 AK029913 adult male testis cDNA, RIKEN full-length enriched library, clone:4931438M07 product:mannosidase 2, alpha 2, full insert sequence [AK029913] KLA .72 .64 .62 .65 .47 .34 .30
ATP .93 .86 1.08 .96 .71 .60 .39
KLA/ATP .63 .67 .76 .69 .74 .56 .31
Man2a2
KLA  ATP  ATP+KLA
 BC055006 mannosidase 2, alpha 2, mRNA (cDNA clone MGC:57099 IMAGE:6491507), complete cds. [BC055006] KLA .57 .53 .48 .54 .43 .27 .31
ATP 1.17 .95 .96 .91 .80 .49 .27
KLA/ATP .62 .61 .68 .59 .64 .46 .28
Man2a2
KLA  ATP  ATP+KLA
 NM_172903 mannosidase 2, alpha 2 (Man2a2), mRNA [NM_172903] KLA .78 .79 .86 .87 .85 .83 .81
ATP 1.07 1.20 1.17 1.02 .92 .77 .72
KLA/ATP .81 .79 .98 1.33 1.01 .84 .72
Maoa
KLA  ATP  ATP+KLA
 NM_173740 monoamine oxidase A (Maoa), nuclear gene encoding mitochondrial protein, mRNA [NM_173740] KLA 1.14 1.11 1.06 1.07 .84 .55 .53
ATP 1.10 1.07 1.33 1.20 1.44 2.37 1.38
KLA/ATP .97 1.11 1.75 1.33 1.27 1.21 1.09
Maob
KLA  ATP  ATP+KLA
 NM_172778 monoamine oxidase B (Maob), nuclear gene encoding mitochondrial protein, mRNA [NM_172778] KLA 1.01 .97 1.01 1.05 1.01 .95 1.01
ATP 1.09 .98 .99 .97 1.03 1.03 .94
KLA/ATP 1.02 1.05 .99 1.02 1.00 .98 .98
Mat1a
KLA  ATP  ATP+KLA
 NM_133653 methionine adenosyltransferase I, alpha (Mat1a), mRNA [NM_133653] KLA 1.08 .94 1.05 .99 .99 1.08 1.05
ATP 1.00 1.02 1.03 1.03 1.00 1.06 1.03
KLA/ATP 1.04 1.03 1.00 1.04 .98 .96 .97
Mat2a
KLA  ATP  ATP+KLA
 NM_145569 methionine adenosyltransferase II, alpha (Mat2a), mRNA [NM_145569] KLA .44 .42 .37 .38 .48 .65 .85
ATP .82 .64 .76 .45 .32 .71 .87
KLA/ATP .40 .38 .41 .33 .29 .53 .33
Mat2b
KLA  ATP  ATP+KLA
 AK038303 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130094D24 product:similar to 5 of METHIONINE ADENOSYLTRANSFERASE REGULATORY BETA SUBUNIT (HYPOTHETICAL 37.6 KDA PROTEIN) [Homo sapiens], full insert sequence [AK0383 KLA .97 1.01 1.66 1.00 .96 1.05 1.11
ATP .97 1.01 .93 .95 1.03 1.01 .93
KLA/ATP .96 .90 .91 .97 1.04 .95 .91
Mat2b
KLA  ATP  ATP+KLA
 NM_134017 methionine adenosyltransferase II, beta (Mat2b), mRNA [NM_134017] KLA .81 .85 .89 1.03 1.00 1.02 1.02
ATP .99 1.03 1.00 .99 .77 .96 .84
KLA/ATP .77 .88 .88 .92 1.06 1.26 .98
Mboat1
KLA  ATP  ATP+KLA
 NM_153546 membrane bound O-acyltransferase domain containing 1 (Mboat1), mRNA [NM_153546] KLA .55 .57 .44 .39 .23 .14 .12
ATP .86 .94 1.05 1.04 .90 .52 .14
KLA/ATP .53 .53 .55 .53 .46 .35 .12
Mboat2
KLA  ATP  ATP+KLA
 AK031682 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030487B18 product:unclassifiable, full insert sequence [AK031682] KLA .94 .98 .99 .97 .92 1.08 1.08
ATP 1.00 .99 1.05 1.01 1.03 1.01 1.07
KLA/ATP 1.02 1.06 .99 1.06 1.08 1.14 .96
Mboat2
KLA  ATP  ATP+KLA
 NM_026037 membrane bound O-acyltransferase domain containing 2 (Mboat2), transcript variant 1, mRNA [NM_026037] KLA .84 .87 .81 .81 .81 .83 .95
ATP 1.03 1.01 1.04 1.01 1.10 1.02 .88
KLA/ATP .89 .88 .98 .91 .89 1.01 1.11
Mcat
KLA  ATP  ATP+KLA
 NM_001030014 malonyl CoA:ACP acyltransferase (mitochondrial) (Mcat), nuclear gene encoding mitochondrial protein, mRNA [NM_001030014] KLA 1.51 1.53 1.49 1.38 1.39 1.52 1.29
ATP .97 .98 .85 .78 .40 .85 1.23
KLA/ATP 1.51 1.55 1.30 1.39 1.04 1.18 1.84
Mccc1
KLA  ATP  ATP+KLA
 NM_023644 methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) (Mccc1), mRNA [NM_023644] KLA .89 .88 .81 .85 .73 .82 1.18
ATP .93 .88 1.22 1.07 .88 .65 1.26
KLA/ATP .83 .88 1.12 .86 .77 .56 .79
Mccc2
KLA  ATP  ATP+KLA
 NM_030026 methylcrotonoyl-Coenzyme A carboxylase 2 (beta) (Mccc2), nuclear gene encoding mitochondrial protein, mRNA [NM_030026] KLA .99 1.00 1.03 .76 .65 .55 .61
ATP 1.04 1.11 .80 .97 .53 .37 .51
KLA/ATP .96 1.03 .63 .76 .49 .39 .35
Mcee
KLA  ATP  ATP+KLA
 NM_028626 methylmalonyl CoA epimerase (Mcee), mRNA [NM_028626] KLA .94 .93 .88 .92 .77 .71 .87
ATP .93 .97 1.28 1.51 1.31 .87 .80
KLA/ATP .88 .96 1.18 1.37 1.28 .95 .83
Mdh1
KLA  ATP  ATP+KLA
 AK077724 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730556L21 product:unclassifiable, full insert sequence [AK077724] KLA .85 .75 .69 .67 .72 .81 .82
ATP .93 .83 .61 .59 .72 .72 .88
KLA/ATP .79 .76 .67 .58 .74 .74 .80
Mdh1
KLA  ATP  ATP+KLA
 NM_008618 malate dehydrogenase 1, NAD (soluble) (Mdh1), mRNA [NM_008618] KLA .79 .72 .66 .66 .52 .49 .57
ATP .98 1.00 1.17 1.09 .96 .70 .66
KLA/ATP .70 .73 .92 .78 .76 .65 .52
Mdh2
KLA  ATP  ATP+KLA
 NM_008617 malate dehydrogenase 2, NAD (mitochondrial) (Mdh2), nuclear gene encoding mitochondrial protein, mRNA [NM_008617] KLA .90 .91 .81 .86 .81 .91 1.26
ATP .96 .86 1.04 .80 1.01 1.36 1.33
KLA/ATP .87 .79 1.04 .71 .95 1.04 .95
Me1
KLA  ATP  ATP+KLA
 NM_008615 malic enzyme 1, NADP(+)-dependent, cytosolic (Me1), mRNA [NM_008615] KLA .95 1.01 1.01 .81 .71 .71 1.97
ATP .94 1.03 1.19 1.09 .93 1.48 .67
KLA/ATP .98 .96 1.04 .89 .65 .87 1.05
Me3
KLA  ATP  ATP+KLA
 AK036221 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630046K15 product:unclassifiable, full insert sequence. [AK036221] KLA 1.04 .98 .99 1.02 1.01 .99 .96
ATP 1.02 1.02 1.01 .98 1.00 .95 1.04
KLA/ATP .98 .99 1.00 1.01 .99 .99 1.00
Me3
KLA  ATP  ATP+KLA
 NM_181407 malic enzyme 3, NADP(+)-dependent, mitochondrial (Me3), nuclear gene encoding mitochondrial protein, mRNA [NM_181407] KLA .97 1.00 .99 .96 .94 .99 .99
ATP 1.01 1.03 .98 .98 .96 .95 1.03
KLA/ATP .98 1.01 .98 .96 1.00 .98 .97
Mecr
KLA  ATP  ATP+KLA
 NM_025297 mitochondrial trans-2-enoyl-CoA reductase (Mecr), nuclear gene encoding mitochondrial protein, mRNA [NM_025297] KLA 1.48 1.62 1.63 1.35 1.44 1.23 1.16
ATP 1.00 1.28 .97 1.45 1.09 .62 .55
KLA/ATP 1.77 1.77 1.16 2.13 1.26 1.00 .49
Mgam
KLA  ATP  ATP+KLA
 AK033548 adult male colon cDNA, RIKEN full-length enriched library, clone:9030616M21 product:hypothetical protein, full insert sequence. [AK033548] KLA 1.16 1.20 1.22 1.21 1.01 1.02 1.07
ATP 1.01 1.01 1.11 2.86 5.71 5.58 1.53
KLA/ATP 1.24 1.24 1.29 1.64 3.84 3.69 1.98
Mgam
KLA  ATP  ATP+KLA
 XM_001481277 gb|PREDICTED: Mus musculus maltase-glucoamylase (Mgam), mRNA [XM_001481277] KLA 1.03 1.04 1.03 1.04 .95 .98 1.06
ATP 1.06 .94 1.05 1.42 2.38 2.12 1.16
KLA/ATP 1.10 1.06 1.06 1.15 1.52 1.64 1.20
Mgat1
KLA  ATP  ATP+KLA
 NM_010794 mannoside acetylglucosaminyltransferase 1 (Mgat1), transcript variant 2, mRNA [NM_010794] KLA 2.09 2.17 2.90 2.22 1.90 1.60 1.14
ATP 1.10 1.31 1.13 1.24 1.25 1.42 1.23
KLA/ATP 2.52 2.52 2.20 2.41 1.84 1.68 1.22
Mgat2
KLA  ATP  ATP+KLA
 NM_146035 mannoside acetylglucosaminyltransferase 2 (Mgat2), mRNA [NM_146035] KLA .64 .68 .66 .62 .78 .74 1.01
ATP 1.07 1.17 .62 .64 .51 .63 1.02
KLA/ATP .65 .74 .40 .43 .38 .55 .60
Mgat3
KLA  ATP  ATP+KLA
 NM_010795 mannoside acetylglucosaminyltransferase 3 (Mgat3), mRNA [NM_010795] KLA 1.02 .98 1.16 .99 .99 1.03 1.08
ATP 1.02 1.03 .95 1.07 1.03 1.03 1.02
KLA/ATP 1.01 .95 1.02 1.03 1.04 1.03 1.07
Mgat4a
KLA  ATP  ATP+KLA
 NM_173870 mannoside acetylglucosaminyltransferase 4, isoenzyme A (Mgat4a), mRNA [NM_173870] KLA 4.19 4.15 4.78 4.90 3.82 4.33 2.57
ATP .99 1.03 1.34 1.31 1.09 2.84 5.50
KLA/ATP 4.42 4.69 5.16 4.33 2.92 4.12 13.74
Mgat4b
KLA  ATP  ATP+KLA
 BC026638 mannoside acetylglucosaminyltransferase 4, isoenzyme B, mRNA (cDNA clone MGC:37502 IMAGE:4984907), complete cds. [BC026638] KLA .85 .71 .64 .53 .43 .55 .75
ATP 1.01 .86 .70 .56 1.01 .92 .77
KLA/ATP .87 .72 .63 .46 .71 .64 .86
Mgat4b
KLA  ATP  ATP+KLA
 NM_145926 mannoside acetylglucosaminyltransferase 4, isoenzyme B (Mgat4b), mRNA [NM_145926] KLA 1.02 .90 .94 .67 .59 .69 .88
ATP 1.11 .96 .66 .74 1.13 1.03 .86
KLA/ATP 1.14 1.02 .79 .65 .90 .84 1.02
Mgat4c
KLA  ATP  ATP+KLA
 AK032009 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330543K19 product:weakly similar to N-ACETYLGLUCOSAMINYLTRANSFERASE VI [Gallus gallus], full insert sequence [AK032009] KLA 1.01 .95 .97 1.03 .96 1.02 1.02
ATP .99 .95 .96 1.07 1.03 .93 .94
KLA/ATP .97 .98 1.10 1.09 .92 .98 1.04
Mgat4c
KLA  ATP  ATP+KLA
 NM_026243 mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) (Mgat4c), mRNA [NM_026243] KLA 1.04 .96 .99 1.03 1.00 .97 .97
ATP .99 1.07 1.06 1.00 1.00 1.07 1.08
KLA/ATP .97 1.08 1.06 1.06 .97 .96 1.09
Mgat5
KLA  ATP  ATP+KLA
 AK015544 adult male testis cDNA, RIKEN full-length enriched library, clone:4930471A21 product:unclassifiable, full insert sequence [AK015544] KLA .40 .36 .29 .25 .39 .72 .74
ATP 1.06 .87 .62 .76 .67 .68 .73
KLA/ATP .42 .31 .25 .30 .58 .78 .52
Mgat5
KLA  ATP  ATP+KLA
 AK036567 adult male bone cDNA, RIKEN full-length enriched library, clone:9830134K01 product:ALPHA-1,3(6)-MANNOSYLGLYCOPROTEIN BETA-1,6-N-ACETYL- GLUCOSAMINYLTRANSFERASE V (EC 2.4.1.155) (ALPHA-MANNOSIDE BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE) (N KLA .34 .32 .36 .70 1.01 1.04 .77
ATP 1.30 .90 1.34 .66 1.41 1.08 1.35
KLA/ATP .37 .30 .67 .49 1.55 .98 1.44
Mgat5
KLA  ATP  ATP+KLA
 NM_145128 mannoside acetylglucosaminyltransferase 5 (Mgat5), mRNA [NM_145128] KLA .84 .85 .81 .86 .77 .98 .90
ATP .97 .87 .82 .87 .78 .89 1.21
KLA/ATP .89 .81 .77 .82 .79 .91 .96
Mgat5b
KLA  ATP  ATP+KLA
 NM_172948 mannoside acetylglucosaminyltransferase 5, isoenzyme B (Mgat5b), mRNA [NM_172948] KLA .95 1.02 .99 1.03 1.05 .99 1.05
ATP 1.02 .96 1.00 1.03 1.02 1.01 1.04
KLA/ATP 1.00 1.05 1.02 1.03 1.01 1.02 1.05
Mgll
KLA  ATP  ATP+KLA
 NM_011844 monoglyceride lipase (Mgll), mRNA [NM_011844] KLA .86 .83 .81 .85 .67 .57 .46
ATP 1.02 1.00 1.15 1.16 1.26 1.27 .74
KLA/ATP .90 .85 1.01 1.05 1.26 1.20 .71
Mlycd
KLA  ATP  ATP+KLA
 NM_019966 malonyl-CoA decarboxylase (Mlycd), nuclear gene encoding mitochondrial protein, mRNA [NM_019966] KLA .77 .70 .74 .89 .75 .81 .66
ATP 1.01 .91 1.04 .78 .38 .62 .81
KLA/ATP .66 .66 .80 .56 .44 .57 .74
Mm.1070
KLA  ATP  ATP+KLA
 158508616 Unknown KLA .89 .89 .78 .84 .68 .70 .71
ATP .97 .94 1.17 1.00 .76 .86 .78
KLA/ATP .86 .84 .86 .80 .67 .68 .60
Mm.10984
KLA  ATP  ATP+KLA
 6678010 Unknown KLA .98 1.03 .96 1.03 .98 .98 .98
ATP .96 .96 1.01 1.06 .93 .93 .93
KLA/ATP .96 .93 .84 .93 1.08 1.19 1.04
Mm.1103
KLA  ATP  ATP+KLA
 142363208 Unknown KLA .97 .98 .93 .96 .92 .94 1.02
ATP .99 .99 1.20 1.21 1.11 1.01 .84
KLA/ATP .99 1.07 1.17 1.26 1.19 1.09 .72
Mm.12773
1
KLA  ATP  ATP+KLA
 142352287 Unknown KLA .97 .93 .99 .98 1.00 1.04 1.07
ATP .98 1.05 1.00 .89 .96 .99 1.13
KLA/ATP 1.00 1.02 1.06 .96 1.00 .91 1.22
Mm.13558
1
KLA  ATP  ATP+KLA
 34328145 Unknown KLA .73 .64 .50 .54 .38 .49 1.02
ATP .88 .84 1.16 .94 .66 .72 .68
KLA/ATP .56 .62 .71 .49 .40 .30 .42
Mm.13732
7
KLA  ATP  ATP+KLA
 116686108 Unknown KLA .93 .84 .81 .69 .58 .47 .53
ATP .94 .87 .87 .75 .38 .23 .41
KLA/ATP .82 .80 .63 .63 .39 .27 .18
Mm.15164
0
KLA  ATP  ATP+KLA
 23943833 Unknown KLA .99 1.01 1.02 .89 .85 .86 .83
ATP 1.05 1.26 .92 1.38 1.01 .90 1.15
KLA/ATP 1.08 1.15 .90 1.23 .78 .92 1.20
Mm.15303
0
KLA  ATP  ATP+KLA
 124301197 Unknown KLA 1.07 1.01 1.05 1.02 .67 .60 .91
ATP .89 .85 1.38 1.28 1.54 1.92 .73
KLA/ATP .90 1.00 1.20 1.05 .93 .58 .57
Mm.15744
2
KLA  ATP  ATP+KLA
 41152515 Unknown KLA 1.09 1.07 .96 1.02 1.04 1.00 1.07
ATP 1.04 .96 .98 1.04 1.04 1.13 1.11
KLA/ATP 1.02 .97 1.03 1.04 1.15 1.23 1.25
Mm.16006
7
KLA  ATP  ATP+KLA
 124487226 Unknown KLA .90 .88 .87 .85 .80 .85 .64
ATP .95 .95 1.00 .94 1.00 .91 .67
KLA/ATP .89 .86 .93 .82 .85 .84 .63
Mm.17905
KLA  ATP  ATP+KLA
 94536843 Unknown KLA 1.05 1.02 1.06 1.01 .76 .88 .91
ATP .91 .83 1.42 .91 .93 1.14 1.10
KLA/ATP 1.01 1.05 1.76 1.10 1.06 .89 .88
Mm.17932
KLA  ATP  ATP+KLA
 142368657 Unknown KLA 1.96 2.16 2.26 2.04 1.94 2.22 1.33
ATP 1.19 1.29 2.96 4.36 1.42 1.27 1.16
KLA/ATP 4.95 7.89 18.00 12.21 3.38 1.85 1.27
Mm.17942
1
KLA  ATP  ATP+KLA
 84993735 Unknown KLA .93 1.00 1.05 1.00 .99 1.01 1.01
ATP 1.02 1.03 1.03 1.05 1.08 .98 1.01
KLA/ATP 1.05 .97 1.04 .99 1.09 1.10 1.00
Mm.1845
KLA  ATP  ATP+KLA
 142351600 Unknown KLA .93 .92 .89 .81 .76 .84 .65
ATP 1.01 .94 1.08 1.00 .77 1.95 1.13
KLA/ATP .91 .84 .85 .81 .59 .66 .77
Mm.18707
9
KLA  ATP  ATP+KLA
 149268188 Unknown KLA 4.07 3.11 3.86 4.46 3.31 3.46 1.63
ATP 1.17 .95 1.34 .60 1.22 1.61 1.03
KLA/ATP 3.87 3.25 5.63 2.01 3.05 3.28 2.19
Mm.18854
4
KLA  ATP  ATP+KLA
 141802696 Unknown KLA .76 .82 .79 .80 .80 .91 .98
ATP .92 .91 1.08 .88 .83 .86 .80
KLA/ATP .73 .82 .86 .84 .85 .83 .66
Mm.18893
9
KLA  ATP  ATP+KLA
 6754247 Unknown KLA .71 .85 .76 .78 .76 .81 .90
ATP 1.13 1.21 1.21 2.93 3.64 1.24 .96
KLA/ATP .77 .82 .96 2.56 4.66 1.65 1.50
Mm.19666
8
KLA  ATP  ATP+KLA
 118131189 Unknown KLA 1.18 1.14 1.10 1.18 1.17 1.29 1.16
ATP 1.01 .95 1.10 1.17 1.10 1.04 1.08
KLA/ATP 1.19 1.15 1.34 1.29 1.33 1.17 1.24
Mm.1978
KLA  ATP  ATP+KLA
 118129966 Unknown KLA .41 .34 .33 .29 .20 .17 .15
ATP 1.01 .98 1.28 1.12 .67 .28 .49
KLA/ATP .35 .38 .45 .37 .33 .22 .20
Mm.21162
KLA  ATP  ATP+KLA
 55742659 Unknown KLA .68 .65 .64 .66 .63 .80 .92
ATP .97 .86 .68 .63 .51 .64 .75
KLA/ATP .64 .64 .66 .57 .61 .62 .62
Mm.21511
5
KLA  ATP  ATP+KLA
 146149315 Unknown KLA .94 .93 .96 .95 .89 .95 1.08
ATP 1.02 .93 1.00 .83 .78 .92 1.58
KLA/ATP .90 .96 .93 .85 .77 .83 .83
Mm.21700
4
KLA  ATP  ATP+KLA
 142350613 Unknown KLA 1.16 1.21 1.14 1.10 1.08 1.08 1.03
ATP 1.02 1.12 1.05 .94 .90 1.04 .89
KLA/ATP 1.19 1.11 1.09 1.02 .98 .94 .95
Mm.22792
4
KLA  ATP  ATP+KLA
 142373198 Unknown KLA 1.61 1.61 1.22 1.43 1.87 1.90 1.75
ATP 1.08 1.06 1.09 2.61 2.93 1.89 2.18
KLA/ATP 1.40 1.68 1.35 1.68 1.51 1.39 2.31
Mm.23812
7
KLA  ATP  ATP+KLA
 168823498 Unknown KLA 1.07 .97 1.04 1.05 1.02 .98 1.02
ATP .95 1.00 .98 1.01 .95 .93 .92
KLA/ATP .93 .98 .98 1.04 1.01 1.02 .98
Mm.23951
KLA  ATP  ATP+KLA
 145864487 Unknown KLA .97 1.03 1.12 .96 1.08 .98 1.33
ATP 1.11 1.26 .84 1.26 .75 .60 1.62
KLA/ATP 1.27 1.25 .70 1.19 .72 .64 1.43
Mm.24244
KLA  ATP  ATP+KLA
 23956161 Unknown KLA 1.04 1.00 .96 1.04 1.53 1.13 1.09
ATP 1.17 1.30 .97 1.10 1.09 1.26 1.10
KLA/ATP .92 1.07 .82 .97 .80 .96 .74
Mm.24411
4
KLA  ATP  ATP+KLA
 71892413 Unknown KLA .97 1.00 1.06 .95 .98 1.03 .99
ATP 1.01 1.04 1.01 .97 .98 1.00 1.05
KLA/ATP 1.05 1.00 .97 1.04 .97 1.04 .99
Mm.24987
3
KLA  ATP  ATP+KLA
 161621251 Unknown KLA 1.11 1.02 1.08 1.36 1.47 1.64 3.59
ATP 1.05 1.00 1.00 .96 1.04 1.20 1.13
KLA/ATP 1.08 1.12 1.23 1.06 1.09 1.31 1.81
Mm.25153
7
KLA  ATP  ATP+KLA
 42475986 Unknown KLA 1.18 1.02 1.08 1.18 1.25 1.39 1.49
ATP 1.09 1.02 1.28 1.04 .62 1.02 1.32
KLA/ATP 1.09 1.15 1.30 1.07 .86 1.04 1.42
Mm.25203
4
KLA  ATP  ATP+KLA
 116268114 Unknown KLA 1.22 1.14 1.15 1.25 1.52 1.40 .89
ATP 1.08 1.16 1.22 1.27 1.07 .83 .62
KLA/ATP 1.02 1.21 1.56 1.55 1.39 .93 .84
Mm.26057
7
KLA  ATP  ATP+KLA
 48525358 Unknown KLA 1.29 1.49 1.41 1.57 2.51 5.49 8.27
ATP .97 .93 1.09 1.12 1.36 2.94 7.70
KLA/ATP 1.32 1.32 1.61 1.48 1.89 2.90 8.20
Mm.26105
4
KLA  ATP  ATP+KLA
 124487274 Unknown KLA .95 1.04 .97 .98 1.01 .94 1.10
ATP 1.00 1.06 .94 1.07 1.01 1.00 .98
KLA/ATP 1.04 .99 .93 1.01 1.11 1.07 1.04
Mm.26684
3
KLA  ATP  ATP+KLA
 94405693 Unknown KLA 1.12 .99 .99 1.00 .97 .98 .96
ATP 1.02 1.08 1.01 .90 1.02 .97 .91
KLA/ATP 1.03 .96 .98 .91 1.05 .90 .97
Mm.26719
KLA  ATP  ATP+KLA
 23680951 Unknown KLA .97 .96 .93 1.05 .94 1.09 .99
ATP .96 1.00 1.02 1.02 1.01 1.04 .94
KLA/ATP 1.13 1.02 .97 1.00 1.09 1.05 1.08
Mm.26915
KLA  ATP  ATP+KLA
 51921286 Unknown KLA 1.02 1.03 .96 1.11 1.05 .96 .96
ATP 1.02 1.00 .98 1.06 1.04 .99 1.08
KLA/ATP .96 .94 1.06 1.00 1.02 1.00 1.03
Mm.26930
KLA  ATP  ATP+KLA
 124487296 Unknown KLA 1.16 1.07 1.03 1.13 1.13 1.32 1.25
ATP .99 1.00 1.05 1.24 1.38 1.37 1.06
KLA/ATP 1.03 1.16 1.14 1.22 1.32 1.29 1.32
Mm.26940
KLA  ATP  ATP+KLA
 113680351 Unknown KLA .71 .71 .72 .65 .63 .83 .93
ATP .94 .87 1.23 1.30 1.21 1.41 1.76
KLA/ATP .70 .69 .89 .88 1.21 1.51 1.45
Mm.27292
7
KLA  ATP  ATP+KLA
 141801850 Unknown KLA .91 .85 .82 .87 .74 .77 .76
ATP .92 .96 1.13 1.28 1.01 .93 .94
KLA/ATP .82 .88 1.06 1.11 .98 .92 .95
Mm.27395
8
KLA  ATP  ATP+KLA
 31560783 Unknown KLA .84 .82 .82 .88 1.05 1.14 1.07
ATP 1.36 1.47 1.11 1.14 1.07 .85 .81
KLA/ATP .97 .93 .90 1.13 1.05 .99 1.01
Mm.28058
KLA  ATP  ATP+KLA
 27754143 Unknown KLA 1.12 1.15 1.01 .86 .91 .85 .73
ATP .96 .95 1.32 1.19 1.11 .67 .59
KLA/ATP 1.01 1.15 1.39 1.20 1.24 .68 .30
Mm.28349
KLA  ATP  ATP+KLA
 140969945 Unknown KLA .72 .74 .71 .78 .71 .72 .71
ATP .92 .89 1.15 1.10 .94 .84 .68
KLA/ATP .70 .70 .91 .86 .88 .80 .51
Mm.28873
KLA  ATP  ATP+KLA
 110431340 Unknown KLA .79 .72 .69 .71 .44 .32 .37
ATP .89 .88 1.17 .98 1.11 .98 .73
KLA/ATP .67 .72 .87 .74 .75 .53 .30
Mm.28924
4
KLA  ATP  ATP+KLA
 118403321 Unknown KLA .84 .83 .89 .94 .83 .96 .76
ATP .79 .69 .94 .64 .55 .66 .71
KLA/ATP .66 .68 .83 .63 .66 .78 .65
Mm.28967
2
KLA  ATP  ATP+KLA
 133893229 Unknown KLA 1.01 1.03 1.00 .97 .97 1.02 1.02
ATP .97 .98 .92 1.05 .98 .99 1.07
KLA/ATP .93 1.03 .95 .99 1.02 1.04 1.05
Mm.29073
1
KLA  ATP  ATP+KLA
 125347157 Unknown KLA .98 .99 1.12 1.02 1.04 1.04 1.05
ATP 1.02 1.06 .97 1.05 .99 1.07 1.02
KLA/ATP .96 .96 .99 1.10 1.07 1.03 1.01
Mm.29128
6
KLA  ATP  ATP+KLA
 89179305 Unknown KLA 1.03 .97 1.00 1.05 1.09 .97 .92
ATP 1.07 1.00 1.01 .96 .93 .98 .93
KLA/ATP 1.06 1.05 1.05 1.04 1.03 .96 1.04
Mm.29150
3
KLA  ATP  ATP+KLA
 34328333 Unknown KLA .61 .60 .60 .53 .51 .56 .69
ATP 1.05 .96 .93 .75 .81 .44 .78
KLA/ATP .66 .58 .67 .52 .58 .47 .55
Mm.29323
3
KLA  ATP  ATP+KLA
 118130035 Unknown KLA .98 1.04 .98 1.05 1.07 .97 .95
ATP 1.02 1.04 1.01 1.02 1.00 1.00 1.00
KLA/ATP 1.03 1.00 .98 .96 1.10 1.03 .98
Mm.29357
KLA  ATP  ATP+KLA
 12963756 Unknown KLA .88 .79 .81 .76 .76 .65 .79
ATP 1.11 1.01 1.16 1.59 1.54 1.33 .84
KLA/ATP .93 .86 .97 1.13 1.39 1.02 .60
Mm.29415
KLA  ATP  ATP+KLA
 146141166 Unknown KLA 1.13 1.04 .97 1.11 .87 .82 .87
ATP .91 .84 1.37 1.34 1.20 1.10 .71
KLA/ATP .97 1.02 1.48 1.40 1.30 1.12 .67
Mm.29467
8
KLA  ATP  ATP+KLA
 124487254 Unknown KLA 1.01 1.07 1.03 .98 1.02 1.09 1.02
ATP 1.02 1.00 1.02 1.08 .96 1.04 .97
KLA/ATP 1.01 1.00 1.05 1.05 1.01 1.06 1.01
Mm.29584
KLA  ATP  ATP+KLA
 20270274 Unknown KLA .71 .64 .54 .49 .33 .33 .49
ATP .84 .85 1.28 1.02 .82 .39 .47
KLA/ATP .57 .64 .77 .60 .52 .30 .19
Mm.29625
KLA  ATP  ATP+KLA
 34536833 Unknown KLA 1.02 .99 1.07 .90 1.01 1.14 1.01
ATP 1.07 1.16 1.05 1.04 .93 .98 1.06
KLA/ATP .98 1.04 1.04 1.06 .93 .96 1.04
Mm.29897
KLA  ATP  ATP+KLA
 56711243 Unknown KLA .98 .97 .95 .97 .94 .93 1.23
ATP .99 1.07 1.10 1.45 1.14 .94 .98
KLA/ATP .97 1.05 1.02 1.31 1.07 1.03 .92
Mm.30009
5
KLA  ATP  ATP+KLA
 145699117 Unknown KLA .70 .74 .85 .84 .90 .85 .90
ATP .83 .77 .93 .98 1.05 1.04 .86
KLA/ATP .72 .70 .86 .97 1.13 .80 .83
Mm.30084
KLA  ATP  ATP+KLA
 158631245 Unknown KLA .80 .75 .72 .79 .65 .70 .67
ATP .89 .81 1.13 .98 .90 .93 .83
KLA/ATP .70 .71 .91 .75 .82 .76 .75
Mm.30102
KLA  ATP  ATP+KLA
 142348692 Unknown KLA 1.04 1.04 .97 1.07 1.02 .93 .90
ATP 1.06 .98 1.13 1.06 1.30 1.19 .78
KLA/ATP .94 1.05 1.13 1.05 1.24 1.12 .84
Mm.30384
7
KLA  ATP  ATP+KLA
 73661177 Unknown KLA .94 1.00 1.07 1.05 .96 1.04 1.08
ATP 1.06 1.01 .98 1.02 .98 .99 1.01
KLA/ATP 1.03 .94 1.13 1.06 1.03 1.03 .99
Mm.30978
KLA  ATP  ATP+KLA
 172072649 Unknown KLA .94 .97 .98 1.02 .98 .97 .96
ATP 1.07 .96 1.09 .95 .99 .92 .96
KLA/ATP .99 1.04 1.03 .98 1.03 1.00 .89
Mm.31830
2
KLA  ATP  ATP+KLA
 124487482 Unknown KLA 1.02 1.02 1.02 1.06 1.03 .98 1.05
ATP 1.00 .99 1.04 1.17 1.04 .98 .96
KLA/ATP 1.04 1.02 1.22 1.05 .99 .99 .99
Mm.31903
8
KLA  ATP  ATP+KLA
 164518941 Unknown KLA .91 .84 .91 .94 .91 .78 .81
ATP 1.19 1.28 1.04 1.53 1.42 1.10 1.11
KLA/ATP 1.08 1.05 1.00 1.43 1.04 .92 .81
Mm.32260
6
KLA  ATP  ATP+KLA
 141803200 Unknown KLA .95 .95 .98 1.03 .96 .93 1.00
ATP 1.02 1.05 .97 .99 1.02 .98 .99
KLA/ATP .96 1.16 1.01 .88 1.02 1.05 1.00
Mm.32260
6
KLA  ATP  ATP+KLA
 94411982 Unknown KLA 1.00 1.02 1.09 1.05 1.08 1.11 1.07
ATP 1.01 .95 1.05 1.08 .97 .94 1.06
KLA/ATP .96 .98 1.10 1.08 .99 1.00 1.04
Mm.32380
5
KLA  ATP  ATP+KLA
 195546943 Unknown KLA 1.01 .94 1.03 1.09 1.03 1.06 .97
ATP .98 .98 1.06 .98 1.00 .95 1.17
KLA/ATP 1.05 1.06 1.05 1.08 1.05 1.09 1.21
Mm.32408
KLA  ATP  ATP+KLA
 124486912 Unknown KLA .80 .80 .70 .70 .54 .49 .63
ATP .90 .85 .99 .86 .71 .39 .56
KLA/ATP .71 .75 .74 .67 .53 .35 .39
Mm.32919
4
KLA  ATP  ATP+KLA
 124486721 Unknown KLA 1.02 .91 .92 .99 .85 .96 .84
ATP .97 .92 1.29 .82 .56 1.00 .95
KLA/ATP .90 .98 1.13 .79 .71 1.06 .84
Mm.32981
0
KLA  ATP  ATP+KLA
 55741832 Unknown KLA 1.02 .84 .68 .95 1.70 .68 .70
ATP 1.13 1.06 1.48 1.46 1.40 1.58 .58
KLA/ATP .82 .80 .95 .85 .60 .70 .50
Mm.33050
7
KLA  ATP  ATP+KLA
 67906182 Unknown KLA .94 .98 .99 1.03 1.05 1.07 .98
ATP .95 1.02 .97 .98 .99 1.05 1.02
KLA/ATP 1.02 1.05 1.01 1.03 .99 .98 .97
Mm.33127
2
KLA  ATP  ATP+KLA
 114431239 Unknown KLA 1.20 1.18 1.18 1.16 1.18 1.25 1.20
ATP 1.02 1.00 2.55 17.57 7.98 3.58 1.31
KLA/ATP 1.29 1.24 3.14 14.38 12.37 7.20 2.04
Mm.33401
KLA  ATP  ATP+KLA
 149255058 Unknown KLA 1.03 1.07 1.00 1.03 1.01 1.03 1.06
ATP 1.12 .98 1.12 1.36 2.32 2.03 1.10
KLA/ATP 1.03 1.00 .99 1.21 1.39 1.58 1.20
Mm.33438
KLA  ATP  ATP+KLA
 46402174 Unknown KLA 1.14 1.18 1.15 .97 .93 .89 .84
ATP 1.02 1.20 2.15 1.34 .98 .89 .86
KLA/ATP 1.23 1.19 .91 1.16 .78 .90 .86
Mm.34137
KLA  ATP  ATP+KLA
 94405716 Unknown KLA 1.11 1.12 1.10 1.07 1.08 1.13 1.36
ATP 1.09 1.14 1.01 1.25 .95 .79 1.23
KLA/ATP 1.01 1.24 .95 1.14 .83 .78 1.30
Mm.3458
KLA  ATP  ATP+KLA
 119226250 Unknown KLA .85 .78 .75 .84 .74 .81 .79
ATP .97 .83 1.09 .93 2.03 1.96 .89
KLA/ATP .81 .72 .89 .63 1.72 1.77 .79
Mm.35517
4
KLA  ATP  ATP+KLA
 142352582 Unknown KLA 1.05 .97 .95 1.03 1.05 .98 .97
ATP .98 1.02 1.00 1.03 .97 1.05 1.01
KLA/ATP .98 .97 1.03 .97 1.00 1.02 .99
Mm.36205
4
KLA  ATP  ATP+KLA
 118130030 Unknown KLA .79 .80 .81 .73 .86 .82 .88
ATP 1.00 1.12 .89 .98 .70 .55 1.34
KLA/ATP .82 .85 .58 .75 .50 .63 .97
Mm.37812
8
KLA  ATP  ATP+KLA
 162139826 Unknown KLA .94 .92 .89 .82 .67 .71 1.85
ATP .88 .91 1.28 .99 .92 1.81 .61
KLA/ATP .85 .89 1.10 .81 .72 .96 1.14
Mm.37889
8
KLA  ATP  ATP+KLA
 93102385 Unknown KLA 1.07 .94 .91 1.12 1.00 1.03 .96
ATP 1.08 1.00 1.10 .94 1.00 1.02 .67
KLA/ATP .96 .94 1.29 1.07 1.14 1.08 .72
Mm.38329
7
KLA  ATP  ATP+KLA
 124487166 Unknown KLA 2.05 2.34 2.70 2.62 3.57 3.14 2.09
ATP 1.14 1.43 1.16 2.23 1.65 1.29 1.61
KLA/ATP 2.51 2.51 1.90 3.84 2.23 2.63 3.57
Mm.38984
8
KLA  ATP  ATP+KLA
 116268117 Unknown KLA .98 1.02 1.01 1.05 .97 .97 .96
ATP .95 1.01 1.04 1.14 .99 .91 1.01
KLA/ATP 1.08 .92 1.02 1.00 .97 .97 .99
Mm.39052
9
KLA  ATP  ATP+KLA
 133892597 Unknown KLA .97 1.02 .97 .88 .79 .79 .92
ATP .93 1.10 1.07 1.22 .76 .47 .72
KLA/ATP .95 .99 .86 1.08 .67 .55 .67
Mm.39818
1
KLA  ATP  ATP+KLA
 9790036 Unknown KLA .48 .51 .55 .56 .86 1.00 .82
ATP .99 1.00 .70 .48 .19 .24 .54
KLA/ATP .57 .48 .28 .29 .18 .29 .63
Mm.40681
KLA  ATP  ATP+KLA
 153792802 Unknown KLA .96 1.01 1.08 .98 1.07 1.15 1.09
ATP 1.04 1.02 1.03 1.13 1.11 1.13 1.16
KLA/ATP 1.06 1.07 .57 1.13 1.25 1.20 1.10
Mm.41173
7
KLA  ATP  ATP+KLA
 124486740 Unknown KLA 6.95 6.26 6.49 5.66 6.34 2.93 3.01
ATP 1.18 1.40 1.03 1.27 1.96 1.87 1.53
KLA/ATP 6.62 7.00 6.07 6.81 2.75 2.22 2.84
Mm.42040
KLA  ATP  ATP+KLA
 146149300 Unknown KLA 7.51 8.44 6.42 6.50 4.95 2.64 3.74
ATP .91 .86 1.41 1.06 5.00 13.26 .50
KLA/ATP 7.10 8.32 10.08 6.10 13.81 8.56 1.67
Mm.42309
9
KLA  ATP  ATP+KLA
 74325340 Unknown KLA .96 1.03 1.01 .90 1.05 1.02 1.05
ATP .97 .94 1.02 1.02 .93 1.05 .99
KLA/ATP .95 .97 .94 1.00 1.05 1.02 .98
Mm.42607
7
KLA  ATP  ATP+KLA
 58743309 Unknown KLA .98 .93 1.04 1.03 .97 .98 1.16
ATP 1.02 .95 1.02 1.06 .96 .95 1.04
KLA/ATP .98 .97 .98 1.01 .99 1.11 .91
Mm.42677
1
KLA  ATP  ATP+KLA
 149234310 Unknown KLA .98 .96 .91 1.07 1.00 .99 .98
ATP .96 1.00 .97 .94 1.03 .95 1.01
KLA/ATP 1.01 .92 .96 .96 1.02 .99 1.00
Mm.42805
KLA  ATP  ATP+KLA
 72004261 Unknown KLA .97 .94 .88 .98 .87 .98 1.02
ATP .88 .91 1.10 1.09 .95 .81 .92
KLA/ATP .85 .94 1.11 1.07 1.08 .98 .81
Mm.43970
2
KLA  ATP  ATP+KLA
 38327645 Unknown KLA .89 .90 .82 .83 .70 .65 .67
ATP 1.00 .95 1.37 1.24 1.13 .76 .97
KLA/ATP .87 .88 1.23 .98 1.02 .64 .36
Mm.43972
3
KLA  ATP  ATP+KLA
 153792336 Unknown KLA .39 .33 .34 .30 .39 .58 .97
ATP 1.12 1.02 1.23 1.06 1.41 1.10 1.25
KLA/ATP .42 .35 .50 .59 1.68 1.10 1.36
Mm.44046
5
KLA  ATP  ATP+KLA
 164607131 Unknown KLA .65 .56 .59 .51 .33 .20 .24
ATP 1.07 .90 1.30 2.88 3.61 4.46 1.07
KLA/ATP .60 .59 .95 2.38 2.99 2.31 .37
Mm.44250
5
KLA  ATP  ATP+KLA
 124487070 Unknown KLA .93 .96 1.03 1.01 .97 .93 1.17
ATP 1.04 .91 .96 .96 .99 .89 .96
KLA/ATP .95 .89 .70 1.01 .95 1.00 .96
Mm.44390
8
KLA  ATP  ATP+KLA
 71043952 Unknown KLA .99 1.00 1.01 1.04 1.01 .98 1.06
ATP 1.03 .97 1.00 .94 .95 .98 .95
KLA/ATP .98 .98 .89 1.04 .94 .99 1.00
Mm.44463
KLA  ATP  ATP+KLA
 118129851 Unknown KLA 1.01 .98 .97 1.02 .93 1.06 1.05
ATP .97 1.01 1.04 1.06 1.02 1.08 .97
KLA/ATP 1.02 1.06 .95 1.04 1.09 1.14 1.03
Mm.44829
2
KLA  ATP  ATP+KLA
 86198313 Unknown KLA 1.12 1.03 1.02 1.14 1.04 1.07 1.02
ATP .95 .98 1.18 1.06 1.12 1.07 1.04
KLA/ATP 1.04 1.15 1.29 1.11 1.16 1.21 1.14
Mm.45742
4
KLA  ATP  ATP+KLA
 85838507 Unknown KLA .42 .38 .47 .72 1.01 1.27 .84
ATP 1.10 1.14 1.55 1.12 .55 .71 .55
KLA/ATP .50 .42 .72 .55 1.18 .69 .68
Mm.45856
3
KLA  ATP  ATP+KLA
 142351405 Unknown KLA .93 .96 .85 .74 .64 .68 .87
ATP 1.03 1.07 1.02 1.04 .94 1.01 1.14
KLA/ATP .98 .98 .75 .87 .68 1.02 1.15
Mm.4610
KLA  ATP  ATP+KLA
 142375308 Unknown KLA 18.33 19.27 25.23 27.01 26.13 21.96 6.28
ATP .93 .96 1.25 1.62 4.21 13.24 6.23
KLA/ATP 18.14 20.17 25.25 25.64 23.63 21.18 26.75
Mm.46142
7
KLA  ATP  ATP+KLA
 120407063 Unknown KLA .93 .93 .95 .88 .83 .83 .97
ATP 1.03 1.01 1.04 1.24 1.43 1.21 1.82
KLA/ATP .97 1.00 .91 .90 1.02 1.10 1.57
Mm.46661
0
KLA  ATP  ATP+KLA
 82894546 Unknown KLA .86 .90 .99 .94 1.02 .83 .91
ATP 1.10 1.04 1.04 1.15 1.03 .93 .84
KLA/ATP .86 .85 1.00 1.10 .94 .85 .90
Mm.46685
9
KLA  ATP  ATP+KLA
 145699102 Unknown KLA .65 .64 .75 .87 .83 .79 .82
ATP .80 .77 .97 .86 1.13 1.05 .85
KLA/ATP .64 .65 .85 .86 1.16 .69 .72
Mm.46777
KLA  ATP  ATP+KLA
 13385513 Unknown KLA .59 .57 .58 .68 .61 .73 1.13
ATP .96 .91 .76 .66 .60 .70 .97
KLA/ATP .56 .58 .64 .66 .66 .75 .75
Mm.47209
5
KLA  ATP  ATP+KLA
 85861217 Unknown KLA .81 .77 .71 .75 .70 .72 .87
ATP 1.08 1.12 .79 .80 .68 .62 .59
KLA/ATP .86 .83 .56 .66 .56 .63 .57
Mm.47565
8
KLA  ATP  ATP+KLA
 145966880 Unknown KLA .20 .19 .15 .15 .17 .47 .71
ATP .85 .82 .70 1.24 1.23 .39 3.48
KLA/ATP .18 .20 .18 .38 .85 .56 2.73
Mm.5662
KLA  ATP  ATP+KLA
 27369991 Unknown KLA 1.04 1.09 .90 .88 .75 .70 1.19
ATP 1.09 1.21 .84 .88 .57 .63 .90
KLA/ATP 1.08 1.06 .73 .89 .61 .60 .72
Mm.58068
KLA  ATP  ATP+KLA
 124487322 Unknown KLA 1.01 .98 1.02 .99 1.04 1.10 1.07
ATP 1.05 1.00 1.07 1.00 1.01 1.02 1.08
KLA/ATP .97 .94 .95 .94 .99 1.08 1.01
Mm.71913
KLA  ATP  ATP+KLA
 118130231 Unknown KLA .93 1.00 1.06 .97 .95 .98 1.04
ATP 1.00 .98 1.08 1.02 .92 .90 .99
KLA/ATP .99 1.01 1.00 .99 .99 .99 1.01
Mm.7329
KLA  ATP  ATP+KLA
 158508431 Unknown KLA 1.07 1.00 .89 .83 .87 .58 .44
ATP 1.19 1.31 1.06 1.47 1.11 .56 .46
KLA/ATP .94 1.10 1.03 1.33 .87 .55 .27
Mm.76062
KLA  ATP  ATP+KLA
 57527869 Unknown KLA 1.29 1.49 1.51 1.51 1.60 1.61 1.64
ATP .94 .88 .90 .96 .83 1.19 1.76
KLA/ATP 1.33 1.31 1.18 1.27 1.06 1.30 1.71
Mm.79179
KLA  ATP  ATP+KLA
 141803280 Unknown KLA .95 1.09 1.04 1.13 1.00 1.10 .98
ATP 1.02 1.17 1.04 1.18 1.06 1.02 1.01
KLA/ATP .98 1.00 1.02 1.01 .98 .93 .99
Mmab
KLA  ATP  ATP+KLA
 NM_029956 methylmalonic aciduria (cobalamin deficiency) type B homolog (human) (Mmab), nuclear gene encoding mitochondrial protein, mRNA [NM_029956] KLA .85 .89 .82 .94 1.03 1.15 1.23
ATP 1.02 1.05 .91 .89 .60 .64 1.73
KLA/ATP .82 .87 1.15 .83 .70 .66 1.02
Mocs1
KLA  ATP  ATP+KLA
 NM_020042 molybdenum cofactor synthesis 1 (Mocs1), transcript variant 1, mRNA [NM_020042] KLA 1.79 1.98 2.19 2.29 2.97 3.11 2.73
ATP 1.04 1.10 1.15 1.46 1.30 1.68 1.29
KLA/ATP 1.97 2.20 2.03 2.45 1.60 1.88 2.90
Mocs2
KLA  ATP  ATP+KLA
 AF091872 molybdopterin-synthase small and large subunit (Mocs2) bicistronic mRNA, complete cds. [AF091872] KLA 1.48 1.65 2.02 2.31 2.45 2.95 1.68
ATP .94 .80 .87 .66 .81 1.86 2.21
KLA/ATP 1.47 1.31 1.62 1.29 1.85 2.40 3.27
Mocs2
KLA  ATP  ATP+KLA
 NM_013826 molybdenum cofactor synthesis 2 (Mocs2), transcript variant 1, mRNA [NM_013826] KLA 1.45 1.49 1.75 2.08 2.20 2.83 1.69
ATP .83 .74 .80 .65 .77 1.68 2.23
KLA/ATP 1.32 1.23 1.38 1.18 1.67 2.36 2.99
Mpi
KLA  ATP  ATP+KLA
 NM_025837 mannose phosphate isomerase (Mpi), mRNA [NM_025837] KLA 1.54 1.45 1.45 1.54 1.57 1.73 1.47
ATP 1.14 1.14 1.15 1.20 1.21 1.34 1.76
KLA/ATP 1.60 1.57 1.94 1.67 1.51 1.73 2.21
Mpst
KLA  ATP  ATP+KLA
 NM_138670 mercaptopyruvate sulfurtransferase (Mpst), nuclear gene encoding mitochondrial protein, mRNA [NM_138670] KLA .87 1.03 .83 .86 .79 1.21 1.35
ATP .99 1.43 1.12 1.05 1.00 .91 1.24
KLA/ATP .91 1.21 1.03 1.10 .87 .73 1.52
Mtap
KLA  ATP  ATP+KLA
 NM_024433 methylthioadenosine phosphorylase (Mtap), mRNA [NM_024433] KLA .83 .89 .73 .73 .55 .39 .64
ATP 1.15 1.28 1.09 1.23 .72 .32 .38
KLA/ATP .98 .95 .79 .89 .52 .29 .20
Mthfd1
KLA  ATP  ATP+KLA
 NM_138745 methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase (Mthfd1), mRNA [NM_138745] KLA .69 .68 .59 .46 .33 .31 .53
ATP .94 1.07 1.11 1.21 .84 .34 .48
KLA/ATP .68 .71 .64 .66 .44 .25 .17
Mthfd1l
KLA  ATP  ATP+KLA
 NM_172308 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like (Mthfd1l), mRNA [NM_172308] KLA .86 .88 .73 .64 .50 .40 .50
ATP .97 .99 1.19 1.03 .96 .86 .32
KLA/ATP .88 .86 .84 .74 .78 .65 .20
Mthfd2
KLA  ATP  ATP+KLA
 NM_008638 methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase (Mthfd2), nuclear gene encoding mitochondrial protein, mRNA [NM_008638] KLA 1.72 1.73 1.41 1.61 2.15 3.05 3.45
ATP 1.13 1.16 .97 1.23 2.55 2.27 2.28
KLA/ATP 1.42 1.75 1.68 1.84 2.13 2.41 2.12
Mthfr
KLA  ATP  ATP+KLA
 AF404274 methylenetetrahydrofolate reductase short isoform (Mthfr) mRNA, partial cds; alternatively spliced. [AF404274] KLA 1.05 .94 .98 .99 .96 1.03 1.08
ATP .94 1.00 .96 1.01 .96 .84 1.11
KLA/ATP .93 .99 .95 1.05 1.01 .99 1.08
Mthfr
KLA  ATP  ATP+KLA
 NM_010840 5,10-methylenetetrahydrofolate reductase (Mthfr), mRNA [NM_010840] KLA 5.09 5.09 6.32 5.94 6.76 6.97 3.52
ATP .98 .92 .91 .80 1.52 3.30 4.30
KLA/ATP 5.03 4.79 4.71 3.89 5.46 7.22 9.94
Mthfs
KLA  ATP  ATP+KLA
 NM_026829 5, 10-methenyltetrahydrofolate synthetase (Mthfs), mRNA [NM_026829] KLA 1.92 1.98 2.10 1.90 1.83 1.41 1.00
ATP .96 .96 1.23 1.33 1.21 .86 1.66
KLA/ATP 2.00 2.22 2.99 2.93 2.57 1.51 1.32
Mtm1
KLA  ATP  ATP+KLA
 BC066847 cDNA clone IMAGE:30056108, containing frame-shift errors [BC066847] KLA 1.95 1.54 1.59 1.45 1.67 1.72 1.56
ATP 1.13 .99 1.79 .67 1.45 1.50 1.16
KLA/ATP 1.94 1.67 2.49 .85 1.57 1.41 1.69
Mtm1
KLA  ATP  ATP+KLA
 NM_019926 X-linked myotubular myopathy gene 1 (Mtm1), mRNA [NM_019926] KLA 1.83 1.97 2.17 2.00 2.01 1.87 2.29
ATP 1.10 1.30 1.18 1.32 .93 1.12 1.07
KLA/ATP 2.00 2.06 1.71 2.12 1.12 1.14 1.76
Mtr
KLA  ATP  ATP+KLA
 AK037599 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130029B16 product:5-methyltetrahydrofolate-homocysteine methyltransferase, full insert sequence. [AK037599] KLA .89 .92 .81 .83 .73 .76 .98
ATP .98 1.11 .85 .93 .68 .72 1.12
KLA/ATP .92 .93 .71 .85 .66 .68 .77
Mtr
KLA  ATP  ATP+KLA
 NM_001081128 5-methyltetrahydrofolate-homocysteine methyltransferase (Mtr), mRNA [NM_001081128] KLA .93 .91 .89 .77 .64 .58 .99
ATP 1.12 1.11 1.05 .87 .71 .69 1.59
KLA/ATP 1.02 .95 .96 .78 .54 .55 .92
Mut
KLA  ATP  ATP+KLA
 X51941 gb|Mouse mRNA for methylmalonyl CoA mutase (EC 5.4.99.2) [X51941] KLA .57 .56 .51 .56 .55 .63 .69
ATP .89 .83 1.05 .71 .41 .29 .88
KLA/ATP .52 .51 .62 .40 .29 .23 .38
Mvd
KLA  ATP  ATP+KLA
 NM_138656 mevalonate (diphospho) decarboxylase (Mvd), mRNA [NM_138656] KLA .53 .53 .53 .53 .54 .48 .81
ATP .95 .97 1.05 1.29 1.06 .87 1.80
KLA/ATP .54 .57 .60 .73 .77 .56 .47
Mvk
KLA  ATP  ATP+KLA
 NM_023556 mevalonate kinase (Mvk), mRNA [NM_023556] KLA .87 .90 .89 .91 .90 .94 .99
ATP .91 .79 .56 .59 .35 .47 1.40
KLA/ATP .89 .74 .56 .61 .43 .43 .65
Nadk
KLA  ATP  ATP+KLA
 NM_138671 NAD kinase (Nadk), mRNA [NM_138671] KLA 1.14 1.21 1.18 1.21 1.38 1.48 2.34
ATP .92 .84 .67 .56 .61 .69 .91
KLA/ATP 1.07 .97 .76 .64 .56 .54 1.71
Nadsyn1
KLA  ATP  ATP+KLA
 NM_030221 NAD synthetase 1 (Nadsyn1), mRNA [NM_030221] KLA .94 .85 .89 .99 .96 1.02 .97
ATP .98 .95 1.19 .81 .73 .70 1.01
KLA/ATP .76 .87 1.17 .90 .82 .78 1.05
Naglu
KLA  ATP  ATP+KLA
 AK158045 adult inner ear cDNA, RIKEN full-length enriched library, clone:F930021C23 product:alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB), full insert sequence [AK158045] KLA 1.06 1.01 1.05 .98 1.02 1.04 1.01
ATP .99 1.05 .96 1.00 1.05 .93 1.03
KLA/ATP 1.03 .99 1.04 1.03 .96 .98 .91
Naglu
KLA  ATP  ATP+KLA
 NM_013792 alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) (Naglu), mRNA [NM_013792] KLA .67 .71 .71 .63 .59 .60 .87
ATP 1.02 1.07 1.00 1.14 .84 .57 .95
KLA/ATP .72 .72 .71 .84 .58 .54 .72
Nags
KLA  ATP  ATP+KLA
 NM_145829 N-acetylglutamate synthase (Nags), transcript variant 1, mRNA [NM_145829] KLA .99 .97 1.02 1.06 1.03 1.03 1.08
ATP .95 .98 1.07 1.12 1.17 1.38 1.26
KLA/ATP .97 1.05 1.10 1.42 1.31 1.52 1.27
Nags
KLA  ATP  ATP+KLA
 NM_178053 N-acetylglutamate synthase (Nags), transcript variant 2, mRNA [NM_178053] KLA 1.01 .98 1.07 1.10 1.02 1.02 1.06
ATP 1.07 1.06 1.12 1.00 1.56 2.35 1.57
KLA/ATP .98 1.02 1.09 .94 1.32 1.66 1.29
Nanp
KLA  ATP  ATP+KLA
 NM_026086 N-acetylneuraminic acid phosphatase (Nanp), mRNA [NM_026086] KLA .56 .58 .56 .59 .66 .93 .79
ATP .92 .82 .70 .42 .61 .53 .68
KLA/ATP .52 .49 .52 .44 .64 .66 .47
Nans
KLA  ATP  ATP+KLA
 NM_053179 N-acetylneuraminic acid synthase (sialic acid synthase) (Nans), mRNA [NM_053179] KLA .67 .67 .63 .55 .48 .54 .67
ATP .95 .97 1.05 1.12 .95 .70 .77
KLA/ATP .67 .67 .69 .70 .77 .59 .46
Naprt1
KLA  ATP  ATP+KLA
 NM_172607 nicotinate phosphoribosyltransferase domain containing 1 (Naprt1), mRNA [NM_172607] KLA .70 .62 .67 .62 .50 .46 .56
ATP 1.01 .90 1.12 .94 .58 .39 .76
KLA/ATP .69 .68 .82 .71 .60 .34 .42
Nat1
KLA  ATP  ATP+KLA
 NM_008673 N-acetyltransferase 1 (arylamine N-acetyltransferase) (Nat1), mRNA [NM_008673] KLA .97 .98 1.00 .94 1.01 .95 1.02
ATP 1.03 .96 1.01 1.04 1.03 .99 1.01
KLA/ATP 1.03 .98 .94 1.00 .99 1.05 .86
Nat2
KLA  ATP  ATP+KLA
 NM_010874 N-acetyltransferase 2 (arylamine N-acetyltransferase) (Nat2), mRNA [NM_010874] KLA 3.59 3.77 3.60 2.69 2.11 2.24 1.44
ATP .96 .91 .74 .42 .39 1.32 1.45
KLA/ATP 3.43 3.33 2.84 1.60 .89 2.12 2.09
Nat3
KLA  ATP  ATP+KLA
 NM_008674 N-acetyltransferase 3 (Nat3), mRNA [NM_008674] KLA 1.00 1.06 1.05 1.02 1.07 1.05 1.11
ATP .98 .99 1.05 1.05 1.04 1.02 1.11
KLA/ATP 1.03 .95 .96 1.03 .96 1.04 .99
Ndst1
KLA  ATP  ATP+KLA
 AK004787 adult male lung cDNA, RIKEN full-length enriched library, clone:1200015G06 product:unclassifiable, full insert sequence. [AK004787] KLA .57 .59 .51 .41 .33 .35 .46
ATP .93 .82 1.09 .86 1.18 1.46 2.12
KLA/ATP .54 .58 .64 .58 1.19 1.35 1.57
Ndst1
KLA  ATP  ATP+KLA
 NM_008306 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (Ndst1), mRNA [NM_008306] KLA 1.04 1.05 1.03 1.00 1.04 .97 .96
ATP 1.07 1.09 .92 .97 .97 1.07 2.76
KLA/ATP 1.07 1.10 .85 .87 1.02 1.17 2.12
Ndst2
KLA  ATP  ATP+KLA
 NM_010811 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 (Ndst2), mRNA [NM_010811] KLA 1.59 1.63 1.85 1.98 2.19 1.85 1.33
ATP 1.17 1.08 .72 .63 .85 1.06 1.80
KLA/ATP 1.78 1.61 1.03 1.13 1.68 1.70 1.96
Ndst3
KLA  ATP  ATP+KLA
 NM_031186 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 (Ndst3), mRNA [NM_031186] KLA 1.02 .98 1.02 .98 .96 .97 1.01
ATP .98 1.02 1.04 1.10 1.02 1.03 .89
KLA/ATP 1.09 1.11 .96 1.05 1.06 1.00 .91
Ndst4
KLA  ATP  ATP+KLA
 NM_022565 N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 (Ndst4), mRNA [NM_022565] KLA .98 .95 .97 1.06 .98 .98 1.02
ATP 1.01 .97 1.02 .97 1.01 1.03 1.01
KLA/ATP .98 1.08 1.02 1.02 1.00 1.01 .95
Ndufa1
KLA  ATP  ATP+KLA
 NM_019443 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 (Ndufa1), nuclear gene encoding mitochondrial protein, mRNA [NM_019443] KLA 1.12 .99 .94 1.16 .97 .95 .86
ATP .95 .93 1.18 1.10 1.13 1.25 1.12
KLA/ATP .93 1.02 1.37 1.17 1.18 1.13 1.07
Ndufa10
KLA  ATP  ATP+KLA
 NM_024197 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 (Ndufa10), nuclear gene encoding mitochondrial protein, mRNA [NM_024197] KLA 1.13 1.13 1.00 .96 1.07 .97 1.14
ATP 1.08 1.11 1.00 1.13 .94 .67 .83
KLA/ATP 1.05 1.21 1.03 1.19 .86 .86 .74
Ndufa11
KLA  ATP  ATP+KLA
 BC053075 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11, mRNA (cDNA clone IMAGE:5694421) [BC053075] KLA 1.24 1.07 1.15 1.23 1.27 1.25 1.24
ATP 1.16 1.19 1.30 1.46 1.49 1.47 1.11
KLA/ATP 1.17 1.31 1.46 1.67 1.47 1.54 1.46
Ndufa12
KLA  ATP  ATP+KLA
 NM_025551 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 (Ndufa12), mRNA [NM_025551] KLA 1.02 .99 .98 1.06 .92 .80 .82
ATP 1.06 1.08 1.43 1.49 1.33 1.01 .84
KLA/ATP 1.03 1.15 1.68 1.51 1.25 1.06 .67
Ndufa13
KLA  ATP  ATP+KLA
 NM_023312 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 (Ndufa13), mRNA [NM_023312] KLA .90 .84 .76 .86 .85 .78 .97
ATP 1.05 .99 1.09 .97 .94 .87 .76
KLA/ATP .82 .87 1.06 .95 .92 .81 .88
Ndufa2
KLA  ATP  ATP+KLA
 NM_010885 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (Ndufa2), mRNA [NM_010885] KLA .85 .93 .79 .83 .79 .81 1.00
ATP .99 1.05 1.12 1.31 1.25 1.09 .93
KLA/ATP .91 .92 .98 1.22 1.15 1.06 1.05
Ndufa3
KLA  ATP  ATP+KLA
 NM_025348 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 (Ndufa3), mRNA [NM_025348] KLA .96 1.02 .98 .97 1.03 1.09 1.07
ATP .95 1.08 1.03 1.38 1.17 .98 1.20
KLA/ATP 1.08 1.08 .97 1.42 1.13 1.17 1.48
Ndufa4
KLA  ATP  ATP+KLA
 NM_010886 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 (Ndufa4), nuclear gene encoding mitochondrial protein, mRNA [NM_010886] KLA 1.01 1.00 .91 .96 .82 .78 .80
ATP .98 .99 1.11 1.17 1.02 1.04 .75
KLA/ATP 1.00 1.08 1.01 1.17 .95 .92 .58
Ndufa5
KLA  ATP  ATP+KLA
 NM_026614 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (Ndufa5), nuclear gene encoding mitochondrial protein, mRNA [NM_026614] KLA .92 .85 .78 .88 .74 .77 .74
ATP .89 .89 1.16 1.14 .96 .86 .67
KLA/ATP .80 .88 1.16 1.04 1.03 .93 .54
Ndufa6
KLA  ATP  ATP+KLA
 NM_025987 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14) (Ndufa6), nuclear gene encoding mitochondrial protein, mRNA [NM_025987] KLA .81 .86 .79 .86 .81 .87 1.11
ATP .98 .98 1.06 1.22 1.16 .73 .78
KLA/ATP .87 .88 .97 1.09 .99 .83 .78
Ndufa7
KLA  ATP  ATP+KLA
 NM_023202 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) (Ndufa7), mRNA [NM_023202] KLA .95 .97 .89 .95 .89 .89 1.01
ATP .98 1.02 1.17 1.34 1.08 .98 .76
KLA/ATP .91 .95 1.06 1.23 1.11 1.03 .98
Ndufa8
KLA  ATP  ATP+KLA
 NM_026703 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 (Ndufa8), nuclear gene encoding mitochondrial protein, mRNA [NM_026703] KLA .93 .87 .78 .98 .76 .89 .91
ATP .94 .89 1.22 1.01 .95 .78 .96
KLA/ATP .81 .81 1.11 .92 .92 .78 .73
Ndufa9
KLA  ATP  ATP+KLA
 NM_025358 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (Ndufa9), mRNA [NM_025358] KLA .91 .80 .82 1.12 .89 .89 1.01
ATP 1.03 .99 1.12 1.08 1.11 .79 .86
KLA/ATP .93 .91 1.43 1.08 1.05 .81 .85
Ndufab1
KLA  ATP  ATP+KLA
 NM_028177 NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 (Ndufab1), mRNA [NM_028177] KLA 1.14 1.08 1.12 1.16 1.05 1.07 1.14
ATP .99 1.02 1.20 1.30 1.17 1.08 1.40
KLA/ATP 1.04 1.13 1.27 1.26 1.23 1.10 1.12
Ndufb10
KLA  ATP  ATP+KLA
 NM_026684 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 (Ndufb10), mRNA [NM_026684] KLA .74 .78 .73 .55 .68 .71 .70
ATP .93 .86 1.09 .97 .93 .77 .84
KLA/ATP .74 .76 .83 .77 .85 .75 .58
Ndufb11
KLA  ATP  ATP+KLA
 NM_019435 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11 (Ndufb11), mRNA [NM_019435] KLA .75 .75 .69 .84 .72 .79 .61
ATP 1.00 .93 1.15 .96 1.03 .98 .83
KLA/ATP .81 .68 1.03 .80 .81 .71 .77
Ndufb2
KLA  ATP  ATP+KLA
 NM_026612 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (Ndufb2), nuclear gene encoding mitochondrial protein, mRNA [NM_026612] KLA .95 .94 .86 .92 .79 .75 .84
ATP .95 .91 1.21 1.25 1.06 .95 .67
KLA/ATP .89 .88 1.16 1.17 1.11 .89 .59
Ndufb3
KLA  ATP  ATP+KLA
 NM_025597 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 (Ndufb3), mRNA [NM_025597] KLA .87 .87 .85 .93 .84 .94 .89
ATP .92 .81 1.28 1.15 1.04 .77 .88
KLA/ATP .86 .96 1.28 1.11 1.19 .89 .90
Ndufb4
KLA  ATP  ATP+KLA
 NM_026610 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 (Ndufb4), nuclear gene encoding mitochondrial protein, mRNA [NM_026610] KLA .89 .87 .76 .84 .73 .77 .83
ATP 1.00 .99 1.13 1.03 .98 .77 .77
KLA/ATP .93 .85 1.04 .99 .88 .78 .63
Ndufb5
KLA  ATP  ATP+KLA
 NM_025316 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 (Ndufb5), nuclear gene encoding mitochondrial protein, mRNA [NM_025316] KLA .99 1.09 1.14 .85 .95 .83 .70
ATP 1.01 1.01 1.32 1.15 1.01 .65 .63
KLA/ATP 1.09 1.02 1.36 1.14 1.07 .58 .30
Ndufb6
KLA  ATP  ATP+KLA
 NM_001033305 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (Ndufb6), nuclear gene encoding mitochondrial protein, mRNA [NM_001033305] KLA 1.08 1.08 .96 1.04 .94 .98 1.04
ATP .93 .99 1.25 1.30 1.20 1.05 .83
KLA/ATP 1.01 1.10 1.30 1.44 1.33 1.14 .81
Ndufb7
KLA  ATP  ATP+KLA
 NM_025843 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (Ndufb7), nuclear gene encoding mitochondrial protein, mRNA [NM_025843] KLA .87 .83 .85 .86 .81 .87 .88
ATP .94 .93 1.08 1.08 .85 .72 .95
KLA/ATP .83 .85 1.00 .96 .92 .83 .83
Ndufb8
KLA  ATP  ATP+KLA
 AK028070 adult female placenta cDNA, RIKEN full-length enriched library, clone:1620401I19 product:similar to NADH-UBIQUINONE OXIDOREDUCTASE ASHI SUBUNIT, MITOCHONDRIAL PRECURSOR (EC 1.6.5.3) (EC 1.6.99.3) (COMPLEX I-ASHI) (CI-ASHI) [Bos taurus], KLA .68 .68 .68 .83 .90 1.08 1.20
ATP .87 .84 .96 .85 .98 1.58 1.39
KLA/ATP .64 .64 .67 .71 .93 1.43 1.53
Ndufb8
KLA  ATP  ATP+KLA
 NM_026061 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (Ndufb8), mRNA [NM_026061] KLA .79 .80 .70 .75 .68 .72 .90
ATP .92 .94 .97 .95 .80 .65 .79
KLA/ATP .74 .76 .78 .74 .70 .63 .68
Ndufb9
KLA  ATP  ATP+KLA
 NM_023172 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (Ndufb9), mRNA [NM_023172] KLA .86 .82 .78 1.03 .93 1.07 1.31
ATP .98 .95 1.05 .84 .78 .82 1.12
KLA/ATP .85 .84 1.01 .80 .76 .99 1.31
Ndufc1
KLA  ATP  ATP+KLA
 NM_025523 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 (Ndufc1), mRNA [NM_025523] KLA 1.00 .96 .87 .96 .85 .90 1.00
ATP .91 .94 1.17 1.18 1.04 1.05 .87
KLA/ATP .93 .96 1.14 1.16 1.08 1.06 .83
Ndufc2
KLA  ATP  ATP+KLA
 NM_024220 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (Ndufc2), mRNA [NM_024220] KLA .93 .90 .83 .94 .86 .99 1.29
ATP .92 .95 1.04 1.05 .91 .67 .83
KLA/ATP .84 .88 .92 .91 .87 .78 .73
Ndufs1
KLA  ATP  ATP+KLA
 AK017924 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830412M15 product:unclassifiable, full insert sequence [AK017924] KLA 1.07 1.00 .94 1.01 1.07 1.00 .96
ATP 1.00 1.00 1.04 .96 1.08 1.03 1.03
KLA/ATP 1.00 1.04 .93 1.00 1.02 1.01 1.04
Ndufs1
KLA  ATP  ATP+KLA
 NM_145518 NADH dehydrogenase (ubiquinone) Fe-S protein 1 (Ndufs1), nuclear gene encoding mitochondrial protein, mRNA [NM_145518] KLA .84 .88 .82 .77 .68 .65 .69
ATP 1.04 1.00 .91 .73 .71 .61 .76
KLA/ATP .92 .82 .76 .60 .54 .57 .56
Ndufs2
KLA  ATP  ATP+KLA
 NM_153064 NADH dehydrogenase (ubiquinone) Fe-S protein 2 (Ndufs2), mRNA [NM_153064] KLA 1.23 1.32 1.28 1.21 1.26 1.03 .94
ATP 1.23 1.26 .82 1.09 .81 .64 .94
KLA/ATP 1.32 1.42 1.17 1.45 .88 .75 .83
Ndufs3
KLA  ATP  ATP+KLA
 NM_026688 NADH dehydrogenase (ubiquinone) Fe-S protein 3 (Ndufs3), mRNA [NM_026688] KLA 1.10 1.03 1.16 1.15 1.08 1.15 1.13
ATP 1.10 1.05 1.21 1.31 1.11 .64 .97
KLA/ATP 1.13 1.10 1.23 1.35 1.20 1.12 1.09
Ndufs4
KLA  ATP  ATP+KLA
 AK035175 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430096G04 product:NADH dehydrogenase (ubiquinone) Fe-S protein 4, full insert sequence [AK035175] KLA .99 .98 .92 .96 .98 1.00 .97
ATP 1.01 1.03 .99 1.01 1.01 1.01 .98
KLA/ATP .96 .98 1.00 1.00 1.01 1.03 .93
Ndufs4
KLA  ATP  ATP+KLA
 NM_010887 NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4), nuclear gene encoding mitochondrial protein, mRNA [NM_010887] KLA 1.41 1.47 1.53 1.80 1.68 1.89 1.38
ATP .91 .92 1.27 1.19 .93 .79 1.01
KLA/ATP 1.33 1.45 2.08 1.91 1.90 1.39 1.11
Ndufs5
KLA  ATP  ATP+KLA
 AK037635 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130032A08 product:unclassifiable, full insert sequence [AK037635] KLA .92 .97 .91 .93 .94 .92 .92
ATP .84 .78 .77 .75 .92 .98 .92
KLA/ATP .83 .78 .84 .74 1.13 .96 .90
Ndufs5
KLA  ATP  ATP+KLA
 NM_001030274 NADH dehydrogenase (ubiquinone) Fe-S protein 5 (Ndufs5), mRNA [NM_001030274] KLA .99 .92 .89 1.03 .91 .96 1.03
ATP 1.00 .96 1.11 1.03 .93 .80 .90
KLA/ATP .89 .96 1.12 1.00 1.04 .91 .72
Ndufs6
KLA  ATP  ATP+KLA
 NM_010888 NADH dehydrogenase (ubiquinone) Fe-S protein 6 (Ndufs6), mRNA [NM_010888] KLA .99 1.00 1.05 1.03 .98 .94 1.18
ATP 1.09 1.15 1.15 1.48 1.33 .91 1.00
KLA/ATP 1.07 1.12 1.10 1.36 1.21 1.05 .94
Ndufs7
KLA  ATP  ATP+KLA
 NM_029272 NADH dehydrogenase (ubiquinone) Fe-S protein 7 (Ndufs7), nuclear gene encoding mitochondrial protein, mRNA [NM_029272] KLA .78 .75 .70 .70 .72 .73 .97
ATP .97 1.02 .99 1.16 .86 .56 .87
KLA/ATP .77 .76 .73 .86 .72 .64 .72
Ndufs8
KLA  ATP  ATP+KLA
 NM_144870 NADH dehydrogenase (ubiquinone) Fe-S protein 8 (Ndufs8), mRNA [NM_144870] KLA .98 1.02 .88 .82 .77 .74 .83
ATP 1.00 1.13 1.00 1.42 1.13 .88 .81
KLA/ATP .95 1.00 .76 1.21 .86 1.06 .91
Ndufv1
KLA  ATP  ATP+KLA
 NM_133666 NADH dehydrogenase (ubiquinone) flavoprotein 1 (Ndufv1), nuclear gene encoding mitochondrial protein, mRNA [NM_133666] KLA .92 .88 .99 .91 .88 .87 .92
ATP 1.15 1.07 1.07 1.12 .92 .67 .83
KLA/ATP .99 .97 .99 1.00 .84 .71 .71
Nme1
KLA  ATP  ATP+KLA
 NM_008704 non-metastatic cells 1, protein (NM23A) expressed in (Nme1), mRNA [NM_008704] KLA .82 .85 .74 .76 .64 .62 .69
ATP .92 .94 1.26 1.20 1.08 .69 1.01
KLA/ATP .78 .84 1.03 .91 .92 .60 .31
Nme2
KLA  ATP  ATP+KLA
 NM_001077529 non-metastatic cells 2, protein (NM23B) expressed in (Nme2), transcript variant 2, mRNA [NM_001077529] KLA .96 .98 .93 .97 .84 .87 .80
ATP .97 .89 1.13 1.04 1.05 1.08 .56
KLA/ATP .95 .95 1.07 1.10 1.06 1.02 .53
Nme3
KLA  ATP  ATP+KLA
 NM_019730 non-metastatic cells 3, protein expressed in (Nme3), mRNA [NM_019730] KLA .74 .77 .74 .64 .53 .37 .29
ATP 1.03 1.05 1.14 1.30 1.07 .75 .75
KLA/ATP .79 .82 .84 1.01 .84 .64 .44
Nme4
KLA  ATP  ATP+KLA
 NM_019731 non-metastatic cells 4, protein expressed in (Nme4), mRNA [NM_019731] KLA .85 .85 .78 .75 .68 .56 .61
ATP .98 1.09 1.08 1.37 .89 .43 .43
KLA/ATP .89 .84 .76 1.08 .70 .48 .26
Nme5
KLA  ATP  ATP+KLA
 NM_080637 non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) (Nme5), mRNA [NM_080637] KLA .96 1.00 .99 1.00 1.03 1.02 1.02
ATP 1.01 1.05 1.04 1.03 1.00 1.00 1.05
KLA/ATP 1.06 .98 1.00 .95 1.03 .98 1.05
Nme6
KLA  ATP  ATP+KLA
 NM_018757 non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) (Nme6), mRNA [NM_018757] KLA .72 .79 .85 .86 .96 1.12 1.75
ATP .94 .95 1.01 .97 .65 .71 .95
KLA/ATP .77 .77 .73 .77 .63 .63 .95
Nme7
KLA  ATP  ATP+KLA
 NM_138314 non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (Nme7), transcript variant 1, mRNA [NM_138314] KLA .78 .77 .80 .93 1.07 1.28 .98
ATP .95 .89 1.00 .88 .63 1.11 1.22
KLA/ATP .73 .77 .81 .72 .77 1.83 1.30
Nmnat1
KLA  ATP  ATP+KLA
 AK152407 bone marrow macrophage cDNA, RIKEN full-length enriched library, clone:I830068L10 product:NMN adenylyltransferase; nicotinamide mononucleotide adenylyl transferase, full insert sequence [AK152407] KLA 1.59 1.41 1.71 1.75 1.77 1.74 1.49
ATP .96 .88 1.13 1.05 .87 1.49 2.19
KLA/ATP 1.41 1.50 1.78 1.54 1.31 1.73 2.33
Nmnat2
KLA  ATP  ATP+KLA
 NM_175460 nicotinamide nucleotide adenylyltransferase 2 (Nmnat2), mRNA [NM_175460] KLA .98 .98 1.02 .98 .95 1.00 1.04
ATP 1.04 1.05 1.04 1.00 .94 .96 1.03
KLA/ATP 1.02 1.04 .99 1.00 1.00 1.03 1.02
Nmnat3
KLA  ATP  ATP+KLA
 NM_144533 nicotinamide nucleotide adenylyltransferase 3 (Nmnat3), mRNA [NM_144533] KLA .49 .44 .41 .40 .34 .52 .80
ATP .94 .82 1.02 .64 .63 .50 .72
KLA/ATP .42 .42 .41 .30 .56 .62 .42
Nnmt
KLA  ATP  ATP+KLA
 NM_010924 nicotinamide N-methyltransferase (Nnmt), mRNA [NM_010924] KLA .98 .99 1.03 .98 .98 1.01 1.00
ATP .92 1.03 1.04 1.02 1.04 5.10 5.18
KLA/ATP .96 1.03 1.04 1.03 .99 2.30 4.68
Nnt
KLA  ATP  ATP+KLA
 NM_008710 nicotinamide nucleotide transhydrogenase (Nnt), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_008710] KLA .90 .88 .87 .79 .72 .58 .50
ATP 1.10 1.11 1.11 .99 .76 .52 .41
KLA/ATP .94 .95 .85 .79 .59 .48 .30
Nnt
KLA  ATP  ATP+KLA
 Z49204 gb|M.musculus mRNA for NADP transhydrogenase. [Z49204] KLA .94 .91 1.05 .93 .79 .64 .54
ATP 1.15 1.17 1.23 1.09 .85 .47 .40
KLA/ATP 1.12 1.02 .91 .86 .62 .49 .30
Nos1
KLA  ATP  ATP+KLA
 NM_008712 nitric oxide synthase 1, neuronal (Nos1), mRNA [NM_008712] KLA 1.01 1.01 1.02 .99 1.02 1.02 1.01
ATP 1.01 1.03 1.02 1.04 1.03 1.01 1.00
KLA/ATP 1.05 1.02 1.02 1.00 1.02 1.03 1.03
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Nos3
KLA  ATP  ATP+KLA
 NM_008713 nitric oxide synthase 3, endothelial cell (Nos3), mRNA [NM_008713] KLA .83 .79 .76 .78 .77 .85 .96
ATP 1.03 1.09 1.03 1.02 .85 .96 1.84
KLA/ATP .80 .78 .79 .80 .79 .78 .91
Nsdhl
KLA  ATP  ATP+KLA
 AK156993 activated spleen cDNA, RIKEN full-length enriched library, clone:F830111P16 product:unclassifiable, full insert sequence [AK156993] KLA 1.06 .94 .95 .88 1.09 .86 .76
ATP 1.14 1.03 1.03 .75 .75 .92 1.02
KLA/ATP 1.05 .98 .92 .70 .84 .71 .76
Nsdhl
KLA  ATP  ATP+KLA
 NM_010941 NAD(P) dependent steroid dehydrogenase-like (Nsdhl), mRNA [NM_010941] KLA .98 1.05 1.03 .95 .97 .87 .89
ATP 1.02 1.16 1.11 1.33 .91 .57 1.05
KLA/ATP 1.08 1.02 .86 1.20 .77 .58 .47
Nt5c
KLA  ATP  ATP+KLA
 NM_015807 5,3-nucleotidase, cytosolic (Nt5c), mRNA [NM_015807] KLA .81 .85 .74 .73 .75 .83 1.14
ATP .94 .90 .95 .96 .58 .52 1.07
KLA/ATP .78 .79 .82 .88 .65 .43 .68
Nt5c1b
KLA  ATP  ATP+KLA
 NM_027588 5-nucleotidase, cytosolic IB (Nt5c1b), mRNA [NM_027588] KLA 1.00 .98 .99 .99 1.00 1.02 1.00
ATP .98 1.02 1.01 .99 1.02 1.00 .94
KLA/ATP 1.01 1.02 .90 1.00 1.09 1.02 1.05
Nt5c2
KLA  ATP  ATP+KLA
 NM_029810 5-nucleotidase, cytosolic II (Nt5c2), mRNA [NM_029810] KLA .68 .66 .66 .62 .73 1.00 .79
ATP .98 1.02 1.06 .95 .65 .73 1.16
KLA/ATP .66 .68 .67 .61 .57 .80 1.07
Nt5c3
KLA  ATP  ATP+KLA
 NM_026004 5-nucleotidase, cytosolic III (Nt5c3), mRNA [NM_026004] KLA 19.31 19.80 19.18 17.01 11.84 11.21 4.96
ATP .98 .97 1.14 1.55 2.72 4.79 2.27
KLA/ATP 18.71 19.81 24.58 21.68 18.82 17.51 13.49
Nt5c3l
KLA  ATP  ATP+KLA
 NM_026561 5-nucleotidase, cytosolic III-like (Nt5c3l), transcript variant 2, mRNA [NM_026561] KLA .94 .91 .95 .90 .80 .79 .91
ATP .94 1.07 1.12 1.08 .86 .71 .87
KLA/ATP .97 .97 .88 .97 .83 .77 .67
Nt5e
KLA  ATP  ATP+KLA
 NM_011851 5 nucleotidase, ecto (Nt5e), mRNA [NM_011851] KLA .96 1.02 1.00 .95 1.00 .99 .99
ATP .98 .99 1.05 1.02 1.04 1.03 1.11
KLA/ATP .97 .99 .96 .95 .96 .99 1.04
Nt5m
KLA  ATP  ATP+KLA
 NM_134029 5,3-nucleotidase, mitochondrial (Nt5m), nuclear gene encoding mitochondrial protein, mRNA [NM_134029] KLA .73 .78 .92 1.14 1.54 2.01 1.80
ATP 1.02 1.06 .94 1.05 .73 .63 1.43
KLA/ATP .73 .76 .74 .85 .77 .87 1.50
Oat
KLA  ATP  ATP+KLA
 NM_016978 ornithine aminotransferase (Oat), nuclear gene encoding mitochondrial protein, mRNA [NM_016978] KLA .79 .83 .76 .68 .61 .53 .63
ATP .97 1.07 1.07 1.30 1.14 .98 .67
KLA/ATP .78 .85 .82 .97 .92 .82 .38
Ocrl
KLA  ATP  ATP+KLA
 NM_177215 oculocerebrorenal syndrome of Lowe (Ocrl), mRNA [NM_177215] KLA .99 .89 .92 .90 .90 1.11 1.10
ATP 1.02 1.03 1.17 .91 .65 .58 1.04
KLA/ATP .93 .90 .90 .75 .58 .54 .81
Odc1
KLA  ATP  ATP+KLA
 NM_013614 ornithine decarboxylase, structural 1 (Odc1), mRNA [NM_013614] KLA 2.10 1.85 1.51 1.36 1.07 .99 .71
ATP 1.15 1.53 4.90 11.04 12.87 14.66 2.00
KLA/ATP 2.01 1.77 3.11 5.19 5.52 7.17 4.50
Ogdh
KLA  ATP  ATP+KLA
 NM_010956 oxoglutarate dehydrogenase (lipoamide) (Ogdh), nuclear gene encoding mitochondrial protein, mRNA [NM_010956] KLA 1.00 1.05 1.10 .95 1.06 1.08 1.30
ATP 1.10 1.28 .95 1.23 .93 1.15 1.82
KLA/ATP 1.27 1.11 .81 1.21 .76 1.13 1.83
Ogdhl
KLA  ATP  ATP+KLA
 NM_001081130 oxoglutarate dehydrogenase-like (Ogdhl), mRNA [NM_001081130] KLA 1.03 1.07 1.03 1.02 1.00 .97 .91
ATP .94 .99 .98 .99 .93 .99 1.01
KLA/ATP .97 1.02 1.03 .93 .95 .90 1.04
Olah
KLA  ATP  ATP+KLA
 NM_145921 oleoyl-ACP hydrolase (Olah), mRNA [NM_145921] KLA 1.09 1.08 .99 1.00 .96 1.07 1.10
ATP .93 1.00 1.07 1.07 1.00 1.02 1.01
KLA/ATP 1.03 1.03 1.01 .97 .99 1.02 .94
Otc
KLA  ATP  ATP+KLA
 BC024893 ornithine transcarbamylase, mRNA (cDNA clone MGC:28946 IMAGE:4196455), complete cds [BC024893] KLA 1.00 1.00 .92 1.03 .95 .98 1.00
ATP 1.05 .95 1.03 1.01 .96 1.05 .99
KLA/ATP .97 .99 .95 1.05 .92 1.00 1.01
Otc
KLA  ATP  ATP+KLA
 NM_008769 ornithine transcarbamylase (Otc), mRNA [NM_008769] KLA 1.01 .98 .99 1.00 .99 .96 1.02
ATP 1.04 1.01 1.02 1.01 1.00 .94 .94
KLA/ATP .96 1.07 1.01 1.00 .95 1.00 .97
Oxsm
KLA  ATP  ATP+KLA
 NM_027695 3-oxoacyl-ACP synthase, mitochondrial (Oxsm), nuclear gene encoding mitochondrial protein, mRNA [NM_027695] KLA 1.05 1.03 1.11 1.27 1.24 1.26 1.18
ATP .94 .81 .79 .56 .47 1.05 1.43
KLA/ATP .99 .98 .95 .76 .59 .84 1.27
P4ha1
KLA  ATP  ATP+KLA
 NM_011030 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide (P4ha1), mRNA [NM_011030] KLA 2.27 2.54 2.62 2.46 2.70 2.58 2.03
ATP 1.02 1.17 1.08 1.56 1.19 1.14 1.50
KLA/ATP 2.57 2.65 2.34 3.34 2.23 2.21 2.25
P4ha2
KLA  ATP  ATP+KLA
 AK053504 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130103J11 product:procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide, full insert sequence. [AK053504] KLA .98 .99 .96 1.00 1.00 .96 .99
ATP 1.03 1.03 1.00 1.00 1.12 1.01 .99
KLA/ATP .97 1.00 .93 .96 1.01 .94 .97
P4ha2
KLA  ATP  ATP+KLA
 NM_011031 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide (P4ha2), mRNA [NM_011031] KLA .79 .75 .66 .63 .42 .33 .31
ATP .88 .90 1.30 1.08 1.25 1.92 .52
KLA/ATP .67 .77 .97 .79 .99 1.07 .55
P4ha3
KLA  ATP  ATP+KLA
 NM_177161 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide III (P4ha3), mRNA [NM_177161] KLA 1.12 1.03 .98 .97 1.00 .99 1.01
ATP 1.03 1.00 1.08 1.00 1.02 .95 1.05
KLA/ATP .94 .95 1.06 .99 .94 .98 1.06
Pafah1b1
KLA  ATP  ATP+KLA
 AK147229 cDNA, RIKEN full-length enriched library, clone:M421028C14 product:platelet-activating factor acetylhydrolase, isoform 1b, beta1 subunit, full insert sequence [AK147229] KLA .96 .98 .98 1.06 1.15 1.11 1.14
ATP 1.37 1.70 1.99 1.78 1.62 1.20 1.11
KLA/ATP 1.44 1.62 1.71 1.45 1.48 1.12 1.21
Pafah1b1
KLA  ATP  ATP+KLA
 NM_013625 platelet-activating factor acetylhydrolase, isoform 1b, beta1 subunit (Pafah1b1), mRNA [NM_013625] KLA .91 .87 .93 .99 1.14 1.21 1.00
ATP 1.00 1.18 1.06 .73 .96 .65 .40
KLA/ATP .82 .80 .87 .71 1.10 .90 .41
Pafah1b2
KLA  ATP  ATP+KLA
 NM_008775 platelet-activating factor acetylhydrolase, isoform 1b, alpha2 subunit (Pafah1b2), mRNA [NM_008775] KLA 1.71 1.86 1.93 1.95 2.18 1.98 1.74
ATP 1.10 1.18 1.04 1.04 1.16 1.73 1.68
KLA/ATP 1.82 1.83 1.66 1.81 1.60 1.70 1.90
Pafah1b3
KLA  ATP  ATP+KLA
 NM_008776 platelet-activating factor acetylhydrolase, isoform 1b, alpha1 subunit (Pafah1b3), mRNA [NM_008776] KLA .87 .90 .84 .76 .75 .62 .71
ATP 1.05 1.14 1.00 1.24 .98 .69 1.00
KLA/ATP .91 .91 .80 1.02 .83 .64 .83
Pafah2
KLA  ATP  ATP+KLA
 NM_133880 platelet-activating factor acetylhydrolase 2 (Pafah2), mRNA [NM_133880] KLA .66 .65 .67 .62 .59 .62 .81
ATP 1.07 .90 .68 .48 .56 .91 .78
KLA/ATP .75 .59 .52 .39 .44 .46 .50
Pah
KLA  ATP  ATP+KLA
 NM_008777 phenylalanine hydroxylase (Pah), mRNA [NM_008777] KLA .99 .93 1.06 .99 1.01 .99 .98
ATP 1.09 1.02 .99 .95 .97 .98 .99
KLA/ATP .97 .93 .97 .95 .95 1.00 .87
Paics
KLA  ATP  ATP+KLA
 NM_025939 phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase (Paics), mRNA [NM_025939] KLA .75 .84 .85 .62 .60 .40 .50
ATP 1.09 1.19 1.06 1.27 .94 .40 .38
KLA/ATP .87 .90 .69 .95 .57 .34 .22
Pank1
KLA  ATP  ATP+KLA
 AK019493 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632412I06 product:hypothetical protein, full insert sequence. [AK019493] KLA .98 .91 .95 .97 .98 .95 .91
ATP .96 1.04 1.05 .96 1.01 1.01 1.04
KLA/ATP .95 1.05 .96 .97 .96 .96 .96
Pank1
KLA  ATP  ATP+KLA
 NM_023792 pantothenate kinase 1 (Pank1), transcript variant 2, mRNA [NM_023792] KLA .47 .50 .46 .55 .39 .35 .42
ATP 1.02 1.06 1.11 1.02 .57 .50 .58
KLA/ATP .48 .44 .56 .59 .48 .38 .34
Pank2
KLA  ATP  ATP+KLA
 NM_153501 pantothenate kinase 2 (Hallervorden-Spatz syndrome) (Pank2), nuclear gene encoding mitochondrial protein, mRNA [NM_153501] KLA 1.16 1.22 1.28 1.19 1.14 1.16 1.25
ATP .97 1.03 1.01 1.01 .73 1.08 1.92
KLA/ATP 1.14 1.16 1.14 1.36 1.03 1.19 2.04
Pank3
KLA  ATP  ATP+KLA
 NM_145962 pantothenate kinase 3 (Pank3), mRNA [NM_145962] KLA 1.08 1.11 .96 .82 .72 .58 .67
ATP 1.10 1.15 1.34 1.53 1.31 .98 .94
KLA/ATP 1.13 1.23 1.10 1.19 1.11 .73 .60
Pank4
KLA  ATP  ATP+KLA
 NM_172990 pantothenate kinase 4 (Pank4), mRNA [NM_172990] KLA .86 .90 .86 .79 .95 .87 1.14
ATP 1.01 1.02 1.07 1.06 1.17 .94 .86
KLA/ATP .83 .85 .99 .92 1.15 .90 .75
Papss1
KLA  ATP  ATP+KLA
 NM_011863 3-phosphoadenosine 5-phosphosulfate synthase 1 (Papss1), mRNA [NM_011863] KLA .86 .95 .84 .89 .77 .70 .81
ATP .99 1.02 1.06 1.10 .74 .64 .75
KLA/ATP .93 .89 .86 .93 .68 .56 .69
Papss2
KLA  ATP  ATP+KLA
 AK029185 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831410G12 product:3-phosphoadenosine 5-phosphosulfate synthase 2, full insert sequence. [AK029185] KLA 1.04 1.07 .97 .95 1.08 1.07 .94
ATP .96 1.01 1.00 1.02 .96 1.01 .97
KLA/ATP .99 1.01 1.02 1.11 1.01 .98 1.02
Papss2
KLA  ATP  ATP+KLA
 NM_011864 3-phosphoadenosine 5-phosphosulfate synthase 2 (Papss2), mRNA [NM_011864] KLA 1.72 1.84 1.85 1.50 1.56 1.01 1.14
ATP 1.07 1.14 1.07 1.00 1.19 1.75 1.07
KLA/ATP 1.64 1.73 1.57 1.58 1.46 1.54 1.10
Pcca
KLA  ATP  ATP+KLA
 NM_144844 propionyl-Coenzyme A carboxylase, alpha polypeptide (Pcca), mRNA [NM_144844] KLA 1.00 1.07 1.11 1.16 1.07 1.01 .68
ATP .90 .97 1.10 1.14 .93 .53 .60
KLA/ATP .99 1.12 1.16 1.19 .84 .59 .56
Pccb
KLA  ATP  ATP+KLA
 NM_025835 propionyl Coenzyme A carboxylase, beta polypeptide (Pccb), mRNA [NM_025835] KLA .76 .77 .67 .65 .45 .41 .42
ATP .97 1.12 .94 1.15 .90 .51 .37
KLA/ATP .83 .82 .80 .88 .65 .46 .28
Pck2
KLA  ATP  ATP+KLA
 NM_028994 phosphoenolpyruvate carboxykinase 2 (mitochondrial) (Pck2), nuclear gene encoding mitochondrial protein, mRNA [NM_028994] KLA .40 .37 .32 .28 .37 .56 .55
ATP .99 .96 .86 .94 1.02 .57 .77
KLA/ATP .40 .37 .31 .35 .42 .35 .46
Pcx
KLA  ATP  ATP+KLA
 NM_008797 pyruvate carboxylase (Pcx), nuclear gene encoding mitochondrial protein, mRNA [NM_008797] KLA 1.28 1.34 1.44 1.30 1.34 1.23 .91
ATP 1.11 1.09 1.19 1.29 1.19 1.49 1.16
KLA/ATP 1.34 1.41 1.63 1.53 1.39 1.05 1.15
Pcyt1a
KLA  ATP  ATP+KLA
 AK163685 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930020C23 product:phosphate cytidylyltransferase 1, choline, alpha isoform, full insert sequence [AK163685] KLA .63 .65 .76 .82 .87 1.04 .67
ATP 1.00 1.10 .81 1.07 2.85 1.72 1.60
KLA/ATP .64 .63 .48 .97 2.62 2.63 1.66
Pcyt1a
KLA  ATP  ATP+KLA
 NM_009981 phosphate cytidylyltransferase 1, choline, alpha isoform (Pcyt1a), mRNA [NM_009981] KLA .67 .77 .90 .96 .99 1.16 .81
ATP .93 1.04 .85 1.22 2.93 1.57 1.91
KLA/ATP .72 .73 .82 1.17 2.79 2.47 1.62
Pcyt1b
KLA  ATP  ATP+KLA
 NM_211138 phosphate cytidylyltransferase 1, choline, beta isoform (Pcyt1b), transcript variant 1, mRNA [NM_211138] KLA .91 .84 .85 .88 .85 .79 .65
ATP 1.04 1.05 .96 .91 .82 .81 .68
KLA/ATP .86 .84 .87 .87 .82 .78 .59
Pcyt2
KLA  ATP  ATP+KLA
 NM_024229 phosphate cytidylyltransferase 2, ethanolamine (Pcyt2), mRNA [NM_024229] KLA .58 .57 .56 .46 .50 .42 .54
ATP .98 .94 1.04 .99 .71 .66 1.11
KLA/ATP .59 .59 .60 .54 .43 .35 .45
Pdha1
KLA  ATP  ATP+KLA
 NM_008810 pyruvate dehydrogenase E1 alpha 1 (Pdha1), nuclear gene encoding mitochondrial protein, mRNA [NM_008810] KLA .92 .96 .94 .92 .94 1.04 1.18
ATP .98 1.03 1.14 1.10 1.02 1.05 .91
KLA/ATP .93 .93 .97 .94 .81 .82 .69
Pdha2
KLA  ATP  ATP+KLA
 NM_008811 pyruvate dehydrogenase E1 alpha 2 (Pdha2), mRNA [NM_008811] KLA 1.04 .95 .98 .99 1.00 1.04 .98
ATP 1.00 .97 .95 1.00 1.01 .99 1.01
KLA/ATP 1.05 1.07 .91 1.02 .98 1.00 1.05
Pdhb
KLA  ATP  ATP+KLA
 NM_024221 pyruvate dehydrogenase (lipoamide) beta (Pdhb), mRNA [NM_024221] KLA 1.14 1.05 1.00 .97 1.03 .90 .88
ATP 1.08 1.10 1.12 1.23 1.24 1.24 1.21
KLA/ATP 1.01 1.16 1.13 1.21 1.23 1.44 1.26
Pdhx
KLA  ATP  ATP+KLA
 NM_175094 pyruvate dehydrogenase complex, component X (Pdhx), nuclear gene encoding mitochondrial protein, mRNA [NM_175094] KLA 1.15 1.12 1.12 1.12 1.07 1.14 1.12
ATP 1.04 1.02 1.14 .94 1.03 1.30 .98
KLA/ATP 1.25 1.20 1.26 1.05 1.08 1.38 .89
Pdxk
KLA  ATP  ATP+KLA
 NM_172134 pyridoxal (pyridoxine, vitamin B6) kinase (Pdxk), mRNA [NM_172134] KLA .40 .38 .31 .27 .21 .31 .50
ATP 1.01 .97 .93 1.01 1.12 .64 2.00
KLA/ATP .41 .38 .32 .38 .74 .80 .80
Pdxp
KLA  ATP  ATP+KLA
 NM_020271 pyridoxal (pyridoxine, vitamin B6) phosphatase (Pdxp), mRNA [NM_020271] KLA .59 .51 .55 .70 1.07 .99 .86
ATP 1.07 1.21 1.26 1.10 .57 .70 .58
KLA/ATP .58 .56 .69 .61 .89 .62 .66
Pemt
KLA  ATP  ATP+KLA
 NM_008819 phosphatidylethanolamine N-methyltransferase (Pemt), nuclear gene encoding mitochondrial protein, mRNA [NM_008819] KLA 1.00 1.08 1.08 .99 .92 .83 .93
ATP 1.08 1.16 1.04 1.22 1.02 .89 .84
KLA/ATP 1.14 1.10 .92 1.05 .83 .76 .71
Pfkl
KLA  ATP  ATP+KLA
 NM_008826 phosphofructokinase, liver, B-type (Pfkl), mRNA [NM_008826] KLA 1.19 1.33 1.34 1.23 1.57 1.49 2.02
ATP 1.17 1.34 1.04 1.45 .92 1.53 .97
KLA/ATP 1.54 1.64 1.36 1.91 1.17 .89 1.61
Pfkm
KLA  ATP  ATP+KLA
 NM_021514 phosphofructokinase, muscle (Pfkm), mRNA [NM_021514] KLA .73 .74 .70 .88 .80 .61 .55
ATP 1.09 1.05 1.01 1.06 .80 .50 .52
KLA/ATP .76 .83 .86 .75 .57 .57 .46
Pfkp
KLA  ATP  ATP+KLA
 BC050264 gb|Mus musculus, clone IMAGE:4503748, mRNA [BC050264] KLA 4.07 3.58 3.25 2.41 1.31 .76 .81
ATP 1.26 1.26 2.77 2.20 4.63 2.57 4.92
KLA/ATP 4.81 4.66 8.95 3.50 3.96 1.60 .91
Pfkp
KLA  ATP  ATP+KLA
 NM_019703 phosphofructokinase, platelet (Pfkp), mRNA [NM_019703] KLA 1.94 1.99 2.15 2.05 1.90 1.20 .85
ATP 1.08 1.05 1.18 1.20 1.40 1.38 .93
KLA/ATP 1.94 2.12 2.35 2.26 1.91 1.36 .88
Pgam1
KLA  ATP  ATP+KLA
 NM_023418 phosphoglycerate mutase 1 (Pgam1), mRNA [NM_023418] KLA .71 .69 .75 .85 .89 .84 1.30
ATP 1.02 1.10 1.00 .99 1.47 2.02 1.36
KLA/ATP .83 .83 .74 .76 1.24 1.73 1.11
Pgam2
KLA  ATP  ATP+KLA
 NM_018870 phosphoglycerate mutase 2 (Pgam2), mRNA [NM_018870] KLA .99 1.05 1.11 1.10 1.10 1.14 1.30
ATP 1.09 1.08 1.17 1.17 1.31 1.63 1.18
KLA/ATP 1.07 1.08 1.06 1.09 1.27 1.42 1.13
Pgap1
KLA  ATP  ATP+KLA
 AK033485 adult male colon cDNA, RIKEN full-length enriched library, clone:9030223K07 product:unclassifiable, full insert sequence. [AK033485] KLA .77 .76 .70 .72 .59 .60 1.13
ATP .92 1.04 1.03 .84 1.04 .78 .42
KLA/ATP .68 .76 .86 .69 1.00 .78 .84
Pgap1
KLA  ATP  ATP+KLA
 AK051360 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130039I04 product:hypothetical protein, full insert sequence [AK051360] KLA 1.03 1.03 1.03 1.08 1.02 1.03 1.13
ATP 1.06 1.09 .88 .90 1.02 .99 .99
KLA/ATP 1.00 .99 .91 .93 .99 .97 1.13
Pgd
KLA  ATP  ATP+KLA
 NM_001081274 phosphogluconate dehydrogenase (Pgd), mRNA [NM_001081274] KLA .91 .94 .94 .76 .80 .67 .93
ATP 1.11 1.22 .84 .96 1.20 1.82 1.59
KLA/ATP 1.01 1.10 .79 .90 .83 1.30 1.75
Pgk1
KLA  ATP  ATP+KLA
 NM_008828 phosphoglycerate kinase 1 (Pgk1), mRNA [NM_008828] KLA .98 1.04 1.04 .99 1.01 1.03 1.16
ATP 1.00 .94 .70 .64 .79 1.34 1.54
KLA/ATP 1.02 .96 .80 .72 .70 .90 1.24
Pgk2
KLA  ATP  ATP+KLA
 NM_031190 phosphoglycerate kinase 2 (Pgk2), mRNA [NM_031190] KLA .96 .97 .96 1.08 .96 1.01 .98
ATP .98 .98 1.07 1.03 1.03 1.00 1.00
KLA/ATP 1.01 1.04 1.02 .95 1.05 .98 1.04
Pgls
KLA  ATP  ATP+KLA
 NM_025396 6-phosphogluconolactonase (Pgls), mRNA [NM_025396] KLA .82 .84 .72 .74 .68 .58 .74
ATP 1.08 1.13 .94 1.33 1.06 .66 .59
KLA/ATP .94 .94 .81 .97 .72 .54 .46
Pgm1
KLA  ATP  ATP+KLA
 NM_025700 phosphoglucomutase 1 (Pgm1), mRNA [NM_025700] KLA 1.08 1.03 .95 .75 .59 .55 .73
ATP 1.02 1.23 1.22 1.42 1.07 .75 1.01
KLA/ATP 1.01 1.10 .84 1.12 .69 .61 .51
Pgm2
KLA  ATP  ATP+KLA
 NM_028132 phosphoglucomutase 2 (Pgm2), mRNA [NM_028132] KLA 1.13 1.21 1.26 1.48 1.52 1.81 1.81
ATP .90 .92 1.07 .99 .80 1.60 1.17
KLA/ATP 1.01 1.16 1.40 1.25 1.48 1.99 1.94
Pgs1
KLA  ATP  ATP+KLA
 NM_133757 phosphatidylglycerophosphate synthase 1 (Pgs1), mRNA [NM_133757] KLA 2.65 2.70 2.52 2.72 2.54 2.28 1.89
ATP .97 .98 1.06 1.17 1.57 2.20 1.91
KLA/ATP 2.60 2.62 2.92 2.95 2.95 2.64 2.37
Phgdh
KLA  ATP  ATP+KLA
 NM_016966 3-phosphoglycerate dehydrogenase (Phgdh), mRNA [NM_016966] KLA 1.06 1.11 .97 .89 .82 .80 .91
ATP 1.02 1.03 1.17 1.33 3.31 3.86 .74
KLA/ATP 1.07 1.06 1.15 1.38 1.78 1.84 .40
Phospho1
KLA  ATP  ATP+KLA
 NM_153104 phosphatase, orphan 1 (Phospho1), mRNA [NM_153104] KLA .99 1.04 1.04 1.14 1.01 1.15 1.21
ATP .95 1.01 .99 1.05 1.11 1.22 1.42
KLA/ATP 1.04 1.02 1.05 1.11 1.01 1.45 1.40
Phospho2
KLA  ATP  ATP+KLA
 AK010147 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310074E15 product:unclassifiable, full insert sequence. [AK010147] KLA 1.03 1.02 1.06 .98 .98 1.00 1.04
ATP 1.08 .99 .96 1.05 1.02 1.03 1.03
KLA/ATP 1.01 .97 .97 .97 1.04 1.02 .93
Phospho2
KLA  ATP  ATP+KLA
 NM_028521 phosphatase, orphan 2 (Phospho2), mRNA [NM_028521] KLA 1.87 2.00 2.27 1.79 1.77 1.97 1.43
ATP 1.03 1.03 1.11 .97 1.82 2.55 1.88
KLA/ATP 1.95 2.13 1.70 1.94 2.10 3.72 2.83
Pi4k2a
KLA  ATP  ATP+KLA
 NM_145501 phosphatidylinositol 4-kinase type 2 alpha (Pi4k2a), mRNA [NM_145501] KLA 1.89 1.83 2.04 2.30 2.46 2.05 1.32
ATP .95 .93 .93 .89 1.73 1.92 1.92
KLA/ATP 1.74 1.80 1.76 1.87 2.87 3.06 2.17
Pi4k2b
KLA  ATP  ATP+KLA
 NM_025951 phosphatidylinositol 4-kinase type 2 beta (Pi4k2b), transcript variant 1, mRNA [NM_025951] KLA 2.43 2.74 2.72 2.24 1.73 1.50 1.40
ATP 1.05 1.21 1.09 1.18 2.83 2.89 1.13
KLA/ATP 2.57 2.54 2.01 2.52 3.67 3.33 1.88
Pi4k2b
KLA  ATP  ATP+KLA
 NM_028744 phosphatidylinositol 4-kinase type 2 beta (Pi4k2b), transcript variant 2, mRNA [NM_028744] KLA 1.95 2.36 2.66 2.48 2.11 1.86 1.76
ATP 1.03 1.13 1.13 1.26 2.32 3.45 1.82
KLA/ATP 2.20 2.30 1.94 2.27 2.45 3.17 3.44
Pi4ka
KLA  ATP  ATP+KLA
 NM_001001983 phosphatidylinositol 4-kinase, catalytic, alpha polypeptide (Pi4ka), mRNA [NM_001001983] KLA 1.06 1.04 1.08 1.09 1.10 .94 .79
ATP 1.02 .99 1.06 .85 1.13 .82 .96
KLA/ATP 1.06 1.02 1.20 .90 1.27 .93 .56
Pi4kb
KLA  ATP  ATP+KLA
 NM_175356 phosphatidylinositol 4-kinase, catalytic, beta polypeptide (Pi4kb), mRNA [NM_175356] KLA .96 .93 .97 1.08 1.24 1.40 1.15
ATP 1.22 1.22 1.14 1.46 1.44 1.15 1.67
KLA/ATP 1.18 1.13 .93 1.19 1.22 1.46 1.18
Pib5pa
KLA  ATP  ATP+KLA
 NM_172439 phosphatidylinositol (4,5) bisphosphate 5-phosphatase, A (Pib5pa), mRNA [NM_172439] KLA 1.02 .98 .92 1.00 .93 .94 1.06
ATP 1.02 1.13 .96 1.00 .95 .89 1.21
KLA/ATP .95 1.00 .90 .91 .88 .93 1.85
Piga
KLA  ATP  ATP+KLA
 NM_011081 phosphatidylinositol glycan anchor biosynthesis, class A (Piga), mRNA [NM_011081] KLA .93 .84 .81 .79 .69 .72 .89
ATP .95 .86 1.11 .77 .86 1.94 1.15
KLA/ATP .87 .77 .98 .63 .81 1.70 1.20
Pigb
KLA  ATP  ATP+KLA
 NM_018889 phosphatidylinositol glycan anchor biosynthesis, class B (Pigb), mRNA [NM_018889] KLA .89 .93 .93 .89 .99 .93 1.23
ATP 1.00 1.04 1.01 1.04 .82 .77 1.16
KLA/ATP .98 1.00 .85 .91 .81 .81 1.02
Pigc
KLA  ATP  ATP+KLA
 NM_026078 phosphatidylinositol glycan anchor biosynthesis, class C (Pigc), transcript variant 1, mRNA [NM_026078] KLA .80 .76 .78 .91 .94 1.11 1.05
ATP 1.04 .86 1.04 .77 .61 1.12 1.21
KLA/ATP .77 .72 .88 .58 .61 .72 1.16
Pigf
KLA  ATP  ATP+KLA
 NM_008838 phosphatidylinositol glycan anchor biosynthesis, class F (Pigf), mRNA [NM_008838] KLA 1.12 1.19 1.19 1.29 1.01 .87 .97
ATP .94 .96 1.47 1.40 1.17 1.12 .93
KLA/ATP 1.02 1.14 1.63 1.40 1.37 1.24 .75
Pigh
KLA  ATP  ATP+KLA
 NM_029988 phosphatidylinositol glycan anchor biosynthesis, class H (Pigh), mRNA [NM_029988] KLA .77 .84 .83 .83 .88 1.09 1.34
ATP .92 .93 .91 .90 .59 .61 1.20
KLA/ATP .71 .73 .70 .68 .60 .67 1.09
Pigk
KLA  ATP  ATP+KLA
 NM_178016 phosphatidylinositol glycan anchor biosynthesis, class K (Pigk), transcript variant 2, mRNA [NM_178016] KLA 1.23 1.40 1.38 1.35 1.21 1.09 1.30
ATP 1.02 1.03 1.15 1.32 1.11 .87 1.12
KLA/ATP 1.33 1.45 1.50 1.59 1.20 .88 .80
Pigl
KLA  ATP  ATP+KLA
 NM_001039536 phosphatidylinositol glycan anchor biosynthesis, class L (Pigl), mRNA [NM_001039536] KLA 1.15 1.24 1.19 1.07 1.29 1.27 1.91
ATP 1.05 1.24 1.09 1.17 .86 .88 1.83
KLA/ATP 1.21 1.18 .93 1.17 .87 .98 1.64
Pigm
KLA  ATP  ATP+KLA
 NM_026234 phosphatidylinositol glycan anchor biosynthesis, class M (Pigm), mRNA [NM_026234] KLA 1.13 1.22 1.28 1.15 1.20 1.10 1.16
ATP .99 1.04 .99 .98 .79 1.01 1.15
KLA/ATP 1.22 1.19 1.07 1.03 .80 .98 1.13
Pign
KLA  ATP  ATP+KLA
 AK082387 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230045A22 product:phosphatidylinositol glycan, class N, full insert sequence. [AK082387] KLA 1.05 .98 .94 1.00 .96 1.00 1.00
ATP .98 1.02 1.03 1.07 .95 .95 .93
KLA/ATP 1.06 1.01 1.01 1.02 .94 .97 1.03
Pign
KLA  ATP  ATP+KLA
 NM_013784 phosphatidylinositol glycan anchor biosynthesis, class N (Pign), mRNA [NM_013784] KLA 1.59 1.62 1.78 1.81 2.02 2.07 2.03
ATP 1.00 1.01 1.16 1.07 .95 1.29 1.37
KLA/ATP 1.58 1.75 1.75 1.40 1.16 1.29 1.65
Pigo
KLA  ATP  ATP+KLA
 NM_020035 phosphatidylinositol glycan anchor biosynthesis, class O (Pigo), mRNA [NM_020035] KLA .86 .89 .91 .80 .98 .90 1.17
ATP 1.07 1.10 .93 .95 .78 .90 1.61
KLA/ATP .94 .89 .77 .75 .66 1.00 1.65
Pigp
KLA  ATP  ATP+KLA
 NM_019543 phosphatidylinositol glycan anchor biosynthesis, class P (Pigp), mRNA [NM_019543] KLA .89 .83 .83 .84 .69 .64 .82
ATP .89 .84 1.33 1.23 .96 .60 .82
KLA/ATP .80 .83 1.01 1.02 .89 .61 .55
Pigq
KLA  ATP  ATP+KLA
 NM_011822 phosphatidylinositol glycan anchor biosynthesis, class Q (Pigq), mRNA [NM_011822] KLA .76 .86 .83 .76 .89 .88 .89
ATP 1.10 1.14 .89 .98 .72 .55 1.34
KLA/ATP .92 .83 .59 .78 .54 .61 1.01
Pigs
KLA  ATP  ATP+KLA
 NM_201406 phosphatidylinositol glycan anchor biosynthesis, class S (Pigs), mRNA [NM_201406] KLA .85 .81 .80 .82 .77 .73 .88
ATP 1.02 1.11 1.06 1.11 .88 .70 .94
KLA/ATP .89 .92 .82 .81 .56 .62 .93
Pigt
KLA  ATP  ATP+KLA
 NM_133779 phosphatidylinositol glycan anchor biosynthesis, class T (Pigt), mRNA [NM_133779] KLA 1.04 1.13 1.03 1.02 1.03 1.14 1.19
ATP 1.02 1.22 .89 1.09 .90 .82 .93
KLA/ATP 1.14 1.30 .86 1.06 .78 .87 .90
Pigu
KLA  ATP  ATP+KLA
 NM_001004721 phosphatidylinositol glycan anchor biosynthesis, class U (Pigu), mRNA [NM_001004721] KLA 1.05 1.10 1.07 .96 1.06 1.02 1.23
ATP 1.09 1.26 1.21 1.42 .99 .87 1.05
KLA/ATP 1.15 1.18 .98 1.28 .90 .83 1.05
Pigv
KLA  ATP  ATP+KLA
 NM_178698 phosphatidylinositol glycan anchor biosynthesis, class V (Pigv), mRNA [NM_178698] KLA 1.14 1.18 1.11 1.20 1.20 1.07 1.04
ATP 1.04 1.11 .98 .96 .91 1.06 .99
KLA/ATP 1.25 1.20 1.09 .98 1.00 .93 1.02
Pigw
KLA  ATP  ATP+KLA
 NM_027388 phosphatidylinositol glycan anchor biosynthesis, class W (Pigw), transcript variant 1, mRNA [NM_027388] KLA .87 .90 .79 .81 .80 .89 1.13
ATP .97 .97 .99 .84 .74 .87 1.12
KLA/ATP .78 .85 .87 .85 .81 .74 .88
Pigx
KLA  ATP  ATP+KLA
 NM_024464 phosphatidylinositol glycan anchor biosynthesis, class X (Pigx), transcript variant 1, mRNA [NM_024464] KLA 1.02 1.04 .99 .96 .94 .98 1.06
ATP .99 1.02 1.16 1.20 1.26 1.15 1.19
KLA/ATP .96 1.08 1.04 1.16 1.06 1.04 1.45
Pik3c2a
KLA  ATP  ATP+KLA
 AK013614 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900035A08 product:phosphatidylinositol 3-kinase, C2 domain containing, alpha polypeptide, full insert sequence. [AK013614] KLA .74 .78 .79 .84 .92 .94 1.06
ATP 1.06 .97 1.01 .84 .84 1.01 1.21
KLA/ATP .75 .70 .74 .76 .80 .88 1.15
Pik3c2a
KLA  ATP  ATP+KLA
 NM_011083 phosphatidylinositol 3-kinase, C2 domain containing, alpha polypeptide (Pik3c2a), mRNA [NM_011083] KLA .77 .75 .74 .86 .90 .93 1.10
ATP 1.20 1.37 1.39 1.09 1.24 1.48 1.18
KLA/ATP .82 .77 .84 1.03 .95 1.28 1.34
Pik3c2g
KLA  ATP  ATP+KLA
 NM_207683 phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide (Pik3c2g), transcript variant 1, mRNA [NM_207683] KLA 1.06 1.04 1.07 1.03 1.00 1.06 1.07
ATP 1.04 1.02 1.06 1.00 .98 .98 .97
KLA/ATP 1.06 1.02 1.01 1.03 1.02 1.04 1.07
Pik3c3
KLA  ATP  ATP+KLA
 NM_181414 phosphoinositide-3-kinase, class 3 (Pik3c3), mRNA [NM_181414] KLA .85 .82 .90 .91 .99 1.01 .87
ATP .92 1.02 .97 1.08 .60 .82 .87
KLA/ATP .80 .86 .79 .90 .66 .94 .92
Pip5k1a
KLA  ATP  ATP+KLA
 NM_008847 phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha (Pip5k1a), mRNA [NM_008847] KLA 1.99 1.84 1.66 1.49 1.49 1.37 1.57
ATP 1.05 1.06 .89 1.54 4.20 2.72 1.58
KLA/ATP 1.95 1.90 1.55 1.60 3.26 2.64 2.25
Pip5k1b
KLA  ATP  ATP+KLA
 NM_008846 phosphatidylinositol-4-phosphate 5-kinase, type 1 beta (Pip5k1b), mRNA [NM_008846] KLA 1.24 1.35 1.11 .92 .57 .72 .86
ATP .86 1.00 .96 1.15 .85 .74 .89
KLA/ATP 1.20 1.22 .97 1.00 .78 .76 1.06
Pip5k1c
KLA  ATP  ATP+KLA
 BC094665 phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma, mRNA (cDNA clone MGC:102155 IMAGE:30356181), complete cds [BC094665] KLA .82 .90 .90 .70 .96 .86 1.21
ATP 1.19 1.45 .92 1.64 1.17 .83 1.33
KLA/ATP .97 1.21 .66 1.20 .91 .92 1.69
Pip5k1c
KLA  ATP  ATP+KLA
 NM_008844 phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma (Pip5k1c), mRNA [NM_008844] KLA 1.40 1.36 1.38 1.39 1.30 1.30 1.27
ATP 1.01 1.16 1.12 1.46 1.38 1.35 1.21
KLA/ATP 1.39 1.44 1.44 1.64 1.41 1.45 1.53
Pip5kl1
KLA  ATP  ATP+KLA
 NM_198191 phosphatidylinositol-4-phosphate 5-kinase-like 1 (Pip5kl1), mRNA [NM_198191] KLA .99 .97 .96 1.03 1.01 1.04 1.02
ATP .98 .92 .97 1.63 2.17 1.17 .99
KLA/ATP 1.05 1.00 1.10 1.19 1.24 1.27 1.06
Pipox
KLA  ATP  ATP+KLA
 NM_008952 pipecolic acid oxidase (Pipox), mRNA [NM_008952] KLA .97 .94 1.00 1.00 .98 1.06 1.01
ATP 1.04 1.01 1.03 1.03 1.06 .93 1.01
KLA/ATP 1.03 1.12 1.07 1.06 .98 1.07 .97
Pisd
KLA  ATP  ATP+KLA
 NM_177298 phosphatidylserine decarboxylase (Pisd), mRNA [NM_177298] KLA .71 .66 .72 .80 .95 .98 1.03
ATP 1.00 .89 .79 .67 .96 1.16 .99
KLA/ATP .69 .65 .58 .58 .90 1.12 .99
Pklr
KLA  ATP  ATP+KLA
 NM_013631 pyruvate kinase liver and red blood cell (Pklr), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_013631] KLA 1.06 1.01 1.12 1.00 .98 1.01 1.07
ATP .98 .94 1.05 1.06 1.01 1.06 1.10
KLA/ATP .97 1.00 1.04 .95 .89 1.05 .97
Pkm2
KLA  ATP  ATP+KLA
 D38379 mRNA for pyruvate kinase M, complete cds. [D38379] KLA .80 .83 .94 .67 .95 .95 1.42
ATP 1.22 1.30 .83 1.14 .99 1.23 2.53
KLA/ATP .99 1.03 .61 .83 .70 1.16 2.54
Pkm2
KLA  ATP  ATP+KLA
 NM_011099 pyruvate kinase, muscle (Pkm2), mRNA [NM_011099] KLA .84 .89 .95 .72 .92 1.03 1.34
ATP 1.05 1.23 .83 1.13 .96 1.20 2.14
KLA/ATP .98 .97 .64 .89 .73 1.20 2.32
Pla2g10
KLA  ATP  ATP+KLA
 NM_011987 phospholipase A2, group X (Pla2g10), mRNA [NM_011987] KLA .99 1.11 1.02 .99 1.00 1.01 1.02
ATP 1.02 .97 1.01 1.03 1.00 1.02 1.04
KLA/ATP 1.04 .96 .95 1.04 1.06 1.05 1.01
Pla2g12a
KLA  ATP  ATP+KLA
 NM_023196 phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] KLA 1.03 1.06 .97 1.00 .78 .75 .92
ATP .91 .99 1.29 1.30 1.20 1.48 1.71
KLA/ATP .92 .99 1.19 1.16 1.06 1.12 1.36
Pla2g12a
KLA  ATP  ATP+KLA
 NM_183423 phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] KLA .90 1.00 .87 .95 .76 .68 .88
ATP .96 .94 1.26 1.24 1.19 1.47 1.88
KLA/ATP .89 .90 1.08 1.07 1.06 1.02 1.59
Pla2g12b
KLA  ATP  ATP+KLA
 NM_023530 phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] KLA .98 .95 1.05 .99 1.03 .99 .94
ATP 1.02 1.04 1.07 1.05 .92 1.04 1.00
KLA/ATP .98 .92 1.10 1.11 1.09 1.03 1.04
Pla2g1b
KLA  ATP  ATP+KLA
 NM_011107 phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] KLA 1.00 1.01 1.01 1.11 1.00 1.28 1.00
ATP .98 1.03 1.09 1.03 1.01 1.02 1.04
KLA/ATP .93 .94 1.01 1.00 .94 1.09 1.07
Pla2g2a
KLA  ATP  ATP+KLA
 NM_001082531 phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] KLA 1.08 .99 1.00 1.06 .98 1.01 .94
ATP 1.07 .98 1.04 1.06 .90 .98 .98
KLA/ATP .98 1.03 1.00 1.04 .94 .97 .96
Pla2g2c
KLA  ATP  ATP+KLA
 NM_008868 phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] KLA .98 .99 1.05 .98 1.01 1.00 1.04
ATP 1.08 1.06 1.09 .93 .92 .92 1.00
KLA/ATP 1.03 1.04 1.02 1.04 .98 1.01 1.02
Pla2g2d
KLA  ATP  ATP+KLA
 NM_011109 phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] KLA 1.02 1.02 .99 .99 1.00 1.01 1.00
ATP .95 1.11 1.10 1.11 .98 .99 1.12
KLA/ATP 1.02 1.00 1.19 1.11 1.00 .96 1.01
Pla2g2e
KLA  ATP  ATP+KLA
 NM_012044 phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] KLA .78 .75 .74 .72 .62 .69 1.40
ATP 1.06 1.00 .92 1.04 .83 .76 3.74
KLA/ATP .78 .80 .69 .74 .70 .74 2.24
Pla2g2f
KLA  ATP  ATP+KLA
 NM_012045 phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] KLA 1.02 .99 1.03 1.01 1.00 .95 .99
ATP 1.01 1.06 1.11 .97 1.09 1.11 .99
KLA/ATP 1.10 1.05 1.04 .95 1.04 1.01 .96
Pla2g3
KLA  ATP  ATP+KLA
 NM_172791 phospholipase A2, group III (Pla2g3), mRNA [NM_172791] KLA 1.04 1.05 1.02 1.01 1.04 1.11 1.00
ATP .96 .97 1.10 .91 .99 .97 1.08
KLA/ATP 1.03 1.11 1.10 .98 .95 .98 1.07
Pla2g4a
KLA  ATP  ATP+KLA
 NM_008869 phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] KLA 3.93 4.49 4.86 6.40 6.44 3.10 1.68
ATP 1.13 1.36 1.27 1.30 1.02 5.37 1.47
KLA/ATP 3.64 4.45 4.76 7.11 2.96 4.08 2.60
Pla2g4b
KLA  ATP  ATP+KLA
 NM_145378 phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] KLA 1.09 1.18 .95 1.01 .97 .97 .77
ATP 1.05 1.14 1.28 .94 .88 1.18 .70
KLA/ATP 1.23 1.43 1.21 1.02 1.15 1.16 .78
Pla2g4c
KLA  ATP  ATP+KLA
 AK145339 1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] KLA 1.09 1.21 1.33 1.17 1.26 1.30 1.05
ATP .97 1.06 1.00 .98 .98 .98 1.05
KLA/ATP 1.19 1.16 1.18 1.13 1.04 1.02 1.06
Pla2g4c
KLA  ATP  ATP+KLA
 NM_001004762 phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] KLA .93 1.00 .94 .93 .94 .94 .96
ATP .98 .96 1.13 .97 .99 .89 .96
KLA/ATP 1.01 1.01 1.07 1.01 .94 1.01 .92
Pla2g4e
KLA  ATP  ATP+KLA
 AK049063 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] KLA 1.03 1.09 1.01 1.01 1.06 .94 1.05
ATP 1.03 1.00 1.06 1.01 .96 1.05 1.05
KLA/ATP .98 1.00 1.01 .98 1.03 .95 1.01
Pla2g4e
KLA  ATP  ATP+KLA
 NM_177845 phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] KLA .97 .95 1.01 .97 1.02 1.03 1.05
ATP .98 .99 1.00 1.10 .98 1.00 1.02
KLA/ATP 1.05 .93 .96 1.03 1.08 1.05 .99
Pla2g4f
KLA  ATP  ATP+KLA
 NM_001024145 phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] KLA 1.08 .99 1.04 1.02 1.04 .98 1.01
ATP .99 1.04 .99 1.03 1.12 1.01 1.25
KLA/ATP .97 1.04 1.10 1.06 1.04 1.03 1.03
Pla2g5
KLA  ATP  ATP+KLA
 NM_011110 phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] KLA .65 .62 .56 .53 .62 1.60 3.01
ATP .90 .82 .88 1.69 1.82 1.26 6.32
KLA/ATP .63 .59 .65 .63 .91 1.56 5.59
Pla2g6
KLA  ATP  ATP+KLA
 NM_016915 phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] KLA .60 .59 .56 .60 .94 1.31 1.59
ATP 1.10 1.14 .95 1.05 1.06 1.13 1.14
KLA/ATP .63 .56 .54 .56 .71 .97 1.55
Pla2g7
KLA  ATP  ATP+KLA
 NM_013737 phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (Pla2g7), mRNA [NM_013737] KLA 1.26 1.32 1.43 1.47 1.87 2.52 4.77
ATP 1.07 1.11 .94 1.24 1.14 3.60 7.17
KLA/ATP 1.38 1.44 1.13 1.63 1.40 4.09 10.65
Plb1
KLA  ATP  ATP+KLA
 AK015993 adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] KLA .99 .99 1.05 1.02 1.03 1.07 1.02
ATP 1.04 1.03 1.07 1.06 1.09 1.01 1.02
KLA/ATP 1.07 1.00 .96 1.09 1.05 1.08 1.01
Plb1
KLA  ATP  ATP+KLA
 AK087596 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] KLA .93 .99 .99 1.07 .98 1.00 .98
ATP 1.08 1.00 .97 1.07 1.04 1.09 .96
KLA/ATP 1.06 .96 1.00 .98 1.04 1.06 .98
Plb1
KLA  ATP  ATP+KLA
 NM_001081407 phospholipase B1 (Plb1), mRNA [NM_001081407] KLA 1.05 1.09 1.05 1.04 1.05 1.03 .85
ATP .96 1.03 1.02 .95 1.06 1.01 .92
KLA/ATP 1.00 1.00 1.09 1.00 .97 .99 .86
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Plcd1
KLA  ATP  ATP+KLA
 NM_019676 phospholipase C, delta 1 (Plcd1), mRNA [NM_019676] KLA 2.80 2.76 2.50 2.05 1.09 .66 1.49
ATP .93 .94 1.22 1.10 .99 1.35 .50
KLA/ATP 2.55 2.84 3.38 2.74 1.98 1.32 .80
Plcd3
KLA  ATP  ATP+KLA
 NM_152813 phospholipase C, delta 3 (Plcd3), mRNA [NM_152813] KLA .58 .56 .49 .61 .70 .74 .87
ATP .98 1.07 .91 .92 .80 .96 1.23
KLA/ATP .58 .55 .59 .61 .75 1.03 1.68
Plcd4
KLA  ATP  ATP+KLA
 NM_148937 phospholipase C, delta 4 (Plcd4), transcript variant 2, mRNA [NM_148937] KLA 1.04 .99 1.00 .99 .95 1.02 1.06
ATP .99 .98 .99 1.13 1.00 1.02 1.04
KLA/ATP 1.04 1.01 1.00 .97 1.10 .99 1.02
Plce1
KLA  ATP  ATP+KLA
 AK035546 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530064F18 product:PANCREAS-ENRICHED PHOSPHOLIPASE C homolog [Homo sapiens], full insert sequence. [AK035546] KLA .99 1.08 1.03 1.00 1.06 1.04 .97
ATP 1.04 1.01 1.02 1.01 .96 1.01 1.06
KLA/ATP .98 .98 .93 1.02 .95 .93 .97
Plce1
KLA  ATP  ATP+KLA
 BC025027 phospholipase C, epsilon 1, mRNA (cDNA clone IMAGE:4948638), with apparent retained intron. [BC025027] KLA 1.07 1.12 1.04 1.10 1.07 1.04 1.04
ATP 1.00 .96 1.06 .99 .98 .96 1.01
KLA/ATP 1.21 1.06 1.13 1.09 1.00 1.08 1.14
Plce1
KLA  ATP  ATP+KLA
 NM_019588 phospholipase C, epsilon 1 (Plce1), mRNA [NM_019588] KLA .98 1.03 .99 .96 1.01 1.04 .96
ATP .98 .99 1.02 1.13 .99 1.01 1.00
KLA/ATP .97 1.11 1.00 1.07 .93 1.06 .99
Plcg2
KLA  ATP  ATP+KLA
 NM_172285 phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285] KLA .76 .74 .68 .66 .71 .92 .95
ATP .96 .90 .95 .87 .81 .79 .91
KLA/ATP .76 .71 .69 .62 .72 .78 .68
Plcz1
KLA  ATP  ATP+KLA
 NM_054066 phospholipase C, zeta 1 (Plcz1), mRNA [NM_054066] KLA 1.02 .99 .97 1.04 .98 .95 .98
ATP 1.01 1.03 1.03 .98 .97 1.00 1.04
KLA/ATP 1.02 1.04 1.03 .99 1.01 1.00 1.01
Pld1
KLA  ATP  ATP+KLA
 NM_008875 phospholipase D1 (Pld1), mRNA [NM_008875] KLA .71 .73 .67 .73 .88 .96 1.25
ATP .99 .88 .73 .68 .45 1.23 1.12
KLA/ATP .70 .67 .58 .59 .48 .91 1.48
Pld2
KLA  ATP  ATP+KLA
 NM_008876 phospholipase D2 (Pld2), mRNA [NM_008876] KLA .51 .54 .48 .51 .73 .79 1.02
ATP 1.06 1.10 .88 1.03 1.04 1.29 1.00
KLA/ATP .63 .52 .40 .57 .65 1.03 1.35
Pld3
KLA  ATP  ATP+KLA
 NM_011116 phospholipase D family, member 3 (Pld3), mRNA [NM_011116] KLA .81 .84 .90 .75 .75 .70 .82
ATP 1.06 1.14 .81 1.15 1.12 .97 1.32
KLA/ATP .94 .92 .73 1.01 .94 1.05 1.20
Pld4
KLA  ATP  ATP+KLA
 NM_178911 phospholipase D family, member 4 (Pld4), mRNA [NM_178911] KLA .66 .73 .82 .67 .90 1.14 1.94
ATP 1.08 1.24 .87 1.26 .86 .50 .75
KLA/ATP .84 .83 .51 .83 .56 .61 1.00
Pmm1
KLA  ATP  ATP+KLA
 NM_013872 phosphomannomutase 1 (Pmm1), mRNA [NM_013872] KLA .55 .55 .47 .42 .36 .34 .70
ATP 1.03 1.07 1.03 1.09 .86 .49 .80
KLA/ATP .57 .56 .55 .54 .46 .36 .44
Pmm2
KLA  ATP  ATP+KLA
 NM_016881 phosphomannomutase 2 (Pmm2), mRNA [NM_016881] KLA 1.22 1.31 1.38 1.28 1.64 1.62 1.69
ATP 1.11 1.26 .84 1.15 .84 1.12 1.63
KLA/ATP 1.39 1.48 .86 1.51 .92 1.24 2.24
Pmvk
KLA  ATP  ATP+KLA
 NM_026784 phosphomevalonate kinase (Pmvk), mRNA [NM_026784] KLA .89 .91 .96 .99 .92 .78 .88
ATP 1.13 .98 1.07 1.10 .70 .51 1.19
KLA/ATP .94 .95 1.06 .91 .80 .44 .53
Pnlip
KLA  ATP  ATP+KLA
 AK007357 10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357] KLA .95 1.03 1.02 1.02 1.04 1.06 1.10
ATP 1.05 1.00 .95 1.10 1.00 1.03 1.02
KLA/ATP 1.02 1.00 .89 1.09 1.09 1.06 1.06
Pnlip
KLA  ATP  ATP+KLA
 NM_026925 pancreatic lipase (Pnlip), mRNA [NM_026925] KLA 1.04 .97 1.04 1.00 1.02 .99 .97
ATP 1.04 1.04 1.04 .96 .95 1.02 .97
KLA/ATP .99 .95 .97 .99 .96 .93 1.00
Pnliprp1
KLA  ATP  ATP+KLA
 NM_018874 pancreatic lipase related protein 1 (Pnliprp1), mRNA [NM_018874] KLA .99 .95 .96 .99 .94 .96 1.01
ATP 1.00 1.00 .98 .96 .99 .87 1.09
KLA/ATP 1.01 1.06 1.01 1.02 1.03 .96 .92
Pnliprp2
KLA  ATP  ATP+KLA
 NM_011128 pancreatic lipase-related protein 2 (Pnliprp2), mRNA [NM_011128] KLA 1.01 .97 1.02 1.07 1.08 .98 1.00
ATP 1.05 1.08 .98 1.02 1.00 1.00 1.02
KLA/ATP 1.05 1.04 .96 .99 1.01 1.03 1.05
Pnmt
KLA  ATP  ATP+KLA
 NM_008890 phenylethanolamine-N-methyltransferase (Pnmt), mRNA [NM_008890] KLA .97 .99 .99 .91 1.02 .97 1.02
ATP 1.02 1.03 .92 1.09 1.05 1.09 .96
KLA/ATP 1.00 1.02 1.02 .96 .96 .93 .95
Pnp1
KLA  ATP  ATP+KLA
 NM_013632 purine-nucleoside phosphorylase 1 (Pnp1), mRNA [NM_013632] KLA 5.68 5.47 6.37 7.13 8.25 8.23 3.96
ATP 1.15 1.04 1.14 1.52 1.68 3.22 3.33
KLA/ATP 5.61 5.86 7.11 8.09 8.18 8.72 9.32
Pnpla2
KLA  ATP  ATP+KLA
 NM_025802 patatin-like phospholipase domain containing 2 (Pnpla2), mRNA [NM_025802] KLA 1.18 1.27 1.25 1.09 1.15 1.14 1.19
ATP 1.05 1.17 1.05 1.82 1.47 1.41 1.10
KLA/ATP 1.34 1.41 1.13 1.96 1.63 1.83 1.72
Pnpla3
KLA  ATP  ATP+KLA
 NM_054088 patatin-like phospholipase domain containing 3 (Pnpla3), mRNA [NM_054088] KLA .88 .99 1.04 .97 1.00 .91 1.03
ATP .95 1.03 1.05 1.03 1.01 .93 .99
KLA/ATP 1.02 1.05 1.00 .94 .95 .98 .95
Pnpo
KLA  ATP  ATP+KLA
 NM_134021 pyridoxine 5-phosphate oxidase (Pnpo), mRNA [NM_134021] KLA .64 .66 .64 .60 .58 .62 .81
ATP 1.07 1.06 1.02 1.08 .78 .55 1.18
KLA/ATP .73 .76 .60 .78 .54 .65 .78
Pola1
KLA  ATP  ATP+KLA
 NM_008892 polymerase (DNA directed), alpha 1 (Pola1), mRNA [NM_008892] KLA .72 .68 .59 .56 .27 .19 .21
ATP .81 .97 1.41 1.22 .71 .29 .16
KLA/ATP .58 .70 .81 .56 .39 .27 .12
Pola2
KLA  ATP  ATP+KLA
 BC006945 polymerase (DNA directed), alpha 2, mRNA (cDNA clone MGC:11533 IMAGE:3602559), complete cds [BC006945] KLA .74 .76 .70 .74 .88 .91 .98
ATP .99 1.03 .83 .78 .96 .76 .92
KLA/ATP .67 .69 .65 .77 .88 .83 1.02
Pola2
KLA  ATP  ATP+KLA
 NM_008893 polymerase (DNA directed), alpha 2 (Pola2), mRNA [NM_008893] KLA .82 .76 .91 .72 .73 .74 .85
ATP 1.12 1.12 .88 1.20 .86 .82 .64
KLA/ATP .89 .84 .75 .84 .78 .91 1.16
Pold1
KLA  ATP  ATP+KLA
 NM_011131 polymerase (DNA directed), delta 1, catalytic subunit (Pold1), mRNA [NM_011131] KLA .24 .21 .20 .18 .18 .29 .36
ATP 1.05 1.05 .96 .99 .52 .26 .32
KLA/ATP .26 .22 .21 .22 .16 .17 .18
Pold2
KLA  ATP  ATP+KLA
 NM_008894 polymerase (DNA directed), delta 2, regulatory subunit (Pold2), mRNA [NM_008894] KLA .77 .83 .69 .68 .59 .49 .57
ATP 1.05 1.09 .97 1.24 .89 .44 .43
KLA/ATP .79 .78 .70 .84 .60 .41 .30
Pold3
KLA  ATP  ATP+KLA
 NM_133692 polymerase (DNA-directed), delta 3, accessory subunit (Pold3), mRNA [NM_133692] KLA 1.14 1.07 1.22 1.22 1.12 1.40 1.10
ATP .99 .95 1.17 .89 1.46 1.74 1.55
KLA/ATP 1.01 1.08 1.54 1.28 1.86 2.34 2.11
Pold4
KLA  ATP  ATP+KLA
 NM_027196 polymerase (DNA-directed), delta 4 (Pold4), mRNA [NM_027196] KLA .81 .88 .80 .78 .85 1.04 1.40
ATP .97 1.07 1.12 1.37 1.19 .86 1.27
KLA/ATP .85 .90 .89 1.07 .90 .94 1.62
Pole
KLA  ATP  ATP+KLA
 AK086490 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930032B21 product:DNA polymerase epsilon, full insert sequence. [AK086490] KLA 1.00 1.00 1.04 .96 .94 .99 1.04
ATP .97 .95 .91 .95 .97 1.06 .95
KLA/ATP .96 .93 1.00 1.01 1.08 1.02 1.01
Pole
KLA  ATP  ATP+KLA
 NM_011132 polymerase (DNA directed), epsilon (Pole), mRNA [NM_011132] KLA .50 .44 .38 .31 .25 .21 .17
ATP 1.12 1.03 1.28 .89 .68 .30 .16
KLA/ATP .45 .44 .56 .38 .30 .21 .14
Pole2
KLA  ATP  ATP+KLA
 NM_011133 polymerase (DNA directed), epsilon 2 (p59 subunit) (Pole2), mRNA [NM_011133] KLA .25 .24 .22 .21 .21 .37 .34
ATP .93 .98 1.11 1.00 .36 .30 .35
KLA/ATP .22 .22 .29 .30 .26 .28 .19
Pole3
KLA  ATP  ATP+KLA
 BC034004 polymerase (DNA directed), epsilon 3 (p17 subunit), mRNA (cDNA clone IMAGE:5117478) [BC034004] KLA .69 .72 .63 .69 .68 .81 .61
ATP .91 .86 1.29 .96 .81 .94 .51
KLA/ATP .62 .54 .85 .64 .70 .75 .44
Pole3
KLA  ATP  ATP+KLA
 NM_021498 polymerase (DNA directed), epsilon 3 (p17 subunit) (Pole3), mRNA [NM_021498] KLA 1.14 1.14 1.23 1.36 1.18 1.15 1.01
ATP 1.02 .98 1.17 1.44 1.40 1.27 1.25
KLA/ATP 1.20 1.24 1.58 1.57 1.60 1.25 1.23
Pole4
KLA  ATP  ATP+KLA
 NM_025882 polymerase (DNA-directed), epsilon 4 (p12 subunit) (Pole4), mRNA [NM_025882] KLA 1.11 1.15 1.15 1.22 1.19 1.31 1.26
ATP 1.00 .99 1.36 1.32 1.34 1.19 .98
KLA/ATP 1.02 1.15 1.58 1.47 1.52 1.10 .85
Polg
KLA  ATP  ATP+KLA
 NM_017462 polymerase (DNA directed), gamma (Polg), mRNA [NM_017462] KLA .67 .66 .76 .65 .85 .74 .84
ATP 1.01 .93 .57 .51 .55 .89 .97
KLA/ATP .70 .67 .41 .41 .44 .69 .67
Polg2
KLA  ATP  ATP+KLA
 NM_015810 polymerase (DNA directed), gamma 2, accessory subunit (Polg2), mRNA [NM_015810] KLA .56 .58 .61 .67 .66 .80 .63
ATP .84 .78 1.12 4.24 1.38 .94 .72
KLA/ATP .52 .54 1.36 4.68 2.77 2.45 .59
Polr1e
KLA  ATP  ATP+KLA
 NM_022811 polymerase (RNA) I polypeptide E (Polr1e), mRNA [NM_022811] KLA 1.01 1.06 .93 .81 .72 .80 1.37
ATP 1.04 1.10 1.09 1.06 .68 1.06 .85
KLA/ATP 1.15 1.13 .87 .96 .60 .72 .56
Polr2a
KLA  ATP  ATP+KLA
 NM_009089 polymerase (RNA) II (DNA directed) polypeptide A (Polr2a), mRNA [NM_009089] KLA 1.21 1.16 1.15 1.16 1.16 1.25 1.12
ATP 1.00 1.09 1.07 1.39 1.35 1.28 1.16
KLA/ATP 1.20 1.18 1.26 1.30 1.30 1.51 1.37
Polr2b
KLA  ATP  ATP+KLA
 NM_153798 polymerase (RNA) II (DNA directed) polypeptide B (Polr2b), mRNA [NM_153798] KLA .91 .91 .92 .73 .77 .80 .83
ATP 1.09 1.18 .96 .80 .64 .75 .93
KLA/ATP 1.01 .98 .74 .74 .53 .72 .71
Polr2c
KLA  ATP  ATP+KLA
 NM_009090 polymerase (RNA) II (DNA directed) polypeptide C (Polr2c), mRNA [NM_009090] KLA 1.45 1.41 1.48 1.33 1.24 1.24 1.34
ATP .97 1.07 1.01 1.06 1.09 1.27 1.13
KLA/ATP 1.48 1.46 1.34 1.46 1.27 1.50 1.26
Polr2d
KLA  ATP  ATP+KLA
 NM_027101 polymerase (RNA) II (DNA directed) polypeptide D (Polr2d), transcript variant 2, mRNA [NM_027101] KLA .89 .90 .80 .87 .86 .94 .99
ATP .95 .95 1.15 1.05 .93 1.45 .80
KLA/ATP .81 .88 .99 .96 .99 1.33 .89
Polr2e
KLA  ATP  ATP+KLA
 AK010567 ES cells cDNA, RIKEN full-length enriched library, clone:2410021N14 product:polymerase (RNA) II (DNA directed) polypeptide E, full insert sequence. [AK010567] KLA .67 .68 .68 .56 .58 .45 .67
ATP 1.14 1.18 1.05 1.26 .91 .63 .80
KLA/ATP .80 .77 .71 .81 .75 .50 .49
Polr2e
KLA  ATP  ATP+KLA
 NM_025554 polymerase (RNA) II (DNA directed) polypeptide E (Polr2e), mRNA [NM_025554] KLA .69 .74 .69 .61 .56 .49 .70
ATP 1.00 1.06 1.02 1.20 .88 .67 .73
KLA/ATP .79 .76 .72 .80 .77 .55 .45
Polr2f
KLA  ATP  ATP+KLA
 NM_027231 polymerase (RNA) II (DNA directed) polypeptide F (Polr2f), mRNA [NM_027231] KLA 1.01 .99 .92 .94 .86 .78 .84
ATP .94 1.00 1.18 1.34 1.14 .88 .91
KLA/ATP .96 1.07 1.23 1.38 1.16 .96 .70
Polr2g
KLA  ATP  ATP+KLA
 NM_026329 polymerase (RNA) II (DNA directed) polypeptide G (Polr2g), mRNA [NM_026329] KLA 2.39 2.22 2.36 2.22 1.69 1.12 1.08
ATP .93 .91 1.27 1.12 1.19 1.43 1.23
KLA/ATP 2.24 2.26 3.23 2.51 3.15 2.36 1.54
Polr2h
KLA  ATP  ATP+KLA
 NM_145632 polymerase (RNA) II (DNA directed) polypeptide H (Polr2h), mRNA [NM_145632] KLA .80 .76 .66 .62 .73 .87 1.14
ATP .90 .91 1.01 .99 1.10 1.32 .98
KLA/ATP .68 .72 .69 .65 .90 1.01 .62
Polr2i
KLA  ATP  ATP+KLA
 NM_027259 polymerase (RNA) II (DNA directed) polypeptide I (Polr2i), mRNA [NM_027259] KLA .67 .69 .68 .78 .80 .90 .99
ATP .98 .88 1.10 .84 .77 1.13 1.17
KLA/ATP .64 .68 .85 .70 .91 1.10 1.03
Polr2j
KLA  ATP  ATP+KLA
 NM_011293 polymerase (RNA) II (DNA directed) polypeptide J (Polr2j), mRNA [NM_011293] KLA .96 .89 .88 1.01 .88 .92 .85
ATP 1.09 1.12 1.38 1.58 1.39 1.15 .89
KLA/ATP 1.05 1.05 1.46 1.33 1.51 1.25 .88
Polr2l
KLA  ATP  ATP+KLA
 XM_888022 gb|PREDICTED: Mus musculus polymerase (RNA) II (DNA directed) polypeptide L (Polr2l), mRNA [XM_888022] KLA .82 .92 .85 .82 .77 .73 .88
ATP .95 1.00 1.15 1.42 1.20 .91 .99
KLA/ATP .86 .89 1.04 1.23 1.25 .91 .59
Polr3a
KLA  ATP  ATP+KLA
 AK039440 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330043C08 product:hypothetical protein, full insert sequence. [AK039440] KLA 1.02 .94 .96 .97 1.13 .97 1.02
ATP .71 .55 .59 .69 .88 .93 .94
KLA/ATP .81 .65 .65 .80 .83 .88 .75
Polr3a
KLA  ATP  ATP+KLA
 NM_001081247 polymerase (RNA) III (DNA directed) polypeptide A (Polr3a), mRNA [NM_001081247] KLA 1.16 1.20 1.27 1.15 1.26 1.17 1.32
ATP .98 1.08 1.07 .92 .80 .99 1.26
KLA/ATP 1.22 1.30 1.18 .99 .78 1.24 1.27
Polr3b
KLA  ATP  ATP+KLA
 NM_027423 polymerase (RNA) III (DNA directed) polypeptide B (Polr3b), mRNA [NM_027423] KLA 1.03 1.05 1.02 1.07 1.11 1.15 1.05
ATP 1.09 1.15 .96 .97 .73 .75 .93
KLA/ATP 1.04 1.12 1.00 1.00 .74 .75 .77
Polr3c
KLA  ATP  ATP+KLA
 XM_131049 gb|PREDICTED: Mus musculus polymerase (RNA) III (DNA directed) polypeptide C, transcript variant 1 (Polr3c), mRNA [XM_131049] KLA 2.33 2.34 2.59 2.37 2.10 1.82 1.42
ATP 1.02 .97 1.12 1.19 .99 1.10 1.14
KLA/ATP 2.34 2.54 2.70 2.54 2.18 1.75 1.88
Polr3d
KLA  ATP  ATP+KLA
 NM_025945 polymerase (RNA) III (DNA directed) polypeptide D (Polr3d), mRNA [NM_025945] KLA 1.08 1.08 .90 .88 .98 .99 1.60
ATP .95 1.00 .94 .89 1.23 1.19 1.21
KLA/ATP 1.06 1.13 .88 .82 .68 .72 .55
Polr3f
KLA  ATP  ATP+KLA
 NM_029763 polymerase (RNA) III (DNA directed) polypeptide F (Polr3f), mRNA [NM_029763] KLA 1.10 1.09 1.09 .98 .95 1.00 1.08
ATP 1.07 1.06 .84 .69 .72 .94 1.06
KLA/ATP 1.13 1.08 .80 .71 .70 .92 .92
Polr3g
KLA  ATP  ATP+KLA
 NM_001081176 polymerase (RNA) III (DNA directed) polypeptide G (Polr3g), mRNA [NM_001081176] KLA .51 .53 .43 .45 .41 .45 .57
ATP .90 .84 .68 .55 .54 .64 .60
KLA/ATP .51 .47 .46 .50 .48 .53 .46
Polr3gl
KLA  ATP  ATP+KLA
 NM_027241 polymerase (RNA) III (DNA directed) polypeptide G like (Polr3gl), mRNA [NM_027241] KLA .60 .51 .54 .55 .57 .70 .53
ATP .99 .86 1.08 .84 .48 .57 .69
KLA/ATP .55 .49 .64 .50 .53 .57 .67
Polr3h
KLA  ATP  ATP+KLA
 NM_030229 polymerase (RNA) III (DNA directed) polypeptide H (Polr3h), mRNA [NM_030229] KLA .89 .85 .75 .81 .76 .85 1.01
ATP .93 .81 .86 .71 .70 .93 .83
KLA/ATP .75 .78 .73 .70 .69 .76 .76
Polr3k
KLA  ATP  ATP+KLA
 NM_025901 polymerase (RNA) III (DNA directed) polypeptide K (Polr3k), mRNA [NM_025901] KLA .72 .72 .66 .69 .63 .74 .85
ATP .87 .84 1.14 .92 .64 .87 .72
KLA/ATP .65 .71 .90 .74 .65 .53 .44
Pon1
KLA  ATP  ATP+KLA
 NM_011134 paraoxonase 1 (Pon1), mRNA [NM_011134] KLA .91 .98 .94 .94 .95 1.01 1.01
ATP 1.06 .93 1.03 1.05 .96 1.05 1.05
KLA/ATP .99 .98 .92 .98 .97 1.02 1.22
Pon2
KLA  ATP  ATP+KLA
 AK018124 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330405I24 product:unclassifiable, full insert sequence [AK018124] KLA 1.00 .95 1.00 .98 .86 .73 .58
ATP 1.05 .96 1.23 .93 .88 .80 .44
KLA/ATP .96 1.03 1.20 .84 .87 .64 .35
Pon2
KLA  ATP  ATP+KLA
 NM_183308 paraoxonase 2 (Pon2), mRNA [NM_183308] KLA .91 .88 .94 .99 .91 .78 .90
ATP 1.06 1.02 .94 1.00 .94 .88 .89
KLA/ATP .90 .97 .98 .95 .76 .74 1.03
Pon3
KLA  ATP  ATP+KLA
 NM_173006 paraoxonase 3 (Pon3), mRNA [NM_173006] KLA .95 .93 .87 .88 .73 .63 1.01
ATP 1.01 .99 1.23 1.15 1.10 1.12 1.16
KLA/ATP .89 .94 1.16 1.03 .89 .80 1.63
Ppap2a
KLA  ATP  ATP+KLA
 NM_008903 phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903] KLA 2.62 2.86 4.01 5.61 7.84 10.88 16.35
ATP 1.01 1.02 1.09 1.28 1.27 2.38 1.44
KLA/ATP 2.78 2.78 2.99 3.43 2.85 3.59 6.59
Ppap2b
KLA  ATP  ATP+KLA
 NM_080555 phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555] KLA 2.73 2.72 2.65 2.39 1.07 1.48 3.26
ATP .99 .97 1.60 2.76 18.64 27.23 9.19
KLA/ATP 2.69 2.80 4.36 4.20 14.33 15.32 17.91
Ppap2c
KLA  ATP  ATP+KLA
 NM_015817 phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817] KLA .94 .88 .91 .79 .65 .46 .51
ATP 1.01 1.03 1.00 1.12 1.24 .90 .83
KLA/ATP .95 .93 .87 .95 .79 .63 .43
Ppat
KLA  ATP  ATP+KLA
 XM_896000 gb|PREDICTED: Mus musculus phosphoribosyl pyrophosphate amidotransferase, transcript variant 3 (Ppat), mRNA [XM_896000] KLA .54 .49 .44 .40 .36 .46 .60
ATP .91 .96 1.03 .85 .83 .81 .67
KLA/ATP .49 .50 .52 .49 .65 .63 .37
Ppcdc
KLA  ATP  ATP+KLA
 NM_176831 phosphopantothenoylcysteine decarboxylase (Ppcdc), mRNA [NM_176831] KLA .52 .50 .46 .57 .63 .84 .95
ATP .95 .81 .76 .61 .46 .55 .89
KLA/ATP .47 .46 .47 .46 .46 .56 .99
Ppcs
KLA  ATP  ATP+KLA
 NM_026494 phosphopantothenoylcysteine synthetase (Ppcs), mRNA [NM_026494] KLA .71 .66 .63 .72 .73 .93 1.01
ATP .93 .81 .72 .49 .43 .94 1.07
KLA/ATP .68 .67 .61 .47 .50 .97 .73
Ppox
KLA  ATP  ATP+KLA
 NM_008911 protoporphyrinogen oxidase (Ppox), nuclear gene encoding mitochondrial protein, mRNA [NM_008911] KLA 1.12 1.19 1.12 1.10 1.21 1.14 1.07
ATP 1.01 .86 .65 .67 .45 .71 1.09
KLA/ATP 1.28 1.00 .69 .77 .56 .69 1.08
Ppt1
KLA  ATP  ATP+KLA
 AK148314 B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370087F11 product:palmitoyl-protein thioesterase 1, full insert sequence. [AK148314] KLA .81 .79 .79 .90 .82 .88 1.24
ATP .98 1.11 1.72 1.24 1.13 .95 1.91
KLA/ATP .80 .85 1.14 .98 .93 .73 1.39
Ppt1
KLA  ATP  ATP+KLA
 NM_008917 palmitoyl-protein thioesterase 1 (Ppt1), mRNA [NM_008917] KLA .88 .86 .86 .89 .78 .73 .81
ATP 1.05 1.02 1.17 1.10 .99 .76 .77
KLA/ATP .83 .85 1.02 .91 .71 .59 .71
Ppt2
KLA  ATP  ATP+KLA
 NM_019441 palmitoyl-protein thioesterase 2 (Ppt2), mRNA [NM_019441] KLA 1.08 1.27 1.22 1.04 1.29 1.14 1.70
ATP 1.13 1.21 .63 .82 .60 .74 1.42
KLA/ATP 1.42 1.32 .63 1.02 .54 .85 2.24
Prdx6
KLA  ATP  ATP+KLA
 AK081980 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130091B17 product:peroxiredoxin 5, related sequence 3, full insert sequence [AK081980] KLA 1.61 1.58 .92 .93 .93 1.08 1.24
ATP 2.61 2.91 4.18 6.45 12.41 12.74 3.19
KLA/ATP 2.79 4.31 7.52 6.17 5.64 6.93 5.25
Prdx6
KLA  ATP  ATP+KLA
 NM_007453 peroxiredoxin 6 (Prdx6), mRNA [NM_007453] KLA 1.33 1.40 1.49 1.32 1.28 1.04 .90
ATP 1.07 1.22 1.15 1.46 2.77 9.93 8.48
KLA/ATP 1.36 1.59 1.61 1.96 1.90 5.10 9.06
Prhoxnb
KLA  ATP  ATP+KLA
 NM_001039678 parahox cluster neighbor (Prhoxnb), mRNA [NM_001039678] KLA .98 .97 1.01 .96 .96 .97 .97
ATP .97 .97 .98 1.02 1.04 1.01 1.03
KLA/ATP .99 1.05 1.01 1.01 1.00 .93 .96
Prim1
KLA  ATP  ATP+KLA
 NM_008921 DNA primase, p49 subunit (Prim1), mRNA [NM_008921] KLA .28 .26 .22 .18 .14 .24 .28
ATP .88 .80 1.35 .98 .50 .25 .26
KLA/ATP .22 .22 .33 .23 .20 .16 .10
Prim2
KLA  ATP  ATP+KLA
 NM_008922 DNA primase, p58 subunit (Prim2), mRNA [NM_008922] KLA .72 .68 .61 .54 .39 .52 .50
ATP .88 .76 .77 .64 .39 .47 .44
KLA/ATP .63 .59 .59 .44 .34 .46 .33
Prodh
KLA  ATP  ATP+KLA
 NM_011172 proline dehydrogenase (Prodh), nuclear gene encoding mitochondrial protein, mRNA [NM_011172] KLA .78 .72 .60 .59 .44 .32 .27
ATP .93 .97 1.11 1.02 .63 .44 .49
KLA/ATP .73 .76 .74 .78 .56 .39 .27
Prodh2
KLA  ATP  ATP+KLA
 NM_019546 proline dehydrogenase (oxidase) 2 (Prodh2), mRNA [NM_019546] KLA 1.03 1.01 1.04 1.07 1.01 1.06 1.04
ATP .96 1.01 1.00 1.00 .93 .98 1.00
KLA/ATP .98 .99 1.09 1.03 1.00 .96 1.03
Prps1
KLA  ATP  ATP+KLA
 NM_021463 phosphoribosyl pyrophosphate synthetase 1 (Prps1), mRNA [NM_021463] KLA .82 .83 .85 .70 .56 .42 .52
ATP 1.00 1.03 1.20 1.21 1.08 .67 .54
KLA/ATP .85 .86 .90 .86 .68 .52 .42
Prps1l1
KLA  ATP  ATP+KLA
 NM_029294 phosphoribosyl pyrophosphate synthetase 1-like 1 (Prps1l1), mRNA [NM_029294] KLA 1.05 .97 .99 1.03 1.04 1.00 1.04
ATP .99 .96 1.04 1.05 1.05 .99 1.07
KLA/ATP .99 1.03 1.07 1.00 1.01 1.01 1.09
Prps2
KLA  ATP  ATP+KLA
 NM_026662 phosphoribosyl pyrophosphate synthetase 2 (Prps2), mRNA [NM_026662] KLA .85 .85 .88 .76 .60 .45 .43
ATP 1.00 1.13 1.18 1.19 .79 .35 .37
KLA/ATP .85 .93 .88 .83 .62 .38 .24
Psat1
KLA  ATP  ATP+KLA
 NM_177420 phosphoserine aminotransferase 1 (Psat1), mRNA [NM_177420] KLA 1.02 1.21 1.24 1.27 1.64 1.59 .38
ATP 1.02 1.01 1.04 1.17 1.27 1.09 .43
KLA/ATP 1.16 1.11 1.04 1.37 1.04 .70 .24
Psph
KLA  ATP  ATP+KLA
 NM_133900 phosphoserine phosphatase (Psph), mRNA [NM_133900] KLA .94 .88 .76 .88 .65 .87 .75
ATP .77 .61 .53 .35 1.23 1.85 .73
KLA/ATP .71 .64 .54 .31 .46 .78 .61
Ptdss1
KLA  ATP  ATP+KLA
 NM_008959 phosphatidylserine synthase 1 (Ptdss1), mRNA [NM_008959] KLA .88 .95 .96 .86 .88 .92 1.05
ATP 1.02 1.05 .90 1.08 .99 .93 1.17
KLA/ATP .95 .93 .81 .85 .67 .83 1.10
Ptdss2
KLA  ATP  ATP+KLA
 NM_013782 phosphatidylserine synthase 2 (Ptdss2), mRNA [NM_013782] KLA .95 .96 1.02 1.06 1.17 1.34 1.27
ATP .90 .93 .92 1.04 .83 .86 1.34
KLA/ATP .93 .96 .93 .90 .90 .96 1.42
Ptgds
KLA  ATP  ATP+KLA
 NM_008963 prostaglandin D2 synthase (brain) (Ptgds), mRNA [NM_008963] KLA 1.19 1.16 1.11 1.19 1.04 .98 .93
ATP .99 .99 1.10 1.07 1.02 1.00 .97
KLA/ATP 1.18 1.18 1.31 1.39 1.09 .89 .90
Ptgds2
KLA  ATP  ATP+KLA
 NM_019455 prostaglandin D2 synthase 2, hematopoietic (Ptgds2), mRNA [NM_019455] KLA .50 .48 .58 .52 .66 .57 .53
ATP 1.03 1.05 1.05 1.36 1.04 .32 .61
KLA/ATP .52 .47 .50 .74 .73 .35 .42
Ptges
KLA  ATP  ATP+KLA
 NM_022415 prostaglandin E synthase (Ptges), mRNA [NM_022415] KLA 16.01 15.00 16.36 20.05 28.20 32.79 23.08
ATP 1.00 1.03 1.44 2.27 10.67 30.61 17.52
KLA/ATP 14.56 16.98 20.33 21.07 21.87 25.39 38.01
Ptges2
KLA  ATP  ATP+KLA
 NM_133783 prostaglandin E synthase 2 (Ptges2), mRNA [NM_133783] KLA 1.02 1.07 1.30 1.30 1.39 1.06 1.43
ATP 1.09 1.14 .97 1.09 .70 1.00 1.20
KLA/ATP 1.19 1.12 .93 1.13 .81 .97 1.37
Ptges3
KLA  ATP  ATP+KLA
 NM_019766 prostaglandin E synthase 3 (cytosolic) (Ptges3), mRNA [NM_019766] KLA 1.26 1.26 1.19 1.10 1.10 1.01 1.20
ATP 1.08 1.21 1.14 1.68 1.49 1.49 .65
KLA/ATP 1.31 1.49 1.19 1.74 1.34 1.12 .78
Ptgis
KLA  ATP  ATP+KLA
 NM_008968 prostaglandin I2 (prostacyclin) synthase (Ptgis), mRNA [NM_008968] KLA 1.05 1.07 .93 1.05 1.05 1.05 1.02
ATP 1.01 .98 1.01 1.04 1.02 .92 1.00
KLA/ATP 1.09 .99 .94 .99 .96 1.01 1.06
Ptgs1
KLA  ATP  ATP+KLA
 NM_008969 prostaglandin-endoperoxide synthase 1 (Ptgs1), mRNA [NM_008969] KLA .74 .74 .76 .74 .61 .53 .18
ATP 1.01 1.05 1.29 1.14 .99 1.16 3.96
KLA/ATP .77 .71 .88 .77 .75 .61 .40
Ptgs2
KLA  ATP  ATP+KLA
 NM_011198 prostaglandin-endoperoxide synthase 2 (Ptgs2), mRNA [NM_011198] KLA 181.04 220.88 218.58 132.79 103.05 22.69 18.02
ATP 2.47 9.45 52.13 208.62 271.22 306.11 6.86
KLA/ATP 233.39 387.29 617.86 ###.## 608.44 290.80 112.22
Pts
KLA  ATP  ATP+KLA
 NM_011220 6-pyruvoyl-tetrahydropterin synthase (Pts), mRNA [NM_011220] KLA 1.12 1.20 1.22 1.18 1.22 1.30 1.00
ATP .84 .77 1.06 .97 .88 .70 .69
KLA/ATP .94 .95 1.32 1.08 1.11 .87 .84
Pycr2
KLA  ATP  ATP+KLA
 NM_133705 pyrroline-5-carboxylate reductase family, member 2 (Pycr2), mRNA [NM_133705] KLA .59 .56 .56 .66 .62 .65 .80
ATP .86 .74 .49 .43 .33 .56 .69
KLA/ATP .53 .50 .41 .30 .29 .54 .52
Pycrl
KLA  ATP  ATP+KLA
 AK004291 18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1110058B13 product:pyrroline-5-carboxylate reductase-like, full insert sequence. [AK004291] KLA .50 .57 .50 .50 .54 .66 .74
ATP .98 .99 .97 1.09 .76 .48 .60
KLA/ATP .58 .55 .48 .54 .59 .53 .44
Pycrl
KLA  ATP  ATP+KLA
 NM_025412 pyrroline-5-carboxylate reductase-like (Pycrl), mRNA [NM_025412] KLA .66 .69 .67 .64 .64 .78 .89
ATP .99 1.01 1.03 1.10 .78 .61 .69
KLA/ATP .66 .69 .70 .69 .68 .63 .56
Pygb
KLA  ATP  ATP+KLA
 NM_153781 brain glycogen phosphorylase (Pygb), mRNA [NM_153781] KLA .91 .83 .91 .78 .88 .87 .81
ATP 1.12 1.17 .92 1.03 .75 .51 .83
KLA/ATP .92 .91 .81 .88 .67 .61 .63
Pygl
KLA  ATP  ATP+KLA
 AK083075 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530044G15 product:weakly similar to GLYCOGEN PHOSPHORYLASE (EC 2.4.1.1) (ALPHA-GLUCAN PHOSPHORYLASE) (STARCH PHOSPHORYLASE) [Mus musculus], full insert sequence [ KLA .85 .87 .84 .91 .88 .84 .95
ATP 1.04 1.03 .99 1.07 .95 .80 .83
KLA/ATP .88 .88 .95 .97 .98 .87 .76
Pygl
KLA  ATP  ATP+KLA
 NM_133198 liver glycogen phosphorylase (Pygl), mRNA [NM_133198] KLA .79 .76 .73 .67 .52 .42 .66
ATP 1.01 .94 1.24 1.10 .92 .55 .44
KLA/ATP .76 .81 .93 .81 .76 .45 .14
Pygm
KLA  ATP  ATP+KLA
 NM_011224 muscle glycogen phosphorylase (Pygm), mRNA [NM_011224] KLA 1.11 1.08 .97 1.00 1.09 1.13 1.19
ATP 1.02 .98 .97 2.09 1.91 1.71 1.11
KLA/ATP 1.15 1.06 .87 1.65 1.87 1.99 1.42
Qars
KLA  ATP  ATP+KLA
 AK161817 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030468K12 product:hypothetical protein, full insert sequence. [AK161817] KLA .86 .79 .83 .83 1.06 .97 .92
ATP .94 .84 .70 .71 1.19 1.03 .94
KLA/ATP .79 .73 .77 .73 1.06 .96 .90
Qars
KLA  ATP  ATP+KLA
 NM_133794 glutaminyl-tRNA synthetase (Qars), mRNA [NM_133794] KLA .78 .80 .80 .70 .70 .73 .76
ATP 1.09 1.06 .92 .98 .86 .83 .80
KLA/ATP .87 .84 .71 .71 .59 .78 .73
Qdpr
KLA  ATP  ATP+KLA
 NM_024236 quinoid dihydropteridine reductase (Qdpr), mRNA [NM_024236] KLA .88 .92 .85 .73 .82 .57 .49
ATP 1.16 1.24 1.00 1.09 1.01 .58 .53
KLA/ATP .86 .99 .90 .92 .70 .50 .25
Qprt
KLA  ATP  ATP+KLA
 NM_133686 quinolinate phosphoribosyltransferase (Qprt), mRNA [NM_133686] KLA 1.01 .99 .88 .93 1.07 .96 1.03
ATP 1.00 .95 1.04 .93 .98 1.05 .92
KLA/ATP 1.02 .97 .99 1.01 1.00 .94 .89
Rdh10
KLA  ATP  ATP+KLA
 NM_133832 retinol dehydrogenase 10 (all-trans) (Rdh10), mRNA [NM_133832] KLA .87 .88 .87 .75 .59 .46 .52
ATP 1.08 1.16 1.00 1.60 1.16 .96 .56
KLA/ATP .90 .91 .84 1.31 1.09 .86 .69
Rdh11
KLA  ATP  ATP+KLA
 AY039032 short-chain dehydrogenase/reductase (Psdr1) mRNA, complete cds. [AY039032] KLA .94 .90 .94 .87 .74 .68 .77
ATP .91 .93 1.39 1.14 1.38 2.76 .84
KLA/ATP .87 .90 1.20 .93 1.15 1.57 1.18
Rdh11
KLA  ATP  ATP+KLA
 NM_021557 retinol dehydrogenase 11 (Rdh11), mRNA [NM_021557] KLA 1.11 1.06 1.22 1.17 1.02 .87 1.00
ATP 1.11 1.06 1.48 1.56 1.69 2.35 1.27
KLA/ATP 1.22 1.21 1.37 1.51 1.44 1.47 1.83
Rdh12
KLA  ATP  ATP+KLA
 NM_030017 retinol dehydrogenase 12 (Rdh12), mRNA [NM_030017] KLA 1.52 1.36 1.48 1.52 1.49 1.57 1.11
ATP .97 1.02 1.33 1.50 1.84 1.82 1.23
KLA/ATP 1.36 1.45 1.97 2.02 2.30 2.27 1.89
Rdh16
KLA  ATP  ATP+KLA
 NM_009040 retinol dehydrogenase 16 (Rdh16), mRNA [NM_009040] KLA 1.03 1.04 1.01 .98 .90 .98 .98
ATP 1.05 .96 1.04 1.04 .94 .98 .96
KLA/ATP 1.08 1.03 .99 .97 .72 .98 .94
Rev3l
KLA  ATP  ATP+KLA
 NM_011264 REV3-like, catalytic subunit of DNA polymerase zeta RAD54 like (S. cerevisiae) (Rev3l), mRNA [NM_011264] KLA .38 .33 .34 .31 .36 .53 1.02
ATP 1.14 .97 1.14 1.03 1.41 1.09 1.27
KLA/ATP .42 .36 .44 .51 1.81 1.08 1.39
Rfk
KLA  ATP  ATP+KLA
 NM_019437 riboflavin kinase (Rfk), mRNA [NM_019437] KLA 1.03 1.05 .97 .96 .86 .77 .86
ATP 1.05 1.20 1.16 1.43 1.21 1.23 1.24
KLA/ATP 1.04 1.09 .95 1.20 .91 .93 1.03
Rgn
KLA  ATP  ATP+KLA
 NM_009060 regucalcin (Rgn), mRNA [NM_009060] KLA .99 .94 .99 .93 .97 1.00 1.04
ATP .98 1.03 .95 .98 .95 .96 .91
KLA/ATP .93 1.03 1.01 .98 .94 .93 .94
RP23-136
K12.4
KLA  ATP  ATP+KLA
 NM_008916 putative phosphatase (Pps), mRNA [NM_008916] KLA 1.35 1.47 1.81 1.90 2.21 2.28 1.37
ATP 1.00 1.04 1.03 1.11 .86 .77 1.25
KLA/ATP 1.45 1.56 1.59 1.74 1.57 1.45 2.55
Rpe
KLA  ATP  ATP+KLA
 NM_025683 ribulose-5-phosphate-3-epimerase (Rpe), mRNA [NM_025683] KLA 2.06 2.10 2.39 2.33 2.29 2.01 1.45
ATP 1.01 1.14 1.25 1.29 .90 .80 .89
KLA/ATP 1.87 2.38 2.22 2.33 1.57 1.08 1.10
Rpn1
KLA  ATP  ATP+KLA
 NM_133933 ribophorin I (Rpn1), mRNA [NM_133933] KLA .79 .80 .74 .71 .66 .66 .86
ATP 1.02 .96 1.08 .94 .93 .86 .96
KLA/ATP .80 .84 .85 .74 .74 .69 .56
Rpn2
KLA  ATP  ATP+KLA
 NM_019642 ribophorin II (Rpn2), mRNA [NM_019642] KLA 1.06 1.03 1.13 .99 1.05 .92 .92
ATP 1.08 1.10 .95 .97 .87 .80 .82
KLA/ATP 1.10 1.10 1.00 1.03 .71 .67 .66
Rpo1-1
KLA  ATP  ATP+KLA
 NM_009085 RNA polymerase 1-1 (Rpo1-1), mRNA [NM_009085] KLA .77 .81 .81 .91 .90 .68 .86
ATP 1.03 .92 .86 .94 2.06 1.70 .91
KLA/ATP .82 .85 .86 .65 1.41 1.49 .92
Rpo1-2
KLA  ATP  ATP+KLA
 AK052672 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630020H17 product:RNA polymerase 1-2 (128 kDa subunit), full insert sequence. [AK052672] KLA 1.03 .94 1.03 1.01 .97 .97 1.00
ATP 1.01 1.00 .99 .94 1.02 .94 1.00
KLA/ATP 1.04 .98 .97 .89 1.01 1.02 .93
Rpo1-2
KLA  ATP  ATP+KLA
 NM_009086 RNA polymerase 1-2 (Rpo1-2), mRNA [NM_009086] KLA 1.64 1.60 1.10 .82 .62 .63 .98
ATP 1.04 1.17 .99 .79 .50 .59 .91
KLA/ATP 1.21 1.54 1.15 .76 .37 .61 .50
Rpo1-3
KLA  ATP  ATP+KLA
 NM_009087 RNA polymerase 1-3 (Rpo1-3), transcript variant 1, mRNA [NM_009087] KLA 1.00 .98 .86 .90 .95 .76 .93
ATP 1.07 1.09 1.20 1.26 1.26 1.12 .99
KLA/ATP .89 1.04 1.10 1.08 1.01 .71 .67
Rpo1-3
KLA  ATP  ATP+KLA
 NM_181730 RNA polymerase 1-3 (Rpo1-3), transcript variant 2, mRNA [NM_181730] KLA 1.06 1.17 1.07 1.08 .99 1.04 .98
ATP .93 .97 1.12 1.27 1.36 1.31 .82
KLA/ATP 1.02 1.06 1.20 1.31 1.28 1.32 .90
Rpo1-4
KLA  ATP  ATP+KLA
 NM_009088 RNA polymerase 1-4 (Rpo1-4), mRNA [NM_009088] KLA .75 .68 .58 .60 .46 .53 1.06
ATP 1.07 .98 1.22 1.00 .69 .74 .75
KLA/ATP .68 .65 .76 .61 .45 .34 .49
Rrm1
KLA  ATP  ATP+KLA
 AK049601 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001L22 product:ribonucleotide reductase M1, full insert sequence. [AK049601] KLA .99 .96 1.17 1.00 1.00 .88 .97
ATP 1.07 .98 .94 .96 .92 .86 .99
KLA/ATP 1.00 1.03 1.00 .96 1.02 1.00 .95
Rrm1
KLA  ATP  ATP+KLA
 NM_009103 ribonucleotide reductase M1 (Rrm1), mRNA [NM_009103] KLA .47 .46 .38 .28 .18 .21 .17
ATP .97 1.01 1.06 .97 .65 .27 .18
KLA/ATP .46 .42 .39 .36 .23 .16 .11
Rrm2
KLA  ATP  ATP+KLA
 NM_009104 ribonucleotide reductase M2 (Rrm2), mRNA [NM_009104] KLA .32 .27 .23 .17 .13 .13 .12
ATP .98 1.00 1.17 1.28 .66 .20 .08
KLA/ATP .28 .25 .30 .30 .23 .13 .08
Rrm2b
KLA  ATP  ATP+KLA
 NM_199476 ribonucleotide reductase M2 B (TP53 inducible) (Rrm2b), mRNA [NM_199476] KLA .93 .90 .89 .95 .97 1.00 1.13
ATP .96 .95 .95 .87 .75 .80 .90
KLA/ATP .84 .85 .89 .84 .78 .78 .88
Sardh
KLA  ATP  ATP+KLA
 NM_138665 sarcosine dehydrogenase (Sardh), mRNA [NM_138665] KLA .91 .92 .92 .95 .79 .75 .70
ATP .98 .90 .98 .94 .75 .74 .67
KLA/ATP .94 .92 .88 .89 .78 .73 .67
Sc4mol
KLA  ATP  ATP+KLA
 NM_025436 sterol-C4-methyl oxidase-like (Sc4mol), mRNA [NM_025436] KLA .43 .37 .41 .44 .44 .41 .54
ATP .95 .92 1.30 .92 .70 .47 1.36
KLA/ATP .41 .37 .45 .38 .35 .23 .37
Sc5d
KLA  ATP  ATP+KLA
 AK080673 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830073K23 product:unclassifiable, full insert sequence [AK080673] KLA .62 .56 .53 .46 .38 .29 .35
ATP .87 .91 1.37 .86 .56 .43 .33
KLA/ATP .54 .49 .72 .72 .72 .39 .20
Sc5d
KLA  ATP  ATP+KLA
 NM_172769 sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) (Sc5d), mRNA [NM_172769] KLA 1.18 1.19 1.17 1.09 .95 .63 .70
ATP .99 1.00 1.31 1.09 .84 1.04 1.51
KLA/ATP 1.09 1.08 1.30 1.20 1.05 .88 .76
Scly
KLA  ATP  ATP+KLA
 NM_016717 selenocysteine lyase (Scly), mRNA [NM_016717] KLA 1.01 .98 1.02 1.06 1.13 1.12 1.31
ATP 1.13 1.20 .97 1.14 .76 .60 1.20
KLA/ATP 1.18 1.16 .99 1.21 .76 .64 1.49
Scp2
KLA  ATP  ATP+KLA
 NM_011327 sterol carrier protein 2, liver (Scp2), mRNA [NM_011327] KLA .88 .85 .85 .77 .71 .68 .66
ATP 1.03 1.13 1.25 1.38 1.10 .63 .47
KLA/ATP .85 .88 .91 1.06 .83 .58 .38
Sdha
KLA  ATP  ATP+KLA
 NM_023281 succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (Sdha), nuclear gene encoding mitochondrial protein, mRNA [NM_023281] KLA .97 1.04 1.13 .96 .99 .90 1.09
ATP 1.09 1.20 .93 1.16 .88 .55 .94
KLA/ATP 1.12 1.16 .82 1.02 .65 .65 .78
Sdhb
KLA  ATP  ATP+KLA
 NM_023374 succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (Sdhb), mRNA [NM_023374] KLA .83 .83 .84 .90 .88 1.22 1.74
ATP 1.08 1.02 1.04 1.19 1.05 .63 .87
KLA/ATP .86 .84 .89 .89 .95 .94 .95
Sdhc
KLA  ATP  ATP+KLA
 NM_025321 succinate dehydrogenase complex, subunit C, integral membrane protein (Sdhc), nuclear gene encoding mitochondrial protein, mRNA [NM_025321] KLA .90 .95 1.00 .93 .95 .84 1.01
ATP 1.19 1.21 .98 1.38 1.06 .58 .88
KLA/ATP 1.07 1.18 .93 1.11 .90 .80 .75
Sdhd
KLA  ATP  ATP+KLA
 NM_025848 succinate dehydrogenase complex, subunit D, integral membrane protein (Sdhd), nuclear gene encoding mitochondrial protein, mRNA [NM_025848] KLA .94 .92 .93 .92 .93 .92 1.07
ATP .98 1.02 1.05 1.16 .96 .91 .94
KLA/ATP .90 .98 .91 1.01 .94 1.06 1.01
Sds
KLA  ATP  ATP+KLA
 NM_145565 serine dehydratase (Sds), mRNA [NM_145565] KLA 1.04 1.04 1.02 1.03 1.07 1.05 .77
ATP .93 .97 .91 .94 1.00 .94 1.00
KLA/ATP .93 .95 1.05 .96 .98 .96 1.05
Sec1
KLA  ATP  ATP+KLA
 NM_019934 secretory blood group 1 (Sec1), mRNA [NM_019934] KLA 1.01 1.02 .90 1.00 1.02 1.02 1.05
ATP .99 1.00 .98 1.04 1.00 1.02 1.03
KLA/ATP 1.02 1.04 1.01 .97 .97 1.01 1.13
Sephs1
KLA  ATP  ATP+KLA
 NM_175400 selenophosphate synthetase 1 (Sephs1), mRNA [NM_175400] KLA .92 .97 .99 .96 .87 .77 .73
ATP 1.04 1.08 .95 .89 .70 .70 .55
KLA/ATP .91 1.05 .85 .92 .75 .73 .46
Sephs2
KLA  ATP  ATP+KLA
 NM_009266 selenophosphate synthetase 2 (Sephs2), mRNA [NM_009266] KLA .74 .81 .66 .57 .59 .85 1.22
ATP 1.00 1.11 .95 .90 .80 .65 .67
KLA/ATP .73 .81 .61 .72 .58 .61 .65
Sgms1
KLA  ATP  ATP+KLA
 NM_144792 sphingomyelin synthase 1 (Sgms1), mRNA [NM_144792] KLA .84 .84 .58 .94 1.49 .66 .71
ATP .98 .97 1.57 1.85 1.32 1.60 .57
KLA/ATP .82 .73 .90 .97 .67 .81 .55
Sgms2
KLA  ATP  ATP+KLA
 NM_028943 sphingomyelin synthase 2 (Sgms2), mRNA [NM_028943] KLA 1.21 1.19 1.18 1.03 .89 .92 1.42
ATP 1.00 .99 1.08 1.22 3.11 11.82 3.08
KLA/ATP 1.17 1.16 1.07 1.21 1.17 3.37 5.49
Sgpl1
KLA  ATP  ATP+KLA
 NM_009163 sphingosine phosphate lyase 1 (Sgpl1), mRNA [NM_009163] KLA .89 .84 .89 .90 .84 .86 1.09
ATP 1.17 1.14 .75 .82 1.35 1.57 1.75
KLA/ATP 1.01 .97 .64 .82 1.08 1.45 1.97
Sgsh
KLA  ATP  ATP+KLA
 NM_018822 N-sulfoglucosamine sulfohydrolase (sulfamidase) (Sgsh), mRNA [NM_018822] KLA .68 .66 .65 .65 .54 .61 .71
ATP 1.00 1.03 1.06 .98 .73 .59 .73
KLA/ATP .72 .67 .69 .66 .52 .56 .57
Shmt1
KLA  ATP  ATP+KLA
 NM_009171 serine hydroxymethyltransferase 1 (soluble) (Shmt1), mRNA [NM_009171] KLA .85 .89 .82 .83 .82 .88 .83
ATP .93 .81 .85 .82 .85 .86 .72
KLA/ATP .81 .83 .91 .86 .85 .86 .72
Shmt2
KLA  ATP  ATP+KLA
 NM_028230 serine hydroxymethyltransferase 2 (mitochondrial) (Shmt2), nuclear gene encoding mitochondrial protein, mRNA [NM_028230] KLA .82 .90 .78 .63 .51 .39 .63
ATP 1.04 1.21 .97 1.44 1.32 .85 .64
KLA/ATP .94 .92 .62 1.01 .59 .49 .32
Slc27a5
KLA  ATP  ATP+KLA
 NM_009512 solute carrier family 27 (fatty acid transporter), member 5 (Slc27a5), mRNA [NM_009512] KLA .94 .95 .95 1.02 1.03 .97 1.02
ATP 1.03 .95 1.04 1.10 .97 .91 1.00
KLA/ATP 1.06 .96 .94 .99 1.04 1.01 1.04
Slc33a1
KLA  ATP  ATP+KLA
 NM_015728 solute carrier family 33 (acetyl-CoA transporter), member 1 (Slc33a1), mRNA [NM_015728] KLA 1.19 1.11 1.28 1.14 1.15 .93 .98
ATP 1.09 1.08 .68 .65 .44 .55 .82
KLA/ATP 1.15 1.11 .74 .74 .50 .52 .63
Smpd1
KLA  ATP  ATP+KLA
 NM_011421 sphingomyelin phosphodiesterase 1, acid lysosomal (Smpd1), mRNA [NM_011421] KLA .68 .66 .67 .87 .91 1.01 1.11
ATP 1.04 1.02 1.06 1.03 1.02 1.30 1.73
KLA/ATP .69 .68 .86 .71 .78 .99 1.64
Smpd2
KLA  ATP  ATP+KLA
 NM_009213 sphingomyelin phosphodiesterase 2, neutral (Smpd2), mRNA [NM_009213] KLA .56 .61 .60 .55 .63 .74 .65
ATP .94 .87 .63 .65 .65 .69 .82
KLA/ATP .62 .59 .56 .47 .73 .79 .65
Smpd3
KLA  ATP  ATP+KLA
 NM_021491 sphingomyelin phosphodiesterase 3, neutral (Smpd3), mRNA [NM_021491] KLA .58 .60 .50 .51 .40 .41 .48
ATP 1.08 1.03 .97 .91 .56 .42 .79
KLA/ATP .57 .59 .58 .59 .47 .44 .56
Smpd4
KLA  ATP  ATP+KLA
 AK164456 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230040E22 product:similar to Hypothetical P-loop containing nucleotide triphosphate hydrolases structure containing protein [Mus musculus], full insert sequence [AK16 KLA .90 .91 .87 .80 .81 .75 .75
ATP 1.01 1.10 1.04 .99 1.03 .84 .41
KLA/ATP .93 .94 .83 .88 .84 .75 .35
Smpd4
KLA  ATP  ATP+KLA
 NM_029945 sphingomyelin phosphodiesterase 4 (Smpd4), mRNA [NM_029945] KLA .98 .97 .97 .94 1.00 1.01 1.02
ATP .97 1.06 .98 1.01 .77 .74 .93
KLA/ATP .94 1.02 .87 1.01 .69 .71 .87
Sms
KLA  ATP  ATP+KLA
 NM_009214 spermine synthase (Sms), mRNA [NM_009214] KLA 1.18 1.13 1.09 1.03 .91 .68 .62
ATP .99 1.03 .86 .77 .69 .49 .56
KLA/ATP 1.08 1.13 .92 .80 .62 .42 .32
Sord
KLA  ATP  ATP+KLA
 NM_146126 sorbitol dehydrogenase (Sord), mRNA [NM_146126] KLA .59 .64 .61 .54 .45 .41 .37
ATP 1.09 1.19 .99 1.21 1.46 1.09 .74
KLA/ATP .69 .69 .59 .66 1.06 1.06 .47
Spam1
KLA  ATP  ATP+KLA
 NM_001079875 sperm adhesion molecule 1 (Spam1), transcript variant 1, mRNA [NM_001079875] KLA 1.12 1.05 .98 1.05 1.02 1.03 1.07
ATP .96 1.02 .85 .96 .97 1.14 1.09
KLA/ATP .96 .95 1.03 1.01 .98 .92 1.03
Sphk1
KLA  ATP  ATP+KLA
 NM_025367 sphingosine kinase 1 (Sphk1), transcript variant 2, mRNA [NM_025367] KLA 2.61 2.50 2.04 1.71 1.19 .91 .74
ATP .94 1.00 2.06 8.09 16.52 12.59 3.53
KLA/ATP 2.64 2.81 3.50 8.13 23.71 16.46 2.22
Sphk2
KLA  ATP  ATP+KLA
 NM_020011 sphingosine kinase 2 (Sphk2), transcript variant 2, mRNA [NM_020011] KLA .64 .74 1.05 1.47 2.15 1.84 1.67
ATP 1.10 1.02 .57 .54 .49 1.29 2.15
KLA/ATP .78 .64 .43 .56 .86 1.90 3.74
Spr
KLA  ATP  ATP+KLA
 NM_011467 sepiapterin reductase (Spr), mRNA [NM_011467] KLA .62 .69 .58 .53 .44 .46 .72
ATP .95 1.09 .91 1.02 .73 .52 .87
KLA/ATP .68 .71 .65 .67 .54 .40 .46
Sptlc1
KLA  ATP  ATP+KLA
 NM_009269 serine palmitoyltransferase, long chain base subunit 1 (Sptlc1), mRNA [NM_009269] KLA 1.34 1.32 1.35 1.36 1.26 1.30 1.31
ATP .98 1.04 1.06 1.00 .76 1.02 1.57
KLA/ATP 1.27 1.44 1.37 1.27 .91 1.12 1.57
Sptlc2
KLA  ATP  ATP+KLA
 NM_011479 serine palmitoyltransferase, long chain base subunit 2 (Sptlc2), mRNA [NM_011479] KLA 2.03 2.10 2.53 2.42 2.17 1.88 1.45
ATP 1.08 1.10 1.17 1.27 2.52 4.23 1.87
KLA/ATP 2.17 2.37 2.54 2.82 3.28 4.03 2.41
Sptlc3
KLA  ATP  ATP+KLA
 NM_175467 serine palmitoyltransferase, long chain base subunit 3 (Sptlc3), mRNA [NM_175467] KLA 1.22 1.31 1.26 1.25 1.20 1.17 1.12
ATP .95 1.03 1.02 .94 1.16 1.40 1.32
KLA/ATP 1.11 1.18 1.28 1.30 1.20 1.22 1.31
Sqle
KLA  ATP  ATP+KLA
 NM_009270 squalene epoxidase (Sqle), mRNA [NM_009270] KLA .41 .38 .35 .27 .26 .24 .42
ATP 1.00 1.02 1.10 .92 .83 .65 1.37
KLA/ATP .43 .42 .32 .31 .26 .23 .31
Srm
KLA  ATP  ATP+KLA
 NM_009272 spermidine synthase (Srm), mRNA [NM_009272] KLA .61 .68 .55 .41 .31 .32 .57
ATP .95 1.06 .92 1.19 .94 .50 .61
KLA/ATP .70 .65 .55 .59 .44 .26 .17
St3gal1
KLA  ATP  ATP+KLA
 NM_009177 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (St3gal1), mRNA [NM_009177] KLA 9.07 8.10 8.07 8.61 6.32 6.17 4.65
ATP .97 .87 1.27 4.14 10.38 21.66 8.10
KLA/ATP 8.21 8.67 10.15 8.82 11.00 12.94 21.26
St3gal2
KLA  ATP  ATP+KLA
 NM_009179 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (St3gal2), mRNA [NM_009179] KLA .70 .72 .72 .65 .58 .53 .65
ATP .96 .96 .88 .76 .61 .60 1.17
KLA/ATP .75 .71 .67 .63 .50 .47 .68
St3gal3
KLA  ATP  ATP+KLA
 NM_009176 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (St3gal3), mRNA [NM_009176] KLA 2.87 3.30 2.81 2.78 2.43 1.70 1.08
ATP 1.01 1.10 .89 1.11 .69 .91 .76
KLA/ATP 3.12 3.19 2.25 2.60 1.52 1.00 .98
St3gal4
KLA  ATP  ATP+KLA
 NM_009178 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (St3gal4), mRNA [NM_009178] KLA 1.75 1.88 2.01 2.31 2.72 1.78 .99
ATP .93 .96 1.01 1.14 .93 .92 .70
KLA/ATP 1.61 1.68 1.65 1.72 1.29 1.01 .95
St3gal5
KLA  ATP  ATP+KLA
 NM_011375 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 (St3gal5), transcript variant 2, mRNA [NM_011375] KLA 1.10 1.09 1.17 1.35 1.33 1.52 1.63
ATP .91 .91 1.00 .84 .59 .29 .98
KLA/ATP .97 1.08 1.24 .95 .88 .56 1.54
St3gal6
KLA  ATP  ATP+KLA
 NM_018784 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (St3gal6), mRNA [NM_018784] KLA .95 .89 1.03 1.00 1.09 1.11 .75
ATP .96 .95 1.35 1.11 .88 .47 .44
KLA/ATP .88 .92 1.18 1.06 .98 .87 .71
St6gal1
KLA  ATP  ATP+KLA
 NM_145933 beta galactoside alpha 2,6 sialyltransferase 1 (St6gal1), mRNA [NM_145933] KLA .46 .43 .38 .39 .27 .26 .23
ATP .93 .84 .69 .57 .43 .38 .26
KLA/ATP .46 .41 .40 .39 .35 .41 .32
St6gal2
KLA  ATP  ATP+KLA
 AK129462 mRNA for mKIAA1877 protein [AK129462] KLA 1.03 .98 1.02 .95 1.01 .99 .95
ATP 1.05 .99 1.01 1.03 .96 1.07 .97
KLA/ATP 1.00 .99 .98 1.04 .98 .98 1.04
St6gal2
KLA  ATP  ATP+KLA
 NM_172829 beta galactoside alpha 2,6 sialyltransferase 2 (St6gal2), mRNA [NM_172829] KLA 1.03 1.01 .99 1.10 1.08 1.05 1.00
ATP .95 1.06 1.02 1.07 .99 1.06 1.10
KLA/ATP .94 1.01 1.06 1.08 .99 1.00 1.06
St6galna
c1
KLA  ATP  ATP+KLA
 NM_011371 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (St6galnac1), mRNA [NM_011371] KLA 1.05 .99 1.02 .95 .97 .98 .98
ATP .96 1.02 1.04 .94 1.02 1.02 1.04
KLA/ATP 1.02 1.01 .98 .95 .99 .92 1.01
St6galna
c3
KLA  ATP  ATP+KLA
 NM_011372 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (St6galnac3), mRNA [NM_011372] KLA .99 .99 .97 1.00 1.02 1.02 .97
ATP 1.03 .94 1.01 1.00 .97 1.09 1.03
KLA/ATP .96 .90 .98 1.01 1.00 1.01 .99
St6galna
c4
KLA  ATP  ATP+KLA
 NM_011373 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (St6galnac4), mRNA [NM_011373] KLA 1.26 1.24 1.31 1.41 1.55 1.34 .98
ATP 1.04 1.02 1.00 1.57 4.04 2.62 1.71
KLA/ATP 1.41 1.29 1.17 1.68 3.23 3.18 1.50
St6galna
c5
KLA  ATP  ATP+KLA
 NM_012028 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (St6galnac5), mRNA [NM_012028] KLA 1.03 1.06 1.04 1.01 1.01 .99 1.03
ATP .99 .98 1.04 1.05 1.04 1.05 .98
KLA/ATP .98 .96 1.05 1.04 1.05 1.05 1.02
St6galna
c6
KLA  ATP  ATP+KLA
 AK035447 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530049M17 product:sialytransferase 7 ((alpha-N-acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha-2,6-sialytransferase) F, full insert sequen KLA 1.01 1.04 .90 .95 .98 .92 1.00
ATP .94 .92 .91 1.41 1.24 1.11 1.26
KLA/ATP .91 .95 .99 1.34 1.20 .98 1.19
St6galna
c6
KLA  ATP  ATP+KLA
 NM_016973 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (St6galnac6), transcript variant 1, mRNA [NM_016973] KLA .71 .71 .70 .64 .64 .65 .68
ATP .98 1.01 .88 1.12 1.17 1.09 1.08
KLA/ATP .71 .71 .71 1.05 1.38 .90 1.03
St8sia1
KLA  ATP  ATP+KLA
 NM_011374 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (St8sia1), mRNA [NM_011374] KLA .96 .94 .94 .99 .94 .93 .91
ATP 1.04 .99 1.05 1.02 .95 .93 .86
KLA/ATP .93 .90 .98 .95 .94 .90 .87
St8sia5
KLA  ATP  ATP+KLA
 NM_153124 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 (St8sia5), transcript variant 2, mRNA [NM_153124] KLA 1.25 1.32 1.17 1.33 1.11 1.31 1.81
ATP 1.00 .94 1.28 1.48 2.83 2.97 1.73
KLA/ATP 1.27 1.24 1.49 1.47 2.95 3.30 2.99
St8sia5
KLA  ATP  ATP+KLA
 X98014 gb|M.musculus mRNA for alpha-2,8-sialyltransferase. [X98014] KLA .97 1.08 1.01 .97 1.07 1.06 1.19
ATP 1.00 1.05 1.01 1.04 1.64 1.66 1.25
KLA/ATP .96 .92 1.04 1.10 1.37 1.73 1.60
Stt3a
KLA  ATP  ATP+KLA
 AK030363 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330402C17 product:OLIGOSACCHARYL TRANSFERASE STT3 SUBUNIT HOMOLOG (B5) (INTEGRAL MEMBRANE PROTEIN 1) homolog [Mus musculus], full insert sequence [AK030363] KLA 1.23 1.24 1.18 1.17 1.00 1.05 1.09
ATP .94 .96 1.28 .97 .87 .70 .70
KLA/ATP 1.13 1.24 1.34 .98 .91 .69 .53
Stt3a
KLA  ATP  ATP+KLA
 NM_008408 STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae) (Stt3a), mRNA [NM_008408] KLA 1.21 1.29 1.21 1.07 1.07 .88 1.08
ATP 1.17 1.46 1.01 1.36 .92 .66 .90
KLA/ATP 1.24 1.45 .82 1.29 .62 .60 .62
Stt3b
KLA  ATP  ATP+KLA
 NM_024222 STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae) (Stt3b), mRNA [NM_024222] KLA .99 1.02 .94 .82 .70 .57 .92
ATP 1.11 1.19 .92 1.18 1.01 .82 1.06
KLA/ATP 1.10 1.22 .70 .85 .69 .64 .60
Sucla2
KLA  ATP  ATP+KLA
 AK016060 adult male testis cDNA, RIKEN full-length enriched library, clone:4930547K18 product:unclassifiable, full insert sequence. [AK016060] KLA .92 1.07 .96 1.02 .97 .95 1.02
ATP 1.08 1.02 1.00 1.06 .92 1.01 .94
KLA/ATP .94 1.04 1.04 .96 .94 .94 .90
Sucla2
KLA  ATP  ATP+KLA
 NM_011506 succinate-Coenzyme A ligase, ADP-forming, beta subunit (Sucla2), nuclear gene encoding mitochondrial protein, mRNA [NM_011506] KLA 1.10 1.02 1.00 1.06 .87 .81 .86
ATP .98 .95 1.30 1.02 .93 .69 .72
KLA/ATP .98 1.02 1.35 1.04 1.00 .61 .52
Suclg1
KLA  ATP  ATP+KLA
 NM_019879 succinate-CoA ligase, GDP-forming, alpha subunit (Suclg1), mRNA [NM_019879] KLA .87 .88 .81 .81 .84 .79 .89
ATP 1.14 1.06 1.05 1.06 .87 .41 .81
KLA/ATP .93 .92 .92 .92 .76 .49 .49
Suclg2
KLA  ATP  ATP+KLA
 NM_011507 succinate-Coenzyme A ligase, GDP-forming, beta subunit (Suclg2), mRNA [NM_011507] KLA .99 1.07 1.08 .88 .74 .49 .67
ATP 1.00 1.14 1.15 1.44 .91 .37 .45
KLA/ATP 1.08 1.08 .94 1.18 .65 .40 .35
Synj1
KLA  ATP  ATP+KLA
 AK080946 4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430216F19 product:SYNAPTOJANIN 1 (EC 3.1.3.56) (SYNAPTIC INOSITOL-1,4,5-TRISPHOSPHATE 5- PHOSPHATASE 1) homolog [Rattus norvegicus], full insert sequence. [AK080 KLA 2.98 2.90 3.08 3.32 2.29 1.91 1.44
ATP .88 .86 1.58 1.20 1.53 2.26 1.97
KLA/ATP 2.79 3.22 4.30 2.74 2.82 2.28 2.35
Synj1
KLA  ATP  ATP+KLA
 XM_001481287 gb|PREDICTED: Mus musculus synaptojanin 1 (Synj1), mRNA [XM_001481287] KLA 3.23 3.00 3.78 3.44 2.82 2.78 1.56
ATP .97 .86 1.21 .59 1.04 1.34 1.07
KLA/ATP 3.33 3.04 4.28 1.80 2.61 2.79 1.99
Synj2
KLA  ATP  ATP+KLA
 AK014584 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632417B14 product:synaptojanin 2, full insert sequence. [AK014584] KLA .87 .82 .75 .78 .71 .96 1.05
ATP .95 1.11 1.78 1.18 .95 1.08 1.89
KLA/ATP .68 .74 .89 .83 .73 .73 1.14
Synj2
KLA  ATP  ATP+KLA
 NM_001113353 synaptojanin 2 (Synj2), transcript variant 1, mRNA [NM_001113353] KLA .45 .41 .40 .44 .48 .65 .72
ATP 1.06 1.04 1.10 .99 .60 .76 1.67
KLA/ATP .44 .41 .45 .46 .46 .52 1.15
Synj2
KLA  ATP  ATP+KLA
 NM_011523 synaptojanin 2 (Synj2), transcript variant 3, mRNA [NM_011523] KLA .62 .59 .54 .64 .49 .57 .57
ATP .95 .90 .94 .78 .61 .60 .78
KLA/ATP .56 .59 .63 .56 .56 .68 .59
Taldo1
KLA  ATP  ATP+KLA
 NM_011528 transaldolase 1 (Taldo1), mRNA [NM_011528] KLA .82 .79 .79 .76 .63 .56 .56
ATP .93 .96 1.02 .91 1.13 1.91 2.17
KLA/ATP .77 .80 .86 .75 .94 1.33 1.43
Tat
KLA  ATP  ATP+KLA
 NM_146214 tyrosine aminotransferase (Tat), nuclear gene encoding mitochondrial protein, mRNA [NM_146214] KLA 1.13 1.09 1.19 1.17 1.14 1.19 1.10
ATP .97 1.08 1.12 1.25 1.02 1.16 1.18
KLA/ATP 1.16 1.21 1.27 1.23 1.22 1.11 1.08
Tbxas1
KLA  ATP  ATP+KLA
 AK048544 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130072B09 product:thromboxane A synthase 1, platelet, full insert sequence. [AK048544] KLA .96 .96 1.09 1.03 .96 1.02 .96
ATP 1.02 .96 .99 .97 .94 .95 1.51
KLA/ATP .97 .97 .95 .95 .92 .96 1.30
Tbxas1
KLA  ATP  ATP+KLA
 NM_011539 thromboxane A synthase 1, platelet (Tbxas1), mRNA [NM_011539] KLA .62 .62 .66 .58 .64 .76 .74
ATP 1.12 1.08 .92 .94 .74 .42 .68
KLA/ATP .69 .73 .61 .62 .42 .33 .51
Tcirg1
KLA  ATP  ATP+KLA
 NM_016921 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 (Tcirg1), mRNA [NM_016921] KLA 1.32 1.42 1.49 1.38 1.94 2.26 1.98
ATP 1.01 1.16 .69 .96 1.24 1.32 2.03
KLA/ATP 1.50 1.58 .90 1.29 1.37 2.08 3.28
Tdo2
KLA  ATP  ATP+KLA
 NM_019911 tryptophan 2,3-dioxygenase (Tdo2), mRNA [NM_019911] KLA .99 1.04 1.03 .98 1.08 1.01 1.02
ATP .98 1.01 .99 .98 1.06 1.06 1.04
KLA/ATP 1.06 .95 1.06 1.02 1.02 1.00 .98
Tgds
KLA  ATP  ATP+KLA
 NM_029578 TDP-glucose 4,6-dehydratase (Tgds), mRNA [NM_029578] KLA 1.13 1.09 1.07 1.18 1.27 1.43 1.49
ATP 1.04 1.05 1.20 1.10 .63 1.05 1.46
KLA/ATP 1.06 1.15 1.27 1.18 .83 1.11 1.50
Th
KLA  ATP  ATP+KLA
 NM_009377 tyrosine hydroxylase (Th), mRNA [NM_009377] KLA 1.00 1.01 1.00 1.00 1.00 1.00 1.00
ATP .98 1.01 1.00 1.00 1.00 .99 1.01
KLA/ATP 1.00 1.01 1.01 1.00 1.01 .98 1.02
Tha1
KLA  ATP  ATP+KLA
 NM_027919 threonine aldolase 1 (Tha1), mRNA [NM_027919] KLA 3.92 4.62 4.23 4.99 4.59 2.42 2.04
ATP .98 .92 .78 .74 .78 1.21 1.03
KLA/ATP 4.35 4.64 3.33 2.80 1.63 1.41 1.50
Thtpa
KLA  ATP  ATP+KLA
 NM_153083 thiamine triphosphatase (Thtpa), mRNA [NM_153083] KLA .57 .56 .52 .57 .53 .51 .52
ATP .92 .86 .78 .59 .29 .64 .97
KLA/ATP .52 .49 .43 .39 .30 .39 .55
Tk1
KLA  ATP  ATP+KLA
 NM_009387 thymidine kinase 1 (Tk1), mRNA [NM_009387] KLA .36 .36 .31 .23 .18 .15 .14
ATP 1.04 1.13 .91 1.21 .52 .15 .09
KLA/ATP .39 .35 .29 .35 .22 .14 .11
Tk2
KLA  ATP  ATP+KLA
 NM_021028 thymidine kinase 2, mitochondrial (Tk2), nuclear gene encoding mitochondrial protein, mRNA [NM_021028] KLA .49 .53 .48 .66 .84 1.01 .86
ATP 1.07 1.02 .91 .96 .52 .41 .73
KLA/ATP .51 .48 .44 .46 .44 .56 .75
Tkt
KLA  ATP  ATP+KLA
 NM_009388 transketolase (Tkt), mRNA [NM_009388] KLA .97 1.00 .97 1.00 .90 .86 .90
ATP .99 1.00 1.03 .97 .89 .83 .58
KLA/ATP 1.01 1.00 .97 .91 .80 .76 .51
Tktl1
KLA  ATP  ATP+KLA
 NM_031379 transketolase-like 1 (Tktl1), mRNA [NM_031379] KLA 1.07 1.01 .98 1.03 .97 .99 .93
ATP 1.02 1.02 .98 .91 .99 1.06 .95
KLA/ATP .96 .98 .96 .99 1.05 .99 1.00
Tktl2
KLA  ATP  ATP+KLA
 AK029871 adult male testis cDNA, RIKEN full-length enriched library, clone:4931419A11 product:TRANSKETOLASE (FRAGMENT) homolog [Mus musculus], full insert sequence [AK029871] KLA 1.09 1.03 1.10 .98 1.03 .96 .94
ATP .96 1.05 .99 1.00 .94 1.02 1.02
KLA/ATP .95 .92 1.15 1.06 .99 .93 .98
Tktl2
KLA  ATP  ATP+KLA
 NM_028927 transketolase-like 2 (Tktl2), mRNA [NM_028927] KLA 1.02 .98 .98 .98 1.01 .97 .98
ATP 1.06 1.01 1.01 .99 .93 1.01 1.06
KLA/ATP 1.02 1.03 .98 .99 .96 1.00 .99
Tm7sf2
KLA  ATP  ATP+KLA
 NM_028454 transmembrane 7 superfamily member 2 (Tm7sf2), mRNA [NM_028454] KLA .93 .90 .79 .88 .63 .52 .33
ATP .84 .94 .97 1.03 .76 .60 .51
KLA/ATP .82 .94 .90 .95 .67 .47 .27
Tph1
KLA  ATP  ATP+KLA
 NM_009414 tryptophan hydroxylase 1 (Tph1), mRNA [NM_009414] KLA .99 1.02 1.03 1.03 1.01 1.00 1.03
ATP 1.07 1.04 1.01 1.02 .99 .98 .98
KLA/ATP 1.00 1.07 1.05 1.37 1.20 1.03 .99
Tph2
KLA  ATP  ATP+KLA
 AY090565 neuronal tryptophan hydroxylase (Ntph) mRNA, complete cds [AY090565] KLA 1.01 .98 .98 1.05 .96 .97 1.05
ATP .94 1.04 .95 .93 .97 .91 .95
KLA/ATP 1.06 1.07 .99 .99 1.05 1.06 .98
Tpi1
KLA  ATP  ATP+KLA
 NM_009415 triosephosphate isomerase 1 (Tpi1), mRNA [NM_009415] KLA .70 .79 .73 .61 .66 .67 1.32
ATP 1.04 1.22 .90 1.30 .95 .86 1.24
KLA/ATP .84 .82 .55 .90 .66 .74 1.54
Tpk1
KLA  ATP  ATP+KLA
 NM_013861 thiamine pyrophosphokinase (Tpk1), mRNA [NM_013861] KLA .97 .98 1.02 .93 .78 .75 .72
ATP .98 1.14 1.09 1.10 .75 .44 .66
KLA/ATP .97 1.03 .81 .91 .61 .53 .58
Tpo
KLA  ATP  ATP+KLA
 NM_009417 thyroid peroxidase (Tpo), mRNA [NM_009417] KLA 1.05 1.05 .87 1.01 1.00 1.03 1.04
ATP 1.03 .95 .99 1.02 1.00 1.00 .91
KLA/ATP 1.01 .99 1.01 1.01 .93 .96 .93
Trak2
KLA  ATP  ATP+KLA
 NM_172406 trafficking protein, kinesin binding 2 (Trak2), mRNA [NM_172406] KLA .94 1.01 1.01 .90 .86 .85 .98
ATP 1.05 1.04 1.02 .95 1.07 1.14 1.01
KLA/ATP 1.04 .93 .84 .79 .80 .95 .93
Treh
KLA  ATP  ATP+KLA
 NM_021481 trehalase (brush-border membrane glycoprotein) (Treh), mRNA [NM_021481] KLA .91 1.00 1.05 .95 1.03 1.04 1.09
ATP 1.00 1.05 1.11 1.06 1.07 .97 1.01
KLA/ATP 1.04 .98 .97 1.15 1.13 1.09 1.04
Trit1
KLA  ATP  ATP+KLA
 NM_025873 tRNA isopentenyltransferase 1 (Trit1), mRNA [NM_025873] KLA 1.13 1.23 1.21 1.12 1.05 1.08 1.37
ATP 1.06 1.12 .96 .82 .91 .83 1.07
KLA/ATP 1.20 1.36 1.15 1.00 .84 1.02 1.17
Tst
KLA  ATP  ATP+KLA
 NM_009437 thiosulfate sulfurtransferase, mitochondrial (Tst), nuclear gene encoding mitochondrial protein, mRNA [NM_009437] KLA .85 .91 .84 .85 .76 .80 1.10
ATP 1.01 1.12 1.44 1.34 .90 .98 1.04
KLA/ATP .84 .98 1.14 1.23 .97 .93 .99
Tsta3
KLA  ATP  ATP+KLA
 NM_031201 tissue specific transplantation antigen P35B (Tsta3), mRNA [NM_031201] KLA 1.02 1.05 1.08 1.10 1.15 1.34 1.35
ATP .94 1.05 .99 1.14 .93 .96 1.14
KLA/ATP 1.09 1.11 1.02 1.21 1.08 1.13 1.51
Tusc3
KLA  ATP  ATP+KLA
 BC003311 tumor suppressor candidate 3, mRNA (cDNA clone IMAGE:3154952), complete cds. [BC003311] KLA 1.07 1.13 1.27 1.18 1.14 .99 .91
ATP 1.09 1.02 .96 1.10 .92 .82 1.13
KLA/ATP 1.17 1.25 .97 .96 .73 .71 .91
Tusc3
KLA  ATP  ATP+KLA
 NM_030254 tumor suppressor candidate 3 (Tusc3), mRNA [NM_030254] KLA 1.28 1.26 1.13 1.34 1.18 1.05 .79
ATP .99 .91 1.18 .99 .84 1.14 1.04
KLA/ATP 1.00 1.11 1.42 1.06 .81 .84 .95
Twistnb
KLA  ATP  ATP+KLA
 NM_172253 TWIST neighbor (Twistnb), mRNA [NM_172253] KLA 1.30 1.25 1.07 .87 .82 .80 1.03
ATP 1.10 1.00 .92 .87 1.26 1.07 .94
KLA/ATP 1.29 1.21 1.09 .82 .79 .85 .59
Tymp
KLA  ATP  ATP+KLA
 NM_138302 thymidine phosphorylase (Tymp), mRNA [NM_138302] KLA .41 .42 .37 .39 .51 .66 1.18
ATP 1.04 1.00 .86 1.08 1.04 1.25 1.40
KLA/ATP .46 .43 .34 .49 .56 .79 .64
Tyms
KLA  ATP  ATP+KLA
 NM_021288 thymidylate synthase (Tyms), mRNA [NM_021288] KLA .82 .81 .75 .71 .48 .30 .16
ATP 1.00 .94 1.32 1.26 .91 .52 .18
KLA/ATP .77 .73 1.07 .96 .80 .38 .18
Tyms
KLA  ATP  ATP+KLA
 X14489 gb|M.musculus thymidylate synthase (TS) gene exons 5 - 7. [X14489] KLA .87 .84 .91 .93 .93 .94 .77
ATP .99 .93 .95 .91 .94 .83 .79
KLA/ATP .87 .89 .92 .82 .85 .87 .85
Tyr
KLA  ATP  ATP+KLA
 NM_011661 tyrosinase (Tyr), mRNA [NM_011661] KLA .99 1.02 .99 1.01 1.00 1.01 1.03
ATP 1.01 .98 .99 1.03 1.00 1.01 1.00
KLA/ATP 1.01 1.00 1.00 1.01 1.00 1.03 .98
Tyrp1
KLA  ATP  ATP+KLA
 NM_031202 tyrosinase-related protein 1 (Tyrp1), mRNA [NM_031202] KLA .97 .98 1.01 .99 .99 .98 .97
ATP 1.01 .99 1.00 .97 .99 1.00 .98
KLA/ATP .98 .99 1.01 .98 .98 .97 1.00
Uap1
KLA  ATP  ATP+KLA
 NM_133806 UDP-N-acetylglucosamine pyrophosphorylase 1 (Uap1), mRNA [NM_133806] KLA 1.24 1.12 1.16 .89 .68 .63 .80
ATP 1.23 1.30 1.14 1.56 1.37 .94 .98
KLA/ATP 1.31 1.37 1.08 1.53 .98 .79 .71
Uap1l1
KLA  ATP  ATP+KLA
 BC043307 UDP-N-acteylglucosamine pyrophosphorylase 1-like 1, mRNA (cDNA clone IMAGE:5042946), partial cds [BC043307] KLA .74 .74 .70 .74 .71 .74 .78
ATP .93 .96 1.11 1.38 1.45 1.06 .86
KLA/ATP .76 .72 .71 1.18 1.19 1.01 .65
Uap1l1
KLA  ATP  ATP+KLA
 NM_001033293 UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 (Uap1l1), mRNA [NM_001033293] KLA .72 .78 .76 .62 .76 .63 .92
ATP 1.17 1.36 .78 1.25 .91 .56 1.59
KLA/ATP .90 .92 .45 .84 .49 .45 .80
Uck1
KLA  ATP  ATP+KLA
 NM_011675 uridine-cytidine kinase 1 (Uck1), mRNA [NM_011675] KLA .58 .60 .69 .76 .92 1.21 1.07
ATP .88 .96 .87 .78 .85 1.54 1.20
KLA/ATP .55 .59 .63 .62 .83 1.60 1.58
Uck2
KLA  ATP  ATP+KLA
 BC004016 uridine-cytidine kinase 2, mRNA (cDNA clone IMAGE:3493906), partial cds [BC004016] KLA .64 .62 .54 .44 .28 .23 .17
ATP .89 .94 1.31 1.78 2.23 2.61 .31
KLA/ATP .58 .57 .64 .67 .72 .95 .40
Uck2
KLA  ATP  ATP+KLA
 NM_030724 uridine-cytidine kinase 2 (Uck2), mRNA [NM_030724] KLA .95 .96 .77 .68 .37 .25 .10
ATP .90 .94 1.56 1.98 2.14 5.67 1.10
KLA/ATP .90 .93 1.09 1.15 .95 1.39 1.71
Uckl1
KLA  ATP  ATP+KLA
 NM_026765 uridine-cytidine kinase 1-like 1 (Uckl1), mRNA [NM_026765] KLA .97 .94 .95 1.01 .99 1.20 1.40
ATP .86 .85 .97 .84 .82 .65 1.12
KLA/ATP .89 .85 1.00 .86 .95 .76 1.37
Ugcg
KLA  ATP  ATP+KLA
 BC050828 UDP-glucose ceramide glucosyltransferase, mRNA (cDNA clone MGC:59317 IMAGE:6512920), complete cds [BC050828] KLA 3.14 2.80 2.93 3.01 1.88 1.45 1.73
ATP 1.22 1.28 1.11 1.66 6.31 4.52 1.39
KLA/ATP 3.05 3.59 2.52 3.22 4.86 5.40 2.39
Ugcg
KLA  ATP  ATP+KLA
 NM_011673 UDP-glucose ceramide glucosyltransferase (Ugcg), mRNA [NM_011673] KLA 2.82 2.78 2.92 2.52 1.85 1.64 1.75
ATP 1.04 1.22 1.55 2.42 5.88 4.88 1.65
KLA/ATP 3.05 3.21 3.10 3.92 5.18 5.21 2.64
Ugdh
KLA  ATP  ATP+KLA
 NM_009466 UDP-glucose dehydrogenase (Ugdh), mRNA [NM_009466] KLA 1.04 1.06 .96 .95 1.09 1.54 1.30
ATP .99 1.06 .89 .91 1.31 3.29 1.49
KLA/ATP 1.04 .98 .73 .85 1.38 2.91 1.59
Ugp2
KLA  ATP  ATP+KLA
 NM_139297 UDP-glucose pyrophosphorylase 2 (Ugp2), mRNA [NM_139297] KLA .94 1.01 .95 .96 .88 1.01 1.02
ATP .97 .98 1.03 .92 .94 1.19 .82
KLA/ATP .93 .94 .85 .78 .82 1.20 .96
Ugt1a1
KLA  ATP  ATP+KLA
 NM_201645 UDP glucuronosyltransferase 1 family, polypeptide A1 (Ugt1a1), mRNA [NM_201645] KLA .95 1.07 1.00 .99 .97 .98 1.02
ATP 1.08 .95 1.02 1.04 1.08 1.03 1.01
KLA/ATP 1.02 .95 .93 1.01 1.01 1.11 1.06
Ugt1a6b
KLA  ATP  ATP+KLA
 NM_201410 UDP glucuronosyltransferase 1 family, polypeptide A6B (Ugt1a6b), mRNA [NM_201410] KLA .89 .86 .93 .93 .89 .86 .89
ATP 1.10 1.05 1.15 1.07 1.01 .99 1.24
KLA/ATP .90 .94 1.02 .89 .87 .81 .92
Ugt1a9
KLA  ATP  ATP+KLA
 NM_201644 UDP glucuronosyltransferase 1 family, polypeptide A9 (Ugt1a9), mRNA [NM_201644] KLA 1.07 .96 .98 1.09 1.03 1.06 1.08
ATP 1.04 .94 1.01 1.07 1.05 1.02 1.06
KLA/ATP 1.05 1.00 .94 1.01 1.03 1.04 1.00
Ugt2a1
KLA  ATP  ATP+KLA
 NM_053184 UDP glucuronosyltransferase 2 family, polypeptide A1 (Ugt2a1), mRNA [NM_053184] KLA 1.01 1.03 .99 .99 .99 1.01 1.02
ATP 1.01 .93 1.04 1.03 1.02 1.01 1.03
KLA/ATP 1.04 1.01 1.01 1.02 1.01 1.02 1.00
Ugt2a3
KLA  ATP  ATP+KLA
 NM_028094 UDP glucuronosyltransferase 2 family, polypeptide A3 (Ugt2a3), mRNA [NM_028094] KLA 1.07 1.01 .97 1.05 1.01 .98 .99
ATP .98 .96 1.04 1.06 .95 .94 1.01
KLA/ATP 1.02 1.00 .94 1.02 1.02 1.01 1.06
Ugt2b1
KLA  ATP  ATP+KLA
 NM_152811 UDP glucuronosyltransferase 2 family, polypeptide B1 (Ugt2b1), mRNA [NM_152811] KLA 1.08 1.01 .95 1.08 1.00 1.04 .97
ATP 1.03 1.14 1.01 1.00 1.01 1.05 1.13
KLA/ATP 1.05 .99 1.06 .98 1.03 .96 .98
Ugt2b34
KLA  ATP  ATP+KLA
 NM_153598 UDP glucuronosyltransferase 2 family, polypeptide B34 (Ugt2b34), mRNA [NM_153598] KLA .98 1.08 .99 1.06 .97 1.05 1.03
ATP 1.06 1.04 .96 1.01 1.03 1.01 .99
KLA/ATP 1.09 .94 1.00 1.07 1.01 1.03 .97
Ugt2b35
KLA  ATP  ATP+KLA
 NM_172881 UDP glucuronosyltransferase 2 family, polypeptide B35 (Ugt2b35), mRNA [NM_172881] KLA .99 1.02 .99 1.01 1.00 .96 1.01
ATP .96 1.02 1.02 .96 .93 1.00 1.02
KLA/ATP 1.01 .99 1.04 1.00 .97 .93 .97
Ugt2b36
KLA  ATP  ATP+KLA
 NM_001029867 UDP glucuronosyltransferase 2 family, polypeptide B36 (Ugt2b36), mRNA [NM_001029867] KLA .95 .95 1.00 1.00 1.03 1.02 .92
ATP 1.02 1.07 1.03 .95 1.01 .93 1.00
KLA/ATP .99 1.05 .98 1.04 1.02 .98 .99
Ugt2b37
KLA  ATP  ATP+KLA
 NM_053215 UDP glucuronosyltransferase 2 family, polypeptide B37 (Ugt2b37), mRNA [NM_053215] KLA 1.02 1.06 1.04 1.05 1.00 1.05 1.03
ATP 1.01 1.03 1.08 1.01 1.05 1.02 1.05
KLA/ATP 1.01 .99 1.11 1.14 1.04 1.08 1.05
Ugt2b38
KLA  ATP  ATP+KLA
 NM_133894 UDP glucuronosyltransferase 2 family, polypeptide B38 (Ugt2b38), mRNA [NM_133894] KLA 1.00 .96 1.04 .99 1.10 .97 .99
ATP 1.02 1.04 1.03 .94 .96 .93 .99
KLA/ATP .98 .97 1.00 .97 .98 1.04 1.02
Ugt2b5
KLA  ATP  ATP+KLA
 NM_009467 UDP glucuronosyltransferase 2 family, polypeptide B5 (Ugt2b5), mRNA [NM_009467] KLA 1.01 .99 1.09 .96 .97 .99 1.01
ATP 1.03 1.02 1.02 1.01 .97 .90 .94
KLA/ATP .99 .99 .98 1.05 1.01 .93 .95
Ugt8a
KLA  ATP  ATP+KLA
 NM_011674 UDP galactosyltransferase 8A (Ugt8a), mRNA [NM_011674] KLA 1.02 1.04 1.04 1.00 .98 1.08 1.00
ATP .98 1.02 1.01 1.02 1.00 1.07 1.07
KLA/ATP .98 1.06 1.04 .94 1.02 .99 1.04
Umps
KLA  ATP  ATP+KLA
 NM_009471 uridine monophosphate synthetase (Umps), mRNA [NM_009471] KLA .43 .42 .37 .41 .44 .66 .83
ATP 1.14 1.06 1.07 1.01 .89 .60 1.03
KLA/ATP .44 .44 .46 .45 .60 .56 .79
Uox
KLA  ATP  ATP+KLA
 NM_009474 urate oxidase (Uox), mRNA [NM_009474] KLA .98 .99 1.00 1.00 1.02 1.02 1.01
ATP .99 .98 .98 1.05 1.02 1.01 1.05
KLA/ATP 1.02 1.00 1.02 1.04 1.02 .99 1.02
Upb1
KLA  ATP  ATP+KLA
 NM_133995 ureidopropionase, beta (Upb1), mRNA [NM_133995] KLA 1.22 1.30 1.23 1.20 1.25 1.21 1.15
ATP 1.06 1.13 1.16 1.14 1.01 1.57 1.24
KLA/ATP 1.23 1.24 1.29 1.26 1.18 1.91 2.90
Upp1
KLA  ATP  ATP+KLA
 NM_009477 uridine phosphorylase 1 (Upp1), mRNA [NM_009477] KLA 1.68 1.67 2.20 2.12 1.95 1.34 1.12
ATP .96 1.07 1.02 1.03 1.04 1.25 1.12
KLA/ATP 1.72 1.64 1.49 1.49 1.47 1.44 1.32
Upp2
KLA  ATP  ATP+KLA
 NM_029692 uridine phosphorylase 2 (Upp2), mRNA [NM_029692] KLA 1.01 1.05 1.04 1.05 1.04 1.04 1.01
ATP 1.06 1.00 1.05 1.01 1.00 1.00 1.03
KLA/ATP 1.05 1.02 1.07 1.03 1.05 1.10 1.04
Uqcr
KLA  ATP  ATP+KLA
 NM_025650 ubiquinol-cytochrome c reductase (6.4kD) subunit (Uqcr), mRNA [NM_025650] KLA .88 .78 .82 .91 .72 .69 .63
ATP 1.13 1.03 1.18 1.31 1.15 1.02 .78
KLA/ATP .92 .91 1.05 1.08 1.03 .85 .61
Uqcrb
KLA  ATP  ATP+KLA
 NM_026219 ubiquinol-cytochrome c reductase binding protein (Uqcrb), nuclear gene encoding mitochondrial protein, mRNA [NM_026219] KLA 1.06 .95 .99 1.09 1.01 1.11 .98
ATP 1.08 .97 1.35 1.07 1.19 1.14 .99
KLA/ATP 1.05 .98 1.49 1.22 1.30 1.24 .92
Uqcrc1
KLA  ATP  ATP+KLA
 NM_025407 ubiquinol-cytochrome c reductase core protein 1 (Uqcrc1), mRNA [NM_025407] KLA .90 .96 .94 .90 .89 .85 .92
ATP .97 1.06 .95 1.10 .92 .73 .89
KLA/ATP .94 .99 .89 1.01 .85 .78 .73
Uqcrc2
KLA  ATP  ATP+KLA
 NM_025899 ubiquinol cytochrome c reductase core protein 2 (Uqcrc2), mRNA [NM_025899] KLA 1.00 1.08 1.05 1.10 1.03 1.08 1.06
ATP .91 .89 1.17 .95 .96 .88 .97
KLA/ATP .95 .96 1.26 1.00 1.07 .97 .92
Uqcrfs1
KLA  ATP  ATP+KLA
 NM_025710 ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (Uqcrfs1), mRNA [NM_025710] KLA 1.21 1.17 1.22 1.37 1.08 .92 .87
ATP .91 .87 1.28 1.14 .97 1.00 .82
KLA/ATP 1.04 1.07 1.52 1.35 1.17 .91 .77
Uqcrh
KLA  ATP  ATP+KLA
 NM_025641 ubiquinol-cytochrome c reductase hinge protein (Uqcrh), mRNA [NM_025641] KLA .94 1.04 1.09 1.06 .95 .94 .90
ATP .95 .90 1.19 1.06 1.10 1.18 .86
KLA/ATP 1.02 1.01 1.34 1.19 1.36 1.28 .90
Uqcrq
KLA  ATP  ATP+KLA
 AK017907 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830407L17 product:Ubiquinol-cytochrome c reductase binding protein, full insert sequence. [AK017907] KLA .95 .93 .98 1.02 1.07 1.14 1.21
ATP .73 .82 .80 .99 1.08 .96 1.08
KLA/ATP .81 .86 .85 .97 .94 1.02 .98
Uqcrq
KLA  ATP  ATP+KLA
 NM_025352 ubiquinol-cytochrome c reductase, complex III subunit VII (Uqcrq), nuclear gene encoding mitochondrial protein, mRNA [NM_025352] KLA .97 .92 .86 .94 .89 1.02 1.25
ATP .90 .84 1.11 1.04 1.07 1.00 .97
KLA/ATP .83 .87 1.15 1.01 1.14 1.06 .89
Uroc1
KLA  ATP  ATP+KLA
 NM_144940 urocanase domain containing 1 (Uroc1), mRNA [NM_144940] KLA .98 .97 .93 .99 1.01 .97 .99
ATP .94 .94 1.07 1.08 1.03 .99 .99
KLA/ATP .88 .97 1.00 1.02 1.00 .93 1.00
Urod
KLA  ATP  ATP+KLA
 NM_009478 uroporphyrinogen decarboxylase (Urod), mRNA [NM_009478] KLA .78 .85 .76 .71 .60 .53 .61
ATP .99 .94 1.19 1.13 .99 .97 1.27
KLA/ATP .83 .89 1.02 .99 .97 .85 1.00
Uros
KLA  ATP  ATP+KLA
 NM_009479 uroporphyrinogen III synthase (Uros), mRNA [NM_009479] KLA 1.00 1.01 .98 .92 1.01 1.30 1.36
ATP .98 .95 .95 .95 .69 .70 1.51
KLA/ATP .95 .99 .91 .90 .82 .86 1.32
Wbscr17
KLA  ATP  ATP+KLA
 NM_145218 Williams-Beuren syndrome chromosome region 17 homolog (human) (Wbscr17), mRNA [NM_145218] KLA .97 1.01 .99 .98 1.06 1.01 1.03
ATP 1.05 .95 1.01 1.08 1.01 1.05 1.01
KLA/ATP 1.04 1.00 .98 1.00 1.02 1.03 1.01
Xdh
KLA  ATP  ATP+KLA
 NM_011723 xanthine dehydrogenase (Xdh), mRNA [NM_011723] KLA 1.82 1.90 2.33 2.06 2.49 2.56 1.77
ATP 1.02 1.15 .98 1.10 1.06 1.02 1.42
KLA/ATP 2.00 2.00 2.02 2.11 1.27 1.56 1.92
Xylb
KLA  ATP  ATP+KLA
 BC026406 xylulokinase homolog (H. influenzae), mRNA (cDNA clone IMAGE:4211747), partial cds. [BC026406] KLA .73 .71 .74 .69 .65 .60 .85
ATP .99 .99 1.00 1.04 .80 .73 .99
KLA/ATP .68 .75 .77 .91 .91 .78 .63
Xylb
KLA  ATP  ATP+KLA
 NM_001033209 xylulokinase homolog (H. influenzae) (Xylb), mRNA [NM_001033209] KLA .68 .61 .65 .60 .48 .48 .68
ATP 1.08 .93 1.29 1.02 .83 .72 .97
KLA/ATP .66 .61 .87 .82 1.07 .66 .57
Xylt1
KLA  ATP  ATP+KLA
 AJ539164 mRNA for xylosyltransferase I (Xylt1 gene) [AJ539164] KLA 1.45 1.45 1.17 1.46 1.28 1.39 1.06
ATP 1.02 1.09 1.29 1.22 1.25 1.39 1.12
KLA/ATP 1.37 1.48 1.52 1.66 1.35 1.52 1.31
Xylt2
KLA  ATP  ATP+KLA
 NM_145828 xylosyltransferase II (Xylt2), mRNA [NM_145828] KLA .81 .84 .84 .92 1.54 2.09 2.23
ATP 1.11 1.13 .82 .75 .48 .65 2.19
KLA/ATP .90 .90 .65 .63 .45 .68 3.07
Znrd1
KLA  ATP  ATP+KLA
 NM_023162 zinc ribbon domain containing, 1 (Znrd1), mRNA [NM_023162] KLA 1.04 1.12 1.28 1.43 1.67 1.76 1.39
ATP 1.01 1.08 1.13 1.34 .81 1.14 1.30
KLA/ATP 1.00 1.16 1.22 1.53 1.21 1.74 1.97